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ABSTRACT 
Antibodies have important clinical applications in the diagnosis, management and treatment 
of diseases, as well as research uses. Many therapeutic antibodies are currently under 
development and a variety of systems have been investigated for their production. In 1989, 
transgenic plants were introduced as a new expression system for recombinant antibodies, 
with many potential advantages. In this thesis, some of the most important characteristics of 
plants have been examined, in order to understand the mechanisms and pathways of 
antibody production in plant cells. The findings have stimulated further investigations to 
determine the capacity of plants for expression of complex proteins. 
Immunoglobulins are multimeric proteins with complex folding and assembly 
requirements. As newly translated polypeptides enter the endomembrane system of the cell, 
they interact with a series of molecular chaperones that control and facilitate these 
processes. The role of the plant HSP70 BiP homologue in this early process is 
demonstrated, mirroring the mechanism that takes place in mammalian cells. Within the 
endoplasmic reticulum and continuing in the Golgi apparatus, the assembled proteins 
undergo N-glycosylation, resulting in complex glycan structures attached to the amino acid 
backbone. This process was also demonstrated to occur in transgenic plants, with glycans 
attached to the same N-linked glycosylation sites used in mammalian cells. 
In mammalian B and plasma cells, immunoglobulins are produced in secreted and 
membrane associated forms. In plants cells, IgG is normally secreted, but it was also 
demonstrated that the mammalian transmembrane sequence could be used to target and 
retain immunoglobulin heavy chain and fully assembled IgG in the plant cell membrane. 
Moreover, these findings were extended to a second and different type of membrane 
protein, CCR-5 a seven transmembrane chemokine receptor. 
Overall, these findings serve to demonstrate the similarities between the plant and 
mammalian secretory pathways and provide a rationale for the efficient production of 
antibodies in plants. This was exemplified by the successful assembly and expression of a 
secretory antibody in plants. By co-expression of four transgenes, a decameric molecular 
complex was assembled in plants at levels of expression of up to 8% of total soluble 
protein. These findings open the way to more widespread use of transgenic plants for 
expressing antibodies, particularly for applications such as passive immunisation for 
infectious diseases or cancer. 
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INTRODUCTION 
It is more than a decade since the production of antibody was first described in transgenic 
plants (Hiatt et al., 1989). However relatively little is still known about the plant 
intracellular mechanisms of protein folding and assembly that make this possible. Targeting 
expression of the recombinant molecules to the endomembrane system and secretory 
pathway of plant cells appears to be essential, and this is also the intracellular pathway for 
antibody synthesis in mammalian cells. Using recombinant antibodies as model proteins we 
have investigated the plant secretory pathway at a number of levels; by studying the 
interactions between immunoglobulin chains and endoplasmic reticulum (ER)-resident 
chaperones, determining whether immunoglobulins are correctly assembled, analysis of 
glycosylation, and by examining the default pathway of secretion. The findings allow us to 
explore further the potential of plants to express more complex proteins, namely membrane 
proteins and a monoclonal secretory IgA (SIgA) molecule. 
SPECIFIC OBJECTIVES OF THE STUDY 
1) Analysis of immunoglobulin assembly in plant cells and the role of ER-resident 
chaperones. 
2) Purification of plant recombinant immunoglobulins for preliminary analysis of 
glycosylation. 
3) Investigation of the targeting of mammalian proteins to the plant cell membrane, 
and to determine if functional proteins could be assembled and retained at this site. 
4) Generation of a recombinant SIgA in plants. 
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CHAPTER 1: LITERATURE REVIEW 
1. Monoclonal antibodies 
The discovery of monoclonal antibodies (MAbs) (Kohler & Milstein, 1975) and their 
subsequent applications have revolutionised biological research. MAbs were initially used 
largely to study the size of the antibody repertoire and to examine the importance of 
somatic mutation in the generation of antibody diversity (Secher et al., 1977). However 
because of some of their unique properties, such as specificity and purity, it soon became 
clear that they could be put to in vitro analytical and diagnostic purposes, and ultimately 
therapeutic uses. 
Over 25 000 MAbs are currently commercially available, the majority of which have been 
generated in small amounts for laboratory-related research. Some MAbs have become 
commercially successful for the diagnosis and treatment of disease, and these may need to 
be produced on a larger scale. Currently, almost a quarter of all biotech drugs in 
development are MAbs, whilst licensed products are available to treat for example; 
alloimmune (e. g. OKT3) [Cosimi, 1983] and autoimmune (e. g. Infliximab) [Lipsky et al., 
1999] conditions, and for anti-tumour (e. g. Herceptin) [Baselga et al., 1996], anti-platelet 
(e. g. Abciximab) [Hamm et al., 1999], or anti-viral (e. g. Palivizumab) [Piedimonte et al., 
2000] activity (reviewed by Breedveld, 2000). 
Advances in antibody engineering have also increased the potential number of applications 
for recombinant antibodies. Novel antibody-related proteins with desirable characteristics, 
such as molecules with reduced size or antibodies fused to enzymes, biological response 
modifiers or toxins can now be generated (Bookman, 1998; Shin et al., 1993). In addition, 
the combination of phage display techniques and protein engineering technology has made 
it possible to isolate and express recombinant antibodies specific for almost any target 
antigen (McCafferty et al., 1990; Winter et al., 1994). 
Although mammalian cells and bacterial expression systems are the most established 
methods for production, yeast and recombinant baculovirus-infected insect cell systems 
have also been used, although at present their applications appear to be more limited. 
Another means of generating recombinant proteins such as antibodies is by the use of 
transgenic animals, but this approach has disadvantages, and is sometimes restricted by 
legal and ethical opinion. 
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In the last fifteen years several groups have demonstrated that transgenic plants are an 
alternative system for expressing not only full-length antibodies (Hiatt et al., 1989; 
Ma et al., 1994), but also small antibody fragments (Benvenuto et al., 1991) at relatively 
high levels. Further refinements in plant biotechnology may make it possible to grow novel 
immunotherapeutic reagents on an agricultural scale, reducing production costs 
significantly at the same time. 
1.1 ANTIBODY STRUCTURE 
Structure of IgG and IgA 
A fully assembled IgG molecule comprises two heavy (H) and two light (L) polypeptide 
chains (HHLL), whose structure is maintained by non-covalent forces and by covalent 
intra- and inter-chain disulphide bonds between cysteine residues (Figure 1). The heavy and 
light chains are composed of variable and constant domains, which are structurally distinct 
and vary in their primary sequence. These domains are formed by the intra-chain disulphide 
links and consist of approximately 110 amino acids. The antigen-binding site is formed by 
the variable regions of the light and heavy chain, where it comprises a groove or cleft. The 
variable domains of both chains contain areas of hyper-variability that constitute the 
complementarity-determining regions (CDRs) and these form the predominant interactions 
with antigens (Jirholt et al., 2001; Mian et al., 1991). The domains in the carboxyl-terminus 
are relatively constant, and form the constant region (Fc), CL on the light chain and CHI, 
CH2 and CH3 on the heavy chain. In some antibody classes, for example IgM and IgG, this 
region of the heavy chain mediates the effector functions of phagocyte opsonisation and 
complement activation. 
The heavy chains in the effector region are dimerised by two disulphide bonds, which 
create a hinge region. As shown in Figure 1, at the hinge region, the light chains are joined 
to the heavy chains by another disulphide bond. There are also many intramolecular 
disulphide bonds between amino acid residues within the light and heavy chains, as well as 
these described intermolecular disulphide bonds (reviewed by Rudd et al., 1991). 
The CHI and CH2 regions are joined by a flexible hinge region, whilst the CH2 and CH3 
domains consist of hydrophobic patches that form an accessible surface, or mini-hinge 
flexible region. Both these hinge regions are susceptible to attack by proteases, such as 
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Figure 1. Schematic representation of an IgG molecule. 
Each class of immunoglobulin has a characteristic type of heavy chain (a, S, y, c and µ), 
and variations in the heavy chain amino acid sequence give rise to subclasses. Mammalian 
immunoglobulin a heavy chain consists of three constant-region domains (Ca 1, Cat, CO) 
[Hunkapiller & Hood, 1989]. In humans and rabbits, multiple a-chain isotypes have been 
identified (Spieker-Polet et al., 1993), whereas in all other species only one IgA isotype is 
found. Two subclasses of IgA have been described in humans, IgAl and IgA2. The major 
structural difference between these two subclasses lie in the hinge region, where the IgA2 
molecule lacks a 16-amino acid sequence (Kawamura et al., 1992), and in their 
carbohydrate composition (Wold el al., 1995). The 16 amino acid sequence in IgAl makes 
this molecule susceptible to bacterial IgA proteases, whereas IgA2 is resistant 





tail-piece at its C-terminus which associates with J chain during the synthesis of IgA 
(Corthesy & Kraehenbuhl, 1999). 
Structure of secretory IgA 
SIgA is a decameric polypeptide complex (Figure 2), consisting of two monomeric IgA 
molecules and two additional polypeptide chains, aJ chain and secretory component (SC). 
The two monomeric IgA molecules (Mr 160 000 each) are dimerised by a glycoprotein 
called J chain in a tail to tail conformation to form dimeric IgA, held by a disulphide bond 
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Figure 2. Schematic representation of secretory IgA. 
J chain is an acidic M1 15 000 polypeptide, found in polymeric immunoglobulins in 
covalent association with dimeric IgA and pentameric IgM molecules (Koshland, 1985). 
J chain is disulphide-bonded to two monomeric a heavy chains in human IgA, and can 
cause structural constraints in the Fc regions of polymeric immunoglobulins, determining a 
partial SC-binding site (Garcia-Pardo et al., 1981). 
The poly immunoglobulin receptor (plgR) is comprised of five extracellular domains, 
comprising 110-120 amino acid residues that share homology with immunoglobulin 
domain sequences, a 23 amino acid membrane-spanning portion, and a cytoplasmic tail of 
about 100 amino acids (Mostov et al., 1984). SC (M, 80 000) represents the extracellular 
portion of the pIgR receptor. Human, rat, mouse, rabbit and bovine SC share extensive 
homology, especially in the first domain and in the cytoplasmic tail (Corthesy & 
Kraehenbuhl, 1999). 
Rabbits have two pIgR primary translation products, as they also express a spliced version 
of the plgR that lacks domains 2 and 3, but is fully competent for transport (Deitcher & 
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Mostov, 1986) and generates SC non-covalently bound to IgA (Frutiger et al., 1987). This 
indicates that the information required for trafficking of the pIgR in epithelial cells resides 
within its cytoplasmic tail. In human SIgA, amino acids 14 - 38 in the N-terminus domain 1 
of SC constitute the IgA binding epitope (Bakos et al., 1991), and a cysteine residue at 
amino acid position 467 in the distal fifth domain is involved in disulphide bridge 
formation with Cys31 1 of one Ca2 domain of dimeric IgA. 
The initial binding of SC to dimeric IgA in vitro is non-covalent, and subsequently inter- 
chain disulphide bridges are formed (Garcia-Pardo et al., 1981). The three-dimensional 
structure of SC has not yet been fully determined. A 14 residue segment of the 103 amino 
acid cytoplasmic domain of SC has been shown to direct the pIgR to the basolateral surface 
(Casanova et al., 1991). The SC is cleaved during transport or at the apical surface, and is 
either released free or bound to dimeric IgA (Mostov et al., 1984) to form a SIgA antibody 
(M, 390 000) (Mestecky & McGhee, 1987) [Figure 3]. 
The association of SC to the IgA molecule has been shown to confer resistance to 
proteolytic enzymes such as; Pronase, papain, trypsin, and pepsin (Underdown & 
Dorrington, 1974; Lindh, 1975). SIgA in duodenal secretions was shown to be more 
resistant than monomeric IgA to the action of proteases (Brown et al., 1970). Furthermore, 
carbohydrate residues present in SC have been shown to anchor SIgA to mucus lining the 
epithelial surface (Phalipon et al., 2002), an important role in SIgA-mediated immune 
exclusion in vivo. 
1.2 GLYCOSYLATION OF IMMUNOGLOBULINS 
A number of quality control mechanisms ensure that newly synthesised proteins attain their 
folded functional form. One important strategy is the covalent attachment of 
oligosaccharides to asparagine residues of nascent polypeptides, a process known as 
N-linked glycosylation. Thus, in the endoplasmic reticulum (ER) and the early secretory 
pathway, glycans play a crucial role in protein folding, oligomerisation, quality control, 
sorting and transport (Helenius & Aebi, 2001). The addition of oligosaccharides is 
beneficial during maturation as it makes folding intermediates more soluble (Rudd & 
Dwek, 1998). In addition, it permits some newly synthesised polypeptides to bind to the 
intracellular chaperones calreticulin and calnexin, which also play an important role in 
protein folding and quality control (reviewed by Helenius et al., 1997). 
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The N-linked glycosylation of recombinant antibodies is an important step towards the 
production of fully functional immunoglobulins in any expression system. Whilst the 
N-linked glycosylation mechanism is conserved in mammalian and plant systems, there are 
differences in the fine details of oligosaccharide trimming and further modification of 
glycans in the Golgi apparatus (Driouich et al., 1993). 
The N-glycosylation process 
N-linked oligosaccharides arise when blocks of 14 sugars are added to newly synthesised 
polypeptides in the ER. The N-linked glycans are attached to the side chain of asparagine 
residues in the consensus sequence Asn-X-Ser/Thr. The initial carbohydrate structure that is 
attached to nascent polypeptides contains two N-acetyl-glucosamine residues, nine 
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Figure 4. Initial N-linked oligosaccharide structures added to polypeptides in the ER. 
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Processing of N-linked glycans occurs along the secretory pathway as the glycoprotein 
travels from the ER to the Golgi apparatus towards its final destination. (Kornfeld & 
Kornfeld, 1985). Glycosidases and glucosyltransferases in the Golgi apparatus successively 
modify the oligosaccharide precursor to high-mannose type N-glycans, and then into 
complex type N-glycans. 
Glycosylation in plants differs from that found in mammalian cells, although the high- 
mannose type N-glycans in plants have structures identical to those present in other 
eukaryotic cells. However plant complex N-linked glycans differ substantially (Driouich et 
al., 1993). For instance, plants do not incorporate sialic acid, and their complex glycans are 
characterised by aß1,2-xylose residue linked to the ß-mannose and an a1,3-fucose residue 
linked to the proximal glucosamine (Lerouge et al., 1998). Larger, complex-type plant 
N-glycans are rare, but have been identified as additional 1,4-fucose and 1,3-galactose 
residues (for structures see Published Papers, Lerouge et al, 1998 - page 369). It has been 
proposed that the presence of either xylose or fucose residues might make recombinant 
plant therapeutic proteins more immunogenic and therefore less desirable (Faye et al., 
1993). 
Glycosylation of IgG 
Generally, there is one conserved N-glycosylation site per heavy chain of IgG in the CH2 
domain of the Fc region (Rademacher et at, 1986). In addition approximately 30 % of 
serum IgG (Parekh et al., 1985) molecules contain sugars in the variable regions of the Fab. 
In each class of immunoglobulin, the conserved N-glycosylation sites on the heavy chain 
domains (CH1, CH2 and /or CH3) are situated in different positions (Rudd & Dwek, 1997). 
It does not seem to be a requirement of immunoglobulin domains to contain a particular 
sugar at a particular site. However, the specific location of the sugar can influence the 
subsequent processing of glycans (reviewed by Rudd & Dwek, 1998). N-glycosylation of 
the Fc contributes to the structural stability of the immunoglobulin. Crystallographic 
studies of human Fc in IgG have revealed that, unlike other immunoglobulin domains, the 
two CH2 domains do not form extensive lateral associations (Deisenhofer, 1981). The 
resulting interstitial region accommodates the oligosaccharides, attached to Asn 297 on each 
heavy chain, so that the carbohydrates create a bridge across the domains (Parekh et 
at., 1985). In IgG Fc, the hinge disulphide bond at Cys 229 may provide a rationale for the 
large interstitial space between the two CH2 domains. Non-covalent interactions between 
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the glycans and the Fc are also believed to help maintain the relative geometry of the CH2 
domains (reviewed by Rudd et al., 1991). 
Glycosylation of secretory IgA 
The glycosylation pattern of SIgA is both complex and highly heterogenous (Endo et al., 
1994). The relative conformation of the two CH2 domains of the IgAl molecule is 
maintained by two inter-chain disulphide bonds at Cys 238 and Cys 239 (Mattu et al., 1998). 
As the interstitial space is non-existent, larger sugars are fully exposed on the outside of the 
IgAl molecule. Subsequently, nearly 90 % of IgAl N-linked sugars are sialylated 
compared with just 15 % on IgG, which are found mainly on the more accessible sugars in 
the Fab' region (Wormald et al., 1997). 
An analysis of both the N- and O-glycans on the individual peptides from SIgA has 
recently been presented (Royle et al., 2003). The IgAl hinge region contains five O-linked 
glycans, that are recognised by the lectin jacalin, and which contribute to flexibility 
between Fc and F(ab)2 fragments (Roque-Barreira & Campos-Neto, 1985). The tail-pieces 
of IgA (atp) and IgM (µtp) both contain an N-linked glycosylation site, the presence of 
which is required for dimer formation in IgA (Atkin et al., 1996). The N-linked 
carbohydrates present on both J chains and the a and p. tail-pieces play a role in 
polymerisation (Yoo et al., 1999). The carbohydrate in µtp has been found to be required 
for the incorporation of J chain (Wiersma et al., 1997). The N-glycan on the atp of IgAl is 
mostly a triantennary complex oligosaccharide (Mattu et al., 1998), whereas IgM has a high 
mannose oligosaccharide carbohydrate in the tail-piece (Wormald et al., 1991). 
Human SC purified from milk is heavily glycosylated with between 5 and 7 N-linked sugar 
side chains that comprise more than 20 % of its molecular mass (Mizoguchi et al., 1982). 
Glycosylation and protein folding 
Early investigations using tunicamycin, an inhibitor of glycosylation, showed that when 
N-glycan addition to proteins is blocked, most non-glycosylated forms of the proteins 
accumulate and are retained in the ER as aggregates (Olden et al., 1982). This led to the 
concept that glycosylation assists protein folding by stabilising the conformation of the 
protein. In particular, the removal of glucose from the core N-linked glycans appears to 
indicate to the sorting apparatus in the luminal compartments, that the protein component is 
correctly folded (Hammond et al., 1994; Fiedler & Simmons, 1995). These sorting steps are 
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now known to be mediated by the intracellular lectin-like chaperones calreticulin and 
calnexin, which specifically associate with monoglucosylated core glycans (reviewed by 
Helenius et al., 1997). 
The lectin interactions of calreticulin and calnexin detain monoglucosylated proteins in the 
ER until they are correctly folded; this is made possible by a cycle of glucosidase II action 
and reglucosylation by a lumenal UDP-glucose: glycoprotein glucosyltransferase, which 
produces the monoglucosylated form (Hebert et al., 1995). This is an elegant system, as the 
glucosyltransferase acts preferentially on unfolded proteins (Sousa et al., 1992), and once 
the folding process is over, the deglucosylated protein can leave the ER. 
Function of Ig glycans 
Glycosylation in antibody constant regions is important in stabilising antibody 
conformation and structure, in modifying the activity of effector functions, shielding the 
protein surface from proteases, and may also provide specific epitopes for recognition 
events (reviewed by Rudd & Dwek, 1998). This is despite the fact that the carbohydrate 
content of each isotype varies significantly (Torano et al., 1977). Furthermore, 
phagocytosis, antigen-dependent cellular cytotoxicity, and the clearance and placental 
transfer of MAbs may be influenced by their glycosylation (Jefferis et al., 1998). 
Non-glycosylated IgG, expressed in tunicamycin-treated cells, was shown to be more 
susceptible to cleavage by papain than normal IgG, indicating that the conserved glycans in 
the Fc provide protection against proteolysis (Leatherbarrow & Dwek, 1984). 
The presence of carbohydrate in the CH2 domain of IgG is also required for Fc-mediated 
functions, such as complement activation and the engagement through Fc receptor binding 
of phagocytic cells (Nose & Wigzell, 1983; Tao & Morrison, 1989). Both non-glycosylated 
and degalactosylated IgG bind less efficiently to the Fcy receptor (Nose & Wigzell, 1983). 
Aglycosyl IgG also demonstrates a loss of binding capacity to monocyte Fc receptors 
(Wright & Morrison, 1997). 
In human IgAl, the effects of site-directed mutagenesis of the conserved N-linked 
glycosylation sites in the C112 region and secreted tail-piece has been studied in CHO 
(Chinese hamster ovary) cell lines to investigate their role in the structure and function of 
human IgAl (Chuang & Morrison, 1997). The mutants showed a reduced affinity for their 
target antigen compared to wild-type IgA. Deletion of the carbohydrate had no effect on 
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the secretion of the antibody, with production of both monomeric and polymeric forms. 
This result differs significantly from that seen with murine IgA, in which the elimination of 
one or both of the N-linked glycosylation sites in the murine IgA C112 region resulted in a 
95 % inhibition of secretion, as well as intracellular degradation of IgA protein (Taylor & 
Wall, 1988). The lack of the tail-piece carbohydrate increased the percentage of IgA 
present as polymers larger than dimers (Chuang & Morrison, 1997). In an earlier study, a 
lack of dimer formation was seen for IgAl lacking the tail-piece carbohydrate, although 
this may have been accounted for by the low endogenous J chain production (Atkin et al., 
1996). 
The effect of glycosylation on antigen binding has also been investigated (Donadel et al., 
1994). Cell lines making human monoclonal IgG, IgA and IgM were treated with 
tunicamycin to block N-linked glycosylation of the proteins. The native and 
non-glycosylated antibodies were then examined for their ability to bind different antigens. 
However in this case the absence of glycosylation did not result in the loss of antigen 
binding activity (Donadel et al., 1994). 
2. Immunoglobulin assembly 
Immunoglobulins are normally synthesised by B cells and plasma cells. The 
immunoglobulin heavy (H) and light (L) chains are synthesised separately with N-terminal 
signal sequences. The signal sequences co-translationally direct the translocation of the 
nascent proteins to the lumen of the ER, where the signal sequences are cleaved by a signal 
peptidase (Von Heijne, 1984). Folding of both H and L chains occurs independently, and 
begins co-translationally (Bergman & Kuehl, 1979). The order of assembly for IgG 
molecules varies according to the isotype; for murine IgGI the order is H, HH, HEIL, then 
HULL, although for IgG2b and IgM the order is H, HL, HHLL (Percy et al., 1976). 
Disulphide bonds are formed with the assistance of the foldase enzyme protein disulphide 
isomerase (PDI) (Noiva & Lennarz, 1992), and a number of chaperones, such as the 
binding protein (BiP), calreticulin and glucose regulated protein 94 (GRP94) contribute 
towards the folding and assembly of immunoglobulins in the ER. 
The assembly of dimeric IgA is initiated with the formation of H2L2 monomer units 
through a pathway in which H+L -* HL -+ H2L2 (Chintalacharuvu et al., 1994). 
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A conserved penultimate cysteine residue of the IgA tail-piece is involved in 
polymerisation (Wiersma et al., 1997). The cysteine residue in the tail-piece of one chain 
forms a disulphide bond with J chain, which in turn forms a disulphide bond with the chain 
of a second monomeric sub-unit (Atkin et al., 1996). However the tail-pieces alone do not 
determine the extent of polymerisation, as structural motifs in the constant region domains 
are also critical for polymer assembly and J chain incorporation (Yoo et al., 1999; Sorensen 
et al., 2000). 
Dimerisation of IgA monomers by J chain occurs in mucosal plasma cells. Although all 
antibody-secreting cells produce J chain, it is incorporated only into polymeric 
immunoglobulins. This polymerisation not only increases the avidity of immunoglobulins 
for antigen, but it can also enhance effector functions such as complement activation and 
binding to Fc receptors in IgM (Smith & Morrison, 1994). In mammals, the J chain is 
added in plasma cells just prior to secretion (Parkhouse & Della Corte, 1973), and is 
essential for the production of SIgA, as J chain-deficient IgA present in secretions does not 
associate with SC (Brandtzaeg & Prydz, 1984). 
The synthesis of SIgA requires a plasma cell secreting dimeric IgA (dIgA) as well as 
epithelial cells expressing the polymeric Ig receptor (pIgR). Normally, dIgA is transported 
across the epithelial barrier by the pIgR which is expressed at the basolateral surface of a 
variety of epithelial cells (Brandtzaeg, 1994). Following binding to the receptor, the 
receptor-ligand complex is internalised and transcytosed (Schaerer et al., 1991), resulting in 
the release of the SIgA complex at the apical surface into the secretion (Mostov, 1994) - 
see Figure 5. 
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Steps: 1. Production 2. Binding to 3. Transport 4. Secretion 
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Schematic of secretory IgA assembly in mammalian cells. 
"The role of chaperones in the endoplasmic reticulum 
The ER is responsible for the folding and quality control of secretory and membrane 
proteins. Protein folding has been described as the process by which the linear information 
contained in the amino-acid sequence of a polypeptide gives rise to the well-defined three- 
dimensional conformation of the functional protein" (Hard, 1996). Although newly 
synthesised proteins enter the ER in an unfolded conformation they depart fully folded 
(Gething & Sambrook, 1992). This process is not spontaneous, but is dependent on a set of 
conserved ER-resident proteins known as molecular chaperones, foldases or 
reticuloplasmins (reviewed by Hendrick & 1tartl, 1993). 
The ER differs from other cellular compartments, such as the cytosol or mitochondria, in 
several important respects. The lumen of the ER is an oxidising environment and is 
buffered by glutathione - which facilitates the formation of disulphide bonds (Hwang et a!., 
1992) - and the ER lumen is the main cellular Ca 2 reservoir (Meldolesi & Poznan, 1998). 
However whilst the complex and dense protein concentration in the ER lumen, estimated at 
more than 100 mg/ml, tends to promote aggregation and malfolding (Hartl, 1996), these are 
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the surroundings in which a battery of ER-resident chaperones control protein folding and 
perform the role of quality control. 
One of the most important characteristics of ER-resident chaperones is their ability to bind 
to nascent substrates. Chaperones can transiently stabilise the unfolded state until either the 
correct folding or transport to a different cellular compartment is achieved (Zimmermann et 
al., 1988; Cheng et al., 1989; Goloubinoff et al., 1989). Chaperones may also prevent the 
aggregation of malfolded proteins under normal and stress conditions (Pelham, 1986). If the 
correct conformation cannot be obtained, chaperones can target the aberrant protein for 
degradation, thus efficiently removing it from the secretory pathway (Klausner & Sitia, 
1990). 
Whereas chaperones may increase the yield but not the rate of folding reactions, the 
foldases are enzymes whose catalytic activity may actually increase the rate of protein 
folding (Gilbert, 1994). The most important chaperones and foldases with respect to 
immunoglobulin folding and assembly that have been identified in mammals are; the 
binding protein (BiP) [Haas & Wabl, 19831, glucose regulated protein (GRP94) [Melnick et 
al., 1992], calreticulin (Sonnichsen et al., 1994), calnexin (Bergeron et al., 1994), and 
protein disulphide isomerase (PDI) [Freedman et al., 1994]. Homologues for all the 
ER-resident chaperones have been identified in higher plants (reviewed by Boston et al., 
1996) and there appears to be a high degree of conservation between these molecules in 
plants, yeast and mammals (Mogelsvang & Simpson, 1998). 
2.1 BINDING PROTEIN (BIP) 
Immunglobulin heavy chain sub-units, unlike light chains, are rarely exported as 
unassembled polypeptides following their synthesis in the ER. Intra-cytoplasmic heavy 
chains were found to be non-covalently associated with either light chains, or with a 
M,, 78 000 polypeptide in murine myeloma cells that did not synthesise immunoglobulin 
light chains (Haas & Wabl, 1983). This polypeptide was initially called immunoglobulin 
heavy chain binding protein (BiP), because of its ability to bind different heavy chain 
isotypes. BiP had also been independently identified as the glucose-regulating protein 
GRP78, which was induced by either a block in glucose synthesis or glucose deprivation in 
fibroblasts (Pouyssegur et al., 1977), and was subsequently shown to be localised within 
the ER (Zala et al., 1980). 
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A 736 base-pair BiP cDNA clone from a murine pre-B cell hybridoma was identified by the 
translation of hybrid-selected mRNA, which yielded a single polypeptide of expected size 
(Haas & Meo, 1988). The C-terminal 142 amino acids of this BAP clone were sequenced, 
revealing a tetrapeptide Lys-Asp-Glu-Leu (KDEL) characteristic of soluble proteins 
retained in the ER lumen. BiP-related RNA transcripts were shown to be constitutively 
expressed in various murine and rat tissues, although only a single copy of the BiP gene 
was detected in mouse and rat. This finding suggested that in addition to its' association 
with immunoglobulin heavy chains, BiP might have a more widespread function. 
Subsequently BiP has been shown to bind transiently to a variety of nascent secretory and 
transmembrane proteins, and to remain permanently bound to malfolded proteins that 
accumulate within the ER (Hendershot et al., 1987). The hypothesis that the presence of 
malfolded proteins may be the primary signal for the induction of BiP was tested by 
expressing wild-type and mutant forms of influenza virus haemagglutinin in simian cells 
(Kozutsumi et al., 1988). Only malfolded haemagglutinins, whose export from the ER was 
blocked, induced BiP mRNA accompanied by an increase in synthesis ofBiP protein. 
BiP is the most abundant of the ER-resident chaperones (Gething & Sambrook, 1992), and 
belongs to the M, 70 heat-shock (HSP70) family of proteins. HSP70s are highly conserved 
among different eukaryotes and have members in every cellular compartment in which 
protein folding takes place (Munro & Pelham, 1986). HSP70 genes can be classified into 
two groups: cognate genes (HSC70) which are expressed under normal growth conditions 
(and not strongly induced by heat shock), and those that are not expressed under normal 
conditions but are heat-shock inducible (Lindquist & Craig, 1988). 
Studies with wild-type and mutant yeast strains deficient in the yeast kar2 gene homologue 
of BiP have shown that BiP is required for the translocation and correct folding of newly 
synthesised proteins in the ER (Sanders et al., 1992; McClellan et al., 1998), as well as for 
retrograde transport across the membrane of aberrant proteins destined for degradation by 
the proteasome (Plemper et al., 1997). Evidence for a similar role for BiP in plants has been 
obtained with the partial complementation of a temperature sensitive yeast kart mutant by 
a tobacco BiP cDNA (Denecke et al., 1991). This evidence suggests that amino acid 
residues important for BiP function in yeast may be evolutionarily conserved between yeast 
and higher plants. 
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Several studies have highlighted the transient association of BiP with mammalian 
immunoglobulin heavy and light chains during their folding and assembly (Bole et al., 
1986; Hendershot et al., 1987; Knittler & Haas, 1992). BiP was shown to bind more 
permanently to misfolded, underglycosylated or unassembled proteins whose transport 
from the ER was blocked (Gething & Sambrook, 1992). BiP is also involved in maintaining 
the permeability barrier of the ER membrane, both before and early on in the translocation 
process (Hamman et al., 1998; Gething, 1999). 
Recognition of polypeptide substrates by BiP 
The chaperone activity of BiP in the ER lumen is dependent on its ability to recognise and 
discriminate between a variety of properly folded and unfolded structures. The 
peptide-binding site of BiP can be filled by 7 amino acid residues, and preferentially binds 
aliphatic side chains, which are typically present inside folded proteins (Flynn et al., 1991). 
A heptameric motif, Hy-(W/X)-Hy-X-Hy-X-Hy, has been identified where Hy is a bulky 
aromatic or hydrophobic residue, W is tryptophan, and X is any amino acid (Blond- 
Elguindi et al., 1993b). Further, a computer-based scoring system was devised to help 
predict BiP-binding sites in natural proteins (Blond-Elguindi et al., 1993b). This technique 
demonstrated that BiiP-binding sites in immunoglobulins were likely to be concentrated in 
sequences that participate in contact sites between the heavy and light chains, and that 
hydrophobic residues destined to become buried in the interface are disproportionately 
present within the potential BiP-binding sites (Knarr et al., 1995). In binding to 
hydrophobic surface regions on the isolated sub-units, BIP may prevent inappropriate 
interactions with other partially folded polypeptides. In this way, non-specific aggregation 
and unproductive side reactions would be suppressed (Knarr et al., 1995). 
BiP and immunoglobulin assembly 
In the course of plasma cell development, immunoglobulin heavy chains are synthesised 
before light chain genes are rearranged and expressed (Taussig, 1988). Immunoglobulin 
heavy chains form homodimers in pre-B cells (Kaloff & Haas, 1995), but in the absence of 
light chains they are retained in the ER through an association with BiP (Haas & Wabl, 
1983; Bole et al., 1986). Initiation of light chain protein expression permits the assembly of 
complete immunoglobulin molecules, which takes place in the ER. However incompletely 
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or incorrectly assembled immunoglobulin molecules remain bound to BiP and are 
ultimately targeted for degradation (Gardner et al., 1993). 
Immunoglobulin light chains 
Immunoglobulin light chains are usually secreted (Baumal et al., 1973), however in some 
instances the export of light chains from the ER is reliant upon association with heavy 
chains (Kohler et al., 1976; Oi et al., 1983). It was subsequently reported that these light 
chains were bound to BiP (Dul & Argon, 1990). However these light chains do not belong 
to the `malfolded' type of BIP ligand, as they are assembled into antibody molecules when 
heavy chains are coexpressed. It was suggested that the association of BiP with light chains 
might be a general event, in which stable complexes are formed in cells which do not 
secrete their light chains, and transient complexes formed in cells which do (Knittler & 
Haas, 1992). 
BiP binds transiently to nascent immunoglobulin light chains in vivo when the variable 
region is unfolded, and is released as the domain folds (Hendershot et al., 1996). 
BiP-binding to a murine lambda light chain during folding was investigated in vivo using 
BiP ATPase mutants which bind irreversibly (Hellman et al., 1999). The lambda light chain 
is composed of two immunoglobulin domains that fold independently of one another, each 
containing multiple potential BiP-binding sites. Although both the wild-type and mutant 
BiP associated with the unoxidised variable region domain, neither BiP protein was found 
to bind to the constant region domain. Subsequent in vitro and in vivo folding analyses 
demonstrated that the constant domain folds rapidly and stably even in the absence of an 
intra-domain disulphide bond. These findings suggest that it is the rate and stability of 
protein folding that determines whether or not a particular BiP-binding site is recognised. 
The presence of a BiP-binding site on a nascent chain does not ensure that BiP will bind 
and become involved its' folding, and it appears that BIP preferentially binds to proteins 
that fold slowly or unstably (Hellman et al., 1999). 
Immunglobulin heavy chains 
Indirect evidence suggested that the first constant (CH1) domain of the immunoglobulin 
heavy chain was required for association with BiP (Hendershot et al., 1987). Whereas 
mutant heavy chains lacking either CH2 or CH3 domains remained in the ER complexed 
with BiP, chains which lacked CH1 were transported along the secretory pathway and did 
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not appear to interact with BiP (Hendershot et al., 1987). It was also suggested that 
sequences within the VH domain may influence the association of immunoglobulin heavy 
chains with BiP (Haas, 1991). 
By using a CHI domain-deleted heavy chain, BiP was shown to bind to other heavy chain 
domains, although these interactions were transient and restricted to unoxidised heavy 
chains (Kaloff & Haas, 1995). The first constant domain (CHI) was thus revealed as the 
stable binding site on unassembled heavy chains. Whilst it is not obvious why BiP should 
bind stably to the CH1 immunoglobulin domain and bind only transiently with other 
domains, two possible explanations have been proposed. The first is that BiP may bind to 
linear hydrophobic regions on nascent chains before they fold, such as VL, in addition to 
hydrophobic faces on folded protein sub-units prior to their assembly into multimers, for 
example to CH1 of heavy chain (Lee et al., 1999). The second explanation is that BiT may 
bind to unfolded areas of the proteins if the CHI domain is unable to fold until it pairs 
successfully with a light chain partner (Lee et al., 1999). Light chains are required in vivo 
to facilitate the folding of the CH1 domain and the release of BiP (Lee et al., 1999; 
Vanhove et al., 2001). 
Regulation of BiP function 
Mammalian BiP exists in interconvertible monomeric and oligomeric forms in vivo that can 
be modified by phosphorylation (Hendershot et al., 1988) and by ADP-ribosylation (Leno 
& Ledford, 1990). There is some evidence that these post-translational modifications may 
be important for the regulation of both the synthesis and polypeptide-binding activity of 
BiP. Conditions that increase the level of unfolded polypeptides in the ER lumen, such as 
heat shock and glucose starvation, may lead to reduced post-translational modification of 
BiP (Carlsson & Lazarides, 1983; Laitusis et al., 1999) and an increase in the proportion of 
the monomeric form (Freiden et al., 1992). As only the unmodified, monomeric BiP 
molecules are found in complexes with unassembled or unfolded proteins, it has been 
suggested that post-translational modifications of BiP may provide a means of tapping a 
reservoir of BiP when it is needed (Gething, 1999). 
Binding affinity for ATP and a weak ATPase activity is a common property of all HSP70's 
(Gething & Sambrook, 1992). In turn, the affinity of the C-terminal domain of BiP for 
polypeptides is dependent on whether the N-terminal nucleotide-binding site is occupied by 
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ATP (low affinity but rapid binding) or ADP (high affinity but slow exchange). Binding of 
a polypeptide to the C-terminal domain increases the rate of ATP hydrolysis by the 
N-terminal ATPase domain (Flynn et al., 1989; Blond-Elguindi et al., 1993a). 
In vitro, proteins associated with BiP can be released by the addition of ATP to the 
complex (Dorner et al., 1990; D'Amico et al., 1992). The use of ATP to reverse the binding 
of HSP70s to their substrates has been used as a diagnostic assay for chaperone activity 
(Nandan et al., 1994). 
BiP in plants 
BiP is the best characterised of the ER-resident chaperones in plants, having been identified 
in a number of different plant species, including tobacco, maize, barley, rice, Arabidopsis, 
spinach, tomato and soybean (reviewed by Boston et al., 1996). In all plant systems 
examined so far, BiP accumulates following treatment with tunicamycin, and during 
glucose starvation (D'Amico et al., 1992). Tunicamycin is an inhibitor of N-linked 
glycosylation which causes the accumulation of misfolded proteins in the ER of both plant 
cells and mammalian cells (Kozutsumi et al., 1988) and results in the increased 
transcription of several chaperones, including BiP and PDI. 
Like yeast and mammalian BiP, spinach BiP has been reported to be encoded by a single 
gene (Anderson et al., 1994). In contrast, several highly conserved isoforms of BiP which 
are encoded by multigene families have been identified in tobacco, maize and soybean 
(Denecke et al., 1991; Fontes et al., 1991). In tobacco, eight cDNA clones of the BiP 
homologue have been isolated, and six were found to be distinct from each other at the 
nucleotide sequence level (Denecke et al., 1991). However most of these nucleotide 
substitutions did not alter the encoded amino acids. The signal sequence and in particular 
the C-terminal part that precedes the HDEL sequence were shown to be the most divergent 
portions of the protein sequence. The biological significance of differences in gene number 
with respect to gene regulation and possible redundancy of function has not yet been 
explained. 
All plant BIPs identified so far contain the tetrapeptide C-terminal ER retention signal 
HDEL (Vitale et al., 1993). There is no evidence to suggest that either lumenal BiP or its 
cytosolic homologue are heat-shock inducible in plants (Denecke et al., 1991; D'Amico et 
al., 1992; Walther-Larsen et al., 1993). The amino acid sequence of one of the members of 
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tobacco BiP (BLP4) [Denecke et al., 1991] has been compared with that of hamster BiP 
(Ting et al., 1987) and yeast BiP (Normington et al., 1989; Rose et al., 1989). The 
alignment studies demonstrated that tobacco BiP has 76 % homology with mammalian BiP, 
and 63 % with yeast BiP. 
Some of the initial investigations into BiP in plants focused on whether the BiP genes were 
expressed in a tissue-specific manner. RNA was extracted from different tissues at several 
developmental stages from tobacco plants (Denecke et al., 1991). BiP mRNA was barely 
detectable in leaves, and was present at only slightly higher levels in roots. Bip mRNA 
levels were modest in stems and petals, but higher BiP mRNA levels were detected in 
flower organs that have secretory tissue, such as the anthers, stigma and style. Of all the 
tissues analysed, germinating seeds 4 days after imbition had the highest BiP mRNA level. 
BiP mRNA levels thus appeared to be most abundant in tissues with high proportions of 
rapidly dividing cells, containing large amounts of ER membranes (Denecke et al., 1991). 
These observations support the theory that BiP is required in the folding process of de novo 
synthesised secretory proteins in unstressed cells. 
The stress-related expression pattern of BiP was examined using germinating tobacco seeds 
shaken in culture medium at 24°C (Denecke et al., 1991). Seeds were incubated in the 
presence of either 20 pg/ml tunicamycin or 5 gM calcium ionophore A23187 for 16 hours 
under standard conditions. In addition, seeds were also subjected to cold shock treatment at 
4°C, and heat shock treatment at 42°C. In each case, total RNA was extracted from 
protoplasts prepared from seeds, and BiP mRNA levels were examined by Northern 
blotting. BiP mRNA levels were elevated in tobacco protoplasts treated with tunicamycin. 
However it is unclear whether the expression of BiP in plant cells is induced directly by the 
presence of misfolded proteins in the lumen of the ER, or by the abnormal glycosylation 
pattern of proteins. In contrast to mammals, tobacco BiP mRNA levels were not elevated 
by treatment with the calcium ionophore A23187. This observation reflects the fact that 
calcium ionophores do not affect the retention of chaperones in tobacco, and so obviates the 
need for de novo BiP synthesis to maintain homeostasis. In order to investigate the role of 
BiP in the transport and secretion of proteins in plants, transgenic tobacco was produced 
with altered Bi'P levels (Leborgne-Castel et al., 1999). Two chimeric genes were generated; 
a wild-type BiP coding region under the transcriptional control of the CaMV 35S promoter, 
and an antisense construct in which the BiP coding region was in the reverse orientation. 
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The stable over-expression of BiP protein in tobacco plants was confirmed by Western 
blotting of plant extracts (Denecke et al., 1991). Whereas BiP mRNA levels were increased 
as much as 150-fold, protein levels were only increased by 5-fold. The large amount of 
degradation products that correlated with over-expression of Bip suggests that a higher 
turnover of BiP occurs when BiP is too abundant. However the pathway for the disposal of 
excess BiP has not been clearly identified (Leborgne-Castel et al., 1999). 
No clear phenotypes were visible with the mature BiP antisense plants, although freshly cut 
plants took longer to produce roots than cuttings from non-transformed plants or BiP- 
overproducers (Leborgne-Castel et al., 1999). In an additional experiment, tobacco BY2 
suspension cultures (Gomord et al., 1998) were transformed with the BiP antisense 
construct. Although it was not possible to generate plants containing significantly reduced 
BiP levels by this antisense inhibition strategy, the number of resistant calli was 
dramatically reduced, suggesting that even small reductions in BiP levels can have a 
detrimental effect on tobacco cell viability. 
In order to examine the effect of artificially increasing BiP protein levels on the unfolded 
protein response (UPR) (Shamu et al., 1994), protoplasts were prepared from 
non-transformed plants and BiP-overproducers (Leborgne-Castel et al., 1999). One 
population was treated for 2.5 hours with tunicamycin (20 p. g/ml). The basal transcript 
levels of endogenous BiP genes were shown to be downregulated in BiP overexpressers. 
The level of BiP mRNA induced by tunicamycin in non-transformed cells was 
indistinguishable from that in transformed cells overproducing BiP which were subjected to 
the same treatment. Thus artificially increasing BiP protein levels results in a 
downregulation of the UPR, as observed in CHO cells (Dorner et al., 1992) and in yeast 
(Kohno et al., 1993). This suggests that BiP transcription may be regulated by a feedback 
mechanism that involves the monitoring of BiP protein levels. Hybridisation using a 
calreticulin-specific probe revealed a similar reduction in the basal calreticulin mRNA 
levels, and demonstrated that the regulatory effect of BIP extends to other ER chaperones 
(Leborgne-Castel et al., 1999). 
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2.2 CALRETICULIN 
Calreticulin was first identified as a Cat-binding protein (Ostwald & MacLennan, 1974). 
More recent evidence confirmed that calreticulin is one of the major Cat+-binding proteins 
in the ER (Michalak et al., 1992), which plays an important role in the regulation of 
intracellular Ca2+ ion homeostasis by modulating Ca2+ storage and transport (Berridge, 
1993; Meldolesi & Pozzan, 1998). Furthermore, calreticulin also acts as a highly versatile 
lectin-like ER chaperone, that participates during the synthesis of a variety of molecules 
such as MHC Class I and HIV gp120 (Michalak et al., 1999, Danilczyk et al., 2000, 
Otteken & Moss, 1996). 
Calreticulin (Mr 46 000) is a soluble analogue of calnexin that resides within the ER lumen 
(Nauseef et al., 1995; Otteken & Moss, 1996). Both calreticulin and calnexin contain a 
lectin-binding site that directs their association with newly synthesised glycoproteins. 
Although many glycoproteins bind to both calreticulin and calnexin, there are differences in 
the range of glycoproteins that each binds. Both calreticulin and calnexin have homologues 
in a diverse range of plant and animal species (Boston et al., 1996; Krause & Michalak, 
1997; Michalak et al., 1999). 
Calreticulin, calnexin and glycoprotein folding 
The working principle of many chaperones, such as BiP, depends upon conformational 
changes driven by the hydrolysis of ATP. However the binding and release of calreticulin 
and calnexin relies upon their interaction with newly synthesised glycoprotcins that have 
undergone partial enzymatic trimming of their core N-linked glycoproteins (Hammond & 
Helenius, 1995). Release from calreticulin and calnexin takes place when the polypeptides 
have undergone oligomeric assembly or attained a fully folded conformation (Hammond & 
Helenius, 1995). In this way both chaperones play a crucial role in the quality control of 
glycoprotein folding. 
The association of calreticulin and calnexin with glycoproteins may be a transient step that 
begins during early maturation and continues post-translationally for variable periods of 
time, ranging from a few minutes to several hours. However with unassembled sub-units of 
oligomers, or permanently misfolded proteins, chaperone association may persist until the 
protein is degraded (reviewed by Helenius et al., 1997). 
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Indirect evidence suggests that the binding of calreticulin and calnexin also involves 
protein-protein interactions. For example, some glycoproteins deprived of glycan addition 
have been shown to co-immmmunoprecipitate with calnexin (Loo & Clarke, 1994). It was 
also observed that class-I heavy chains may be chemically cross-linked to calnexin at a site 
close to the transmembrane region (Margolese et al., 1993). It is possible that 
oligosaccharides serve to bring the substrate and calnexin into close proximity and 
thereafter a protein-protein interaction, typical of classical chaperones, takes place 
(reviewed by Helenius et al., 1997). 
As the lectin specificities of calreticulin and calnexin are identical, there is extensive 
overlap between their substrate glycoproteins (Ware et al., 1995; Spiro et al., 1996), and in 
some cases they can even associate simultaneously with the same glycoprotein (Otteken & 
Moss, 1996). However it has been shown that the vesicular stomatitis virus (VSV) 
G glycoprotein binds to calnexin but not to calreticulin (Peterson et al., 1995). It was also 
demonstrated that calreticulin dissociates more rapidly than calnexin as the folding of the 
T cell receptor (Van Leeuwen & Kearse, 1996), and influenza virus haemagglutinin 
proceeds (Hebert et al., 1997). Mutation of glycosylation consensus sites of influenza 
haemagglutinin demonstrated that the location of N-linked glycans plays a role in 
differential calnexin and calreticulin binding (Hebert et al., 1996). 
Calreticulin and calnexin in plants 
Relatively little is known about the lectin-like activity of caireticulin and calnexin in plants. 
Some evidence that glycans are involved in the folding process came from the fording that 
assembly of phaseolin, a seed storage protein, occurs at a faster rate when glucose trimming 
by ER glucosidases is inhibited (Lupattelli et al., 1997). 
The first calnexin-like protein reported in plants was identified in Arabidopsis thaliana 
(Huang et al., 1993). Subsequently, calnexin has been isolated from soybean and maize 
(Goode et al., 1995). Although the role of calnexin has mainly been studied in human and 
mouse cells, the high degree of conservation identified suggests that it might function 
similarly in plants. 
A calreticulin-like protein, of approximately 55 kDa, was initially purified from spinach 
leaves (Menegazzi et al., 1993). Since then, calreticulin has been cloned from several other 
angiosperms, including barley, in which two isoforms were detected with Cat+-binding 
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activity similar to that reported for mammalian calreticulin (Chen et al., 1994). 
Subsequently, calreticulin was shown to be a marker protein for the ER in tobacco 
(Denecke et al., 1995). Calreticulin has also been identified in maize (Dresselhaus et al., 
1996) and soybean (Goode et al., 1995), and is the major calcium storage protein in the ER 
of pea plants (Hassan et al., 1995). More recently calreticulin was characterised in Ginkgo 
biloba, a plant considered to have one of the earliest gymnosperm lineages (Nardi et al., 
1998). 
The involvement of calnexin in protein folding and oligomerisation in plants was raised by 
evidence that it associates with a vacuolar H+-translocating ATPase, which is a membrane 
spanning protein (Li et al., 1998). Calnexin and BiP were found in association with this 
ATPase from oat seedlings, and the presence of calreticulin was not excluded (Li et al., 
1998). It is unclear whether there is a BiP/calnexin/nascent ATPase complex, or whether 
BiP and calreticulin bind successively to the folding intermediates of the ATPase. 
Relative levels of calreticulin expression have been investigated in different tobacco 
tissues, and were found to be similar to that of the ER-resident chaperone BiP (Denecke et 
al., 1995). For both transcripts the lowest level was observed in leaves. Higher levels were 
detected in roots and stems, and the highest abundance was found in floral tissues and 
germinating seeds, both of which contain cells with high secretory activity. Experiments 
using tobacco cotyledon cells demonstrated that calreticulin was localised in the ER lumen 
of germinating tobacco seeds (Denecke et al., 1995). 
Using RNA extracted from tobacco protoplasts incubated in culture medium containing 
tunicamycin (20 µg/ml) for up to 9 hours, expression patterns for calreticulin dissimilar to 
those of other ER-resident proteins were reported (Denecke et al., 1995). Transcripts of 
calreticulin, BiP, and PDI were detected, and whereas tunicamycin treatment mainly 
induced BiP and PDI, the effect on calreticulin expression was much less (Denecke et al., 
1995). Thus, whereas BiP and PDI may be regulated by the UPR feedback mechanism, it 
appears that alternative signal transduction pathways might exist for calreticulin. This could 
explain how other stress and hormone treatments resulted in the enhanced synthesis of 
different ER chaperones (Denecke et al., 1995). 
The tobacco homologue of calreticulin was identified in protein complexes isolated from 
tobacco cells in vivo (Denecke et al., 1995). The most abundant complex formed by 
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calreticulin also involved a M, 75 000 protein that was found to be associated even in the 
absence of ER stress (Denecke et al., 1995). Subsequently this protein was identified as 
BiP, although the presence of this novel BiP-calreticulin complex cannot be explained by 
the established lectin-binding activity of calreticulin (Spiro et al., 1996), as BiP is not a 
glycoprotein. Although the BiP-calreticulin complex was disrupted by ATP, calreticulin 
associated with BiP was neither unfolded nor partially or improperly folded (Crofts et al., 
1998). Pulse-chase experiments were used to demonstrate that the BiP-calreticulin complex 
was stable and not due to the presence of transiently unfolded calreticulin. Additional 
studies showed that the interaction appears to involve a very large proportion of the cellular 
BiP compared with a small proportion of cellular calreticulin. Immunoprecipitations 
performed with extracts from in vivo labeled protoplasts isolated from BiP-overexpressing 
plants showed additional recruitment of BiP to the complex with calreticulin, as observed 
by a higher BiP/calreticulin ratio (Crofts et al., 1998). In contrast, calreticulin over- 
expression led to an increase in non-complexed calreticulin, and demonstrated that it was 
the level of BiP that determined the degree of complex formation with calreticulin. 
Binding of BiP to calreticulin was also compared with the binding of BiP to an assembly- 
defective protein. Transgenic plants were used which overproduce a mutant phaseolin 
monomer, a model ligand for BiP (Pedrazzini et al., 1994; 1997). Protoplasts were pulse 
labeled and immunoprecipitations performed with anti-phaseolin, anti-BiP, or anti- 
calreticulin antisera. The results showed that BiP which bound to calreticulin and the BiP 
associated with assembly-defective phaseolin represented different subsets of the BiP pool 
(Crofts et al., 1998). 
Calreticulin is known to mask BiP epitopes that are not masked by unassembled phaseolin 
molecules and it has been suggested that it may interact with a different region of the 
molecule. It is unlikely that calreticulin acts as a co-factor for BiP, as BiP has been 
associated with either a malfolded protein or with calreticulin, but never with both at the 
same time (Crofts et al., 1998). It has been proposed that the BiP-calreticulin complex 
might act as a buffer to modulate the concentration of free BiP in the ER. Any excess BiP 
not required for the folding of nascent proteins could be recruited into the complex for 
storage (Crofts & Denecke, 1998). Another possibility is that the BiP-calreticulin complex 
might be part of a larger structure that involves other chaperones, similar to those detected 
using cross-linking experiments in mammalian cells (Tatu & Helenius, 1997). The co- 
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immunoprecipitation of BiP with calreticulin has so far not been demonstrated in mammal 
cells. Although mammalian calreticulin has been identified in complexes without Biip 
(Oliver et al., 1997), in plants only a very small proportion of the cellular calreticulin is 
involved in binding the huge majority of BiP. 
2.3 CHAPERONE SELECTION AND INTERACTIONS 
Proteins synthesised within the ER lumen interact differently with chaperones, some 
interacting first with BiP and later with calnexin (Hammond & Helenius, 1994; Kim & 
Aryan, 1995), whilst others bind calnexin and calreticulin but do not associate with BiP 
(Braakman et al., 1991; Xu et al., 1998). During the folding of newly synthesised proteins 
in the ER, BiP has been shown to act sequentially with a member of the HSP90 family 
GRP94 (Melnick et al., 1994), and to cooperate with PDI (Braakman et al., 1992; Puig & 
Gilbert 1994) and calreticulin (Tatu & Helenius, 1997). 
In a recent study, the maturation of two glycoproteins, E1 and p62, from the Semliki forest 
virus was analysed in CHO cells to investigate chaperone selection (Molinari & Helenius, 
2000). The results from this study suggest that a choice is made between chaperone systems 
during the translocation of a glycoprotein in the ER. One of the systems comprises BiP and 
perhaps PDI, whilst the other comprises calnexin, calreticulin and the oxidoreductase 
enzyme Erp57. The initial binding of one chaperone appears either to delay or prevent 
binding of the other chaperone. 
Mutants of influenza haemagglutinin (IHA) were also made to investigate whether the 
position of N-linked glycans in the sequence of a glycoprotein correlated with differential 
chaperone-binding (Molinari & Helenius, 2000). The results indicated that glycoproteins 
such as p62 and HA, which contain glycans close to the NH2-terminus, entered the 
calnexin/calreticulin pathway directly without prior association with BiP. However, 
proteins such as El and the VSV glycoprotein, which are glycosylated closer to the 
COOH-terminus, initially bound with BiP (Molinari & Helenius, 2000). Using 
castanospermine, an inhibitor of the calnexin/calreticulin pathway, p62 and IHA could be 
re-directed to the BiP pathway. This result demonstrated that the presence of N-linked 
glycans per se does not prevent BiP from binding, but rather promotes the association of 
the alternative chaperones. A number of cellular and viral proteins with N-linked glycans 
28 
within the first 50 residues of the NH2-terminus have all been shown to fold independently 
of BiP (Molinari & Helenius, 2000). 
A large ER-localised multiprotein complex containing a subset of chaperones and folding 
enzymes - including BiP and PDI - has been identified (Meunier et al., 2002). This subset 
of ER chaperones formed an ER network capable of binding to unassembled, incompletely 
folded immunoglobulin heavy chains, rather than existing as free pools that assembled onto 
the substrate protein. The components of the calnexin/calreticulin system were either not 
detected in the complex, or only very poorly represented. 
3. Guy's 13 Monoclonal antibody and passive immunotherapy 
Passive immunisation involves the delivery of pathogen-specific antibodies to a host. Many 
of the potential side-effects of active immunisation are minimised through local passive 
immunisation, such as the possibility of eliciting cross-reactive responses. This approach 
has been proposed as a means of preventing the colonisation of teeth by mutans 
streptococci and the development of caries (Lehner et al., 1985; Michalek et al., 1987; 
Filler et al., 1991; Otake et al., 1991). 
MAb Guy's 13 is a murine IgGI class of antibody, and was originally raised against the 
cell surface adhesin (SA I/II) homologue from S. sobrinus. It recognises a common protein 
epitope shared by all serotypes of mutans streptococci and binds strongly to S. mutans, 
which is the principle causative bacteria in dental caries (Mitchell et al., 1987; Smith & 
Lehner, 1989). Topical application of MAbs such as Guy's 13, directly onto tooth surfaces, 
protected against S. mutans colonisation and caries in monkeys (Lehner et al., 1985). 
Similar protection from colonisation was subsequently demonstrated in human volunteers 
(Ma et al., 1987; Ma et al., 1989). Furthermore, recolonisation by S. mutans in human 
carriers could be completely prevented using MAbs (Ma et al., 1990). 
Although Guy's 13 has potential as an anti-caries immunotherapeutic MAb, one significant 
drawback remains, namely the high cost of generating the large quantities of MAbs 
required for passive immunotherapy using conventional hybridoma techniques. 
Recombinant heterologous expression systems may be especially valuable in these 
circumstances, although an added difficulty in this application, is the requirement for full- 
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length antibody, rather than antibody fragments which are not protective in vivo (Ma et al., 
1990). 
3.1 MUCOSAL IMMUNITY 
Dental caries is the result of a mucosal infection, and therefore represents a valuable model 
for the study of mucosal immunity by both innate and adaptive defence mechanisms. The 
innate mechanisms comprise the mucosal barrier, mucins, salivary factors (McGhee & 
Mestecky, 1990), and various anti-microbial peptides (Weinberg et al., 1998). 
Innate immunity not only provides a physical anti-microbial defence, but also determines 
how pathogens activate the adaptive mucosal immune system and control the nature of the 
immune response (Bendelac & Fearon, 1997). Adaptive immunity requires the antigens to 
cross the epithelial layer and reach the underlying organised lymphoid tissue, where antigen 
presentation and priming of B and T cells can take place. Antibodies play a major role in 
the protection of all mucosal surfaces, and on average an adult produces and transports into 
secretions around 10 g each day (McGhee & Mestecky, 1990). 
The major salivary immunoglobulin is secretory IgA (SIgA), and in adult whole saliva the 
relative contributions of SIgA, IgG and IgM are approximately 200,1, and 1 mg per 
1000 ml, respectively (Brandtzaeg et al., 1970). Approximately 60 % of the secretory 
antibodies are of the SIgAl subclass, the remainder belonging to the SIgA2 subclass 
(Delacroix et al., 1982). Antibodies specific for protein antigens are predominantly of the 
IgAl subclass, whereas bacterial lipopolysaccharide and carbohydrate antigens lead 
preferentially to IgA2 antibody production. 
As described previously, SIgA antibodies are multivalent, and adapted to cross-link target 
pathogens in the mucosal environment. SIgA responses can be elicited in saliva by the 
stimulation of either central lymphoid tissue or local inductive sites of the mucosal immune 
system. The central inductive sites include gut-associated lymphoid tissue (GALT) and 
nasal-associated lymphoid tissue (HALT). Stimulation with antigen at these sites results in 
the sensitisation of specific IgA-committed B cells and their dissemination and homing to 
remote effector sites, including the salivary glands (Mestecky, 1987). 
Compared with SIgA levels in the oral cavity (Challacombe & Lehner, 1976), much 
smaller amounts of IgM, IgG and monomeric IgA from blood reach the surface of teeth in 
gingival crevicular fluid (GCF). Levels of these immunoglobulins in GCF are raised in 
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gingivitis and periodontal disease (Russell et al., 1999), and may play a role in mucosal 
defence around the oral cavity. Clearly the defence of the oral mucosa is a complex 
process, supported by a number of versatile and normally highly effective mechanisms. 
Mechanism of action of IgA antibodies 
Unlike IgG and IgM, IgA is non-inflammatory and does not promote phagocytosis (Kilian 
et al., 1988). However there are a number of mechanisms whereby SIgA can exert a 
protective effect; by direct inhibition of microbial adherence to host mucosal epithelial cells 
(Liljemark et al., 1979), through blocking specific adhesin-receptor interactions, or by 
interfering with hydrophobic interactions. SIgA may also neutralise microbial toxins and 
enzymes (Gilbert et al., 1983; Holmgren et al., 1972). SIgA is also capable of viral 
neutralisation (Russell-Jones et al., 1981) either by direct blocking of receptor binding or 
through viral aggregation. 
SIgA can inhibit microbial penetration through the mucous layer, a process termed immune 
exclusion (Stokes et al., 1975). The polymeric structure of SIgA enhances its avidity for 
antigens and promotes microbial aggregation. The consequent formation of complexes 
facilitates microbial clearance in secretions and reduces the microbial load at the epithelial 
surface (Neutra et al., 1991). SIgA is also involved in the export of microbes that have 
already crossed the mucosal barrier. Polymeric IgA in transit to the mucosal surface may 
encounter microbes or antigens that are already present in the mucosal epithelium or 
connective tissue, and transport them back out (Kaetzel et al., 1991). This principle has 
been demonstrated for intracellular neutralisation of Sendai virus in which IgA antibodies 
interfered with viral replication by binding to newly synthesised viral proteins within 
infected cells (Mazanec et al., 1992). 
4. Production of Monoclonal antibodies 
MAbs are conventionally produced by immunising animals (usually rats or mice) with an 
antigen to stimulate the production of antibody forming plasma cells. These are harvested 
from the animal's spleen, fused with a myeloma cell line grown in culture, and a single 
hybrid clone of B cells selected. This "immortal" cell line is called a hybridoma, and the 
combined output of antibody from a hybridoma is completely homogenous - all the 
antibody molecules are identical and have the same specificity for antigen (Kohler & 
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Milstein, 1975). 
In the early days of hybridoma technology, hybridoma cells were then injected into the 
peritoneal cavity of an animal, and MAbs were harvested from ascitic fluid that collected. 
This technique generates a high yield of antibody, between 1- 20 mg/ml. However there 
are disadvantages to using ascitic methods, in particular related to animal welfare concerns. 
Individual batches of harvested ascitic MAb may vary in quality, and can be contaminated 
with blood and bioreactive chemokines. There is also a potential risk of contamination by 
viruses that are pathogenic to humans. 
In the last 20 years or so, a range of in vitro production systems has been developed. There 
are three main types of in vitro production; static and agitated suspension cultures, 
membrane-based and matrix-based culture, and high cell density bioreactors. These systems 
differ in terms of their ease of handling, the yield of antibody, and the maximum achievable 
antibody titre (reviewed by Hu & Aunins, 1997). However, using a variety of mammalian 
expression vectors, selection and amplification protocols, CHO cell lines capable of 
producing MAbs at levels exceeding 1 g/L can now be obtained almost routinely. For the 
applications of MAbs to expand into additional therapeutic areas, however it was proposed 
that a 5- to 10-fold increase over these levels may be needed (Trill et al., 1995). 
Species that are phylogenetically closer to humans generally have more elements of the 
glycosylation machinery in common, although there remain differences between the 
glycosylation characteristics of rodent cell lines and human tissues (Jenkins et al., 1996). 
Some workers have expressed concerns regarding the quality of IgG MAbs produced in 
vitro, noting that in some cases the glycosylation pattern of antibody generated in 
bioreactors differs from that in vivo (Leibiger et al., 1995). The loss of correct 
Fv-associated glycosylation can also result in decreased antigen-binding activity (Leibiger 
et al., 1999). 
4.1 BACTERIAL EXPRESSION OF IMMUNOGLOBULIN 
Bacterial expression systems offer a convenient means of engineering antibody fragments 
for a variety of applications (Huston et al., 1988). The host in which most recombinant 
antibody methods were developed is the bacterium Escherichia coli. Growth of bacteria is 
rapid and inexpensive, and a number of vectors are available for expression and 
manipulation of cloned genes. DNA can be introduced directly into E. coli (transformation) 
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or by infectious bacteriophage (transfection). Genetic constructions of antibody fragments 
(such as Fab' and scFv) can be quickly assessed and various selection methods can be 
applied. It is also easier to scale-up the production of antibody fragments in E. coli than in 
mass culture of mammalian cells such as hybridomas. 
Functional antibody fragments can only be assembled correctly in an oxidising 
environment. In bacterial expression systems this involves the secretion of precursor 
proteins into the bacterial periplasm. This process mimics the secretion of protein into the 
lumen of the ER in mammalian antibody-producing cells (Wall & Kuehl, 1983). 
However there are several disadvantages associated with bacterial expression systems; 
recombinant proteins may form inclusion bodies, which necessitates costly in vitro 
refolding. Prokaryotes do not glycosylate heterologous proteins (Letourneur et al., 1995), 
which effectively excludes the use of E. coli for the production of glycoproteins - where the 
glycan chain is essential for biological activity or efficacy - and bacterial expression 
systems were not thought to be able to produce full-length antibodies. 
Efforts to assemble full-length functional antibodies in bacterial expression systems have 
been generally unsuccessful. Genes for a murine µ heavy chain and a A, light chain 
immunoglobulin were inserted into bacterial plasmids containing the E. coli tip promoter 
and ribosome binding site (Boss et al., 1984). The induction of transcription from the trp 
promoter resulted in accumulation of both light and heavy chains, although both were 
found as insoluble proteins. However, following extraction and purification of the 
immunoglobulin containing fractions, antigen-binding activity was detected (Boss et al., 
1984). 
Recently, a study demonstrated that by optimising the ratio of secreted heavy and light 
chains, high-level expression and assembly of several full-length humanised IgGs could be 
achieved in the E. coli periplasm (Simmons et al., 2003). In particular, one aglycosylated 
anti-tissue factor IgG1 antibody (aTF) was thoroughly evaluated, and showed tight binding 
to antigen and to the neonatal receptor (Simmons et al., 2003). Production of aTF in E. coli 
was scaled up to yield approximately 150 mg/L of assembled antibody, which was then 
purified using immobilised protein A. If increases in titre can be achieved, this technology 
may provide a rapid, and potentially inexpensive method for the production of aglycosyl 
full-length therapeutic antibodies. 
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4.2 YEAST EXPRESSION 
The yeast Saccharomyces cerevisiae can synthesise, process and secrete higher eukaryotic 
proteins (Hitzeman et al., 1983). The addition of a large number of mannose residues to the 
core oligosaccharide is a common feature of most yeast strains (Herscovics & Orlean, 
1993), and has been shown to compromise the efficacy of recombinant proteins, such as the 
hepatitis B surface antigen (Kniskem et al., 1994). Both yeast and fungi contain high- 
mannose carbohydrate chains (Jeenes et al., 1991) but are not able to convert these into 
complex-type structures. Mutant yeast strains, in which N-glycosylation is confined to core 
oligosaccharide residues with a limited mannose content, have been used to overcome this 
problem (Kniskem et al., 1994). 
Yeast strains that secrete a correctly folded and functional mouse-human chimeric IgG 
antibody have been produced (Horwitz et al., 1988). Between 50 - 70 % of the heavy 
chains were associated with light chain, and the chimeric whole antibody exhibited 
antibody-dependent cellular cytotoxicity and bound to target cancer cells (Horwitz et al., 
1988). 
The synthesis, processing and secretion of IgM antibody X light and µ heavy chains in yeast 
have also been demonstrated (Wood et al., 1985). A significant proportion of the yeast µ 
heavy chains was N-glycosylated, although the yeast and mammalian µ probably differ in 
carbohydrate composition. Medium supernatants from cultures of cells transformed with 
plasmids containing X or It inserts, contained ). or µ protein respectively. Functional 
antibodies were detected in yeast cells that co-expressed both antibody chains in vivo. 
Although antibody activity was recovered from a soluble cell extract prepared from 
transformed yeast, the efficiency of assembly of functional antibodies was very low (Wood 
et al., 1985). 
The filamentous fungus Aspergillus niger has also been used to produce full-length 
humanised IgGI (Ward, unpublished data). The antibody was correctly assembled and 
bound antigen. The secreted level of full-length IgGI was similar to that found in 
mammalian systems, and higher than previously reported in microbial systems. 
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4.3 BACULOVIRUS EXPRESSION IN INSECT CELLS 
The baculovirus expression system is capable of expressing biologically active mouse, 
human, human-mouse hybrid and human-mouse chimeric antibodies of the IgG, IgM and 
IgA classes as well as antibody fragments in insect cells (reviewed by Potter et al., 1993). It 
also permits the combinatorial expression of immunoglobulin with other polypeptides, such 
as J chain, much more rapidly than with stably transfected mammalian lines. The system 
has the advantage of rapid development, as well as relatively high yields (Haseman & 
Capra, 1990). 
Unlike the reducing environment of bacterial cytoplasm, the insect cytoplasmic 
environment allows proteins to fold properly, disulphide bonds to form, and post- 
translational processing, such as N- and O-glycosylation to take place. Ovarian cell lines 
from Spodopterafrugiperda (fall armyworm) cells infected with recombinant baculovirus 
were used to produce a functional murine IgG heterodimer (Haseman & Capra, 1990), and 
a murine monoclonal IgG antibody directed against lipoprotein I of Pseudomonas 
aeruginosa (Zu Putlitz et al., 1990). Functional immunoglobulin heterodimers could be 
produced by coinfecting insect cells with separate heavy and light chain-expressing 
baculoviruses as well as by infection with a single baculovirus containing both genes under 
the control of separate promoters (Haseman & Capra, 1990). However in addition to the 
complete heterodimer, the formation of insoluble immunoglobulin aggregates was observed 
in the insect cell lysates. 
Recombinant human monomeric IgAl has also been expressed in S. frugiperda cells 
(Carayannopoulos et al., 1994). A baculoviral vector that encodes human J chain was also 
used to express the J chain in S. frugiperda cells. Subsequently, insect cells triply infected 
with viruses expressing IgA light chain, heavy chain and J chain were able to assemble 
dimeric IgA. However the assembly was inefficient, as most remained in a monomeric 
form, which was secreted into the cell supernatant (Carayannopoulos et al., 1994). These 
data will be discussed in detail in Chapter 5. 
Most evidence indicates that the N-glycosylation capabilities of the baculovirus system are 
limited to producing simple oligomannose-type oligosaccharides (James et al., 1995), and 
few studies have demonstrated complex N-linked glycans (Davidson et al., 1990). However 
recently, paucimannosidic oligosaccharides that are not commonly found on mammalian 
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glycoproteins were identified (Ailor & Betenbaugh, 1999). Immunoblot analysis of 
baculovirus expressed recombinant IgAl from cell lysates demonstrated N-glycosylation of 
heavy chain in the C112 region and the C-terminal tail. The type of glycosylation present on 
the recombinant antibodies was examined by comparing the reactivity of baculoviral IgAl 
and serum IgAl with different lectins. The results were consistent with the presence of 
N-linked high-mannose oligosaccharides, and O-linked disaccharides on the recombinant 
IgAl molecule. Functionally, the recombinant baculoviral IgA monomer was still 
recognised by several IgAl-specific monoclonal antibodies, and remained susceptible to 
cleavage by an IgAl -specific protease (Ailor & Betenbaugh, 1999). 
The cDNA encoding the N-terminal 589 amino acids of the extracellular domain of the 
human pIgR has also been inserted into vectors to generate recombinant baculo- and 
vaccinia viruses (Rindisbacher et al., 1995). After infection of insect and mammalian cells, 
the resulting truncated protein corresponding to human SC was secreted with high 
efficiency into serum-free culture medium. The insect cell/baculovirus system yielded up to 
50 mg human SC per litre of culture, almost 5 times that produced by the mammalian 
cells/vaccinia system. Although the M, of these two forms of recombinant human SC 
differed, as a result of different glycosylation patterns, both retained the capacity to bind to 
dIgA purified from hybridoma cells. 
One of the major limitations of the baculovirus-insect cell expression system is its 
inefficiency to process heterologous proteins correctly, and the formation of insoluble 
aggregates. Consequently, attention has focused on improving the yield of functional 
proteins using recombinant baculovirus-infected insect cells by supplementing secretory 
processing proteins which are either absent or limited in supply in the host insect cell. The 
over-expression of a human HSP70 cytosolic chaperone increases the solubility and 
secretion of a recombinant IgG protein in insect cells, by enhancing the solubility of the 
immunoglobulin light chain precursor (Ailor & Betenbaugh, 1998). 
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5. Transizenic Plant Biotechnology 
Products of plant genetic engineering first came to market in the United States, and then 
more recently in Europe. Examples include a slow-ripening tomato, as well as soy and 
cotton plants resistant to herbicides and insects (reviewed by Birch, 1997). In the last 
decade or so it has become clear that plant systems may be especially useful for the 
expression and production of recombinant molecules. Undoubtedly, one of the major 
attractions is the potential for growing immunotherapeutic reagents on an agricultural scale, 
with significantly reduced costs of production. 
Modern plant genetic engineering involves the transfer of the desired genes into the plant 
genome, and subsequently the regeneration of a whole plant from the transformed tissue. 
The most often used method for transferring genes into plants is Agrobacterium-mediated 
transformation (Zambryski et al., 1989). Agrobacterium tumefaciens is a naturally found 
pathogenic soil bacterium that is able to transfer DNA into a plant's genome. DNA vectors 
have been designed from the Agrobacterium tumour-inducing plasmid (pTi) DNA which 
carries desired genes into the plant (Zambryski et al., 1989). Tobacco plants can be 
transformed and regenerated relatively easily using Agrobacterium, and as a result they are 
often used as a model system, along with Arabidopsis, potato, tomato, and soy plants (Park 
et al., 1996; Tinland, 1996). 
It had been thought that infection by Agrobacterium was limited, by host range restrictions, 
to dicotyledon and gymnosperm species. However Agrobacterium-mediated transformation 
has also been achieved in monocotyledon species, such as rice and maize (Chan et al., 
1993; Ishida et al., 1996; Park et al., 1996). The common monocotyledonous crop plants 
have proved more amenable to transformation through ballistic micro-projectile 
bombardment techniques (Christou, 1995). As with Agrobacterium, the foreign gene is 
integrated into the plant genome and traditional breeding techniques can then be employed 
to generate transgenic seed stocks, for simple and stable storage or distribution. 
Alternative methods to express heterologous proteins in plants involve the use of viral 
vectors. Two main strategies have been employed, the first of which involves foreign gene 
transcription, in which the foreign gene is expressed as a soluble protein. The second 
strategy involves the engineering of viral coat proteins in fusion with antigenic peptides or 
proteins, whilst allowing the continuing assembly and formation of infectious viral particles 
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that display antigen on their surface. Two of the most widely used plant viruses are tobacco 
mosaic virus (TMV) [Donlon et al., 1991] and cowpea mosaic virus (CPMV) 
[Lomonossoff& Hamilton, 1999]. 
5.1 GENE CONSTRUCTS 
Foreign genes transferred into plants are chimeric constructs that comprise the gene coding 
sequence fused to plant functional regulatory signals, the promotor and polyadenylation 
sequences. The regulatory signals which permit gene expression in plants are often derived 
from the 19S and 35S transcripts of the cauliflower mosaic virus (CaMV) [Odell et al., 
1985], or from Agrobacterium genes (Bevan et al., 1983; De Greve et al., 1983; Di Rita & 
Gelvin, 1987). The choice between constitutive promoters, such as the CaMV 35S or the 
maize ubiquitin 1 promoter must be evaluated on an empirical basis. It is often desirable to 
achieve high-level antibody accumulation in the most suitable organs for storage and 
extraction, normally the leaves and seeds. Seed-specific promoters, such as the glutelin 
promoter (Goto et al., 1999) may be beneficial in some plants, however constitutive 
promoters may generate better results in cereals such as rice and wheat (Drakakaki et al., 
2000). 
Another consideration for vector design is the incorporation of features to permit 
appropriate targeting of the antibody - for example, deciding whether or not secretion via 
the endomembrane system is the chosen biosynthetic route. In the first publication that 
demonstrated the production of antibodies in transgenic plants, transformants from 
constructs lacking a mouse leader sequence contained very low levels of u and y chains, 
although Southern and Northern blots demonstrated the presence of the transgene (Hiatt et 
al., 1989). Furthermore, none of the plants that expressed leaderless immunoglobulin 
chains contained assembled gamma-kappa complexes. 
The presence of a mouse leader sequence led to the expression of x and y-chains at much 
higher levels and production of functional antibodies. It was suggested that this might be as 
a result of enhanced translation of the immunoglobulin messengers or through the increased 
stability of each protein as a consequence of sub-cellular sequestering or secretion (Hiatt et 
al., 1989). Increased antibody stability may be achieved by retaining the newly synthesised 
molecules in the ER. This can be carried out using a 3' KDEL sequence in the vector, which 
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is translated into a tetrapeptide signal that causes the proteins to be retained in the ER 
(Conrad & Fiedler, 1998; Napier et al., 1992). 
5.2 RECOMBINANT ANTIBODY PRODUCTION IN TRANSCENIC PLANTS 
The first full-length antibody produced in plants was an IgG1 antibody (6D4) expressed in 
tobacco that recognised a synthetic phosphonate ester (P3), and catalysed the hydrolysis of 
certain carboxylic esters (Hiatt et al., 1989). The y heavy chain and x light chain cDNAs 
were cloned individually into the plant expression vector pMON530 (Rogers et al., 1987). 
This vector contains plant selectable markers, promoters, E. coU and Agrobacterium origins 
of replication and a mouse immunoglobulin signal sequence upstream from the polymerase 
chain reaction (PCR) insert. Subsequently, transgenic plants were regenerated using these 
constructs (Hiatt et al., 1989). 
Transgenic plants containing the antibody light or heavy chains were cross-pollinated and 
the seeds harvested (Hiatt et al., 1989). 11 out of 18 of the F1 offspring expressed both y 
and x chains together whilst Western blotting and ELISAs demonstrated that 95 % of these 
plants contained assembled functional antibody. The functional activity of the plant-derived 
antibody was compared with that of the original ascites-derived antibody, by ELISA with a 
P3-BSA conjugate as antigen. The catalytic activities of both antibodies differed by less 
than an order of magnitude, and antigen specificity was confirmed by inhibition of P3-BSA 
binding by free P3, in which the half-minimal inhibition was about 10 mM for both 
antibodies. A surprisingly high level of accumulation of functional 6D4 antibody was 
observed in the transgenic plants, greater than 1% of the total extractable protein (Hiatt et 
al., 1989). 
Coordinate expression of immunoglobulin heavy and light chain genes in a single vector 
yielded high levels of functional antibodies to a fungal cutinase in the roots of transgenic 
tobacco (Van Engelen et al., 1994). The heavy and light chain cDNAs were amplified by 
PCR, fused to a signal sequence for secretion, and expression was under the control of the 
CaMV 35S and TR2' promoters in a single T-DNA - the chimeric genes were cloned in 
tandem in a divergent orientation. Western blotting showed assembly to a full-size antibody 
(Van Engelen et al., 1994), as well as an F(ab)2-like fragment which is probably a result of 
proteolytic breakdown. The construct with divergent promoters directed accumulation of 
functional antibodies up to 1.1 % of the total soluble protein (TSP) [Van Engelen et al., 
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1994]. 
Currently, a number of MAbs produced in plants are in development. In the United States, 
clinical trials on an anti-cancer antibody produced in corn have been performed. Transgenic 
soybeans are also being developed that produce humanised IgG1 antibodies against HSV-2 
(Herpes simplex virus-2) [Zeitlin et al., 1998], a disease that infects approximately 20 % of 
adults in the United States (Fleming et al., 1997). 
A humanised IgGI MAb directed against glycoprotein B of HSV-2 produced in transgenic 
soybean plants (Zeitlin et al., 1998) was compared with the same antibody expressed in 
mammalian cell culture (Co et al., 1991) in a number of assays, including diffusion and 
stability in mucous as well as prevention of vaginal transmission of genital herpes in the 
mouse. These two MAbs were indistinguishable when examined by SDS-PAGE, and their 
affinity was almost identical (5.3 x 10 -7 M'1) [Zeitlin et al., 1998]. Using a mouse model of 
vaginal transmission of HSV-2 infection (Whaley et al., 1994), it was demonstrated that 
vaginal delivery of the plant antibody and the mammalian cell culture-expressed MAb 
provided similar levels of protection against a vaginal inoculum of HSV-2 (Zeitlin et al., 
1998). In vivo, the HSV-2-induced cytopathic effect was reduced by 50 % with a MAb dose 
of 0.2 - 0.3 µg/ml, whereas 100 % protection required a MAb dose of 10 pg/ml. Protection 
against symptomatic infection required less MAb, 50 % protection being provided by a 
MAb dose of 0.01 - 0.1 gg/ml, and 100 % protection was provided at a dose of 
1- 10 gg/ml (Zeitlin et al., 1998). 
The diffusion of the humanised anti-HSV-2 MAb expressed in soybean plants and 
mammalian cell culture in human mid-cycle cervical mucous and water was compared 
(Zeitlin et al., 1998). Neither of the MAbs was slowed in mucous, although it had been 
suggested that differences in glycosylation might affect the ability of a plant-derived 
antibody to diffuse in mucous (Saltzman et al., 1994). These findings are important because 
in order to function effectively on a mucosal surface, antibodies should be able to diffuse 
freely through mucous and bind to their antigen. 
Following exposure to human cervical mucous and semen, both plant and mammalian cell 
cultured-expressed MAbs had similar neutralising activity in vitro (Zeitlin et al., 1998). 
Following incubation in semen for 25 hours at 37 °C, both MAbs retained 75 % of their 
neutralisation activity compared with untreated antibody. Subsequently, following 
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incubation in cervical mucous for 25 hours at 37 °C, the plant antibody retained 100 % of 
its neutralisation activity (Zeitlin et al., 1998). 
5.3 PRODUCTION OF GUY'S 13 MONOCLONAL ANTIBODIES 
Guy's 13 IgG was expressed in transgenic tobacco using the same technology as for the 
6D4 IgG antibody (Ma et al., 1994). mRNA was purified from the Guy's 13 hybridoma cell 
line and cDNA prepared. DNA encoding the gamma heavy chains and kappa light chains of 
Guy's 13 were amplified by PCR using degenerate oligonucleotides, and cloned into 
pL530, a constitutive plant expression vector derived from pMON530, which contains a 
mouse immunoglobulin leader sequence upstream of the cloning site (Rogers et al., 1987). 
The recombinant vector was introduced into Agrobacterium tumefaciens. 
Two additional forms of a hybrid Guy's 13 heavy chain were constructed using a similar 
approach. These encoded chimeric heavy chains consisting of Cy and Ca chain domains. 
The a-chain sequences were derived from a murine IgA MAb MOPC 315 (Ma et al., 
1994). Transgenic plants were regenerated and those that expressed heavy chains were 
cross-pollinated with those expressing light chains, and the resulting seeds germinated. 
Thus three different forms of Guy's 13 MAb were expressed in plants, all of which contain 
the identical kappa light chain, but have different heavy chains. Plant Guy's 13 IgGI 
contains the original gamma heavy chain. Guy's 13 with IgG/IgA hybrid heavy chain 
consisting of var-yl-a2-a3 domains was termed plant Gl/A, and Guy's 13 with IgG/IgA 
hybrid heavy chain consisting of var-yl-y2-a2-a3 domains was termed plant G2/A (Ma et 
al., 1994). The latter therefore contains an extra constant region domain when compared 
with IgG or IgA. 
The functionality of the plant antibodies was tested by ELISA, which confirmed the 
specific recognition of purified SA I/II. The plant antibodies also recognised the native 
antigen on the surface of S. mutans cells. Extracts from transgenic plants that expressed 
single light or heavy chains were not capable of binding antigen. Competitive inhibition 
with the three plant antibodies demonstrated recognition of the identical streptococcal 
epitope to that of the original murine-derived Guy's 13 (Ma et al., 1994). All three plant 
antibodies caused aggregation of S. mutans, which confirmed that the Guy's 13 heavy and 
light chains assembled into bivalent antigen-binding molecules (Ma et al., 1994). 
A total of 10 antibody-producing plants were produced for each form of Guy's 13, in which 
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the yield of recombinant antibody was approximately 1% TSP (Ma et at, 1994). This 
study demonstrated the potential for antibody engineering of the constant region of the 
antibody, which does not appear to affect the ability of plants to assemble the antibody and 
suggested that it might be possible to generate a recombinant plant SIgA version of 
Guy's 13. 
The aims of my study were to; 
1) analyse immunoglobulin assembly in plant cells and the role of ER-resident chaperones, 
and to purify plant recombinant immunoglobulins in order to carry out a preliminary 
analysis of glycosylation, 
2) investigate targeting of mammalian membrane proteins to the plant cell membrane, and 
to determine if functional proteins could be assembled and retained at this site, and 
3) to generate a recombinant SIgA in plants, and to analyse its function and make 
a comparison with its murine IgG counterpart. 
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CHAPTER 2: MATERIALS AND METHODS 
The recipes for all solutions marked * can be found in the Appendix. 
2.1 EXPRESSION AND ASSEMBLY OF RECOMBINANT IMMUNOGLOBULIN 
POLYPEPTIDES IN TRANSGENIC TOBACCO PLANTS 
2.1.1 PREPARATION OF CRUDE PLANT EXTRACTS FOR ELISA 
Approximately 250 mg leaf tissue from plants between 3 and 4 weeks old was 
homogenised in 500 µl ice-cold Tris buffered saline (TBS*) containing leupeptin 
(10 µg ml) [Roche Diagnostics, UK], and centrifuged at 14 000 g for 2 minutes. 
Supernatants were either used immediately or stored in aliquots at - 20 °C. The total 
soluble protein (TSP) concentration of the plant extracts was measured using the 
Bradford protein assay (BioRad, UK). 
2.1.2 PREPARATION OF ELISA PLATES AND ASSAY CONDITIONS 
To screen putative transgenic plants, immunoglobulin heavy and light chain specific 
capture ELISAs were prepared. An antigen-specific (SA I/II) ELISA was used to detect 
whole antibody binding to native antigen. 
ImmobilonTM microtitre plate wells (Nalge, Nunc International, UK) were coated with 
50 µl of the appropriate coating solution and left overnight at 4 °C. The coating 
solutions comprised the following ligands at predetermined optimal concentrations; 
a) Purified SA I/II (2 µg ml') in TBS was kindly supplied by Dr. Charles Kelly, 
Guy's Hospital, London, 
b) Log phase growth S. mutans (NCTC 10449) resuspended in bicarbonate buffer 
pH 9.8 (S mutans grown in Todd-Hewitt broth (Russell et al., 1980) was also 
provided by Dr. Charles Kelly, 
c) Affinity purified goat anti-mouse K chain (1 pg mr) [TCS Biologicals, UK], 
d) Affinity purified goat anti-mouse yl chain (0.6 µg ml") [SigmaAldrich, UK], 
e) Affinity purified goat anti-mouse a chain (1 µg ml") [SigmaAldrich, UK]. 
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ELISA plates were then washed three times with TBS containing 0.05 % (v/v) 
Tween-20 (TBST). To block non-specific binding, 200 µl TBS containing 5% (w/v) 
non-fat milk was added to each well, and the plate left for 2 hours at room temperature. 
The blocking buffer was removed, and the plate used immediately or stored at - 20 °C. 
100 µl of sample supernatants was added in duplicate serial two-fold dilutions (in TBS) 
to the microtitre plate. Non-transformed wild-type plant extracts were used as a negative 
control. For SA I/1I, x light chain and yl heavy chain assays the positive sample control 
was affinity purified Guy's 13 mouse MAb (50 ng mr). For the a heavy chain assay the 
positive control was an IgA monoclonal antibody (TEPC 21,2 µg mi ) [SigmaAldrich, 
UK]. In all cases incubation was at 37 °C for 2 hours. Aller washing with TBST, bound 
immunoglobulin chains were detected with 50 µl of an appropriate conjugated secondary 
antibody for 2 hours at 37 °C. 
The following secondary antibodies were used; 
a) Affinity purified goat antiserum to mouse x chain conjugated with horseradish 
peroxidase (HRP) [1: 1000 dilution, Caltag, USA], 
b) Affinity purified goat antiserum to mouse yl chain conjugated with either alkaline 
phosphatase (1: 1000, SigmaAldrich, UK), 
c) Affinity purified goat antiserum to mouse a chain conjugated with alkaline 
phosphatase (1: 1000, SigmaAldrich, UK), 
Alkaline phosphatase-conjugated antibodies were detected with disodium 
p-nitrophenylphosphate (PNPP) [SigmaAldrich, UK]; IIRP-conjugated antibodies were 
detected with 2,2-azino-di-(3-ethyl-benzathiazoline sulfonate) [ABTS] (Roche 
Diagnostics, UK). Levels of antibody expression were measured by absorbance at 
405 nm (A405) or 450 nm (A450) [for PNPP or ABTS respectively]. 
Expression levels of recombinant proteins were determined by comparison of titration 
points for plant samples in an antigen specific ELISA, with those of Guy's 13 IgG at 
known concentrations. For antibody expressing plants, capture was with streptococcal 
antigen I/II (2 µg/ml). Detection was with HRP-labeled anti-kappa or anti-gamma chain 
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specific antiserum for IgG, or with rabbit anti-secretory component followed by 
HRP-labeled anti-rabbit IgG antiserum for secretory antibody. 
2.1.3 SDS-PAGE 
Crude leaf homogenates (described in section 2.1.1) were analysed by sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) [Laemmli et al., 1970] 
followed by Western blotting. Samples (10 - 20 µl) were heated at 100 °C for 4 minutes 
in 2X SDS-PAGE sample buffer* in the presence (reducing conditions) or absence 
(non-reducing conditions) of 5% (v/v) ß-mercaptoethanol, and loaded onto either 4% 
(w/v) or 10 % (w/v) polyacrylamide gels. The 10 % (w/v) acrylamide gels incorporated a 
stacking gel* comprising 5% (w/v) acrylamide. Electrophoresis, using a mini gel system 
(Hoeffer Scientific Instruments, UK), was at 200 V. 
2.1.4 WESTERN BLOTTING 
For Western blotting, proteins separated on SDS-PAGE gels were transferred onto 
nitrocellulose membrane (Biotrace NT' membrane, Pall Gelman Sciences, UK) using a 
wet vertical transfer system (WB2 blotting apparatus, Anachem, UK), run at 150 V for 
30 minutes in transfer buffer*. 
After transfer, free binding sites on the nitrocellulose membrane were blocked in TBS 
containing 5% (w/v) non-fat milk powder (Marvel, UK) and 0.05 % (v/v) Tween-20 
(TBST) for 2 hours at room temperature or overnight at 4 °C. The membrane was then 
incubated in appropriate primary antisera in TBST for 2 hours at 37 T. 
a) Affinity purified goat antiserum to mouse x chain (1: 1000 dilution; Caltag), 
b) Affinity purified goat antiserum to mouse yl chain (1: 1000; SigmaAldrich, UK), 
c) Affinity purified goat antiserum to mouse a chain (1: 1000; SigmaAldrich, UK) 
d) Affinity purified sheep antiserum to rabbit secretory component (1: 500, 
SigmaAldrich, UK). 
The membrane was washed in two changes of TBST for 1 hour at room temperature. 
The appropriate alkaline phosphatase secondary antibody was then applied for 2 hours at 
room temperature with gentle shaking; 
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a) Affinity purified rabbit antiserum to goat IgG conjugated to alkaline phosphatase 
(1: 1000, SigmaAldrich, UK), 
b) Affinity purified donkey antiserum to sheep secretory component conjugated to 
alkaline phosphatase (1: 1000, SigmaAldrich, UK) 
The membrane was washed a further three times with TBST, and the bound antibody 
was visualised by incubation with insoluble alkaline phosphatase substrate buffer* 
containing nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (Promega, 
UK). 
2.1.5 PREPARATION OF PLANT EXTRACTS FOR IMMUNOBLOTTING AND NORTHERN BLOTTING 
To ensure the homogenous nature of the cellular material for both protein and RNA 
extraction, tissue samples were ground in liquid nitrogen and the homogenous powder 
was split into two aliquots, and either used immediately or stored at - 80 °C. 
For protein analyses, the powder from approximately 250 mg leaf or flower tissue from 
plants between 8 and 9 weeks old, was homogenised in 500 µl ice-cold Tris buffered 
saline (TBS*) containing leupeptin (10 µg ml') [Roche Diagnostics, UK], and 
centrifuged at 14 000 g for 2 minutes. Supernatants were either used immediately or 
stored in aliquots at - 20 °C. The total soluble protein (TSP) concentration of the plant 
extracts was measured using the Bradford protein assay (BioRad, UK). 
2.1.6 PREPARATION OF PLANT RIVA 
Total RNA was extracted from young plants two months after germination, essentially as 
described by Logemann et al., (1987). Leaf or flower tissue was frozen in liquid nitrogen 
with a pre-cooled pestle and mortar and rapidly ground to a powder. This was mixed 
with two volumes of ice-cold guanidine hydrochloride buffer (8 M guanidine 
hydrochloride, 20 mM NMS, 20mM EDTA, 50 mM 2-mercaptoethanol, pH 7). After 
agitation it was added to one volume of phenol : chloroform : isoamyl alcohol 
(25 : 24 : 1, v/v/v), mixed thoroughly, and centrifuged at 12 000 g for 45 minutes. The 
aqueous phase was collected, mixed with ethanol (0.7 volumes) and 1M acetic acid 
(0.2 volumes), and incubated at -20 
°C for 16 hours. Following centrifugation, the 
precipitate was washed three times with 3M sodium acetate, pH 5.2, and then once with 
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70 % ethanol. The pellet was dissolved in sterile RNAse-free water (SigmaAldrich, UK) 
containing RNAse free DNAse (Promega, UK), and incubated at 37 °C for 1 hour, then 
at 70 °C for 5 minutes. Assessments of RNA concentration and purity were made using 
the GeneQuant II RNA/DNA Calculator (Amersham Pharmacia BioTech, UK). RNA 
samples were stored in aliquots of sterile RNase free water at -70 °C. 
2.1.7 ANALYSIS OF BIP AND CALRETICULIN RNA EXPRESSION 
Total mRNA, extracted from the leaves and flowers of wild type and transgenic plants, 
was examined by Northern blotting and hybridisation, using specific DNA probes under 
conditions that had previously been optimised in a series of preliminary experiments. 
2.1.8 PREPARATION OF DNA PROBES FOR NORTHERN BLOTTING 
A 2420 base pair DNA fragment (BLP4) from the tobacco homologue of BiP (Denecke 
et al., 1991) that had been inserted into the Smal site of the plasmid pGEM3Z 
(Promega, UK) was provided by Dr. Jurgen Denecke, University of Leeds, UK. 
E. coli cells (DH5-a GibcoBRL, UK) were transformed with the recombinant pGEM3Z 
plasmid, essentially as described in section 2.4.4, and miniprep plasmid DNA was 
prepared using a commercially available kit (Qiagen, UK). A sample of the purified 
plasmid was digested with Alul and EcoRl (Promega, UK) to reveal the DNA insert of 
expected size, and this linearised DNA was isolated using the QlAquick'"' Gel extraction 
kit, Qiagen, UK. The sequence of the insert was confirmed using a commercial kit 
employing the di-deoxy chain termination procedure (SequenaseTM Version 2.0, 
AmershamPharmacia Biotech, UK) - described in section 2.4.5. 
Recombinant linearised plasmid DNA (100 ng, dissolved in Tris-EDTA, pH7.4) was 
boiled for 3 minutes and placed on ice for 2 minutes then centrifuged briefly, before 
adding to a sterile tube containing a Ready To GOTM d-CTP labeling bead 
(PharmaciaAmersham Biotech, UK). 5 µl [a- 32P] dCTP (3000 Cimmol-1) and sterile 
distilled water were added to a total of 50 µl, and mixed gently. The labeling mixture 
was incubated at 37 °C for 30 minutes. To stop the reaction 5 µl of 0.2 M EDTA (pH 8) 
was added. Unincorporated nucleotides were removed by passing the mixture through 
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Sepharose CL-6B (PharmaciaAmersham Biotech, UK). Labelled DNA was stored at 
-20'C. 
A 1400 base pair DNA fragment from the castor bean calreticulin gene cloned into 
Bluescript KS' (Stratagene, USA) was kindly supplied by Dr. Sean Coughlan, Du Pont 
Agrochemicals, USA (Coughlan et al., 1997). E. coli (DH5-a, GibcoBRL, UK) were 
transformed with this recombinant plasmid essentially as described in section 2.4.4. 
Miniprep DNA was prepared using a commercially available kit (Qiagen, UK). 
Recombinant Bluescript KS+ plasmid DNA was digested with Xhol and EcoRl (Roche 
Diagnostics, UK) to release the DNA insert of expected size. The calreticulin DNA 
insert was sequenced as described in section 2.4.5. To prepare the calreticulin probe for 
use in hybridisations, plasmid DNA was linearised with Xhol and incubated with d-CTP 
Ready To GJ"'' labeling beads as described above. 
2.1.9 NORTHERN BLOTTING OF PLANT RNA 
All solutions and equipment contacting RNA were treated by cleaning in RNAeasy 
solution (MerckEurolab, UK) followed by rinsing in autoclaved 0.1 % (v/v) 
diethylpyrocarbonate-treated water*. 15 µg of total plant RNA (prepared as described in 
section 2.1.6) was separated by electrophoresis on a 1.5 % (w/v) agarose gel. For one 
250 ml gel, 220 ml of distilled water containing 3.75 g of agarose and 0.1 µg ml'' 
ethidium bromide was autoclaved for 20 minutes at 120 °C, and the mixture allowed to 
cool down to 60 °C. 25 ml of 10 X MOPS buffer* preheated to 60 °C, and 7.5 nil 35 % 
(v/v) formaldehyde were added. The solution was mixed gently and poured into an 
RNase-free gel casting tray. 
For each sample of RNA and RNA markers (SigmaAldrich, UK), the following premix 
was prepared: 2 pl 10 X MOPS /3 µl 35 % (v/v) formaldehyde / 10 µl formamide. Up 
to 5 µl of RNA was added to 15 µl of premix, and the volume brought to 20 µl with 
water. Immediately prior to loading the samples were heated at 60 °C for 10 minutes, 
and 5 pl of 5X RNA loading buffer* was added. The gel was submersed in 1X MOPS 
buffer. Samples were run at a constant voltage of 100 V for approximately 2 hours:, 
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The gel was soaked for 30 minutes in 50 mM NaOH / NaH2PO4/ 5 mM EDTA, rinsed in 
RNAse-free water and soaked for a further 45 minutes in 20 X SSPE* to elute the 
formaldehyde. The gel was viewed under UV light and photographed alongside a 
transparent ruler. RNA was blotted onto a Hybond N+ nylon using a transfer pyramid 
with 20 X SSPE as the transfer buffer for 16 hours. The membrane was air dried for 
45 minutes, and the RNA fixed to the membrane by ultra violet (UV) crosslinking (UV 
Crosslinker, Hoefer Scientific Instruments) for 90 seconds. 
2.1.10 HYBRIDISATION 
Following Northern blotting, the Hybond N+ membrane was prehybridised in 50 µl cm 2 
of prehybridisation buffer* at 42 °C for 3 hours. Labeled probe (prepared as described in 
section 2.1.8) was denatured by the addition of 1 volume of deionised formamide 
(SigmaAldrich, UK) and heated for 5 minutes at 90 °C, then kept on ice. The denatured 
probe was added to the filter, and incubation was for 16 hours at 42 °C. The membrane 
was washed briefly with 100 ml 0.1 X SSPE / 0.5 % (w/v) SDS at room temperature to 
remove most of the free probe. 100 ml of the same buffer heated to 42 °C was added to 
the membrane, with shaking for 30 minutes at 42 °C. One additional wash was usually 
sufficient to ensure that the membrane background was low. The membrane was washed 
once with 0.1 X SSPE at room temperature to remove SDS, blotted dry between filter 
paper and sealed in plastic SaranwrapTM, prior to exposure on BiomaxTM MS film 
(Kodak Scientific Imaging, UK) at -70 °C for 72 hours. 
2.1.11 IMMUNOBLOT DETECTION OF BIP AND CALRETICULIN PROTEIN 
Flower homogenates from 6 wild type plants were pooled and used as a positive control 
on each protein immunoblot. Leaf extracts from 6 wild type plants were pooled and used 
as a pooled wild type control. 
Crude plant extracts were analysed on 10 % (w/v) polyacrylamide by SDS-PAGE under 
reducing conditions (Laemmli et al., 1970), followed by Western blotting (as described 
in section 2.1.4). Polyclonal rabbit antisera to tobacco BiP was kindly donated by 
Dr. Jurgen Denecke, University of Leeds, UK, and used at 1: 5000 dilution. Polyclonal 
rabbit antisera to tobacco caireticulin was also generously provided by Dr. Denecke, and 
used at 1: 5000 dilution. 
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The levels of BiP and calreticulin protein in each sample were compared by densitometry 
using the Syngene GeneGeniuslM image analysis software (Synoptics Ltd., Cambridge, 
UK) to allow relative quantification. Results were expressed relative to the amount of 
BIP or calreticulin detected in the flower extract present on each Western blot. 
2.1.12 PREPARATION OF PROTOPLASTS 
To compare the amount of BiP or calreticulin associated with recombinant 
immunoglobulins in the different plant extracts, it was important that an equal number of 
plant cells were used in each case. To do this, we prepared equal numbers of plant 
protoplasts, and carried out immunoprecipitations using either the lysed cell contents, or 
the protoplast medium supernatant. 
Protoplasts were prepared from the leaves of 2-5 week old tobacco leaves. Leaves were 
surface sterilised by immersion in; 0.5 % (v/v) sodium hypochlorite for 1 minute, 70 % 
(v/v) ethanol for 30 seconds, 1% (v/v) sodium hypochlorite for 1 minute, and sterile 
distilled water for 1 minute, and then air dried in a fume hood. Using a scalpel blade, the 
surface of the underside of the leaf was cut every 1-2 mm. Leaves were then transferred 
onto the surface of 7 ml 1X enzyme digestion buffer* in disposable petri dishes at room 
temperature. The leaves were placed on the liquid surface without wetting the upper 
side, then left overnight at 25 °C in the dark. 
The digestion buffer was removed, 6 ml of K3 buffer* was added dropwise to the leaves 
and the dishes shaken gently to release the protoplasts. The suspension was filtered 
through a sterile 100 µm-mesh nylon filter, previously wetted (bottom side) in K3 buffer. 
The filtrate was collected in a sterile tube. Protoplasts were transferred into 50 ml 
Falcon"' tubes (Beckton Dickinson, UK). Tubes were centrifuged for 20 minutes at 60 g 
using a swing-out rotor without applying the brake. Following centrifugation, vital 
protoplasts formed a floating layer, whereas dead cells formed a pellet. The vital 
protoplasts were removed carefully using a wide-bored pipette, and washed twice in four 
volumes of W5 buffer* by centrifugation at 60 g for 5 minutes. Following a further 
centrifugation for 10 minutes at 60 g, the pellet was resuspended in 2 ml W5 buffer and 
cells were counted using a haemocytometer. Cells were centrifuged again, and 
resuspended in W5 buffer at a concentration of 2x 106 cells/ml. 
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2.1.13 IMMLINOPRECIPITATION OF CHAPERONES ASSOCIATED WITH RECOMBINANT 
IMMUNOGLOBULINS 
For immunoprecipitation studies all manipulations were performed on ice or at 4 °C, 
using ice-cold buffers. 2x 106 protoplasts isolated from transgenic plants were 
homogenised by adding 4 volumes of ice-cold homogenisation buffer*, supplemented 
immediately before use with CompleteTM anti-protease mix (Roche Diagnostics, UK). 
Samples were vortexed, centrifuged at 14 000 g for 5 minutes at 4 T. The insoluble 
pellet was discarded, and the protoplast homogenate either used immediately or stored at 
-80 °C. 
A fraction of the protoplast homogenate (250 µl) was brought to a volume of 1 ml with 
NET-gel buffer*. Samples were centrifuged for 4 minutes at 12 000 g, and supernatants 
transferred to new microtubes, then centrifuged again to remove precipitating material. 
This supernatant was incubated with rabbit anti-mouse IgG/A/M (Zymed Inc., USA) 
[1: 1000] for 4 hours on ice. 
125 µl of a 10 % (v/v) suspension of Protein-A-Sepharose (Amersham Pharmacia 
Biotech, UK) prepared in NET buffer* was added, and the sample incubated for 2 hours 
at 4 °C with slow rotation. Protein-A-Sepharose was pelleted by centrifugation for 2 
minutes at 12 000 g, the supernatant discarded, and the beads resuspended in 1 ml of 
NET-gel buffer and centrifuged again - this step was repeated three times. To determine 
chaperone activity, 4 mM ATP (SigmaAldrich, UK) was included in the NET-gel buffer 
for three washes. An equal volume of 2X SDS-PAGE loading buffer (between 
30 - 40 µl) was added to the beads, mixed well and boiled for 4 minutes. The sample 
was centrifuged for 2 minutes at 12 000 g at room temperature, and loaded onto 10 % 
(w/v) SDS-PAGE, prior to Western blot analysis. 
2.1.14 DETECTION OF BIP AND CALRETICULIN ASSOCIATED WITH 
IMMUNOGLOBULIN CHAINS 
Chaperone proteins were visualised by Western blotting using either; the polyclonal 
rabbit anti-BiP antiserum or the polyclonal rabbit anti-calreticulin antiserum, followed by 
an alkaline phosphatase labeled anti-rabbit IgG antiserum (as described in section 2.1.4). 
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2.2 N-CLYCOSYLATION OF A RECOMBINANT PLANT VERSION OF GUYS 13 MAb 
2.2.1 PURIFICATION OF RECOMBINANT PLANT IEG 
Mature transgenic tobacco plants expressing Guy's 13 MAb were homogenised in a 
Waring1M blender on ice with 1.5 volumes of extraction buffer (37.5 mM Tris-HC1 pH 
7.5,50 mM NaCl, and 10 pg mf' leupeptin). After centrifugation of the homogenate at 
12 000 g for 30 minutes at 4 °C, ammonium sulphate was added to 50 % saturation. 
After 2 hours at 4 °C, the solution was centrifuged again, and the pellet resuspended in 
TBS* to 1/5 of the original volume. The final solution was then centrifuged at 25 000 g 
for 30 minutes at 4 °C. The concentrated extract was filtered through a 0.45 µm filter 
and loaded onto a HiTrap Protein-G column (Amersham Pharmacia Biotech, UK). The 
IgG was eluted with 0.1 M glycine-HC1 pH 2.7 and neutralised with 1.5 M Tris-HCl pH 
9.5. The preparation was loaded onto a goat anti-mouse IgGI Sepharose column 
(SigmaAldrich, UK), eluted with glycine-HCI 0.1 M pH 2.5, neutralised with 1.5 M 
Tris-HCI pH 9.5, dialysed overnight against PBS and passed through a 0.22 µm filter. 
The protein concentration was estimated by measuring the absorbance at 280 nm. 
The purity of the preparations was assessed by SDS-PAGE, essentially as described in 
section 2.1.3. Plant recombinant Guy's 13 samples were boiled for 4 minutes in 75 mM 
Tris-HC1 (pH 6.8) containing 2% (w/v) SDS with or without 5% (v/v) 
ß-mercaptoethanol, then separated on a 10 % (w/v) acrylamide gel. Proteins were 
visualised by staining acrylamide gels in Coomassie blue (SigmaAldrich, UK) followed 
by destaining with a solution of 20 % methanol, 10 % acetic acid. Alternatively, the 
protein bands were transferred to nitrocellulose for Western blotting (as described in 
section 2.1.4). 
2.2.2 PREPARATION OF RECOMBINANT PLANT GUY'S 13 Fab FRAGMENTS 
Purified recombinant plant Guy's 13 was incubated with papain (1: 100) [SigmaAldrich, 
UK] in 0.1 M Tris-HCl, pH 7 containing 2M EDTA and 20 mM cysteine, for 16 hours 
at 37 °C. The reaction was stopped by incubation with 0.1 M iodoacetamide for 1 hour 
at 37 °C. Contaminating Fc was removed by incubation with Protein-G Sepharose beads 
(Amersham Pharmacia Biotech, UK) for 5 hours at 37 °C, and the supernatant was 
recovered by centrifugation. 
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2.2.3 ELISA ANALYSIS OF PLANT ANTIBODY AND Fab FRAGMENT BOUND TO SA I/II 
ELISA plates were coated with SA VII at a predetermined optimal concentration 
(2 pg ml-'), as described in section 2.1.2. Solutions of plant antibody were applied for 
2 hours at 37 °C. The plates were washed with TBST, and either anti-mouse x chain 
(TCS Biologicals, UK), anti-mouse yl chain (SigmaAldrich, UK) or anti-plant xylose 
antibodies (kindly donated by Dr. Loic Faye, University of Rouen, France) were applied 
for 2 hours at 37 °C. After further washes, incubations in appropriate alkaline 
phosphatase-conjugate antisera were performed for 2 hours at 37 °C. Finally, detection 
was carried out using disodium p-nitrophenylphosphate (Sigma-Aldrich, UK). 
Absorbance was read at 405 nm. 
2.3 TARGETING AND RETENTION OF RECOMBINANT IMMUNOGLOBULIN CHAINS 
TO PLANT CELL MEMBRANES 
2.3.1 IMMUNOCLOBULIN CHAIN DETECTION BY ELISA 
Young plant leaves were homogenised in TBS containing leupeptin (10 µg ml") as 
described in section 2.1.1, although 1% (v/v) Nonidet P40 (NP40) was included in 
homogenisation buffer as indicated. Following centrifugation at 14 000 g for 2 minutes, 
the supernatant was added in 3-fold dilutions to microtitre plates that had been coated 
with either; goat anti-mouse yi antisera (1: 1000, SigmaAldrich, UK) or SA I/II 
(2 pg mr'), and blocked with 5% (w/v) non-fat dry milk (Marvel, UK) in TBST buffer. 
Immunoglobulin chains present in plant homogenates were detected by ELISA as 
described in section 2.1.2. 
2.3.2 ELISA ANALYSIS OF PROTOPLASTS 
Protoplasts were isolated from leaf tissue (as described in section 2.1.12) and 
resuspended at 2x 106 cells ml'. For ELISA analysis of protoplasts, supernatants from 
overnight digestions were also collected and applied to microtitre plates. Protoplast 
aliquots were also harvested on a sucrose cushion (12 % w/w), resuspended in 1X 
enzyme digestion buffer lacking enzymes, and disrupted by sonication. The samples were 
centrifuged at 50 000 rpm for 45 minutes at 4 °C. Cell pellets were resuspended in TBS 
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buffer containing leupeptin (10 µg m1") and 1% (v/v) NP40, and applied to microtitre 
plates as described in section 2.1.2. 
2.3.3 IMMUNOFLUORESCENT STAINING OF PROTOPLASTS 
Protoplasts were prepared (as described in section 2.1.12), and resuspended at 
2x 106 m1' in W5 buffer. For immunofluorescence studies, protoplasts were not fixed 
but essentially maintained as live cells. Fluorescein isothiocyanate (FITC) labelled goat 
anti-mouse kappa chain (1: 25, SigmaAldrich, UK), or FITC labelled goat anti-mouse yl 
antiserum (1: 25, SigmaAldrich, UK) were added to the protoplasts, and incubated for 
3 hours at 25 °C in the dark. Protoplasts were then washed 3 times in 3 volumes of W5 
buffer by centrifugation at 60 g for 5 minutes, and viewed by fluorescence microscopy 
using an Olympus BH2 microscope. 
For control samples, protoplasts from a plant transformed with an irrelevant protein 
were incubated for 3 hours at 25 °C in the dark, with a polyclonal rabbit antibody against 
Arabidopsis plasma membrane proton pump ATPase antisera (1: 100), kindly donated by 
Dr. Mike Sussman (University of Wisconsin, USA). Protoplasts were washed 3 times in 
W5 buffer as before, prior to incubation with FITC labelled goat anti-rabbit IgG (1: 25, 
SigmaAldrich, UK), for a further 3 hours, and then washed 3 times in W5 buffer. 
2.3.4 EXPRESSION OF THE CHEMOKINE RECEPTOR CCR-5 
A cDNA clone of human CCR-5 chemokine receptor was kindly donated by Professor 
Thomas Lehner, Department of Immunobiology, Guy's Hospital, London. Transgenic 
plants were prepared by Dr. Pascal Drake, Department of Oral Medicine and Pathology, 
Guy's Hospital, London. 
2.3.5 ANALYSIS OF TRANSGENIC PLANTS BY RT-PCR 
The expression of the transmembrane domain of the chemokine receptor molecule 
CCR-5 was investigated by RT-PCR. Total RNA was purified from putative transgenic 
plants expressing CCR-5 protein, as described in section 2.1.6. RT-PCR was performed 
using specific CCR-5 oligonucleotides (refer to the Appendix), essentially as described in 
section 2.4.1. 
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2.3.6 IMMUNOFLUORESCENCE STUDIES 
Protoplasts were prepared from plants (described in section 2.1.12) that were shown to 
express a product of the expected size in a RT-PCR using specific CCR-5 
oligonucleotides. Protoplasts were incubated in W5 buffer containing partially specific 
monkey antisera (1: 100) raised against the human CCR-5 molecule, which was kindly 
provided by Dr. Lesley Bergmeier, Guy's Hospital, London. The protoplasts were 
washed, and incubated in W5 buffer containing FITC labelled rabbit anti-monkey IgG 
antibodies (1: 25) [SigmaAldrich, UK], washed and observed under UV microscopy. 
Protoplasts from non-transformed plant (WT) and from transgenic plants expressing an 
irrelevant protein were treated in similar fashion, and were examined under UV 
microscopy. 
2.4 EXPRESSION AND ASSEMBLY OF A SECRETORY ANTIBODY 
IN TRANSGENIC TOBACCO PLANTS 
2.4.1 REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION (RT-PCR) 
Putative transgenic plants expressing murine J chain were screened for the production of 
J chain RNA transcript by reverse transcriptase polymerase chain reaction (RT-PCR) 
with specific J chain oligonucleotides. 
RNA can be reverse transcribed into single-stranded cDNA (Mierendorf & Pfeffer, 
1987) using Virus Reverse Transcriptase (MMuLV RT) [Promega, UK]. Approximately 
2 µg of plant RNA template was used in 20 µ1 reaction mix comprising; 2 µl Oligo- 
p(dT), S primer, 2 µl 10 X Reaction buffer (100 mM Tris, 500 mm KC1; pH 8.3), 5 mM 
MgCl2,2.5 mM Deoxynucleotide (dNTP) mix, 1 µl RNase Inhibitor (50 U), 0.8 ti 
MMLV Reverse Transcriptase (20 U), and sterile water as required. 
Control reactions were performed in the absence of reverse transcriptase, to confirm that 
any bands detected by PCR were derived from RNA. Reactions were incubated at 37 °C 
for 1 hour. Approximately 5 ng of template DNA was amplified in 100 µl reaction mix 
comprising; 50 pmol oligonucleotide primers, 200 mM dNTP, 10 µl 10 X PCR buffer 
[100 mM Tris-HC1(pH 9.0), 15 mM MgC12,500 mM KCl] with 2.5 U Taq polymerase. 
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Oligonucleotides were purchased from Oswel (University of Southampton, UK), and 
were used to amplify DNA encoding specific sequences found in; J chain, yl heavy 
chain, and a constitutive chloroplast ribonucleoprotein (rubisco). Details of the primers 
can be found in the Appendix. 
Amplification was for 30 cycles: at 96 °C for 30 seconds for denaturing, at 55 °C for 
60 seconds for annealing, and at 72 °C for 90 seconds for extension. This was followed 
by a final extension at 72 °C for 10 minutes. Aliquots of the reaction mixture were 
analysed by agarose gel electrophoresis and used immediately or kept at -20 °C for 
longer periods. 
2.4.2 AGAROSE GEL ELECTROPHORESIS 
DNA samples were analysed against a1 kb or 100 base pair (bp) marker (GibcoBRL, 
UK) in 1% agarose gels (Seakem LE agarose gel, Flowgen, UK) in TAE buffer*, 
following addition of DNA loading buffer*. Electrophoresis was run using the GNA-100 
gel electrophoresis apparatus (AmerhsamPharmacia Biotech, UK) at 90 V in TAE 
buffer. DNA bands were visualised by ethidium bromide staining (0.5 µg m1"ß in water) 
and gels were photographed under UV exposure. 
In order to isolate DNA fragments, following staining in ethidium bromide, bands were 
excised and the DNA recovered using a commercially available gel extraction kit 
(Qiagen, UK). The samples were resuspended in a volume of 50 µl, and the purity of the 
DNA was confirmed by gel electrophoresis. 
2.4.3 RE-CLONING OF J CHAIN 
To confirm the sequence of the J chain construct, we isolated the J chain construct 
expressed in transgenic plants by RT-PCR and re-cloned into the plasmid vector 
Bluescript KS" (Stratagene, UK), using the restriction enzyme sites Xhol and EcoRl. 
Approximately equal amounts of J chain DNA and Bluescript KS* plasmid DNA were 
used for ligation. The ligation reaction comprised; the insert, vector, 10 U of T4 DNA 
ligase (GibcoBRL, UK), 1X ligation buffer [20 mM Tris-HCI, 1 mM EDTA, 5 mM 
DTT, 60 mM KCI, 50 % (v/v) glycerol, (pH 7.5) AmershamPharmacia Biotech, UK], in 
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a total volume of 20 µl. Ligations were incubated at room temperature overnight, and 
then de-salted by passing through Sepharose CL-6B. 
2.4.4 TRANSFORMATION 
1 µl of recombinant Bluescript KS" vector was incubated with 20 pl E. coli cells (DH5-a, 
Gibco BRL, UK) on ice for 30 minutes. The mixture was incubated at 42 °C for 
45 seconds, then placed on ice for 2 minutes. 500 µl sterile SOC medium* was added, 
and incubated at 37 °C for 2 hours. Cells were plated onto solid Luria Bertani (LB) 
medium* containing ampicillin (100 µg m1), and coated with 40 µI 2% X-Gal solution* 
and 4 µl 1M IPTG solution*, and incubated at 37 °C overnight. White colonies resistant 
to the antibiotic were picked and grown in LB medium containing 100 µg ml's ampicillin 
at 37 °C overnight. Plasmid DNA was purified using a commercially available kit 
(Qiagen, UK) and stored at - 20 °C. 
An aliquot of the purified plasmid DNA was digested with Xhol and EcoRl in 
accordance with supplier's instructions. Protocols for the use of these enzymes can be 
found in Sambrook et al., (1989). Samples of digested plasmid, and undigested plasmid 
(as a control) were assessed by agarose electrophoresis. 
2.4.5 DNA SEQUENCE ANALYSIS 
Purified plasmid DNA prepared from J chain expressing transgenic plants was sequenced 
by the di-deoxy chain termination procedure, using T3 and T7 sequencing primers 
(AmershamPharmacia Biotech, UK) - details in the Appendix - and a commercially 
available kit (Sequenasee Version 2.0, Amersham Pharmacia Biotech, UK). 
1-5 µg double stranded DNA (ds DNA) in a volume of 5 µl was denatured by 
incubation with 2 µl of NaOH (2N) for 10 minutes at room temperature. DNA was 
recovered by spin column chromatography using Sepharose CL-6B into a tube 
containing 1 µl of primer at 5 pmol t1' and 2 pI of 5X buffer (200 mM Tris-HC1 
(pH 7.5), 100 mM MgCl2,250 mM NaCI). Labeling mix (5.5 µl) for each reaction was 
comprised of 1 µl 0.1 M DTT, 2 µl of labeling mix buffer (7.5 µM dGTP, 7.5 µM dCTP, 
7.5 µM dTTP; diluted 1/5 in water), 0.5 µl (0.185 MBq) of [35"S]-dATP, and 2 µ1 of T7 
DNA sequenase (13 Uµ1") diluted 1/8 in diluting buffer [10 mM Tris-HC1 (pH 7.5), 
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5 mM DTT, 0.5 mg ml"' Bovine Serum Albumin (BSA)] to the DNA. 3.5 111 of the mix 
was then added to four tubes containing 2.5 µ1 of ddNTPS (A-C-G-T). Samples were 
incubated at 37 °C for 5 minutes. Reactions were stopped by adding 4 µl of stop buffer 
(95 % formamide, 20 mM EDTA, 0.05 % bromophenol blue, 0.05 % xylene cyanol FF). 
Samples were either analysed immediately or stored at -20 °C. 
Samples to be analysed were heated for 2 minutes at 90 °C, immediately put on ice and 
aliquots (3 µl) were applied to a sequencing gel. The gel was run with parameters set at 
2000 V, 50 - 60 mA and 50 - 60 W. Electrophoresis was for 30 minutes to 6 hours 
depending on the distance from the primers that had to be sequenced. Gels were then 
transferred to a fixing solution for 30 minutes before being dried on a heat vacuum 
device and exposed to Kodak Biomax MR-1 X-ray film. The film was developed and the 
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CHAPTER 3: RESULTS I 
Expression and assembly of recombinant immunoglobulin polypeptides 
in trans2enic tobacco plants 
As described in Chapter 1, a number of transgenic plant lines have previously been 
prepared, that were studied in this thesis. In this Chapter these plants were utilised to 
investigate specific events in the plant secretory pathway, namely protein folding and 
glycosylation. The ability of plants to perform these functions represents two of the key 
benefits of this eukaryotic heterologous protein expression system. 
The original observation (Hiatt et al., 1989) that functional immunoglobulins were 
correctly assembled and expressed at high levels in plants, even though there are no 
homologous proteins in plants, suggested that the mechanisms of protein assembly in plants 
and mammals are broadly similar. Within the endoplasmic reticulum (ER) of mammalian 
cells, a series of chaperones and enzymes are involved in protein assembly, of which the 
best characterised include the immunoglobulin binding protein (BiP) and calreticulin. 
Homologues of these molecules have been identified in plants, and we wanted to confirm 
their involvement in antibody assembly in plants. 
Within the ER and further along the secretory pathway, N-linked glycosylation is an 
important post-translational modification. As discussed earlier, the addition of glycans to a 
protein not only influences protein folding, but also the susceptibility to proteolytic 
degradation, protein function and immunogenicity. Therefore, we carried out a preliminary 
analysis of N-linked glycosylation on plant derived IgG. 
Overall the aims were; 
1) to identify transgenic plants expressing either immunoglobulin heavy or light chains, or 
functional assembled IgG from seed stocks and characterise the expression levels of 
each recombinant protein. 
2) to determine if plant BiP and calreticulin participate in transgenic plants, in the folding 
of recombinant immunoglobulin heavy and light chains and the assembly of an IgG 
monoclonal antibody. 
3) to purify recombinant IgG from plants and perform preliminary glycosylation analysis. 
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3.1 Identification of transgenic plants and comparison of recombinant protein 
expression levels. 
Stable homozygous seed stocks were used to generate the plants used in this study. 6 plants 
representing each line were selected and the accumulation of transgenic gene product 
(none, kappa chain, gamma chain or both chains) was examined. Kappa and gamma chain 
capture ELISAs were performed to detect the presence of these chains, an assay for co- 
expression of kappa and gamma chains utilised streptococcal antigen on the solid phase. 
This latter assay confirms and measures the assembly of functional antibody. 
The ELISAs confirmed recombinant protein accumulation and demonstrated that the 
titration curves for each of the 6 transgenic plants in each group were very similar, with no 
significant differences observed between plants in the same group (Figure 3.1), although 
there were differences between groups. In all the assays, supernatant from a Guy's 13 
hybridoma cell culture was used as positive control, and an extract from a wild-type non- 
transformed tobacco plant was used as the negative control. 
The relative accumulation levels for each group were calculated from ELISA results by 
comparison with known Ig standards, and expressed as a percentage of total soluble 
protein: 
Construct Percentage Mean +/- standard deviation 
K 0.007 +/- 0.001 
Y 0.207 +/- 0.023 
IgG 1.270 +/- 0.210 
Table 1: Accumulation levels of recombinant immunoglobulins in transgenic plants. 
Thus, y chain accumulation was approximately 30 times higher than K chain accumulation, 
which is consistent with previous findings (Hiatt et al., 1989). The level of accumulation of 
functional IgG antibodies was higher still, with greater than 1.2 % of total extractable 
protein found to be functional IgG antibody. 
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3.2RiP 
3.2.1 Detection of BiP RNA 
Northern blot analysis of transgenic plants using a BiP DNA probe is shown in Figure 3.2. 
Flower and leaf tissue from six transgenic plants representing each construct were used and 
results from 2 plants in each group are shown. A transcript of the expected size for BiP was 
found in all plant lines in both flowers (Panel A) and leaves (Panel B). Overall, the BiP 
transcript was more prominent in flower samples as expected (Denecke et al., 1991). 
Between lines, the levels of hybridising transcripts varied, with a pattern that was 
consistent between flower and leaf samples. BiP transcript was highest in those plants 
expressing the heavy chain alone. Low transcript levels were detected in the wild type 
plants or those expressing light chain alone, and an intermediate level of transcript 
expression was found in plants expressing assembled IgG. 
The results suggest that BiP expression may be increased when cells are actively secreting 
proteins such as recombinant immunoglobulin heavy chain or assembled immunoglobulin. 
However, BiP mRNA levels do not correlate with overall recombinant protein expression 
levels, as although IgG plants express approximately 6-fold more protein than the 
respective heavy chain plants, the mRNA expression level is visibly less. 
3.2.2 Detection of total BiP protein in transgenic plants 
Western blotting was used to detect BiP protein in crude leaf extracts from transgenic 
plants. A representative immunoblot is shown in Figure 3.3, in which extracts from two 
wild type plants, and two plants each expressing: unassembled heavy chains, unassembled 
light chains, or assembled immunoglobulin were analysed. Equal amounts of leaf tissue 
were used to prepare the samples, and detection was with an anti-tobacco BIP antiserum, 
kindly provided by Dr. Jurgen Denecke. 
The crude extract from the flower of a wild type plant was used as a positive control to 
demonstrate the expected position of BiP (Mr 75,000) on Western blot. The flower extract 
was used as a marker solely because BiP protein levels are normally higher in flowers 
(Denecke et al., 1991). A single immuno-reactive band of the expected size was detected, 
and no cross-reactive bands were found. Using the same mass of starting leaf material, the 
lowest level of total BiP was detected in leaf extracts from wild type plants, and no 
difference was observed in plants that expressed unassembled x light chain. The highest 
65 
levels of BiP protein were detected in leaf extracts from plants expressing unassembled 
gamma heavy chains, and those that expressed assembled IgG. 
The same BiP specific immunoblots were performed using all 6 plants for each transgene 
previously assayed by ELISA for recombinant protein expression (section 3.1) [data not 
shown]. The relative total levels of BiP were then compared by densitometric analysis of 
the immunoblots. For standardisation purposes, the same pooled sample derived from 
flower tissue was used in each blot, and arbitrarily measured as 100 % for the purposes of 
densitometric measurements. Furthermore, the same pooled sample from wild type plant 
leaf tissues was used throughout. 
Individually, BiP protein expression in each group of 6 plants was fairly uniform. The wild 
type plant leaf samples yielded a mean densitometry reading approximately 55 % that of 
the flower sample (Figure 3.4). In leaf tissue from transgenic plants expressing the kappa 
light chain, the gamma heavy chain, and IgG, mean total BiP protein expression was higher 
than that in wild-type plants. However, only the differences between y and WT groups, and 
between IgG and WT groups reached significance (F=6.41, p=0.003 ANOVA). In the y and 
IgG groups, BiP protein expression was approximately double that of wild type plants. 
However, no significant difference was observed between y and IgG plants. 
3.2.3 Detection of BiP protein associated with immunoglobulin chains 
To investigate the specific association of BiP with recombinant immunoglobulin chains we 
prepared protoplasts from wild type and transgenic plants (expressing x light chain, y heavy 
chain and full-length IgG) and looked for co-immunoprecipitation of BiP with the 
recombinant proteins. 
Equal numbers of protoplasts were prepared from each transgenic or control plant, lysed, 
and the lysates were immunoprecipitated (described in Materials and Methods) using an 
antisera to murine light and heavy chains. Following SDS gel-electrophoresis and blotting 
onto nitrocellulose, immunodetection was with an anti-BiP antiserum and results from one 
series of experiments are shown in Figure 3.5 panel A. Co-precipitating BiP was clearly 
recovered from transgenic plants expressing only heavy chain (y). A smaller amount of 
BiP was co-precipitated from plants that produced assembled immunoglobulin (IgG). A 
faint BiP band was detected from plants expressing light chain (K) alone. No BiP was 
precipitated from wild type plants that did not express recombinant immunoglobulin 
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chains, and there were no cross reactive bands from this preparation or from a control 
reaction containing only the protoplast lysis buffer. 
It had already been demonstrated in a collaborative study that the majority of IgG is 
secreted from protoplasts (Frigerio et al., 2000). To demonstrate that the BiP interaction 
with immunoglobulin chains was an intracellular phenomenon, the immunoprecipitation 
experiment was also carried out using protoplast lysates in comparison with protoplast 
culture medium (Figure 3.5B). The anti-BiP antiserum did not cross-react with Guy's 13 
IgG. BiP was detected in immunoprecipitates from IgG transgenic protoplasts, but not from 
the protoplast medium, indicating that BiP is not secreted as a complex with 
immunoglobulin. 
To confirm that co-precipitation of Biz' reflected real chaperone action, we tested whether 
the interaction of BiP with immunoglobulin chains was sensitive to ATP. For these 
experiments, protoplasts were prepared from transgenic plants expressing only the Ig heavy 
chain. The cells were lysed as before and cell homogenates were immunoselected with 
either anti-BiP or anti-mouse IgG antisera. The results are shown in Figure 3.6. With anti- 
BiP immunoprecipitation, a BiP band is detected in samples with or without addition of 
ATP at equivalent levels. A strongly cross-reactive polypeptide which is approximately the 
same size as the y chain (Mr 50K) is also detected, but this is most likely to represent the 
heavy chain of the rabbit anti-BiP immunoglobulin used for immunoprecipitation. When 
immunoprecipitation was performed with a Goat anti-Mouse IgG antiserum, the BiP 
reactive band is detectable in the absence of ATP (right hand panel). However, the intensity 
of this band is diminished upon incubation with ATP, suggesting a ligand-chaperone 
relationship between the BiP and Ig heavy chain. 
3.3 Calreticulin 
Calreticulin, like BiP, is a highly conserved ER resident chaperone (Denecke et al., 1995). 
It is the major calcium binding protein in the ER (Michalak et al., 1992) and it has been 
shown to form an abundant complex with BiP (Crofts et al., 1998). The role of calreticulin 
as a chaperone was demonstrated in the folding and assembly of major histocompatability 
complex (MHC) class I molecules (Sadasivan et al., 1996), and it is known to bind 
specifically to newly synthesised glycosylated proteins (Otteken & Moss, 1996). However, 
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in plasma cells, no role has yet been reported for calreticulin in the folding and assembly of 
immunoglobulins. 
3.3.1 Detection of calreticulin RNA 
Using the same plants described for the BiP studies, RNA was extracted from the leaves 
and flowers of each of the 6 plants representative of each construct, and used in Northern 
hybridisations with a calreticulin specific DNA probe. The results from two plants (per 
construct) are shown in Figure 3.7. 
A transcript of the expected size (1.4 kb) for calreticulin was found in each of the plant 
lines examined. The results mirrored those for BiP in that the levels of calreticulin 
transcript were highest in plants expressing the heavy chain alone (y), and the lowest levels 
were found in wild type plants or those expressing light chain alone (x). An intermediate 
level of transcript expression was found in plants expressing assembled IgG. Similar results 
were found in flower and leaf tissues. 
3.3.2 Detection of total calreticulin protein in transgenic plants 
Western blotting was used to detect total calreticulin protein in crude leaf extracts prepared 
from wild type and transgenic plants. As with BiP (Section 3.2.2), 6 plants per construct 
were used, and the western immunoblot bands were analysed by densitometry, and 
compared against the standardised flower extract (100 %). 
The pattern of total calreticulin expression in the different plants was similar to that found 
for BiP. The lowest levels were detected in wild-type leaf extracts and plants expressing 
kappa chain (x) alone. Higher levels of calreticulin were detected in plants expressing 
assembled IgG and the highest expression levels were in plants expressing unassembled 
immunoglobulin heavy chains (y). In this case, the differences between both WT and 
Kappa groups compared with the Gamma group were statistically significant (F=6.65, 
p=0.003 ANOVA). 
3.3.3 Detection of calreticulin protein associated with immunoglobulin chains 
In contrast to BiP, it was not possible to detect calreticulin in association with recombinant 
immunoglobulin chains (Figure 3.9). Protoplasts were prepared from non-transformed 
(WT) and transformed (y and IgG) plants. Lysed cell extracts were immunoprecipitated 
with antiserum to murine IgG (heavy and light chains), and after SDS-PAGE and 
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immunoblotting, detection was with either anti-calreticulin (A) or anti-BiP (B) antisera. No 
co-precipitating bands of the expected size for calreticulin were detected from any plant 
(Panel A), as compared with calreticulin present in a WT flower extract. However, as 
shown previously, co-precipitating BiP was detected from the same heavy chain y plant 
sample but not WT (Panel B). 
3.4 N-glycosylation of a recombinant plant version of Guy's 13 MAb 
Post-translational modification of proteins by glycosylation is a characteristic of all higher 
eukaryotes, and plant proteins contain both N-linked and O-linked glycans. Most clinically 
significant mammalian proteins including antibodies, are glycosylated, and their 
glycosylation can affect their physiochemical properties. Indeed, many of the properties of 
antibodies are dependent on their glycosylation; such as immunogenicity, half-life in vivo, 
sensitivity to proteases, normal secretion, and correct assembly (Crottet & Corthesy, 1998; 
Taylor & Wall, 1988). 
Native complex glycans in plant proteins can be heterogenous, although they are usually 
smaller than mammalian complex glycans and contain different terminal sugar residues 
(Lerouge & Faye, 1996). Complex glycans in plants, as in insects and yeast, do not contain 
sialic acid residues, and may contain xylose and/or a(1,3)-fucose residues instead of 
a(1,6)-fucose residues (Sturm et al., 1987). N-acetyl neuraminic acid is a prevalent 
terminal residue in mammals but has not been shown in plants. The aim in this study was to 
perform a preliminary analysis of antibody glycosylation in plants, in anticipation of a 
definitive structural analysis. 
3.4.1 Purification of recombinant plant IgG 
To facilitate N-glycosylation analysis it was necessary to purify the recombinant plant 
version of Guy's 13 from mature transgenic plants. Plant proteases and secondary 
metabolites can complicate the purification of compounds from plant tissues, but relatively 
few simple steps were sufficient to purify the recombinant plant immunoglobulins 
(described in Materials and Methods). 
The IgG was purified from mature tobacco plants, essentially by ammonium sulphate 
precipitation and protein G affinity chromatography. The yield of IgG antibody over 5 
separate purifications each processing approximately l Kg fresh weight plant tissue was 
between 1-2.5 mg kg" fresh weight of plant leaves. 
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The purity of the preparations was assessed by SDS-PAGE; plant recombinant Guy's 13 
samples were separated under non-reducing conditions using SDS-PAGE in 7.5 % (w/v) 
acrylamide, and visualised by staining in Coomassie blue (Figure 3.10). Samples were 
taken at various points along the purification process. The crude plant extract (lane 1) 
shows no evidence for an IgG band of the expected molecular size, suggesting that the 
expression levels are below the limit of detection. Ammonium sulphate precipitation (lanes 
2 and 3) concentrates plant proteins. Following purification on protein G beads, only 4 
major bands were eluted (lane 4), the highest band migrates at the expected rate for this 
IgG. Three other protein bands observed may represent contaminants or degradation 
products of IgG. The lower two of these bands were removed by the anti-Mouse IgG 
sepharose affinity chromatography step (lanes 5-7), leaving a purified eluate consisting of 
primarily of IgG. These fractions were also monitored by antigen specific ELISA to 
confirm that the purified protein retained antigen binding activity (Figure 3.11). Guy's 13 
hybridoma cell culture supernatant and extraction buffer were used as positive and negative 
controls respectively. Antigen binding was observed in the starting material (crude plant 
extract), as well as the eluates from the protein G and anti-IgG affmity chromatography 
steps. There was no significant loss of activity between these latter two steps, even though 
the SDS-PAGE indicated removal of two major contaminating bands. 
3.4.2 Distribution of N-glycans on recombinant plant Guy's 13 MAb 
The predicted amino acid sequence of the MAb Guy's 13 heavy chain had revealed two 
potential sites for N-linked glycosylation (unpublished data). These are the common 
conserved site in the hinge region of the Fc fragment and a site on Asn-74 located in the 
variable domain. Fab fragments of the murine Guy's 13 IgG were prepared by papain 
digestion, and through a collaboration with Dr. Loic Faye at University of Rouen, we have 
shown that both sites are glycosylated in the mouse derived version of the antibody. The 
distribution of plant N-glycans on the two potential N-glycosylation sites of the plant 
version of Guy's 13 was therefore investigated by western blotting and ELISA analysis. 
The purified plant IgG was digested by papain. Coomassie blue staining of the digested 
sample demonstrated that the digestion had progressed to completion (Figure 3.12). 
Samples were run under reducing and non-reducing conditions. Under reducing conditions 
(left panel), the control IgG degrades into heavy (approx. Mr 55K) and light (approx. Mr 
25K). The digested Fab preparation resolves into light and heavy chain (Fd) fragments, the 
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latter having an approx. M1 of 30K. Under non-reducing conditions (right panel), intact IgG 
migrates with an approx. M, of 180K. There is no evidence of intact IgG in the two papain 
digested samples, the largest visible bands running between Mr 40-50K. These are likely to 
represent the Fab fragment and Fc fragment. Smaller fragments are likely to represent 
further breakdown products of the Fc fragment, as papain is also known to cleave at two 
further positions in the Fc. 
The immunoglobulin fragments were separated by SDS-PAGE under non-reducing 
conditions and immunoblotted with anti-heavy and anti-light chains, as well as with plant 
glycan (0-(1,2)-xylose)-specific antibodies, kindly supplied by Dr. L. Faye (Figure 3.13 A). 
All three detecting antibodies bound to intact IgG, thereby confirming that the plant derived 
IgG was glycosylated (lanes 1). A band at approximate Mý 48K was recognised by both the 
anti-heavy and anti-light chain antisera, suggesting that this represents the Fab fragment. 
This band was also recognised by the anti-plant ß-(1,2)-xylose antiserum. A smaller 
fragment (approx. M, 25-30K) was also recognised by both the anti-heavy and anti- plant 
ß-(1,2)-xylose antisera, but not the anti-light chain antiserum (lanes 2). This is likely to 
represent an Fc fragment that includes the glycosylation site at the Fc hinge region. The 
specificity of the anti- plant ß-(1,2)-xylose antiserum was confirmed by the absence of 
binding to murine derived IgG and Fab (lanes 3 and 4). 
These results were confirmed in a functional ELISA. As shown in Figure 3.13B, the full- 
length plant version of Guy's 13 bound to SA I/II, and was recognised by anti-heavy chain 
(anti-Fc fragment), anti-light chain, and anti-xylose antibodies (Columns 1). Fab fragments 
produced by papain digestion of the plant antibody also bound SA MI, and were still 
recognised by anti-light chain and anti-xylose antibodies but not by anti-heavy chain 
antibodies (Columns 2). The detection of plant N-glycans on the Fab fragment was 
confirmed after protein G absorption of the papain-digested material to remove any 
contaminating intact IgG (Columns 3). 
Overall the results demonstrate that Guy's 13 IgG antibody is glycosylated in plants in a 
manner similar to that found in the murine derived version. The data confirms that not only 
is the hinge region glycosylation site utilised, but also the N-glycosylation site within the 
Fab fragment (i. e. Asn74 on the heavy chain). As described in the following Discussion 
section, this work led to the collaboration with the group of Dr. Loic Faye at the University 
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of Rouen, in which we have performed a complete structural analysis of the glycoforms 
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Figure 3.1: ELISA titration curves for individual plant extracts. For light and heavy chain 
ELISAs, capture was with the relevant specific antiserum and detection was with a horseradish 
peroxidase labeled antiserum. For IgG assay, capture was with streptococcal antigen I/II at 
2 µg ml-' and detection was with a horseradish peroxidase labeled anti-IgG antiserum. 
Controls were Guy's 13 IgG hybridoma cell culture supernatant and an extract from a wild 
type non-transformed plant. Results are the mean absorbance from duplicate wells. 
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Figure 3.2: Detection of BiP transcript in extracts of RNA from wild type and transgenic 
tobacco plants by Northern blotting. 15 µg total RNA were run in each lane, blotted onto 
nitrocellulose and probed with a labeled BiP DNA probe. The expected position of BiP 
transcript is indicated. Each of the four panels in each set is from the same nitrocellulose 
blot and probed in an identical manner. (A) RNA extracted from flower tissue, (B) RNA 
extracted from leaf tissue. Samples from two representative plants for each transgene were 
used as indicated - wild type non-transformed plants, x chain or y chain expressing plants, 
and plant co-expressing x and y chains. 
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Figure 3.3: Detection of total BiP protein in crude leaf extracts by western blotting 
using a rabbit anti-BiP antiserum, followed by alkaline phosphatase labeled anti- 
rabbit IgG antiserum. The samples used were: a flower extract as positive control, 
wild type leaf extracts, x chain expressing plants, y chain expressing plants, and IgG 
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Figure 3.4: Relative levels of total BiP expression in leaf tissue from different 
plants. A standardised preparation of flower tissue was used as the 100 % level. 
Relative values were obtained by densitometric analysis of BiP-specific 
immunoblots. Data are shown as mean values for 6 plants + standard deviation. 
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Figure 3.5: Detection of BiP associated with immunoglobulin chains by co- 
immunoprecipitation and western blotting. 
A) Protoplasts were lysed and immunoprecipitation was with an anti-Mouse light and 
heavy chain antiserum. After purification with Protein A sepharose, samples were run on 
10 % SDS-PAGE and blotted onto nitrocellulose. Detection was with a rabbit anti-tobacco 
BiP antiserum, followed by an alkaline phosphatase labeled anti-rabbit IgG antiserum. 
Samples were: wild type non-transformed protoplasts, K chain transgenic plant protoplasts, 
g chain transgenic plant protoplasts, IgG transgenic plant protoplasts and protoplast lysis 
buffer. The expected position for Bill (Mr 75K) is indicated. 
B) Immunoprecipitation was performed as above. Samples are Guy's 13 IgG hybridoma 
cell culture supernatant (G13 IgG), lysed protoplast preparation from IgG transgenic plant 
(cells) and the protoplast culture medium after overnight incubation with IgG transgenic 
protoplasts (medium). The expected position for BiP (MT 75K) is indicated. 
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Figure 3.6: ATP release of BiP from recombinant 
immunoglobulin heavy chain in immunoprecipitates from 
gamma chain expressing protoplasts. Protoplasts were lysed and 
immunoselection was with either an anti-BiP or an anti Mouse 
IgG antiserum. After SDS-PAGE and transfer to nitrocellulose, 
detection was with a rabbit anti-BiP antiserum, followed by an 
alkaline phosphatase labeled anti-rabbit IgG antiserum. Results 
were consistent over several replicates. 
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Figure 3.7: Detection of calreticulin transcript in plant RNA by Northern blotting. 
15 µg total RNA from (A) flower tissue, (B) leaf tissue were run in each lane, 
blotted onto nitrocellulose and probed with a labeled calreticulin DNA probe. The 
expected position of calreticulin transcript is indicated. Each of the four panels in 
each set is from the same nitrocellulose blot and probed in an identical manner. The 
samples used were: wild type non-transformed plants, x chain expressing plants, y 


















Figure 3.8: Relative levels of total calreticulin expression in leaf tissue from different 
plants. A standardised preparation of flower tissue was used as the 100 % level. 
Relative values were obtained by densitometric analysis of calreticulin-specific 
immunoblots. Data are shown as mean values for 6 plants + standard deviation. 
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Figure 3.9: Western blot analysis of immunoprecipitates from plant protoplasts. 
The source material was transgenic plants. (A) The blot was probed with rabbit 
anti -calreticulin serum followed by alkaline phosphatase-conjugated anti-rabbit 
serum. A crude flower extract was included as a positive control for recognition 
by the antibody. (B) The blot was probed with anti-BiP serum followed by 
alkaline phosphatase-conjugated anti-rabbit serum. M, protein molecular size 
markers; G13 - Guy's 13 IgG hybridoma cell culture supernatant; WT - wild type 
non-transformed tobacco; y- gamma chain transgenic tobacco; IgG - kappa and 
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8. Eluate from goat anti-mouse IgG sepharose 
Figure 3.10: SDS-PAGE monitoring of IgG purification from plants. 
Samples taken at the indicated steps were run on SDS-PAGE under non- 
reducing conditions and visualised by Coomassie blue staining. Molecular 
















Figure 3.11: Antigen specific ELISA to monitor purification of antibody from 
plants. The samples indicated were incubated in ELISA wells pre-coated with 
streptococcal antigen I/II at 2 µg mF'. Detection of binding was with a 
horseradish peroxidase labeled anti-mouse IgG antiserum. 
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Figure 3.12: SDS-PAGE monitoring of papain digestions of plant derived IgG. 
Undigested (IgG) and digested (Fab) samples were run on SDS-PAGE under 
non-reducing (- ß-ME) or reducing (+ ß-ME) conditions and visualised by 

























Figure 3.13: Immunodetection of complex-type plant N-glycans on Fab and Fc fragments. 
(A) Immunoblot of plant Guy's 13 and papain digested fragments under non-reducing 
conditions. Three panels are shown, in which detection was with (a) anti-heavy chain, (b) 
anti-light chain, and (c) anti-xylose antibodies. Lanes 1- undigested plant antibody Guy's 
13 (4 jig); lanes 2- papain digested plant antibody Guy's 13 (4 µg); lanes 3- undigested 
mouse MAb Guy's 13 (4 µg); and lane 4- papain digested mouse MAb Guy's 13 (4 µg). 
(B) ELISA analysis of the plant Guy's 13 antibody and Fab fragment binding to 
streptococcal antigen 1111. Detection was with either anti-heavy chain (Fc fragment)[1: 16 
dilution], anti-light chain (1: 128 dilution) or anti-xylose (1: 16 dilution) antibodies. 
Columns I- undigested plant antibody Guy's 13; Columns 2- papain digested plant 
antibody Guy's 13; Columns 3- papain digested MAb Guy's 13 absorbed by Protein G; 
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3.5 Discussion 
In this chapter, we have investigated two key events in protein expression that occur in the 
secretory pathway, namely protein folding and assembly and glycosylation. Overall, the 
results show that these events in plants closely match those that occur in mammalian cells. 
This is important not only because it provides the explanation for the successful expression 
of antibodies in plants, but also because it generates the rationale for expressing other 
mammalian proteins using the transgenic plant expression system, examples of which are 
discussed in the following two chapters. 
Firstly, we have examined the potential role for two important ER resident chaperones in 
immunoglobulin folding and assembly. In mammalian cells, the requirement for ER 
resident chaperones in the assembly of immunoglobulins has been recognised for some 
time (Haas & Wabl, 1983). The best characterised of these is BiP (binding protein or 
GRP78) [Haas, 19911, which was initially shown to bind Ig heavy chains, and later light 
chains (for review see Melnick & Argon, 1995). Association with Ig chains occurs 
immediately after synthesis, and usually lasts for a matter of minutes if there are no 
abnormal folding or assembly events (Melnick et al., 1994; Knittler & Haas, 1992). A 
number of BiP binding sites have been mapped within the antibody molecule (Knarr et al., 
1995) and dissociation of BiP is ATP-dependent (Melnick et al., 1994). The successful 
assembly of IgG in yeast and insect cell systems may be attributable to the presence of 
appropriate protein chaperones, as yeast possesses a homologue of BiP, termed Kar2 (Rose 
et al., 1989; Vogel et al., 1990). Although a native Bi'P has not been identified in insect cell 
lines, candidate insect protein chaperones have been identified that may perform a similar 
role (Jarvis et al., 1990). Indeed, when insect cells were engineered to express murine BiP, 
increased expression of functional antibodies was found alongside a decrease in the 
formation of abnormal protein aggregates (Hsu et al., 1994). 
One of the potential advantages of the plant expression system is the presence of an 
indigenous BiP which is highly conserved as compared with murine BiP, with 
approximately 69 % overall homology at the amino acid level This compares with yeast 
BiP which has 64 % overall homology with murine BiP. In tobacco, BiP mRNA expression 
is highest in tissues containing rapidly dividing cells or those that are involved in secretion 
(Denecke et al., 1991), whereas in maize, BiP is expressed most abundantly in endosperm 
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development (Fontes et al., 1991). Also, plant BiP expression is associated with the 
accumulation of abnormal proteins (Pedrazzini et al., 1994). 
In plants it was previously demonstrated that efficient assembly and expression of 
immunoglobulins could only be achieved by using a leader sequence to target the 
recombinant immunoglobulin proteins to the ER and the secretory pathway (Hiatt et al., 
1989). This might be due to enhanced translation of recombinant proteins or to increased 
stability of the proteins resulting from their sub-cellular localisation. In this chapter, 
evidence has been put forward that demonstrates the association of the plant BiP 
homologue with folding and assembly of Ig light and heavy chains and we propose that the 
involvement of ER-resident chaperones promotes processing and expression of 
immunoglobulin molecules in plants. 
Previous analysis of the constitutive expression patterns of BiP mRNA has suggested that 
expression is low in tobacco leaves (Denecke et al., 1991). For this reason, in these 
investigations we have used leaf tissues initially, so that any elevation in BiP would be 
more readily detected over the low background of constitutive expression. BiP mRNA was 
differentially expressed in four plant lines that expressed no transgenic product, Ig light or 
heavy chain, or assembled IgG. The highest BiP expression was found in plants expressing 
heavy chain only, BiP expression was relatively lower in plants that express both light and 
heavy chains, but still elevated as compared with non-transgenic plants. The results are 
consistent with the putative role of BiP in binding to and retaining unassembled sub-unit 
proteins (Haas & Wabl, 1983; Knittler et al., 1995) and in folding and assembly of 
immunoglobulin chains in cells that are highly active in terms of recombinant protein 
production and secretion. The relative decrease in BiP mRNA in IgG expressing plants as 
compared with heavy chain expressing plants might be attributable to the successful 
assembly of heavy chains into immunoglobulin. This reduces the levels of non-assembled 
heavy chain, and allows the release and recycling of BiP. 
Immunoblotting experiments also appeared to demonstrate a trend in the expression 
profiles of the total amounts of BiP and calreticulin protein present in transgenic leaf 
extracts. Lower levels of BiP and calreticulin protein were detected in wild type plants, and 
plants expressing x light chains. Higher levels of BiP and calreticulin protein were detected 
in transgenic plants expressing y heavy chains, and assembled IgG. These differences might 
be explained simply by differences in expression levels of unassembled light and heavy 
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chains, and assembled IgG. In the original experiments which demonstrated the production 
of antibodies in transgenic plants (Hiatt et al., 1989), the yield of antibody chain was 
increased in plants expressing both y and x chains, indicating that assembly of the y-ic 
complex might enhance stability. Our ELISA results support this fording, and also confirm 
that the level of x chain expression is much lower than that of y chains. However, the 
expression levels of assembled IgG were approximately 6-fold greater than that of y heavy 
chains alone, but this was not reflected in the levels of total BiP or calreticulin detected. 
This indicates that chaperone levels in transgenic plants expressing immunoglobulin chains 
are regulated by other factors. 
When we examined co-immunoprecipitation between BiP or calreticulin and recombinant 
immunoglobulin chains, we found convincing evidence for an interaction between BiP and 
light and heavy chains, but not for calreticulin. BiP protein co-precipitated with 
immunoglobulin chains extracted from protoplast intracellular fluid, but not from secreted 
Ig chains. This indicates that the Bid'-Ig chain interaction in plants is not artefactual and is 
consistent with the model of BiP binding transiently in the ER to Ig chains during protein 
folding and processing. The results matched those found by Northern blot, in that most BiP 
protein was immunoprecipitated in plants expressing the Ig heavy chain only. Less was 
detected from plants expressing both light and heavy chains, even though more Ig heavy 
chain protein is consistently recoverable from IgG expressing plants. Again this is 
consistent with the model for BiP in assisting protein folding and increasing throughput of 
the ER. 
In mammals, BiP associates with both Ig light and heavy chains (Knittler & Haas, 1992; 
Haas & Wabl, 1983), and by immunoprecipitation, similar results were found in plants. The 
relatively weak signal observed may have been because the immunoprecipitation protocol 
was optimal for heavy chains and not light chains. However in view of the finding that BiP 
mRNA expression was not elevated in light chain-expressing plants, an alternative 
explanation is that the levels of light chain accumulation are generally very low in single 
transgenic plants. Previous estimates of the accumulation levels of light chain have 
generally been 20-fold lower as compared with plants expressing light and heavy chains 
together (Hiatt et at, 1989). 
We have also investigated whether calreticulin might be involved in the chaperoning of 
immunoglobulins in plants and found no evidence. Although we cannot exclude the 
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possibility that an extremely rapid interaction occurs between calreticulin and 
immunoglobulin chains, our findings appear to be consistent with mammalian expression 
of immunoglobulins (Melnick & Argon, 1995), and demonstrates a specific and appropriate 
interaction between immunoglobulins and chaperones in plants. There is increasing 
evidence for separate chaperone pathways involving either BiP or calreticulin/calnexin 
(Molinari & Helenius, 2000) and it remains to be determined if the plant calreticulin 
pathway is equally functional for mammalian proteins. 
We have been able to confirm and extend these studies with BiP through a collaboration 
with Dr. Lorenzo Frigerio at the University of Warwick (Nuttall et al., 2002). Using the 
transient expression system in protoplasts, the co-immunoprecipitation of BiP with 
immunoglobulin heavy chains in an ATP dependent manner was confirmed. An important 
fording in this study, was further confirmation of the functional nature of the interaction 
between BiP and immunoglobulin heavy chain. To test the hypothesis that the co- 
expression of the companion is chain should compete with BiP for association with the IgG 
heavy chain, tobacco protoplasts were co-transfected with a fixed amount of DNA 
encoding heavy chain and with increasing amounts of light chain-encoding DNA. The 
results showed that when heavy chain (y) expression is constant, an increase in light chain 
(x) expression is paralleled by a decrease in the amount of BiP that is co-selected from the 
cell homogenates. When the same samples were run on non-reducing SDS-PAGE, it was 
demonstrated that co-transfection of the light chain resulted in the assembly of the IgG 
heterotetramer in a dose dependent manner. Therefore, the presence of the light chain 
triggers assembly of the IgG tetramers and causes BiP to be partially released from the 
heavy chains. 
Surprisingly, no interaction was observed between BiP and light chain when light chain 
was transiently expressed in protoplasts alone. The difference in results between transient 
expression and those found in our transgenic plant protoplasts may be due to a difference in 
expression levels of immunoglobulin light chain between the two systems. Alternatively, it 
may reflect a more rapid turnover of transiently expressed light chains, which would lead to 
its interaction with the pool of unlabelled BiP within the time frame of our observation. 
Preliminary data suggest that in plants expressing only Ig light chains, these light chains are 
normally secreted (Frigerio, unpublished). In contrast when expressed alone, heavy chain 
accumulates intracellularly and co-localises in the ER with BiP. When assembled, the 
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immunoglobulin complex is secreted (Frigerio et al., 2000). Thus BiP may be involved in 
the chaperoning of light chains in plants, but as the protein is efficiently secreted, the 
detectable signal in the BiP co-immunoprecipitation assay may be too low. 
The association of BiP with folding and assembly of recombinant immunoglobulin chains 
in plants is significant. Protein translocation and folding in the ER can be one of the rate 
limiting steps in protein secretion, and the presence of protein chaperones is important for 
high efficiency turnover, leading to high levels of production. It has been reported that the 
overexpression of BiP (and PDI) in yeast cells greatly improves the efficiency of folding 
and secretion of single chain antibody fragments (Shusta et al., 1998). Likewise, when BiP 
is overexpressed in transgenic plants, it is able to alleviate ER stress induced by 
tunicamycin (Leborgne-Castel et al., 1999). It will be very interesting to test the effects of 
BiP overexpression in plants expressing our model immunoglobulins. 
The passage of proteins through the secretory pathway in plants is a complicated process 
(Vitale, 2001) and it is clear that BiP is not the only chaperone involved. In mammals, a 
few other chaperones that are involved with immunoglobulins have been identified so far 
(Melnick & Argon, 1995; Melnick et al., 1994). Of these, plant homologues to GRP 94, 
and protein disulphide isomerase (Shorrosh & Dixon, 1991) have been identified, and it 
will be important to establish their role in Ig assembly. 
The results from our experiments suggest that in transgenic plants expressing recombinant 
immunoglobulins, BiP and calreticulin might be coordinately regulated. However a 
chaperone function for calreticulin in immunoglobulin assembly has not been identified. 
BiP and calreticulin represent a large proportion of the steady state content of the ER lumen 
and can be considered as a measure for ER abundance (Denecke et al., 1995). ER-resident 
chaperones, such as BiP, are thought to be regulated through a feedback mechanism known 
as the malfolded protein response. BiP has been found in association with calreticulin, both 
in the presence and absence of ER stress (Crofts et al., 1998). The BiP-calreticulin complex 
was stable in vivo, and BiP appears to be the binding protein and calreticulin the ligand. 
Although it was suggested that the BiP-calreticulin complex could provide a buffer for the 
concentration of free BiP, the precise function of the complex is not clear. 
In the second part of this investigation of immunoglobulin processing through the plant 
secretory pathway, we have investigated the presence of glycans at N-glycosylation sites 
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that are known to be utilised in the murine system. Many mammalian proteins have been 
successfully produced in plants, demonstrating the fidelity with which plants can express 
transgenes and fold and assemble the protein product. Glycosylation is another important 
area in which a level of fidelity is required, in order to maintain function and biological 
activity. Thus the potential use of plants as expression systems for the production of 
therapeutic recombinant proteins is often dependent on the ability of plants to produce and 
glycosylate mammalian glycoproteins. 
In order to perform these studies, it was necessary first to establish a methodology for 
purification of IgG from plants, to avoid contamination with other plant glycoproteins. 
There are several problems inherent and unique to purifying rAbs from plants. Some of 
these difficulties are caused by the presence of polyphenolic compounds, such as tannins. 
Furthermore, once plant tissue is damaged in order to extract recombinant proteins, a 
number of potentially toxic vacuolar contents are also released. These include secondary 
metabolites, such as nicotine in tobacco, proteases, polysaccharides, lipids, and DNA, all of 
which may reduce protein yield. These chemicals may additionally have a toxic effect or 
cause sensitisation of humans to the plant antigens. Effective methods for the removal of 
phenolic compounds from aqueous plant extracts are being developed, for example 
polyamide minicolumns that remove more than 99 % polyphenolic compounds from 5 mg 
of extract (Collins et al., 1998). 
A purification protocol for a TMV-specific full-length rAb from a transgenic tobacco plant 
cell suspension culture has been described (Fischer et al., 1999a). The antibody was 
derived from a stably transformed transgenic plant, and although targeted for secretion by a 
murine leader sequence, was retained by the cell wall in suspension culture. The primary 
plant cell wall was partially digested by enzymatic treatment, resulting in a total release of 
the rAb into the extraction buffer. Purification of the IgG was achieved by cross-flow 
filtration, followed by protein A affinity chromatography, which lead to a 100-fold 
concentration of the rAb and efficient removal of contaminants (Fischer et al., 1999a). Gel 
filtration was used as a final purification step, and more than 80 % of the expressed full- 
length IgG from plant cell extracts was recovered. 
For the purposes of our studies, we were able to purify approximately 1 mg IgG from 
plants, using standard methodologies of protein concentration by ammonium sulphate 
precipitation, followed by affinity chromatography. We were able to achieve purification to 
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two bands on Coomassie blue stained SDS polyacrylamide gels. 
It was already known that MAb Guy's 13 contains two potential N-glycosylation sites on 
the heavy chain, located on the Fc and Fab fragments, both of which are glycosylated in the 
murine version of the antibody. Using a functional antigen-specific ELISA and 
immunoblotting we showed that plant complex N-glycans are also located on both the Fc 
and Fab fragments of the plant Guy's 13 antibody. This plant specific glycosylation was 
sufficient to generate soluble and biologically active IgG. 
Using the same purification protocol, we have scaled-up purification to 10 mg IgG, which 
allowed a detailed structural analysis of the N-linked glycans associated with Guy's 13, and 
a comparison between murine and plant versions of the same antibody by our collaborators 
at the University of Rouen (Cabanes-Macheteau et al., 1999). We found that whereas the 
mouse Guy's 13 contained only 4 different complex-type glycans, the plant Guy's 13 was 
more heterogeneous in glycosylation. Eight different oligosaccharides were identified on 
the plant antibody, representing an array of structurally related oligosaccharides from high- 
mannose-type N glycans (identical to mammalian high-mannose glycans), to complex 
structures containing the ß(1,2)-xylose and a(1,3)-fucose residues that are characteristic of 
plant glycoproteins. N-acetylglucosamine residues were the major oligosaccharides 
N-linked to the recombinant plant Guy's 13 antibody, a fording that is consistent with 
secretion of the molecule from plant cells (Lerouge et al., 1998). However the large 
structural heterogeneity of the recombinant plant glycans could also be the consequence of 
the extraction of the antibody from other compartments of the plant secretory pathway. 
Previously it was shown that storage of the recombinant plant antibody in the endoplasmic 
reticulum or in the vacuole results in N-glycans having unprocessed or truncated structures 
(Lerouge et al., 1996). 
The differences observed in the glycosylation pattern of the plant version of Guy's 13 MAb 
compared with the murine version have no effect on antigen binding or specificity. 
However, it was suggested that these differences could represent an important limitation to 
the use of plant recombinant mammalian glycoproteins if the plant glycans are 
immunogenic (Bardor et al., 2003). The potential immunogenicity of a plant derived 
antibody has indeed been investigated in a clinical trial using human subjects, to be 
described more fully in the Discussion section of Chapter 5. A purified form of Guy's 13 
MAb expressed in plants was topically applied to the oral cavity of human volunteers on 
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six occasions. No evidence of an immune response to the plant recombinant glycoprotein 
was detected (Ma et al., 1998). 
In order to investigate the potential systemic immunogenicity of plant glycans, Dr. Daniel 
Chargelegue in our laboratory made use of the plant derived Guy's 13 MAb expressed in 
this study, to perform a parenteral challenge in mice (Chargelegue et al., 2000). The same 
strain of mice (BALG/c) was used in this study as had been used to generate the original 
Guy's 13 MAb, thus allowing analysis of the immunogenicity of a self-protein displaying 
foreign plant glycans. Four groups of six mice were immunised subcutaneously with 30 µg 
mouse Guy's 13 MAb, the same antibody produced in transgenic tobacco plants, affinity 
purified horseradish peroxidase (HRP) -a standard plant glycoprotein - or PBS. HRP 
contains both of the predominant immunogenic plant carbohydrates, a(1,3)-fucose and 
0(1,2)-xylose, and was used as a positive control for plant glycoprotein. Immunisations 
were performed in the presence of 50 % alum as an adjuvant, to increase the chances of 
generating an immune response. Antibody responses were analysed by ELISA, and 
BlAcore studies, with pre-immune sera used as negative controls. 
The mice immunised with HRP raised high IgG titres to HRP, although these antibodies 
did not cross-react with recombinant plant Guy's 13 antibody. None of the mice immunised 
with mouse Guy's 13 raised detectable antibody responses to mouse Guy's 13, plant Guy's 
13 or HRP. In the group immunised with recombinant plant Guy's 13, two out of six mice 
had low reactivity to plant recombinant Guy's 13 as detected in ELISA. When these two 
positive sera were diluted 1/5 and tested for their reactivity to plant glycans, neither 
inhibited the binding of the anti-IIRP rabbit immune-sera to recombinant plant Guy's 13. 
As these sera did not react to the mouse Guy's 13 MAb either, it was suggested that these 
results represented reactivity to small residual amounts of tobacco protein present at the 
end of the purification of the plant recombinant antibody. For future clinical studies, it will 
be important to make sure that these contaminants are removed before immunisation, 
perhaps by a final ion-exchange step or by gel filtration HPLC chromatography. 
Although no haematological or serological adverse effects were detected following the 
human clinical trial of the mouse Guy's 13 MAb expressed in plants (Ma et al., 1998), it is 
still conceivable that sensitisation to the plant complex-type N-glycans on the plant Guy's 
13 antibody might take place. In the future it might be advantageous to generate a 
recombinant plant antibody with a carbohydrate profile structurally more consistent to one 
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derived from mammalian cells. This could involve removing the complex glycans 
altogether by altering the heavy-chain sequence and removing the site for Winked 
glycosylation. Alternatively, the use of mutant plants lacking enzymes intrinsic to the 
glycosylation pathway might be a solution to this problem (Von Schaewen et al., 1993). 
Progress has also been made towards "humanising" the glycosylation pathway in plants 
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CHAPTER 4: RESULTS II 
Tar2etin2 and retention of recombinant proteins 
to plant cell membranes 
We have previously shown that the default pathway for IgG molecules in plants involves 
secretion out of the cell with extracellular accumulation, probably in the apoplastic space 
(Chapter 3 and Frigerio et al., 2000). This is identical to the fate of immunoglobulin 
molecules produced in mammalian plasma cells. However, in mammalian cells (B cells 
and plasma cells), another form of antibody is also found, as a surface antigen receptor. 
This membrane associated form differs from the secreted form, only by having slightly 
larger heavy chains than those of secreted antibody, due to the presence of an extra 71 
amino acid residues at the carboxyl terminus of each heavy chain. The extra amino acid 
residues are arranged in 3 domains that are highly conserved within the murine Cy I, Cy2a 
and Cy2b as well as the Cµ genes -a 17 residue acidic extracellular hinge region, a 26 
residue hydrophobic intra-membrane portion, and a 28 residue hydrophilic intracellular 
portion (Yamawaki-Kataoka et al., 1982). 
The aims of this part of the study were to: 
1) determine if a murine Ig heavy chain could be targeted to the plant cell membrane 
using a murine Ig membrane retention sequence. 
2) to examine if a functional antibody could be assembled and retained at the plant cell 
membrane, and to investigate the effect of this retention sequence on the expression of 
Ig heavy chain and assembled IgG in transgenic tobacco plants. 
3) to extend the investigation of recombinant protein targeting to the plant plasma 
membrane, using a non-immunoglobulin mammalian membrane protein - CCR-5 a 
7-transmembrane protein, in order to explore further the capacity for plants to 
accommodate heterologous recombinant membrane proteins. 
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The transgenic plants used in this part of the study were those expressing; 
1) Guy's 13 MAb light chain (x) 
2) Guy's 13 MAb heavy chain (yl), amino acids 1- 457 
3) Guy's 13 MAb membrane heavy chain (myl), amino acids 1- 528, including the 
71 amino acid membrane retention sequence 
The sequence of the murine membrane retention polypeptide is shown in Figure 4.1 along 
with a diagrammatic representation of the three domains -a short hinge region, the 
transmembrane sequence and an intracellular tail. 
The agrobacterium mediated transformation and regeneration of these plants were as 
described (Ma et al., 1994; Vine et al., 2001). As before, antibody expressing plants were 
produced by crossing the light chain plant with either the heavy (yl) chain plant to 
generate IgG plants, or with the membrane heavy (my 1) chain plant to generate mIgG 
plants. In all experiments, non-transformed (WT) plants were included as a negative 
control. 
4.1 Detection of recombinant immunoglobulin chains by ELISA 
Crude plant extracts were prepared from transgenic plants and the presence of 
immunoglobulin heavy chain was detected using a murine immunoglobulin yl heavy chain 
specific capture ELISA. Representative data are shown in Figure 4.2 for plants expressing 
IgG, myl and mIgG. In the IgG transgenic plant, Guy's 13 heavy chain was detected in 
plant extracts, and no difference was observed in the presence or absence of 1% NP40 for 
membrane solubilisation. No heavy chain was detected in the non-transformed (WT) 
control plant. The results for two myl and mIgG plants are shown. Although some heavy 
chain was detectable when plant extracts were prepared without detergent (-NP40) in these 
plants, there was a marked increase in heavy chain yield when membranes were solubilised 
(+NP40), suggesting that the majority of the heavy chain is associated with membranes in 
the plant cell. 
Functional antibody was detected using an antigen specific ELISA, where streptococcal 
antigen I/II was coated on the ELISA wells, and detection of bound antibody was by a 
murine immunoglobulin yl heavy chain specific antiserum. The results are shown in 
Figure 4.3. Antigen specific Guy's 13 antibody was detected in the IgG plant and the 
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presence or absence of NP40 in the extraction buffer again had no effect. In plants 
co-expressing both the myl and x chains (i. e. mIgG plants), the antibody was also 
correctly assembled. As with the heavy chain specific ELISA (Figure 4.2), in mIgG plants, 
antibody was detected at a level 2-3 dilution steps higher in the presence of NP40, 
indicating that membrane solubilisation was necessary to release the accumulated 
antibody. The titration curves for IgG activity and heavy chain expression (Figure 4.2) 
were similar in these plants, indicating that there was little free heavy chain present and 
that most was assembled into functional antibody. No antigen binding was detected in 
extracts from non-transformed plants, or plants expressing myl alone, as binding to native 
antigen requires both heavy and light chains. 
4.2 Protoplast analysis 
The ELISA data supported the hypothesis that my! and ntigG were associated with 
membranes. We have investigated the expression of these recombinant molecules using 
protoplasts, to a) confirm the absence of antibody secretion, and b) to demonstrate that the 
membrane retention sequence results in protein retention in the plasma membrane. 
Protoplasts were prepared from transgenic and control plants. The overnight protoplast 
culture supernatants, and solubilised membrane preparations were analysed by ELISA for 
the presence of immunoglobulin heavy chain (Figure 4.4). 
There was little or no detectable immunoglobulin heavy chain in the membrane 
preparations from transgenic plants expressing the soluble form of IgG only (IgG plants), 
although there were detectable levels of secreted antibody in the culture supernatant. In 
contrast, the recombinant heavy chain was detectable in myl plants in the ultracentrifuged 
membrane pellet resuspended in buffer containing NP40, but not the ultracentrifuged 
supernatant from the cell wall digestion buffer, which suggests that recombinant myl is not 
secreted. Similar results were found for mIgG plants, although there were low levels of 
functional antibody detected in the supernatant. As before, the levels of myl detection were 
similar between myl and mIgG plants. The data for the positive control (Guy's 13 IgG 
from murine hybridoma culture supernatant) and a negative control (WT) plant are also 
shown. 
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4.2.1 Im munotluorescent staining of protoplasts 
Immunofluorescent staining with FITC labeled specific antisera was used to demonstrate 
the presence or absence of the recombinant proteins associated with the cell membrane of 
transgenic plant cells. For these studies, protoplasts were maintained as live cells. As 
controls, protoplasts were prepared from non-transformed (WT) plants as well as plants 
expressing irrelevant recombinant proteins. 
Figure 4.5 shows the autofluorescence from protoplasts due to chlorophyll (Panel 1), from 
a control plant, transformed with an irrelevant protein. The autofluorescence is red and 
confined to the chloroplasts. Some of the cells appeared misshapen cells, but the majority 
were intact and apparently healthy. There was no FITC staining after incubation with FITC 
labeled anti-rabbit IgG antiserum (Panel 2) demonstrating the absence of cross reactive 
membrane proteins. Panels 3 and 4 show protoplasts from the same plant labeled with 
antibodies specific for the constitutive plasma membrane H+-ATPase (De Witt et al., 
1996), which is a positive control plasma membrane marker protein. The bright green 
staining is evident, demonstrating the peripheral distribution of this protein. 
For immunoglobulin heavy chain detection, protoplasts were probed with an FITC labeled 
anti-mouse gamma chain antiserum (Figures 4.6 and 4.7). Cells from wild-type plants 
(WT) were autofluorescent (Figure 4.6, Panels 1 and 2) but did not stain with FITC labeled 
anti-mouse antiserum (Figure 4.6, Panel 3). Approximately 1 in 30 protoplasts from non- 
transformed plants showed only weak fluorescence. In contrast, cells from my! plants 
demonstrated bright surface staining (Figure 4.7, Panel 1) which is distinct from the 
chloroplasts and has a more circumferential localisation (Figure 4.7, Panels 2 and 3). The 
proportion of fluorescing cells in the m' 1 leaf preparations varied between 10 to 40 %. In 
the most highly fluorescing preparations, approximately 20 % of the cells were brightly 
fluorescent, a further 20 % had moderate fluorescence and the remainder emitted minimal 
or no fluorescent signals. The fluorescent pattern associated with protoplasts expressing 
nryl was similar to that seen when protoplasts were incubated with antiserum to plasma 
membrane H+-ATPase, the control plasma membrane marker (Figure 4.5, Panels 3 and 4). 
Membrane associated antibody was also demonstrated by immunofluorescence detection 
of light and heavy chain expression in protoplasts from transgenic plants. Protoplasts were 
labeled with either FITC labeled anti-mouse kappa chain, or FITC labeled anti-mouse 
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gamma chain antisera. With the anti-kappa chain reagent, there was no specific staining of 
cells from non-transformed plants (WT), nor from those only expressing the my! chain 
(Figure 4.8, Panels 1 to 4). This demonstrates the specificity of the anti-kappa chain anti- 
serum, and the absence of cross-reactivity with Ig heavy chain myl cells were positively 
stained (as before) for anti-gamma chain (Figure 4.9, Panels 3 and 4). Protoplasts from 
plants co-expressing myl and kappa demonstrated surface staining both with anti-kappa 
(Figure 4.8, Panels 5 and 6) and anti-gamma (Figure 4.9, Panels 1 and 2) antisera. This 
confirms the presence of surface immunoglobulin heavy chain in mIgG plants, as well as 
the co-localisation with kappa chain at the same site. The frequency of brightly stained 
protoplasts from mIgG plants was similar to that found with myl plants stained with anti- 
gamma chain antiserum. 
4.3 Expression of the chemokine receptor CCR-5 
The demonstration that the Ig membrane anchoring sequence was functional in plants was 
the first of its kind for mammalian targeting sequences. We were interested to extend these 
observations to other mammalian membrane proteins, in order to establish the potential for 
mammalian membrane protein expression in plants in general. 
CCR-5 is a chemokine receptor, and a member of the 7-transmembrane segment G-protein 
coupled receptor (GPCR) family (Samson et al., 1996)). These receptors are found 
primarily on the surface of T cells and macrophages in the immune system. Thus the aim 
was to express a recombinant CCR-5 protein in transgenic plants, and to determine if the 
protein was targeted to the cell membrane. 
A cDNA clone encoding human CCR-5 was kindly provided by Professor T. Lehner. This 
sequence, along with its native leader sequence was cloned into the pMON 530 plant 
expression vector (used for all the transgenic plants studied) under the control of the 
CaMV 35S promoter. Transgenic plants were generated by Dr. Pascal Drake in our 
laboratory. 
4.3.1 RT-PCR confirmation of transeenic plants. 
Putative transgenic plants expressing CCR-5 were screened by RT-PCR using specific 
CCR-5 oligonucleotides (sequences shown in Appendix). A major band of approximately 
1000 bp, the expected size, was detected in 3 out of 4 plants tested (Figure 4.10). In each 
case the PCR was performed using cDNA (+) or the parent RNA (-) [i. e. with no reverse 
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transcriptase - as described in Materials and Methods] to confirm the absence of 
contaminating genomic DNA in the RNA preparations. 2 control plants were included, one 
non-transformed wild type plant, and one plant transgenic for an irrelevant protein. 
4.3.2 ELISA and Western blot analysis of transgenic plants. 
Transgenic plants identified by RT-PCR were used for analysis by ELISA and Western 
blot. As for the detection of immunoglobulin chain, crude leaf extracts were prepared in 
tris buffered saline, with protease inhibitor (leupeptin), but no recombinant protein was 
detectable by either a CCR-5 capture ELISA or immunoblotting using a monkey 
anti-CCR-5 antiserum (results not shown). Unlike the my! and mIgG expressing plants, 
addition of detergents - SDS, Triton X-100, NP-40 to the extraction buffer made no 
difference and we were unable to detect CCR-5 protein by these immunological 
techniques. 
4.3.3 Protoplast immunofluorescence 
Immunofluorescent staining of protoplasts was performed using the CCR-5 specific 
monkey antiserum kindly provided by Dr. Lesley Bergmeier. Bound antibody was detected 
using FITC labeled anti-monkey antiserum. 
As with the FITC labeled rabbit antisera used in the membrane Ig experiments, 
approximately 1 in 30 protoplasts from non-transformed plants (WT) showed weak 
background fluorescence (not shown). In contrast, cells from the CCR-5 plants 
demonstrated bright surface staining (Figure 4.11). The numbers of fluorescing cells in 
each preparation varied between 20 to 40 %. The fluorescent pattern associated with 
protoplasts expressing the CCR-5 molecule was similar to that observed with protoplasts 
incubated with antiserum to plasma membrane H± ATPase, and membrane associated IgG 
as described in the previous section. 
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Anti-Rabbit IgG FITC Anti-H(+)-ATPase/ Anti-Rabbit IgG FITC 
Figure 4.5: Protoplasts from a control transformed plant incubated with (Panels 3 and 4) or 
without (Panels I and 2) rabbit anti-H(+)-ATPase, followed by FITC-labelled goat anti-rabbit 






Figure 4.6 : Immunofluorescent staining of non-transformed protoplasts. Non- 
transformed plant (WT) cells incubated with FITC-labelled goat anti-mouse yl 
antiserum showing auto-immunofluorescence under UV illumination (Panels I and 2) 







Figure 4.7: Immunofluorescent staining of transgenic protoplasts from m7 l 
transformed plants. Protoplasts from transgenic plants expressing my] chain, 
incubated with FITC-labelled goat anti-mouse yl antiserum under UV 











WT my1 mIgG 
Figure 4.8: Immunofluorescent staining of non-transformed and transgenic protoplasts with 
FITC labeled goat anti-mouse kappa antisera. Samples are shown with UV illumination, with 
(Lower) or without (Upper) a 460 nm filter. WT cells (Panels 1 and 2), myl cells (Panels 3 and 










Figure 4.9: Immunofluorescent staining of transgenic protoplasts with FITC labeled goat anti- 
mouse yl antisera. Samples are shown with UV illumination, with (Lower) or without (Upper) 
460 nm filter. mIgG cells (Panels 1 and 2), myl cells (Panels 3 and 4). 
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Figure 4.10: Agarose gel electrophoresis of an RT-PCR performed using samples of 
plant mRNA. The PCR was performed with CCR-5 specific oligonucleotides. The 
reaction products were visualised by staining the gel in a solution of ethidium 
bromide and observing under UV light. Samples are; 1-4, putative transgenic plants 
expressing CCR-5; WT - non-transformed plant; T- transgenic plant expressing an 
irrelevant recombinant protein; Plasmid control - pBluescript containing CCR-5 gene 
insert. "+" indicates cDNA was used as template for the RNA, "-" indicates the 
template was purified RNA, before reverse transcription. DNA size markers (lane M) 





Figure 4.11: Immuno fluorescent staining of protoplasts from transgenic plants 
expressing CCR-5. Incubation was with a monkey anti-CCR-5 antiserum, followed 
by a FITC labeled anti-monkey IgG antiserum. Cells were viewed under UV 




The expression of antibodies in plants has many potential applications, including human 
health that is likely to require extraction and purification, as well as plant health where 
targeting to sub-cellular compartments might be required. In the latter case, it has already 
been shown that cytosolic single chain Fv fragments can protect against viral infection 
(Tavladoraki et al., 1993). We have already shown that the default pathway for 
recombinant IgG in plants is secretion, once the immunoglobulin chains have been targeted 
to the endomembrane system with a leader peptide. In this chapter, we have investigated 
the targeting of full-length antibodies to the plant cell membrane, using the native murine 
immunoglobulin transmembrane sequence with a view to potential applications beyond 
antibody production for immunotherapy. 
The murine immunoglobulin transmembrane sequence encodes a short extracellular 
region, a hydrophobic transmembrane sequence comprising 26 amino acid residues and a 
hydrophilic 28 residue intracellular domain (Tyler et al., 1982). Here we have shown that 
immunoglobulin heavy chain bearing this sequence is retained by the plant plasma 
membrane. Using a simple procedure, soluble recombinant protein could not be detected 
unless extraction was performed in the presence of a non-ionic detergent - NP40. It is 
most likely that the recombinant heavy chain is retained in the cell membrane as the 
protein was targeted to the secretory pathway by a signal sequence, and also because the 
heavy chain was readily detected by immunofluorescence of protoplasts. Furthermore, the 
my! assembled correctly with the immunoglobulin light chain which does not possess a 
transmembrane sequence but is also targeted for secretion using a related signal sequence. 
Assembly of light and heavy chain occurs in the ER in plants (Nuttall et al., 2002) and 
mammals and they emerge at the cell membrane as fully assembled immunoglobulin. We 
have demonstrated in the mIgG plants that the kappa and gamma chains are co-localised to 
the cell membrane using immunofluorescence and that they remain correctly assembled at 
this site as antibody, using a functional antigen specific ELISA. The staining pattern of 
both myl and mIgG at the plasma membrane was similar to that seen for a native plasma 
membrane component [H(+)-ATPase pump], indicating that these recombinant proteins are 
being targeted to the plasma membrane in a normal manner. Our studies do not however 
exclude the possibility that the recombinant antibodies might also be distributed elsewhere 
in the plant cell and further investigation of the fine cellular distribution of myl and mIgG 
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needs to be studied by sub-cellular fractionation studies or immuno-electron microscopy. 
Recently it has been demonstrated that engineered immunoglobulins originally targeted for 
secretion, can also be retained in the ER and the vacuole (Hadlington et al., 2003). It 
remains to be determined if the murine immunoglobulin transmembrane sequence 
possesses signals that are specifically recognised by plants, but the accumulation of a 
significant proportion of the recombinant immunoglobulin heavy chain and antibody at the 
cell membrane suggests a default secretory pathway to the cell surface. 
The mIgG appears to be more readily dissociated from plant cell membranes than myl 
alone as shown by the detection of antibodies in plant extracts without NP-40. This may 
be due to over accumulation of IgG in the extracellular compartment, or it is possible that 
the additional burden of the membrane anchored recombinant antibody destabilises the cell 
membrane. However, protoplasts prepared from these plants appeared no less robust than 
others prepared from non-transformed plants. The functional ELISA of extracts from myl 
and mIgG plants (Figure 4.2) suggests a higher level of accumulation of assembled IgG 
compared with the heavy chain clone by 2 dilution steps (approximately 10-fold). This is 
consistent with previous findings (Hein et al., 1991) that suggested that Ig heavy chains are 
stabilised in plants by assembly into antibody. Not all protoplasts expressed the myl heavy 
chain and this is consistent with the finding that the 35S CaMV promotor does not direct 
expression in all cells all of the time (Barnes, 1990; Benfey & Chua, 1989). It will be of 
interest to determine which cell types express the recombinant immunoglobulin chains and 
at which stages of development. 
Many membrane proteins have proved difficult to express in recombinant systems. 
Membrane proteins have different forms (Figure 3, next page) and in the second part of 
this study we have extended our findings on membrane immunoglobulins by investigating 
a different kind of mammalian membrane protein, the chemokine receptor CCR-5. The 
CCR-5 receptor is found primarily on T cells and macrophages. It is a member of the 
7-transmembrane segment G-protein coupled receptor (GPCR) family of proteins and 
therefore unrelated to the immunoglobulin supergene family of proteins. Although 
7-transmembrane proteins have a variety of different functions, they all have a highly 
conserved 3-dimensional structure (Muller, 2000). In all 7-transmembrane proteins, the 
portion within the lipid bilayer consists mainly of hydrophobic amino acids. These are 
usually arranged in an alpha helix, so that the polar -C=O and Nl groups at the peptide 
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bonds can interact with one another, rather than with their hydrophobic surroundings. 
Those parts of the polypeptide that project out from the bilayer usually have a high 
percentage of hydrophilic amino acids. In addition, those that project into the aqueous 
surroundings of the cell are mainly glycoproteins, with many hydrophilic sugar residues 
attached to the part of the polypeptide exposed at the surface of the cell. Whilst more than 
150 different members of the 7-transmembrane domain protein family have been 
identified, all have the C-terminal end of the peptide facing the cytoplasm and the 











Figure 3: Schematic representation of membrane proteins. 
The expression of CCR-5 protein could not be detected from crude transgenic plant 
extracts by ELISA or Western blot. We believe that this could be due to either very low 
levels of expression (below the limits of detection), or more likely that the protein was 
denatured and degraded during extraction. However we were able to detect CCR-5 mRNA 
by RT-PCR of transgenic plants. We have also demonstrated surface staining of plant 
protoplasts using an antibody specific for CCR-5, in a similar manner to that used for 
detecting membrane immunoglobulin. Further studies will be required to demonstrate the 




preliminary studies suggest that a 7-transmembrane mammalian protein may be treated and 
sequestered in plants in the same manner as in humans. 
There are many potential applications for membrane protein expression in plants. In the 
case of antibodies, retention and accumulation of specific antibodies in an extracellular 
compartment might help to prevent infection by interfering with microbial invasion. There 
may also be applications related to the use of cell suspension cultures or protoplasts, for 
example in the large scale adsorption of antigens. Furthermore, plant antibodies that 
accumulate but are largely retained in the apoplasm may be useful in the area of 
phytoremediation and environmental clean-up. 
For multiple membrane spanning proteins, such as CCR-5, plants might offer a solution to 
the particular difficulties that have been associated with the expression of these kinds of 
proteins. Most GPCRs are expressed naturally at low levels (Khorana, 1992), and thus far 
no system has resulted reproducibly in levels of protein expression suitable for their 
purification (Stanasila et al., 1998). Bacterial, yeast, or insect cell expression of GPCRs 
can result in protein misfolding, aggregation and heterogeneity (Tate & Grisshammer, 
1996). The generally low levels of expression and dependence of GPCRs on the 
hydrophobic intramembrane environment have also complicated attempts to study their 
structure. Recombinant CCR-5 has been expressed in Chinese hamster ovary cells, and 
surface expression confirmed by flow cytometry (Zhao et al., 1998). From a variety of 
mammalian cells that have been examined, the highest CCR-5 expression levels were 
observed in canine thymocytes and human embryonic kidney cells (Mirzabekov et al., 
1999). It was proposed that scale-up of these cells could allow the purification of milligram 
amounts of the CCR-5 protein. None of these cell culture systems is straightforward, 
requiring sterility and expensive media. Our findings suggest that plants may be an 
alternative system. 
The function of CCR-5 is to act as a receptor for binding chemokines, the end result of 
which is to recruit cells of the immune system to the site of tissue damage or disease 
(Raport et al., 1996). HIV-1 takes advantage of the presence of these chemokine receptors 
to gain access to the cell via a fusion-mediated event (Alkhatib et al., 1996). The 
identification of non-functional CCR-5 alleles in individuals (Zimmerman et al., 1997) 
provided fresh ideas for prevention strategies, such as blockage or inhibition of receptor 
function by immunisation with portions of, or the entire CCR-5 to generate appropriate 
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antibodies (Bogers, unpublished). Recombinant CCR-5 protein might also be used in 
biochemical and structural studies, or for diagnostic assays and screening purposes. 
An exciting possibility that is raised by our findings, is the potential for using mammalian 
membrane receptor proteins as targets that would initiate signalling mechanisms in plants. 
However, a considerable amount of further engineering would be required. For example, in 
addition to niIgG, the B-cell receptor complex involves two other proteins (alpha and beta 
chains) which each have a tyrosine-based activation motif in their cytoplasmic tails that 
triggers the signalling pathway in B cells. The G-protein signalling pathway is a highly 
conserved mechanism for transducing extracellular signals in a variety of organisms, and 
the superfamily of 7-transmembrane receptors is a central component of this pathway. The 
first 7-transmembrane receptor identified in higher plants was shown to be encoded by the 
gene GCR1 in Arabidopsis thaliana (Plakidou-Dymock et al., 1998). The protein encoded 
by the GCRI gene shows high amino acid similarity to 7-transmembrane receptors from 
three different families, and is involved in cytokinin signal transduction. The cloning and 
characterisation of IARI, a gene required for auxin conjugate sensitivity in Arabidopsis 
has also been reported (Lasswell et al., 2000). IARI structurally resembles and has 
detectable sequence similarity to a family of metal transporters, and was shown to encode a 
novel protein with seven predicted transmembrane domains, with homologues in 
Drosophilla, nematodes and mammals. G proteins have thus been implicated in a number 
of signalling events in plants. 
Finally, a further potential application of this initial work is to use membrane targeting 
sequences for other bioactive proteins that could be expressed at the plant cell surface. As 
a scientific tool the immunoglobulin transmembrane sequence could be useful as a marker 
for analysis of protein expression in plants, as well as having applications in the sorting of 
protoplasts by fluorescence-activated cell sorting (FACS) [Galbraith, 1989]. In mammalian 
cells, cross linking of surface proteins often leads to capping and intemalisation and if this 
occurs in plants, cell surface antibodies could be used as a means of internalising foreign 
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CHAPTER 5: RESULTS III 
Expression and assembly of a secretory antibody in 
transgenic tobacco plants 
The first studies on passive immunotherapy against dental caries were performed with 
Guy's 13, a murine IgG monoclonal antibody that binds to streptococcal antigen I/11, the 
cell surface adhesion protein of Streptococcus mutans. The oral cavity contains a complex 
oral flora and a number of bacterial proteases. For this reason, passive immunotherapy with 
a secretory antibody would be preferable to IgG. Indeed, the predominant form of 
immunoglobulin in mucosal secretions is secretory IgA, which, as described in the 
Literature Review, has higher functional affinity and is more resistant to proteolytic 
degradation than IgG. 
An engineered form of the Guy's 13 gamma heavy chain had already been expressed in 
plants, in which the Cy3 domain was replaced by the Ca2 and CO domains of a murine 
alpha heavy chain (Ma et al., 1994). It had also been demonstrated that this chimaeric 
heavy chain (designated y/a heavy chain) assembled correctly with the original kappa light 
chain to form functional antibody (designated IgA/G). 
The aims of this part of the study were to: 
1) determine if higher assembly forms of immunoglobulin could be expressed in plants, 
initially by co-expression of Ig light, heavy and joining chains to produce dimeric 
antibodies in a single plant. 
2) if successful, to co-express a further recombinant protein - secretory component - in 
order to assess the potential for assembly of a monoclonal secretory antibody. 
3) examine the efficiency of assembly of Guy's 13 secretory antibody, 
4) perform functional studies to compare the recombinant plant SIgA to the native murine 
IgG. 
For these studies transgenic Nicotiana tabacum plant lines that had previously been 
generated were used (Ma et al., 1994). These expressed; 
1) Guy's 13 MAb heavy chain (yl) 
2) Guy's 13 MAb light chain (x) 
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3) Chimaeric Guy's 13 MAb heavy chain (y 1 /a) 
4) Chimaeric Guy's 13 MAb heavy chain (y2/a) 
5) Murine Joining (J) chain* 
6) Rabbit secretory component (SC) 
*The DNA and amino acid sequences are shown in the Appendix. 
The parent singly transformed parent plants (x, yl, y2/cc and yl/a) were initially screened 
for transgene expression by ELISA (data not shown). The crossing of light and heavy 
chain-secreting plants resulted in; 3 out of 10 Fl progeny plants expressing kappa and 
gamma chains together, 4 of 17 plants expressing both kappa and the yl/a heavy chain, and 
3 of 8 plants expressing both kappa and the plant y2/a heavy chain together, as 
demonstrated by Western blotting and ELISA (section 5.1 below). 
5.1 Detection of recombinant immunoglobulin chains and assembled monomeric 
immunoglobulins in transeenic tobacco slants 
The F1 progeny of the first cross between light and heavy chain transgenic plants was 
expected to include plants that co-expressed both chains and assembled them into 
functional antibody monomers. Western blots of representative plants from this cross are 
shown in Figures 5.1 and 5.2. 
Figure 5.1 Panel A demonstrates the expression of Guy's 13 light chains under reducing 
conditions. Using the murine hybridoma culture supernatant as a positive control, Guy's 13 
light chain is detected at approximate M 25K (lane a). No cross-reactive bands were 
detectable in wild type non-transformed plants (lane e). However in plants expected to co- 
express light chain with the Guy's 13 yl, y2/a and yl/a heavy chains, light chain of the 
predicted M, was detected (lanes b, c and d respectively). Figures 5.1 B and 5.1 C show the 
Guy's 13 heavy chains expressed in the same plants. Using an anti-murine yl heavy chain 
antiserum, the native murine Guy's 13 heavy chain from hybridoma culture supernatant is 
detectable as a double band under reducing conditions (Figure 5.1B, lane a). The Mr is 
approximately 55K, and the difference between the two bands is due to glycosylation 
differences. In plants, Guy's 13 yl heavy chain is detectable predominantly as a single band 
(lane b), which may indicate that all the heavy chains are glycosylated in the same way. 
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The heavy chains of plant yl/a and y2/a were detected with an anti-alpha heavy chain 
antiserum under reducing conditions (Figure 5.1C, lanes c and d). The heavy chain of plant 
yl/a (lane d) has a relative molecular mass of approximately K 60K and the plant y2/a 
heavy chain is larger (approximate M, 70K). These findings are consistent with the 
molecular weights predicted by sequence analysis, as the y2/a heavy chain includes an 
extra inununoglobulin domain in comparison with the yl/a and the native yl heavy chains. 
A number of other bands were detected in the transgenic plant extracts. These are likely to 
represent proteolytic fragments of either light/heavy chain complexes, or of the heavy 
chain, as no bands were detected in the extract from the wild type plant (lane e). 
The same samples were also run under non-reducing conditions to assess the assembly of 
immunoglobulin molecules (Figure 5.2). Detection was with a labeled anti-kappa light 
chain antiserum in all cases. All three transgenic plant lines assembled immunoglobulin of 
the expected M. for their respective full-length antibody. The plant Guy's 13 antibody (lane 
b) has the same Mr as the mouse Guy's 13 (lane a) - approx. Mr 170K, but the plant y2/a 
(lane c) and plant yl/a (lane d) antibodies have slightly higher Mr as predicted from the 
differences in the heavy chain sequences. Again, several smaller proteolytic fragments were 
also detected, which is consistent with the fact that a number of proteases are released by 
plants during the antibody extraction procedure (Hiatt et al., 1989). That these are antibody 
fragments is confirmed by the absence of any detectable bands in the wild type plant extract 
(lane e). 
5.2 ELISA results 
The Western blot results demonstrated co-expression of light and heavy chains in plants, 
and the assembly of higher molecular weight complexes which were of the expected M, for 
immunoglobulin tetramers. In order to confirm the assembly of immunoglobulins, and their 
correct functionality, an antigen-specific ELISA was used to demonstrate the presence of 
functional antigen binding sites. 
Titration curves for extracts from three representative transgenic plants binding to the 
specific streptococcal antigen (SA I/II) are shown in Figure 5.3. Specific antibody was 
detectable in all three transgenic plant extracts, and the titration curves were similar to that 
of the murine hybridoma cell culture supernatant used at the same concentration. The 
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binding of the Gl/A plant antibody appeared to be slightly lower than the other antibodies, 
although the titration curve was similar. No SA I/II binding was detected in the negative 
control plant, nor did extracts from plants individually expressing light or heavy chains 
have binding activity. These findings demonstrate that the transgenic plants expressing both 
light and heavy chains assembled the antibody molecule correctly to form a functional 
antigen binding site and confirmed that single light or heavy chains are not capable of 
binding the antigen. 
Based on these results, it was decided to use the y2/a heavy chain construct expressing 
plants for further crossing to develop secretory antibody plants. The reasons for this are 
discussed in more detail in the Discussion section of this chapter. An antibody expressing 
plant homozygous for both light and y2/a heavy chains was generated by a self- 
fertilisation, followed by screening of the resulting seeds by back-crossing with wild type 
plants. The parent plant was identified as homozygous for heavy and light chains if all the 
offspring tested (12 out of 12) bound to SA I/II antigen in the ELISA. 
5.3 Identification of transgenic plants expressing J chain 
Plants had previously been regenerated following transformation with the gene encoding 
murine J chain. These were initially screened by ELISA and Western blotting using a 
variety of antisera raised against murine and human J chain (kindly supplied by 
Dr. M. Parkhouse, and Nordic Pharmaceuticals), but without success. 
To confirm the sequence of the J chain insert, the J chain construct inserted into transgenic 
plants was re-isolated from regenerated plants and cloned into the plasmid Bluescript KS+. 
DNA sequencing identified a single amino acid change from the expected sequence - an 
arginine residue in place of a lysine at amino acid position number 130. This is a 
conservative change, which may simply be a mouse strain variation. The complete DNA 
sequences of murine J chain and plant J chain are shown in the Appendix. 
Although expressed protein could not be detected in plant extracts, it was felt that this was 
due to the quality of the antisera available as well as low levels of expression. Putative 
J chain transgenic plants were subsequently screened using the reverse transcriptase- 
polymerase chain reaction (RT-PCR). Heterozygous plants selected on this basis were used 
for further cross fertilisation studies. 
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5.4 J chain RT-PCR 
Figure 5.4A shows the RT-PCR products derived from reactions using J chain specific 
oligonucleotides (lanes a- d) with cDNA prepared from plant mRNA. The sequences of 
the J chain specific oligonucleotides are shown in the Appendix. A positive J chain control 
plasmid (described in the Appendix) is shown in lane a. A product of the expected size, 
700 bp, was detected from cDNA derived from a plant transformed with murine J chain 
DNA (lane b). No PCR products were detected in reactions from either a wild type plant 
(lane c), or a monomeric Guy's 13 antibody expressing plant (lane d). Negative control 
reactions were performed with mRNA without any reverse transcriptase (lanes e -g), and 
no bands were detected, demonstrating the absence of any cDNA in the samples. 
As a control experiment to confirm the isolation of mRNA, an RT-PCR was carried out 
with rubisco specific oligonucleotides (sequences of the rubisco oligonucleotides are shown 
in the Appendix), using cDNA prepared from plant mRNA. A product of approximately 
600 bp, the expected size of the rubisco fragment was detected in each of the reactions 
performed (Figure 5.4B, lanes a- c). However when an RT-PCR was performed using the 
same mRNA in the absence of any reverse transcriptase, the 600 bp product was not 
detected (Figure 5.4B, lanes d -t). This result demonstrates the presence of RNA specific 
for the constitutive rubisco gene in the extracts of plant RNA, and acts as a control for the 
mRNA preparations. 
The heterozygous plants that expressed the murine i chain were crossed with homozygous 
plants that expressed IgG/A (with y2/a heavy chain). Immunoblot screening of crude plant 
extracts from the progeny of this cross demonstrated that in 4 out of 16 plants, three major 
bands could be detected under non-reducing conditions with an anti-mouse kappa chain 
specific antiserum. An immunoblot of one representative plant extract is shown (Figure 5.5) 
alongside the parent plant extract expressing the monomeric IgG/A and Guy's 13 murine 
hybridoma culture supernatant. As before, murine Guy's 13 IgG has a slightly faster 
mobility than the chimaeric IgG/A molecule that has an approximate M, 210-220K (lanes d 
and c). The same Mf 210-200K band was observed in the extract from the plant 
co-expressing light, y2/a heavy and J chains (lane b). In addition, a higher molecular 
weight band, approximately twice the weight of the monomeric IgG/A was observed which 
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is likely to represent dimerised antibody (dIgA/G). No cross-reactive bands were observed 
in extract from wild-type non-transformed plants. 
5.5 Cross fertilisation of dimeric IgA/G and SC transgenic plants 
Transgenic plants expressing rabbit secretory component were identified by Western 
blotting using a specific antiserum kindly supplied by Dr. James Casanova (results not 
shown). Homozygous SC transgenic plants were generated by self-fertilisation, followed by 
screening of the resulting seeds by back-crossing with wild type plants. The parent plant 
was identified as homozygous for heavy and light chains if all the offspring tested (12 out 
of 12) bound to SA I/II antigen in the ELISA 
Mature plants that expressed dIgA/G were crossed with a homozygous plant that expressed 
SC. Using one plant representing each of the primary transgenics (J chain and secretory 
component) and their filial recombinants (IgG/A, dIgA/G and SIgA/G), the presence or 
absence of 3 of the relevant chains (heavy, light and SC) was detected by Western blotting 
(Figure 5.6). The plant samples were run under reducing conditions with 
ß-mercaptoethanol. Heavy and light chains (of expected M) were detected in all antibody 
expressing plants - IgGI control, IgG/A, dIgA/G and SIgA/G, but not in wild type, J or SC 
transgenic plants (Upper and Middle Panels). Secretory component was only detected in the 
SC and SIgA/G plants (Lower Panel). Only the SIgA/G plants were shown to co-express 
the heavy, light and SC chains. No cross-reactive bands were observed in the wild-type 
non-transformed control plant extract. 
Under non-reducing conditions, increasingly higher molecular weight immunoreactive 
bands were detected as more of the polypeptide chains were co-expressed. Thus the SIgA/G 
plant that co-expressed light, heavy and J chains with secretory component produced a high 
molecular mass band of approximate M, 470 (SIgA/G) in protein immunoblot analysis 
using an anti-mouse kappa chain specific antiserum (Figure 5.7, Panel a, lane 5). Such a 
molecular size is consistent with that expected for a secretory Ig and the relationship of this 
band with those seen previously in monomeric immunoglobulin and dimeric 
immunoglobulin expressing plants is illustrated in Figure 5.7 (Panel a, lanes 3 and 4). This 
immunoblot was probed with an anti-kappa light chain reagent, as the kappa chain is 
common to all forms of the Guy's 13 antibody expressed in plants. 
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Probing the same plant extracts with antiserum specific to SC confirmed that the high 
molecular mass protein contained SC (lane 7), whereas none of the other major Ig bands 
were recognised. In a transgenic plant that secreted SC alone without other 
immunoglobulin chains, no bands were detected with the anti-light chain antiserum (lane 
6). Nor were any other high Mr proteins detected under non-reducing conditions with 
anti-SC antiserum (lane 9). Hence there was no evidence that SC assembled with 
endogenous plant proteins or produced multimers. No cross-reacting proteins were detected 
in extracts from the wild type control plant (lanes 2 and 10). 
Complete dissociation of SC from Ig heavy chains only occurred under reducing 
conditions, suggesting that the SC chain is at least partially covalently linked in the fully 
assembled SIgA/G molecule. The molecular mass of the major SC band under reducing 
conditions was about M, 50 kDa, slightly lower than expected (M, 66.5 kDa), and slightly 
lower in SC transgenic plants as compared with SIgA/G plants (Figure 5.6). This may be 
due to proteolysis, which can occur in the intact plant or during sample preparation. SC 
bound to dimeric IgA is often found proteolysed to smaller but biologically active forms 
in vivo (Ahnen et al., 1986). However in the protein immunoblot analysis under 
non-reducing conditions, the molecular mass difference between dIgA/G and SIgA/G was 
approximately K70 kDa, as expected (Figure 5.7, lanes 4 and 5). 
5.6 Correct assembly of SC to immunoglobulin 
In mammals, the assembly of SC with antibody requires the presence of the J chain 
(Brandtzaeg & Prydz, 1984), we now investigated whether this was also the case in plants. 
Plants expressing monomeric IgG/A (without J chain) were cross-fertilised with 
homozygous SC-expressing plants. In the progeny that co-expressed IgG/A and SC, only 
the monomeric IgG/A form of the antibody was detected in Western blot, and no higher 
molecular mass forms (Figure 5.8 Upper Panel, lanes 1 and 2). Antiserum to SC recognised 
free SC but did not recognise proteins associated with Ig (Figure 5.8 Lower Panel). This 
result was confirmed in all plants examined. 
Crossing a plant that expresses dimeric IgA/G with a homozygous plant that expresses SC 
is predicted to generate 8 possible genotypes, shown in Table 2. However only one of these 
is predicted to contain copies of the heavy, light, J chain and SC genes (Table 2, 
highlighted in red). Subsequently, 2 out of 15 plants tested contained a M, 470 kDa 
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SIgA/G molecule (a representative plant is shown in lane 3). No cross-reactive bands were 
detected in the wild-type non-transformed plant (lane 4). This finding confirmed the 
requirement of the J chain for SC association with Ig and suggests that the nature of this 
association is the same in plants and mammals. 
Genotypes from cross between 
dimeric IgA/G and SC plants 
KJ a/y SC 
KJ SC 
K a/y SC 





Table 2: Possible genotypes from crossing heterozygous dimeric IgA/G plants with 
homozygous SC plants. 
5.7 Functional antibody studies of recombinant plant IgG and SIgA/G 
Functional antibody studies were carried out with samples from transgenic plants 
expressing either; SIgA/G, dlgA/G, IgG/A, SC, or J chain using antigen-specific ELISAs. 
Detection was with either an anti-light (kappa) chain reagent or anti-SC antiserum. Guy's 
13 hybridoma cell culture supernatant (IgG) was used as a positive control. 
All plants expressing antibody light and heavy chains assembled functional antibodies that 
specifically recognised SA I/II (Figure 5.9 Panel A). The levels of binding and titration 
curves were similar to those of the original mouse hybridoma cell supernatant. No SA 1/II 
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binding was detected with wild type plant extracts, or from plants expressing only the 
J chain or SC. 
The binding of antibody to immobilised purified SA I/II was also detected with antiserum 
to SC (Figure 5.9 Panel B). In this assay, only the SIgA/G plant antibody binding was 
detected, and not the functional antibodies in either the IgG/A or the dIgA/G plants. These 
results confirm that SC was assembled with antibody in the SIgA/G plant but did not 
interfere with antigen recognition or binding. 
Binding of the plant secretory antibody to antigen in its native bacterial context was also 
confirmed (Figure 5.9 Panel Q. In an ELISA using S. mutans whole cells as antigen, 
specific binding was observed in the extract from SIgA/G plants using the anti-secretory 
component antiserum. As with SA I/II, no binding was detected in any of the other 
transgenic plant extracts. 
5.8 Levels of expression and efficiency of assembly of recombinant SIgA/G in plants 
The assembly of functional IgG molecules in plants has been reported as being very 
efficient (Hiatt et al., 1989), based on the expression levels observed. The expression levels 
of functional SIgA/G in tobacco leaves were measured in 12 different transgenic plants, by 
an antigen specific ELISA using Guy's 13 IgG at known concentration as the standard. The 
data are shown in Figure 5.10. The expression levels are expressed as a percentage of the 
total soluble protein (TSP) content of each plant extract, (as measured by the Bradford 
protein assay). No detectable antibody binding was observed in WT non-transformed 
plants. Two IgG plants expressed IgG at approximately I% of TSP when using anti-kappa 
chain antiserum for detection, but no binding activity was detected using the anti-secretory 
component antiserum in these plants. In the SIgA/G plants, using the anti-secretory 
component antiserum for detection, a range of levels were observed, with an average of 
5.2 % and the highest expression level representing 8% of TSP. 
Densitometric analysis (Syngene GeneGeniusTM image analysis software, Synoptics Ltd., 
Cambridge) of the Western blots suggests that in the dIgA/G, the dimeric antibody 
population constitutes a major proportion - almost 57 %- of the total antibody (Figure 5.5, 
lane 1). In the secretory IgA/G plants, the SIgA/G complex represents up to approximately 
40 % of the total assembled antibody (Figure 5.8 lane 3). However protein immunoblot 
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analysis potentially underestimates the total extent of assembly of SIgA/G because it only 
detects antibody that is covalently linked to SC, whereas SIgA can occur in vivo as a 
mixture of covalently and non-covalently linked molecules (Schneiderman et al., 1989; 




















Figure 5.1: Western blot analysis of plant samples reduced with 5% (v/v) 
ß-mercaptoethanol. Samples were separated by 10 % SDS-PAGE. 
Detection was with; goat anti-mouse x chain antiserum (Panel A); goat 
anti-mouse yl chain antiserum (Panel B); goat anti-mouse a chain 
antiserum (Panel C). Samples are; a- Guy's 13 mouse hybridoma culture 
supernatant, b- plant Guy's 13, c- plant y2/a, d- plant yl/a, e- wild 








Figure 5.2: Western blot analysis of plant samples 
separated by 6% SDS-PAGE under non-reducing 
conditions. Detection was with goat anti-mouse x chain 
antiserum, followed by alkaline phosphatase-labeled rabbit 
anti-goat IgG antiserum. Samples are; a- Mouse Guy's 13 
hybridoma culture supernatant, b- plant Guy's 13, c- 
plant y2/a, d- plant yl/a, e- wild type non-transformed 
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Figure 5.3: Binding of plant Guy's 13 samples to purified SA I/II 
in ELISA, detected using a horseradish peroxidase-conjugated 
goat anti-mouse light and heavy chain antiserum. The results are 
expressed as the mean absorbance +/- standard deviation of 
duplicate results from three separate experiments. The starting 
concentration of each antibody sample was adjusted to 1.5 µg/ml, 
and used in serial twofold dilutions. 
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Figure 5.4: Agarose gel electrophoresis of reverse transcriptase polymerase 
chain reactions (RT-PCR) performed using samples of plant mRNA. Reaction 
products were visualised with ethidium bromide staining under UV light. 
A) PCR was performed with J chain specific oligonucleotides (Appendix). 
Samples are; a- positive J chain control plasmid; b- transgenic plant expressing 
the J chain; c- wild type plant; d- transgenic plant expressing monomeric Guy's 
13 IgG. Negative control reactions are shown in lanes e-g, in which plant mRNA 
was used in the absence of any reverse transcriptase; e- transgenic plant 
expressing the J chain, f- wild type plant, g- transgenic plant expressing 
monomeric Guy's 13 IgG. 
B) PCR was performed with rubisco specific oligonucleotides. (Appendix). 
Samples are; a- wild type plant, b- transgenic plant expressing the J chain, c 
transgenic plant expressing monomeric Guy's 13 IgG. Negative control reactions 
are shown in lanes d-f, in which plant mRNA was used in the absence of any 
reverse transcriptase; d- wild type plant, e- transgenic plant expressing the J 
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Figure 5.5: Protein immunoblot of plant extracts prepared under non- 
reducing conditions, detected with antisera to the mouse K light chain. 
Samples were prepared and separated on 4% (w/v) SDS-PAGE. The 
samples are; a- wild type plant, b- transgenic plant expressing modified 
heavy and light chain genes of Guy's 13 and the J chain, c- transgenic 
plant expressing modified heavy and light chain genes of Guy's 13, 
d- Mouse Guy's 13 hybridoma culture supernatant. Relative molecular 
masses (x103) are indicated. 
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Figure 5.6: Protein immunoblot of plant extracts. Samples were separated 
on 10 % (w/v) SDS-PAGE under reducing conditions with 5% (v/v) ß- 
mercaptoethanol. Detection was with antisera to mouse yl heavy chain 
(upper panel), the mouse x light chain (middle panel), or rabbit SC (lower 
panel). 
Samples are; IgG - Guy's 13 hybridoma cell culture supernatant; WT - non- 
transformed wild type plant; IgG/A, transgenic plant expressing modified 
heavy and light chain genes of Guy's 13; dIgA/G, transgenic plant 
expressing modified heavy and light chain genes of Guy's 13 and the J 
chain; SIgA/G, transgenic plant expressing modified heavy and light chain 
genes of Guy's 13, the J chain, and SC; SC, transgenic plant expressing SC; 
and J, transgenic plant expressing the J chain. Relative molecular masses 
(x103) are indicated. 
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Figure 5.7: Protein immunoblot of plant extracts prepared under non- 
reducing conditions, detected with antisera to the mouse x light chain (left 
lanes) or to rabbit SC (right lanes). Samples were prepared and separated on 
4% (w/v) SDS-PAGE. Samples are; IgG- Guy's 13 hybridoma cell culture 
supernatant; WT - non-transformed wild type plant; IgG/A, transgenic plant 
expressing modified heavy and light chain genes of Guy's 13; dIgA /G, 
transgenic plant expressing modified heavy and light chain genes of Guy's 13 
and the J chain; SIgA/G, transgenic plant expressing modified heavy and 
light chain genes of Guy's 13, the J chain, and SC; SC, transgenic plant 
expressing SC; and J, transgenic plant expressing the J chain. Relative 













Figure 5.8: Co-expression of IgG/A with SC. Protein immunoblot of 
plant extracts. 
Upper panel: Samples were separated on 4% (w/v) SDS-PAGE under 
non-reducing conditions. Detection was with goat antisera to the x light 
chain 
Lower panel: Samples were separated on 10 % (w/v) SDS-PAGE under 
reducing conditions. Detection was with sheep antisera to SC. 
IgA/G-SC lanes I and 2 are transgenic plants expressing modified 
heavy and light chain genes of Guy's 13 and SC; sIgA/G is a transgenic 
plants expressing modified heavy and light chain genes of Guy's 13, 
SC and J chain; WT is a non-transgenic wild type control plant. 
Relative molecular masses (x 103) are indicated. 
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Figure 5.9: Functional antibody expression in transgenic N. tabacum. (A) Plant extract binding to purified SA I/II, detected with HRP-labeled antiserum to the K light chain. (B) Plant extract binding to purified SA I/II, detected with sheep antiserum to SC followed by 
alkaline phosphatase-labeled donkey antiserum to sheep Ig. (C) Plant extract binding to 
streptococcal cells, detected with sheep antiserum to SC followed by alkaline 
phosphatase-labeled donkey antiserum to sheep Ig. Guy's 13 hybridoma cell culture 
supernatant (IgG) was used as a positive control. The initial concentration of each 
antibody solution was 5µg/mL Dilution numbers represent serial double dilutions. Results 











Detection with: anti-SC antiserum anti-K antiserum 
Figure 5.10: Antibody expression levels in transgenic plants. Antigen specific ELISA 
was used to determine the titration points for all samples. Plant extracts were detected 
with anti-secretory component antibody or anti-kappa chain antibody as indicated. 
Concentration values were determined by comparison with a Guy's 13 IgG standard. 
Values are expressed as percentage of total soluble protein. 
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5.9 Discussion 
Most infections start at the mucosal surfaces of the body, including the eyes, respiratory 
tract, gastro-intestinal tract, and the uro-genital tract. In 1994, mucosal infections caused 
almost 11 million fatalities worldwide, accounting for more than half of the deaths caused 
by communicable diseases, and almost a quarter of deaths by all causes (Murray & Lopez, 
1994). In the USA alone, more than 12 million people are infected with sexually 
transmitted diseases (STDs) each year, at an estimated annual cost of over $12 billion (Eng 
& Butler, 1997). In animal models and human studies, antibodies have been shown to 
prevent a variety of these diseases (Veazey et al., 2003; Piedimonte et al., 2000; Zeitlin et 
al., 1998). Topical passive immunisation with MAbs may therefore provide an economic 
and highly effective means of improving public health (reviewed by Zeitlin et al., 1999). 
Topical passive immunotherapy requires relatively large amounts of MAb. In our dental 
caries clinical trials, approximately 20 mg of antibody was required to treat each human 
volunteer (Ma et al., 1998). The commercial development of this antibody would 
undoubtedly require its' production on a large scale, perhaps amounting to many hundreds 
of kilogrammes of antibody per year in the UK alone, well beyond the capability of 
traditional technologies. For this reason, we have studied plants as an expression system for 
recombinant antibodies. 
The most appropriate antibody isotype for mucosal delivery on most human mucosal 
surfaces is likely to be secretory IgA (SIgA). In the case of dental caries, a monoclonal 
SIgA antibody may possess several advantages over IgG in the prevention of S. mutans 
colonisation. One of the advantages to using secretory antibodies at mucosal surfaces is the 
resistance to proteolysis that has been observed with SIgA antibodies (Corthesy, 1997). It 
has been suggested that secretory antibodies might survive longer than serum antibodies in 
the mucosal environment due to the protective presence of the secretory component 
(Underdown & Dorrington, 1974; Mestecky & McGhee, 1987). Although the mouth does 
not contain significant amounts of indigenous proteases compared to the gastro-intestinal 
tract, it does contain a variety of bacterial proteases from the normal commensal oral flora. 
In our studies, the susceptibility of plant derived SIgA/G to pepsin digestion has been 
studied, and we have demonstrated a measurable increase in resistance to proteolytic 
degradation. This may turn out to be highly significant, as it suggests that oral delivery of 
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plant derived secretory antibodies for immunotherapy of gastric and duodenal infections 
could be possible. In further studies that were performed with the plant derived secretory 
IgA/G antibody, a significant in vivo benefit was demonstrated for the secretory antibody 
over IgG in terms of stability and survival in the oral cavity (Ma et al., 1998). This was 
investigated by examining the survival of the two forms of Guy's 13 antibodies applied 
topically into the oral cavity. Six human volunteers were used and the baseline limits of 
detection were determined using control subjects who were given bovine serum albumin in 
PBS by the same method as that used for the MAbs. Following the application of either IgG 
MAb or SIgA/G solution to the teeth, both antibodies were detectable after 30 minutes. In 
subjects who received IgG, the recoverable antibodies on teeth and in saliva then decreased 
rapidly and were undetectable after 24 hours. In contrast, SIgA/G was detectable for at least 
72 hours on teeth and for up to 48 hours in saliva. The detection assay required functional 
antigen binding and the SIgA/G antibody could be detected with both an anti-light chain as 
well as an anti-SC reagent which does not cross-react with either heavy or light chains. The 
results therefore suggest that the antibody recovered remained functionally intact in the oral 
cavity. 
Another advantage of using plant derived secretory antibodies derives from the increased 
valency of secretory immunoglobulins as compared with IgG. It was previously shown that 
Guy's 13 IgG and the F(ab")2 fragment were protective in humans, but that the Fab' 
fragment was not (Ma et al., 1990). This suggested a requirement for at least bivalent 
antigen binding. The rationale for the use of the plant SIgA/G antibody was that there is a 
progressive increase in valency and avidity from the ineffective monomeric Fab', to the 
protective dimeric F(ab)2 and IgG, to the tetravalent SIgA/G, which may correlate with 
protective efficacy. The increased avidity of secretory antibodies would augment bacterial 
aggregation and immune exclusion. Using the plant derived SIgA/G molecule, we have 
been able to demonstrate that the affmity of antigen binding is equivalent to that of the 
native IgG, however the avidity of binding was increased, as predicted by the dimeric form 
of SIgA/G (Ma et al., 1998). 
The binding affinity of the plant SIgA/G to streptococcal antigen I/1I was compared with 
that of the native mouse IgG Guy's 13 by surface plasmon resonance (Ma et al., 1998). The 
binding curves for both forms of antibody at equimolar concentrations were similar for both 
the association and dissociation phases. The values for ke, kd and Kd were calculated from 
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sensorgrams using five concentrations for each antibody. There was no difference between 
the deduced dissociation constants for plant SIgA/G (Kd = 5.2 x 10'10M) and IgG 
(Kd = 1.3 x 10-9 M) monoclonal antibodies. This assay was optimised for a 1: 1 molecular 
interaction, so it is unlikely that differences in avidity would be apparent. However like the 
ELISA results reported earlier in this chapter, surface plasmon resonance analysis does 
serve to confirm the correct assembly of the antigen binding site of the antibody in plants 
and shows that antigen recognition is unaffected by any differences in antibody structure, 
due to the complex nature of the SIgA/G molecule or variations between plant and murine 
glycosylation. 
A comparison of the functional affinities of the two antibody preparations was determined 
using a competition ELISA. In this assay, addition of excess antigen in the fluid phase 
favours multivalent interactions with antibody (Ma et al., 1998). Approximately 4-fold 
higher antigen concentration was required to inhibit binding of IgG to SA I/II by 50 % 
(ICso =- 43 nM), compared with the plant SIgA/G (IC50 =- 11 nM), which demonstrates 
that the SIgA/G preparation had a higher functional affinity than IgG. As the dissociation 
constants of the two antibodies are the same (as shown by surface plasmon resonance), this 
difference can be accounted for by the higher avidity of the tetravalent SIgA/G and dIgA/G 
molecules compared with the bivalent IgG molecule (Steward & Chargelegue, 1997). 
The most valid functional assay for this plant derived antibody was a human clinical trial, 
testing the protective efficacy against Streptococcus mutans colonisation in the oral cavity 
(Ma et al., 1998). The plants prepared in this study were used to generate sufficient biomass 
for purification of 100 mg monoclonal secretory antibody by Planet Biotechnology Inc. 
This material was then used in a clinical trial. 
The clinical protective efficacy of MAb Guy's 13 IgG had previously been established by 
preventing colonisation by S. mutans and dental caries in animals (Lehner et al., 1985), as 
well as by preventing both exogenous colonisation (Ma et al., 1989) and recolonisation by 
indigenous S. mutans (Ma et al., 1990) in humans. The ability of the plant Guy's 13 
SIgA/G preparation to prevent recolonisation by S. mutans was therefore determined 
alongside the murine IgGI MAb (Ma et al., 1998). Two control groups were included; one 
that was sham-immunised with saline and another that received a non-specific plant/bovine 
IgG preparation. The latter control was used to exclude the possibility that a non-specific 
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plant component might co-purify with immunoglobulins and prevent bacterial colonisation. 
Volunteers were chosen who already harboured oral S. mutans. They were treated with 
topical chlorhexidine gluconate for nine days to deplete the oral flora and eliminate 
S. mutans. Thereafter, antibody or control solutions were applied directly to their teeth for 
three weeks, two applications per week. Samples of dental plaque and saliva were collected 
at intervals up to four months to monitor the recolonisation of S. mutans. In every subject, 
topical chlorhexidine reduced the levels of S. mutans to below detectable limits in both 
plaque and saliva. In saliva, recolonising S. mutans was initially observed after 21 days in 
one individual in the group receiving plant/bovine IgG. At 58 days, recolonisation of 
S. mutans was found in all subjects in both control groups, and levels continued to rise until 
the end of the experiment at 120 days. In contrast, neither the four subjects treated with the 
plant SIgA/G preparation nor the four treated with murine Guy's 13 IgG recolonised for the 
duration of the experiment. Similar results were found in dental plaque samples. 
The specific nature of this immunotherapeutic approach was tested by monitoring the levels 
of Actinomyces, a Gram positive commensal bacterial species commonly found in the oral 
cavity, in subjects receiving either plant/bovine IgG or the plant SIgA/G preparation. As 
with S. mutans, Actinomyces spp. fell to undetectable levels following treatment with 
chlorhexidine, but in contrast to the finding with S. mutans, both the non-immunised and 
immunised groups recolonised within 21 days and the Actinomyces spp. were restored to 
pre-experimental levels by 88 days. This fording supports the specific nature of the action 
of Guy's 13 MAb, as application of the antibody had no effect on the recolonisation of 
Actinomyces spp. or the rate at which this bacterial species was re-established in the oral 
cavity. 
The more widespread use of secretory IgA in passive immunisation has been hindered until 
now by the complexity of the molecule and technical difficulties in producing sufficiently 
large quantities. Previously both IgA and SIgA have been partially purified on a small scale 
from milk (Brandtzaeg, 1970), bile (Taylor & Dimmock, 1985), and transfected mouse 
myelomas (Terskikh et al., 1994). One of the earliest methods involved the in vitro 
conjugation of SC with dimeric IgA from several different mammalian species (Mach, 
1970). Free SC purified from both human and bovine milk was labeled with [1251] and 
incubated with purified human myeloma polymeric IgA. Chromatographic analysis showed 
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that almost 90 % of the labeled free SC could be bound to the polymeric IgA (Mach, 1970). 
Other attempts to generate SIgA involved the in vivo insertion of subcutaneous "backpack" 
tumours of hybridoma cells secreting monoclonal IgA against Vibrio cholerae (Winner et 
al., 1991). IgA hybridomas that produced dimeric monoclonal IgA antibodies were 
generated from Peyer's patch lymphocytes after oral immunisation of mice with a strain of 
Vibrio cholerae. Hybridoma cells were then injected subcutaneously into 1 day old 
syngeneic mice, which resulted in the secretion of monoclonal SIgA onto mucosal surfaces 
(Winner et al., 1991). This system was used as a novel experimental model to assess the 
protective actions of individual IgA antibodies, and demonstrated that a single monoclonal 
SIgA could protect mice against intestinal disease caused by oral challenge with a lethal 
dose of V. cholerae. 
The co-expression of recombinant IgA with J chain using the baculovirus insect cell system 
has been described elsewhere (refer to the Literature Review), but unlike our experience 
with plants only a small proportion of the expressed antibody was dimerised, most 
remaining in a monomeric form (Carayannopoulos et al., 1994). 
Recombinant SIgA has been generated in an in vitro coculture system that simulates the 
in vivo receptor-mediated transport of dimeric IgA antibodies (Hirt et al., 1993). 
Hybridoma cells that provide a continuous supply of dimeric IgA (dIgA) were co-cultivated 
with a monolayer of Madin-Darby canine kidney (MDCK) cells expressing rabbit 
polymeric immunoglobulin receptor (pIgR). Approximately 20 % of the dIgA transported 
into the apical medium of this coculture system was covalently linked to SC and recovered 
as SC-dIgA complexes (Hirt et al., 1993). Doubling the number of hybridoma cells in the 
basolateral matrix doubled the concentration of IgA in the basal medium, but did not 
increase the rate of dIgA transport. The expression of pIgR was shown to be rate-limiting in 
the transport process. 
Further efforts to produce recombinant SIgA focused on the in vitro combination of 
purified dimeric IgA and SC using recombinant baculo- and vaccinia viruses (Rindisbacher 
et al., 1995) are described in the Literature Review. In another study, the hybridoma cell 
line ZACC3 expresses Y. cholerae lipopolysaccharide (LPS)-specific mouse IgA molecules 
as a population of monomeric, dimeric and polymeric forms (Lullau et al., 1996). 
A combination of ultrafiltration, ion-exchange chromatography and size exclusion 
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chromatography was used to separate out milligram quantities of these three forms. 
Dimeric IgA and polymeric IgA (pIgA) bound strongly to LPS, whereas the monomeric 
form of IgA form did not. SIgA was reconstituted in vitro by combining recombinant SC 
and purified dIgA and pIgA. Surface plasmon resonance-based binding experiments 
demonstrated that purified reconstituted SIgA and IgA molecules recognised LPS with the 
same affinity (Lullau et al., 1996). 
The first report of the production of SIgA by a single mammalian cell has been made using 
a murine polymeric IgA-producing myeloma cell secreting mouse-human chimaeric IgAl 
specific for the hapten dansyl, transfected with cDNA encoding human SC 
(Chintalacharuvu & Morrison, 1997). Almost all of the expressed SC was secreted 
covalently associated in SIgA, and only a minor band of free SC was seen in the 
supernatant. To determine their in vivo stability, dimeric IgA and SIgA proteins were 
purified and introduced into the stomach of BALB/c mice for 150 minutes. Dimeric IgA 
(dIgA) was more rapidly eliminated from the mice than SIgA, and more total and antigen- 
specific SIgA was recovered from intestinal washes, suggesting that SIgA was more stable 
in the intestines than dimeric IgA. However SDS-PAGE analysis of the IgA precipitated 
with antigen showed a major band corresponding to Fab' fragments in intestinal washes 
from mice given either SIgA or dIgA. Inununoprecipitates of anti-a and anti-x chain also 
showed a major band corresponding to Fab' and Fc fragments and several minor higher 
molecular mass bands (Chintalacharuvu & Morrison, 1997). 
A correctly assembled chimaeric mouse-human SIgA specific for the respiratory syncytial 
virus F glycoprotein has been expressed recently in CHO cells (Berdoz et al., 1999). An 
advantage to using CHO cells is that they secrete proteins with N- and O-linked 
glycosylation patterns similar to those found in human cells, and furthermore CHO cells 
can also be grown to high density in bioreactors (Parekh et al., 1989). A single CHO cell 
was sequentially transfected with expression vectors carrying respectively chimaeric heavy 
and light chains, human J chain, and human SC, with independent selective markers 
(Berdoz et al., 1999). In the best producing clones, up to 20 µg of recombinant SIgA was 
recovered per 106 cells in 24 hours. Although this technique may appear to be capable of 
producing sufficient quantities of SIgA for immunotherapy, gene amplification might not 
favour higher expression levels, as mammalian cell lines cannot process nascent 
glycoprotein beyond a certain limit. In an earlier study, secreted recombinant human SC 
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was produced in mammalian cell lines using vaccinia virus recombinants (Cottet & 
Corthesy, 1997). However the yield of secreted recombinant human SC could not be 
improved by using a very potent T7/vaccinia virus hybrid system. It was suggested that 
saturation in the synthesis of ER chaperones such as calreticulin, calnexin, and PDI may 
limit the heterologous expression of SC in these cells. 
In plants, it was already known that assembly of functional IgG molecules is very efficient 
(Hiatt et al., 1989). Here we have extended the fidelity of plant assembly to include 
dimerisation of monomeric antibody by the J chain. We have also shown that plants 
engineered to simultaneously express an immunoglobulin light chain, hybrid IgG/A heavy 
chain, J chain and secretory component (SC) produce a chimaeric SIgA molecule. The 
transgenic plants are capable of expressing functional recombinant SIgA antibodies 
efficiently, at levels of up to 8% total soluble protein. This level of expression is much 
higher than those previously reported for full-length IgG, which range from 0.35 % (Van 
Engelen et al., 1994) to 1.3 % of total soluble protein in tobacco leaves (Ma et al., 1994). 
We hypothesise that this increase in expression level may be due in part, to the increased 
resistance to proteolytic degradation in planta. 
Using the transgenic plant material generated in this work, Hein and Wang have examined 
the efficiency of secretory component assembly with dimeric IgA by comparing the 
amounts of bound and unbound SC in plant extracts (unpublished, personal 
communication). Their estimates of approximately 50 % covalent assembly match those 
made in our laboratory and support the observation that multimeric protein assembly in 
plants is highly efficient. 
The recombinant SIgA/G produced in transgenic tobacco plants is a hybrid molecule. It 
contains murine light, heavy and J chains and rabbit secretory component. Moreover, the 
recombinant plant SIgA/G molecule contained y2/a heavy chains, which contain an extra 
gamma CH2 domain, compared with conventional antibodies. This did not appear to affect 
the assembly or antigen binding of the molecule. Retaining the yCH2 domain might have a 
number of potential advantages in incorporating other functional regions; such as the 
complement-binding domain, in preserving a protein G binding site - which may simplify 
purification of the antibody - and in binding to macrophages. Some of these additional 
properties of SIgA/G may enhance the function of the complex in passive immunotherapy, 
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although under some circumstances these biological properties might be undesirable. In 
principle it should not be difficult to produce a SIgA/G antibody that lacks the yCi12 
domain in these cases. 
Our findings confirm that in transgenic plants, as in mammals, the J chain is required for 
SC to assemble with antibody (Brandtzaeg & Prydz, 1984). A major proportion of the SC is 
associated with the dimeric form of IgA/G in plant extracts, as demonstrated by Western 
blotting. We confirmed that the rabbit secretory component (SC) was assembled with 
antibody in the SIgA/G complex but did not interfere with antigen recognition or binding. 
Despite the increased complexity of the plant SIgA/G molecule, the assembly of the antigen 
binding site was well preserved in plants, resulting in an affinity that is equivalent to that of 
the original IgG. This demonstrated that antigen recognition was unaffected by any 
differences in antibody structure, as a result of the complex nature of the SIgA/G molecule, 
or differences between plant and murine glycosylation. 
A key difference between plants and mammals in the synthesis of SIgA lies in the site of 
assembly of the molecule. As described in the Literature review, in mammals dimeric IgA 
is synthesised and assembled in plasma cells, secreted extracellularly, whereupon it binds to 
the poly-immunoglobulin receptor (pIgR) produced by an epithelial cell. Following a 
process of transcytosis across the epithelial cell the pIgR is cleaved leaving SC attached to 
dimeric IgA. Thus two distinct cell types are involved. In plants, assembly of the secretory 
immunoglobulin takes place entirely within individual cells that co-express the four 
constituent chains (Ma et al., 1995), and this probably occurs within the endoplasmic 
reticulum (Frigerio et al., 2001). Thus in plants only single cells are required. This suggests 
that in mammals, the extracellular phase of dIgA assembly with secretory component is 
designed more to allow secretion of the antibody onto mucosal surfaces rather than to 
facilitate SIgA assembly itself. 
In summary, there are many potential applications for secretory antibodies in mucosal 
immunotherapy and prevention. Although a number of strategies and expression systems 
have been used to produce secretory IgA antibodies, only plants appear to offer the 
potential for antibody production on the scale necessary to contemplate immunotherapeutic 
applications. An important breakthrough emerging from these studies is that the plant 
SIgA/G MAb prevented bacterial colonisation in a human clinical trial. This was the first 
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reported clinical trial of a secretory antibody in humans and a key step in realising the 
potential for pharmaceutical production using transgenic plants. 
The levels of expression of SIgA/G already achieved represent one of the highest reported 
for a recombinant protein in plants. However it would clearly be advantageous to increase 
the level of antibody expression within the plant still further. The targeting of recombinant 
proteins to specific cellular locations (reviewed by Russell, 1999) is one such approach. 
With this in mind, more information on the precise site of antibody degradation may permit 
the most appropriate cellular location for maximum antibody accumulation to be selected. 
In addition, the assembly of secretory antibodies in plants has particular protein-folding and 
disulphide cross-linking requirements, and may involve plant homologues for molecular 
chaperones such as BiP and PDI, as discussed in Chapter 3. It is possible that in the future, 
strategies to optimise the level of antibody expression in plants may exploit the 
manipulation of chaperone levels. Once optimal expression strategies have been realised, 
then agricultural scale production of antibody-producing plants could realistically yield 





Plant biotechnology has many applications that will be of benefit not only to the developed 
world, but particularly to developing countries. The first stage has been the introduction of 
genetically modified food crops, that will help to improve food productivity, reduce the use 
of agricultural chemicals and help to tackle the ever mounting problem of malnutrition. 
Other industrial crops, such as cotton, have followed and the next few years will see more 
and more conventional crops moving to genetically modified varieties around the world. 
Right from the start, the potential for using genetically modified plants for non-food uses 
was recognised, including the prospect of producing recombinant pharmaceuticals. The 
main attractions lay in the potential cost savings, the ability to produce on a large 
(agricultural) scale and the possibility of using edible transgenic plant material for the oral 
delivery of medicines. 
From a commercial standpoint, monoclonal antibodies (MAbs) are generally regarded as 
the single most important class of protein in pharmaceutical development. They currently 
represent about 25 % of the clinical drug development pipeline and a recent Bank of 
America report has estimated that by 2010, there will be around 90 marketed monoclonal 
antibody products in the West. This will stretch production facilities to, and beyond, the 
limit. At present, 4 MAbs consume 75 % of the global capacity for antibody production. 
Furthermore, as indications for chronic use are developed, an order of magnitude increase 
in MAb requirements is expected. One of the major challenges that the industry faces, is 
how to meet this escalating demand for MAbs, that is projected to be up to 100 times 
current capacity by 2010. Currently, scalability is limited by the capacity of existing cell 
fermentation systems and the cost and 4-5 year lead time required for building and 
validating a new manufacturing facility. 
Although heterologous expression systems exist for MAbs, none are regarded as ideal. In 
the most commonly used bacterial expression systems, the folding accuracy of 
recombinant proteins is usually low, and they are often stored in inclusion bodies. E. coli 
does not permit the formation of inter-domain disulphide bonds, and appears inefficient at 
producing full-length antibodies, moreover it does not carry out glycosylation. In bacterial 
expression systems as well as transgenic animals or mammalian cell culture, the co- 
purification of oncogenic and blood-borne pathogens is a significant concern in the 
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production and purification of antibodies, particularly when medium requirements 
incorporate derivations of animal products (Fischer et al., 1999b). 
For all these reasons, there was considerable interest when the expression of a monoclonal 
antibody in transgenic plants was first reported (Hiatt et al., 1989). Nowadays, it is 
relatively straightforward to express a MAb in transgenic plants and many plant species 
have been utilised, including maize, rice, potato and alfalfa. Antibody expression in plants 
compares relatively favourably with more-established expression systems, however so far 
expression levels of proteins are still usually lower when compared with bacterial 
expression levels. Relatively little is known about the cellular mechanisms involved in 
plants, and a better understanding of these processes is likely to lead to new strategies to 
optimise antibody expression, as well as the identification of new multimeric proteins that 
can be expressed in plants. 
Our study began with an investigation into how the plant ER responds to the expression of 
immunoglobulin chains as heterologous secretory proteins. We studied the involvement of 
BiP and calreticulin in the folding and assembly of recombinant immunoglobulin heavy 
and light chains in transgenic plants. Our fording that BiP is actively involved in antibody 
processing, might explain the efficiency and relatively high yield of functional antibody 
production that can be achieved in plants. It will be of great interest to identify other 
chaperones within the plant endomembrane system that take part in MAb folding and 
assembly, and to try to discover bottlenecks in the pathway that could be alleviated by 
chaperone engineering. The feasibility of this approach has already been adopted for BiP 
and calreticulin in tobacco (Denecke et al., 1993; 1995). 
The next step was to determine the extent of glycosylation of plant derived MAbs. We 
showed that N-linked glycans were added to the same sites that were used by the parent 
murine hybridoma. A subsequent detailed analysis using the antibody purified in this work 
showed that whereas the mouse MAb contained only complex-type glycans, the plant 
version was more heterogenous in glycosylation, containing five high-mannose structures 
comprising 40 % of the glycans, and three complex structures, comprising 60 %. These 
differences in the glycosylation pattern of the plant version of Guy's 13 MAb had no effect 
on antigen binding or specificity, but it has been suggested that they might lead to 
immunogenic or even allergenic reactions, upon clinical administration (Bardor et al., 
2003). Plant derived njq lgplpnal antibodies from this study were utilised to study the 
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potential immunogenicity of the plant glycans following both mucosal administration in 
human subjects and parenteral immunisation in mice (Ma et al., 1998; Chargelegue et al., 
2000). No evidence for immune recognition was detected in either case. Nevertheless, 
although it may seem that plant glycans do not present an immunological challenge when 
presented on a MAb, this will remain a potential area for concern. For this reason, research 
into engineering of the glycosylation pathway in plants may be a pragmatic approach to 
avoiding the issue altogether. 
Having passed through the Golgi apparatus, the default pathway for IgG in plants is 
secretion (Frigerio et al., 2000). This may not be the optimal end-result for recombinant 
MAbs. Other groups have studied the retention of immunoglobulins in the ER (Conrad & 
Fiedler, 1998), and here we investigated the possibility of targeting and retention of IgG in 
the plasma membrane. Many eukaryotic membrane proteins have proved difficult to 
express in recombinant systems. But in plants, we have demonstrated that the native 
membrane association sequence from B cells (Tyler et al., 1982), can act as a membrane 
targeting sequence in plants. Unlike retention in the ER, an increase in accumulation 
levels was not observed above that achieved in plants that secreted IgG. As an extension to 
these findings, we also demonstrated that a second type of mammalian membrane protein 
- the seven transmembrane chemokine receptor CCR-5 - could be expressed in the plant 
plasma membrane. This demonstrated that a more generalised approach can be used for 
expressing membrane proteins in plants. 
Utilising membrane retention sequences may have several applications. Firstly, controlling 
secretion of the recombinant protein is likely to have a beneficial environmental impact, by 
preventing leakage of the protein into the rhizosphere or other external plant fluids. 
Secondly, it might lead to easier antibody purification strategies, as the antibody can be 
initially purified in a non-soluble fraction. Finally, there may be advantages for antibodies 
intended for in planta purposes. These applications might comprise the immunomodulation 
of plant antigens or proteins of non-plant origin, in order to manipulate the plant's 
metabolism, and intra- or extracellular immunisation (Tavladoraki et al., 1993), to achieve 
resistance against plant pathogens. 
In the final part of the thesis, we have described a further development of our studies, from 
expressing the simplest immunoglobulin tetrameric complex to the more complex 
decameric structure that comprises a secretory antibody. We demonstrated that plants 
153 
engineered to simultaneously co-express an immunoglobulin light chain, a hybrid IgG-A 
heavy chain, aJ chain and a secretory component (SC) could produce a chimeric SIgA 
molecule. The recombinant plant SIgA-G was targeted to the endoplasmic reticulum, 
where it accumulated at levels of up to 8% of soluble plant protein. These studies 
ultimately led to the use of this secretory antibody in a clinical trial, in which it was 
demonstrated for the first time, that a plant-derived recombinant pharmaceutical was 
efficacious in humans (Ma et al., 1998). 
This work has investigated not only some of the cellular processes involved in antibody 
production in plants, but it has also explored some novel applications for which this 
knowledge can be applied. An understanding of how multimeric protein complexes 
assemble and the capacity of plants to achieve this, would open the way for the design and 
engineering of new complex proteins, built around a basic immunoglobulin structure. It 
may be possible to envisage many other therapeutic molecules which are amenable to 
expression in plants, for which, like secretory antibody, plants represent the only practical 
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APPENDIX 
All chemicals were ordered from SigmaAldrich, UK, unless stated otherwise. 
1 BUFFERS AND SOLUTIONS 
Alkaline phosphatase substrate buffer: 100 mM NaCl, 5 mM MgC12 , 100 mM 
Tris-HCI, pH 9.5,300 mg mr' nitroblue tetrazolium (NBT), and 150 mg ml"' 5-bromo-4- 
chloro-3-indolyl phosphate (BCIP). NBT solution and BCIP, both 50 mg ml', stored at 
-20 °C. 
Ampicillin, 1000 X: 100 mg mr' ampicillin was dissolved in distilled water, sterilised by 
filtration and stored at - 20 °C. 
Complete"' protease inhibitor mix (Roche Diagnostics, UK): one tablet was dissolved 
in 2 ml H2O to make a 12.5 X stock. 1/12.5 volume of this stock was added to protoplast 
homogenisation buffer just before use. 
DEPC-treated water :2 ml diethylpyrocarbonate (DEPC) was added to 2L distilled 
water, left at 37 °C overnight and autoclaved prior to use. 
Deionised formamide: 5g of mixed-bed resin [BioRad - AGSOI-X8(D)] was added to 
100 ml of formamide and gently stirred for 30 minutes, filtered and stored at -20 °C. 
DNA loading buffer, 6 X: 0.25 % bromophenol blue, 0.25 % xylene blue, 40 % sucrose. 
Enzyme digestion mix, 10 X: 4% Cellulase (Calbiochem, UK), 2% Pectinase 
(Calbiochem, UK), dissolved in K3 medium, stirred vigorously for 20 minutes, collected 
and centrifuged at 14 000 g for 15 minutes at 4°C to precipitate insoluble material. The 
mixture was filter sterilised, aliquoted and stored at -20 °C, avoiding more than two 
freeze-thaw cycles. 
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Formaldehyde gel running buffer, 5 X: 0.1 M MOPS, pH 7.0,40 mM sodium acetate, 
and5mMEDTA, pH8. 
IPTG: a solution of IM Isopropyl-ß-D thiogalactopyranoside (IPTG) was made in 
distilled water, filter sterilised, aliquoted and stored at -20 °C. 
K3 medium: 3.78g Gamborg's B5 basal medium with minimal organics, 750 mg 
CaC12.2H20,250 mg NH4NO39 136.2 g sucrose, 250 mg xylose, 
lmg 6-benzylaminopurine, lmg a-napthaleneacetic acid in 1L distilled water. A stock 
solution of 5 mg ml"' 6-benzylaminopurine in IM NaOH was adjusted to pH 5.5 with a few 
drops of 1M KOH, filter sterilised , and stored at -20 
°C. 
Luria Bertani (LB) broth: 10 g NaCI, 10 g bactotryptone, 5g yeast extract in 1L 
distilled water, adjust to pH 7.4, and autoclave. 
Luria Bertani (LB) agar medium: 1L of LB broth and 15 g bacteriological agar. 
MOPS buffer, 10 X: 0.2 M 3-[N-morpholino]pr0panesulf0nic acid) [MOPS], 10 mM 
EDTA, 50 mM sodium acetate. The pH was adjusted to 7 with NaOll, and then 
autoclaved prior to use. 
NET buffer, 1 X: 50 mM Tris-HCI, pH 7.5,150 mM NaCI, I mM EDTA, 0.1 % Nonidet 
P-40, and 0.02 % sodium azide. 
NET-gelatin buffer, 1 X: as NET buffer supplemented with 0.025 % gelatin. A2% stock 
of gelatin in water was autoclaved, and sodium azide added to 0.02 %, then stored at 4 °C. 
The inclusion of gelatin in the buffer is necessary to reduce non-specific co-precipitation of 
contaminants. 
PBS, 10 X: 80 g NaCI, 2g KCI, 14.4 g Na2HPO4i 800 ml distilled water, adjust to I L, 
pH7.4. 
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PBST, 1 X: 1X PBS (pH 7.4) containing 0.5 % Tween 20. 
Prehybridisation mixture: 50 % deionised formamide, 5X SSPE, and 5% SDS. The 
components were mixed in this order, and the mixture kept at 60 °C to prevent 
precipitation of SDS. 
10 % Protein A-sepharose suspension: Protein A-sepharose (AmershamPharmacia 
Biotech, UK) was swollen in NET buffer for at least 3 hours with occasional agitation, in a 
50 ml tube. Once the beads had sedimented, the supernatant was carefully removed. 
Tris-HCl (1M, pH 7.5) was added to the beads, and allowed to stand for 1 hour with 
occasional agitation. The supernatant was removed, and the beads washed once with NET 
buffer. The beads were allowed to sediment, the supernatant was removed, and 9 bead 
volumes of NET buffer were added. The suspension was stored at 4 °C. 
Protoplast homogenisation buffer. 200 mM Tris-HCI, pH 8,300 mM NaCI, I% Triton 
X-100, and I mM EDTA, stored at 20 °C in aliquots, and I% (v/v) Nonidet P40 (NP40) 
was added when stated. 
RNA sample loading buffer, 5 X: 50 % glycerol, I mM EDTA, p11 8,025 % 
bromophenol blue and 0.25 % xylene cyanol. 
SDS-PAGE resolving gel - 10 %: 10 ml of 30 % Acrylamide/bis (19: 1) [Scotlab, UK], 
7.5 ml of 1.5M Tris-HC1(pH 8.8), 0.3 ml 10 % (w/v) SDS, 12 ml distilled water, 225 µl 
10 % (w/v) ammonium peroxodisulphate (APS), 15 µl NNN'N'-tetramethyethylene- 
diamine (TEMED). 
SDS-PAGE resolving gel -4%: 3.9 ml of 30 % Acrylamide/bis (19: 1) [Scotlab, UK], 
7.5 ml of 1.5 M Tris-HC1 (pH 8.8), 0.3 ml 10 % (w/v) SDS, 17.85 ml distilled water, 
300 µl 10 % (w/v) APS, 30 µl TEMED. 
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SDS-PAGE stacking gel -5%: 5.1 ml 30 % Acrylamide/bis (19: 1) [Scotlab, UK], 
3.75 ml 0.5 M Tris-HCI (pH 6.8), 300 µ1 10 % (w/v) SDS, 20.4 ml distilled water, 300 µl 
10 % (w/v) APS and 30 µ1 TEMED. 
SDS-PAGE sample loading buffer, 2 X: 125 mm Tris-HCI (pH 6.8), 4% SDS, 0.2 
bromophenol blue, 20 % glycerol, 200 mM dithiothreitol, 2% ß-mercaptoethanol. 
SDS-PAGE running buffer, 5 X: 15.1 g Tris base, 72 g glycine, 900 ml distilled water, 
50 ml 10 %(w/v) SDS, adjust volume to 1 L. 
Sequencing gel: 34.5 g Urea , 11.25 ml 
Acrylamide/bis (37.5: 1) [Scotlab, UK], 15 ml 
TBE (5 X), adjust volume with distilled water to 75 ml and add 105 µl TEMED, 255 µl 
10 % (w/v) APS. Pour gel using a syringe, avoiding air bubbles. The glass plates must be 
degreased using alcohol prior to use. The gel is light sensitive. 
Sequencing fixing solution: 5% glacial acetic acid, 5% methanol, adjust the volume with 
distilled water to 2 L. 
SOC medium: To 950 ml distilled water, add 20 g tryptone, 5g yeast extract, 0.5 g NaCl, 
dissolve, and add 250 mM KCI to pH 7.0. Adjust volume to 1 L, autoclave and when cold 
add 20 mM glucose. 
SSC, 20 X: 3M NaCI, 0.3 M C6HSNa3O7.2H20, pH 7 adjusted with IM HCI4 sterilised by 
autoclaving. 
SSPE, 20 X: 3.6 M NaCl 
, 0.2 M 
Na2HPO4, and 20 mM EDTA, pH 6.5, sterilised by 
autoclaving. 
TAE buffer, 50 X: 242 g Tris base, 57.1 mi glacial acetic acid, 100 ml EDTA 0.5 M 
(pH 8.0), adjust volume to I L. 
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TBE buffer, 5 X: 54 g Tris base, 27.5 g boric acid, 20 ml EDTA 0.5M (pH 8.0), adjust 
volume to 1L with distilled water. 
TBS, 10 X: 88 g NaCl, 12.12 g Tris base, pH 8.0, adjust volume to 1L with distilled 
water. 
TE buffer: 10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0). 
Tris-HCI 1M, pH 8: 121. lg of Tris base was dissolved in 800 ml H2O, and 42 ml HCl 
added. The solution was sterilised by autoclaving. 
Tris-HCI 1M, pH 7.4: 121.1 g of Tris base was dissolved in 800 ml 1120, and 70 ml HCI 
added. The solution was sterilised by autoclaving. 
Western blotting transfer buffer. 15 g Tris base, 72 g glycine, 1L methanol, adjust 
volume to 5L with distilled water. 
W5 buffer: 9g NaCl, 0.37 g KCI, 18.37 g CaCI2.2H20,0.9 g glucose per litre. 
X-Gal: a solution of 40 mg mr' 5-Bromo-4-chloro-3-indolyl-p-D-galactopyranoside 
(X-Gal) was made in dimethyl-formamide. The tube was stored in the dark at -20 °C 
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2 OLIGONUCLEOTIDES 
Oligonucleotides were purchased from Oswel, UK. 
J chain oligonucleotides (21-mers); 
3' primer 5' TAT GAA TTC CTA GTC AGG GTA 3' 
5' primer 5' TAT CTC GAG ATG AAG ACC CAC 3' 
71 heavy chain oligonucleotides (27-mers); 
3' Pie' 5' CTT AAG CTT ACA ATC CCT GGG CAC AAT 3' 
5' primer 5' CTT CTC GAG TCA GGA CCT GAC CTG GTG 3' 
Constitutive chloroplast nbonucleoprotein (rubisco) oligonucleotides (18-mers); 
3' primer 5' AGA TAC GGG AGC TIT CTG 3' 
5' primer 5' GGG TGC ATG TTA GAT GGT 3' 
CCR-5 oligonucleotides; 
3' Pier 5' TGC TCT AGA CTA CAA GCC CAC AGA TAT TTC 3' 
5' primer 5' CAT GCC ATG GAT TAT CAA GTG TCA 3' 
ß-actin oligonucleotides (26-mers); 
3' primer 5' CCT AGA AGC ATT TGC GGT GCA CGA TG 3' 
5' primer 5' TCA TGA AGT GTG ACG TTG ACA TCC GT 3' 
T3 sequencing primer (17-mer); 
5' ATT AAC CCT CAC TAA AG 3' 
T7 sequencing primer (17-mer); 
51 TTA ATA CGA CTC ACT AT 3' 
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3 MOLECULAR BIOLOGY TECHNIOUES 
3.1 POLYMERASE CHAIN REACTION (PCR) 
Approximately 5 ng of template DNA was amplified in 100 µl reaction mix comprising 
50 pmol oligonucleotide primers, 200 mM dNTP, lOµ110 X PCR buffer [100mM Tris-HC1 
(pH 9.0), 15 mM MgC12,500 mM KCl] with 2.5 U Taq polymerase. The mixture was 
overlaid with 20 - 30 µl of mineral oil. 
Amplification was for 30 cyles: 30 seconds at 95 °C for denaturing, 30 seconds at 55 °C 
for annealing and 1 minute at 72 °C for extension. This was followed by a final extension at 
72 °C for 10 minutes. Aliquots of the reaction mix were analysed by agarose gel 
electrophoresis. Samples were either used immediately for cloning or frozen at - 20°C. 
3.2 GENERAL LIGATION 
Purified DNA was ligated at a molar ratio of insert: vector (2: 1). The reaction comprised; 
the insert, vector, 10 U of T4 DNA ligase, 1X ligation buffer [20 mM Tris-HCI, 1mM 
EDTA, 5 mM DTT, 60 mM KCI, 50 % (v/v) glycerol, (pH 7.5) AmershamPharmacia 
Biotech, UK], in a total volume of 20 mL Ligation were incubated at 4 °C for 16 hours. 
3.3 DESALTING LIGATION SAMPLES 
50 - 100 µ1 of glass beads (425 - 600 microns, SigmaAldrich, UK) were placed in a pierced 
centrifuge tube followed by 250 µl of Sepharose CL-6B (AmershamPharmacia Biotech, 
UK). The tube was inserted into a second microfuge tube and centrifuged at 1500 xg for 1 
minute. The second tube was discarded and replaced with a fresh one. The sample to be 
de-salted was applied to the Sepharose and nucleic acid was recovered by centrifugation as 
before. 
3.4 RESIRICITON ENZYME DIGESTS 
For analysis or isolation of inserts, isolated plasmid was incubated with 5- 10 Units 'of 
restriction enzymes (New England Biolab Inc. UK) per µg of DNA. The digests were then 
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analysed by agarose gel electrophoresis. When required, digestion reactions were stopped 
by heat inactivation at 70 °C for 10 minutes. 
3.5 CLEANING PLASMID DNA SAMPLES 
To prepare plasmid DNA for sequence analysis, pellets were dissolves in 200 µl of sterile 
distilled water. An equal volume of phenol : chloroform : isoamyl alcohol (24 : 24 : 1, 
v/v/v) [SigmaAidrich, UK] was added to the sample, which was vortexed and centrifuged 
for 5 minutes at 15 000 g. The aqueous phase was transferred to a clean tube and 1/10 
volume of 3M sodium acetate (pH 5.2) and 2.2 volumes of ethanol 100 % was added and 
the sample kept on ice for 5 minutes. DNA was recovered by centrifugation for 20 minutes 
at 15 000 g. The pellet was washed in 80 % ethanol (1 ml), kept on ice for 5 minutes and 
then centrifuged for 10 minutes at 15 000 g. The pellet was air-dried before being dissolved 
in 20 µl of TE buffer. Samples were stored at - 20 °C and aliquots were analysed by 
agarose electrophoresis. 
3.6 DNA SEQUENCING 
Sequencing reactions were performed using the SequenaseTM Version 2.0 DNA 
sequencing kit (USB Amersham Life Sciences, USA). Double stranded DNA (ds DNA), 
either plasmid or PCR product (1-5 µg in 5µl) was denatured by incubation with 2 µl of 
NaOH (2N) for 10 minutes at room temperature. DNA was recovered by spin column 
chromatography (refer to Appendix section 3.3) into a tube containing 1 ml of primer at 
5 pmol t' and 2 µl of 5X buffer (200 mM Tis-HC1(pH 7.5), 100 mM MgC12,250 mM 
NaCl)- Labelling mix (5.5. µl) comprising for each reaction of 1 µl of 0.1 M DTT, 2 µl of 
labelling mix buffer (7.5 pM dGTP, 7.5 µM dCTP, 7.5 pM dTTP; diluted 1 /5 in water), 
0.5 µl (0.185 MBq) of [35 S]-dITP, and 2 pl of 77 DNA sequenase (13 Upl') diluted 1/8 
in diluting buffer (10 mM Tris-HCI (pH 7.5), 5 mM DTT, 0.5 mg ml"' BSA) to the DNA. 
3.5 p1 of the mix was then added to four tubes containing 2.5 µ1 of ddNTPS (A-C-G-T). 
The samples were incubated at 37 °C for 5 minutes. Reactions were stopped by adding 4µl 
of stop buffer (95 % formamide, 20 mM EDTA, 0.05 % bromophenol blue, 0.05 % xylene 
cyanol FF). Samples were analysed immediately or stored at -20 °C. 
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Samples to be analysed were heated for 2 minutes at 90 °C, immediately put on ice and 
aliquots (3 µl) were applied to a sequencing gel. The gel was run with parameters set at 
2000 V, 50 - 60 mA and 50 - 60 W. Electrophoresis was for 30 minutes to 6 hours 
depending on the distance from the primers that had to be sequenced. Gels were then 
transferred to a fixing solution for 30 minutes before being dried on a heat vacuum device 
and exposed to Kodak Biomax MR-1 X-ray film. The film was developed using the Fuji 
RGII automated sequencer and the sequence was read manually. 
3.7 GENERAL MATERIALS 
Enzymes: Taq DNA polymerase enzyme was from AmershamPharmacia Biotech, UK. 
RNAse and Dnase, were from New England Biolabs Inc., UK. 
Molecular mass markers: DNA size markers were purchased from Gibco BRL, UK. 
Radioisotopes: [35S]_dATp was purchased from ICN Biomedicals, UK. 
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4 MURINE AND PLANT J CHAIN SEQUENCES 
The plant J chain PCR product was sequenced and found to be identical to the murine 
J chain (Matsuuchi et al., 1986), except for a single codon (highlighted in Figure 1a below) 










FVY. HLSDVCKKCDPVEVELE 100 
GATCAGGTTGTTACTGCCACCCAGAGCAACATCTGCAATGAAGACGATGGTGTTCCTGAG 360 
DQVVTATQSNICNEDDGVPE 120 






Figure 1 a: The nucleotide and deduced amino acid sequence of the murine J chain PCR 
product. The underlined nucleotides indicate location of restriction sites. 
S BRADFORD PRO IEIN ASSAY 
Protein concentrations were determined by using a dye-binding assay (Bradford) according 
to manufacturer's instructions. 25 µl of sample was added to I ml of Coomassie plus 
TM 
protein assay reagent (Pierce, UK) and the Absorbance 595 nm was then measured. 
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ER-resident chaperone interactions with recombinant antibodies 
in transgenic plants 
James Nuttall'"*, Nicholas Vine'-', Jane L. Hadlington', Pascal Drake? Lorenzo Frigerio'"' 
and Julian K. -C Ma; t 
'Deparonent of Biological Sciences, University of Warwick, Coventry, UK 2 Unit of Immunology, Department of oral Medicbse 
and Pathology, Guy's Hospital, London, UK 
In this study, we demonstrate that the folding and assembly 
of IgG in transgenic tobacco plants is orchestrated by BiP 
(binding protein), an endoplasmic reticulum resident chap- 
erone. Expression of BiP and calreticulin was examined in 
transgenic tobacco plants that express immunoglobulin 
drains, either singly or in combination to form IgG anti- 
body. BiP mRNA expression was lowest in wild-type 
nontransformed plants and those that expressed immun 
globulin light chain alone. Higher niRNA levels were 
detected in plants expressing fully assembled immunoglo- 
bulin (light and heavy chains), and the most abundant levels 
of RNA transcript were found in those plants that expressed 
imniunoglobulin heavy chain alone. Estimation of total BAP 
demonstrated a similar pattern, with the highest levels 
detected in plants expressing immunoglobulin heavy chain 
alone. Immunoprecipitation studies demonstrated that BiI 
was associated with immunoglobulin chains extracted from 
protoplast lysates, but not from secreted fluids. Again, most 
BiP was coprecipitated from plants expressing heavy chain 
only and those that produced full length IgG. The binding of 
BiP to Ig heavy chains was ATP-scnsitive. Co-expression of 
heavy and light chain resulted in IgG assembly and dis- 
placement of BST' from the heavy chain as the amount of light 
chain increased. Although calreticulin mRNA and total 
protein levels varied in a similar manner to those of BiP in the 
transgenic plants, there was no evidence for association 
between calreticulin and Ig chains, by coimmunoprncipita. 
tion. The results indicate that BiP, but not calreticuWi, takes 
part in immunoglobulin folding and assembly in transgenic 
plants. 
Keywords BH'-, IgC; transgenic plants; iminunoglobulin 
assembly, chaperones. 
A wide variety of functional recombinant antibody mole- 
cules have been expressed successfully in transgenic plants, 
ranging from small monomeric fragments [1-31 to full length 
IgG [2,4,5] as well as more complex multimeric secretory 
antibodies [6]. The synthesis, folding and assembly of 
complex mammalian proteins, such as full length immuno- 
globulins (Igs) in plants can be extremely efficient, resulting in 
expression levels of between 1 and 5% of total plant protein [4,6,7], that compare favourably with mammalian hybri- doma cell culture. Protein folding and assembly within cells is 
a complex process with stringent quality control mechanisms 
(reviewed in [8]). It is largely regulated by enzymes and an 
array of molecular chaperones. In mammalian and plant 
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cells, the best characterized chaperone is BiP (binding 
protein), a lumenal endoplasmic reticulum (ER) resident 
member of the heat shock protein 70 family of stress proteins 
[9J. BiP has been identified in various mammals [10 13], yeast 
[14,15] and plants [16,17]. By binding to newly synthesized 
polypeptides, BiP is thought to stabilize partially folded 
intermediates during folding and assist in the assembly of 
protein oligomers [18]. BiP also has other functions in protein 
translocation into the ER, prevention and dissolution of 
protein aggregates and retention of misfokied or unassem- 
bled subunit proteins [18,19]. Plant BiP shares approximately 
69% homology with mammalian BiP at the amino acid level 
[16] and is similarly involved in assisting the folding of plant 
proteins [17,20]. BiP is also found in association with 
assembly defective proteins in plants [21,22]. 
Calreticulin is a highly conserved protein also found in 
the ER and nuclear envelope [23]. It is the major calcium 
binding protein in the ER [24] and also appears to act as a 
storage site for BAP [25]. Calceticulin is a stress-induced 
protein [26] and shames several regions of sequence homo. 
logy (42-78%) with the chaperone calnexin [27,28]. Its own 
role as a chaperone has been demonstrated in the folding 
and assembly of major histocompatibility (MIIC) dass I 
molecules [29] and the envelope glycoprotcin from human 
inununodeficiency virus [30J. As with calncxin, calreticulin 
binds specifically to glycosylated proteins, and in at least one 
example (I1IV gpl6O) both calnexin and c lreticulin are 
associated with the newly synthesized molecule [30J. 
In mammalian cells, the interactions between immuno- 
globulin chains and chaperones have been partially 
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characterized. Newly synthesized heavy and light chains 
associate with BiP immediately after synthesis [31,32]. The 
interaction is brief but BiP displays a strong preference for 
early folding intermediates over mature molecules. There- 
after, a relay of chaperones is likely to be involved [33], 
including GRP94 and possibly GRP170 [34], as well as 
protein disulphide isomerase [35]. 
Relatively little is known about ER chaperones in plants. 
Limited evidence is available for the interaction of BiP and 
CR (c alreticulin) with newly synthesized endogenous and 
defective polypeptides, whereas a systematic study of 
chaperone interaction with heterologous proteins has not 
been performed. The aims of this study were to determine 
how the plant ER responds to the expression of heterolo- 
goes secretory proteins. We therefore studied the involve- 
ment of BiP and calreticulin in the folding and assembly of 
recombinant immunoglobulin heavy and light chains in 
transgenic plants that express the assembled form of an IgG 
monoclonal antibody or individual IgG heavy or light 
chains. If those chaperones were to be actively involved in 
antibody processing, this might explain the efficiency and 
relatively high yield of functional antibody production that 
can be achieved in plants. 
EXPERIMENTAL PROCEDURES 
Transgenic plants 
Three homozygous, transgenic, Nkotiana tabacwn plant 
lines that have been described previously were used in this 
study [5]. These plant lines expressed the light chain of a 
murine IgG I antibody alone (x), the heavy chain alone (y), or 
both is and y chains (IgG). Nontransformed wild-type (WT) 
plants were used as a control. The transgenes were intro- 
duced into the tobacco plants using agrobacterium [361, 
under the control of the CaMV 35S promoter and a mouse 
änmunoglobulin leader sequence to target the gene products 
for secretion through the ER Transgenic plants coexpressing 
ýmunoglobulin light and heavy chains were generated by 
cross-fertilization between parent plants. The plants used in 
this dy were grown under sterile conditions. 
(Caltag. USA), or anti-(mouse IgGI) (gamma I chain 
specific) (Ihe Binding Site, UK) at a concentration of 
5 µgmL'1. For IgG detection, the plates were incubated 
with purified streptococcal antigen at a concentration of 
2 pginL t. Plates were incubated for 16 h at 4 °C. washed 
twice in sterile distilled water and blocked by addition of 
2.5% (w/v) BSA in NaCVP; with a2h incubation at 37 °C. 
For the assay, leaf extracts were centrifuged (20 000 g, 
10 min, 4 °C) and aliquot added in duplicate to the ELISA 
plate wells. Plates were incubated for 16 h at 4 °C after 
which they were washed five tines with distilled water with 
0.5% (v/v) Tween 20. Secondary antibody was an affinity- 
purified HRPO-conjugated anti-(mouse ic) (Caltag. USA) 
or y serum (Tire Binding Site, UK) as appropriate. 
Detection was with tetramethylben2idine dihydrochloride 
peroxidase substrate (Sigma, UK). Colour development was 
allowed to proceed for 10 min, then 25 pL of 2u 112S04 
were added to each well and the absorbance read at 450 mit 
on an EUSA plate reader (Anthos, UK). 
RNA extraction 
Total RNA was extracted from young plants two months 
after germination, essentially as described by Logmann 
et al. [3Th Briefly, leaf tissue was frozen in liquid nitrogen 
and rapidly ground to a fine powder. This was mixed with 
two vols of ioe cold guanidine hydrochloride buffer (8 M 
guanidine hydrochloride, 20 mm Mes, 20 mm ®TA, 
50 mm 2-mercaptoethanol, pII 7). After agitation it was 
added to one vol of phenol : chloroform : isoamy] alcohol 
(25 : 24: 1. v/v/v), mixed thoroughly, and centrifuged at 
12 000 g for 45 min. The aqueous phase was collected, 
mixed with ethanol (0.7 volumes) and IM acetic acid (02 
vols), and incubated at -20 °C for 16 h. After centrifuga- 
tion, the precipitate was washed three times with 3M 
sodium acetate, p1152, and once with 70% ethanol. The 
pellet was dissolved in sterile RNAsc free water (Sigma, 
UK) containing RNAse free DNAse (Promega, UK), and 
incubated at 37 °C for 1 h, then at 70 °C for 5 min. RNA 
concentration and purity were assessed using the Gene. 
Quant II RNA/DNA Calculator (I nga, UK). 
Western blotting and EUSA 
To confirm the expression of each immunoglobulin chain, 
leaf extracts were examined by Western blot analysis, using 
specific antisera [51 For total BiP assay, 8 mm leaf punches 
were taken from 6-week-old-plants. Samples were extracted 
in Naa/Tris, PH 8, with 10 mg il 1 leupeptin (Calbio- 
chem). Aliquots of the protein extracts were separated by 
SDS/PAGE under reducing conditions and blotted onto 
nitrocellulose membranes. The membranes were blocked in 
NaCI/Tris containing 0.05% (v/v) Tween 20 and 1% (w/v) 
nonfat dry milk, and then incubated with a rabbit anti- 
(tobacco BiP) antiserum (kindly supplied by J. Denecke, Leeds University, Leeds, UK) for 2h at 37 °C. Bound 
antibody was detected using an alkaline phosphatase- 
conNgated goat anti-(rabbit IgG) serum (Sigma, UK) in 
conjunction with nitroblue tetrazolium/5-bromo-4-chloro- 
3-indolyl phosphate (Bio-Rad, UK) detection reagents. Capture ELISAs were used to quantify recombinant 
protein expression in transgenic plants. ELISA plates (Nunc Immobilon, UK) were coated with either anti-(mouse x) 
DNA probe preparation 
The plasmid pGEM3Z (Promcga) containing a 2420 bp 
DNA fragment (BLP4) from the tobacco homologue of BiP 
was kindly provided by J. Den ckc. A 1400 bp DNA 
fragment from the castor bean caireticulin gcnc cloned into 
Bluescript KS" (Stratagcne, USA) was kindly supplied by 
S. Coughlan, Du Pont Agrochemicals, USA [38]. Fsd erl- 
chia coil DI 15a (GibcoBRL) was transformed and plasinid 
DNA was prepared using a commercially available kit 
(Qiagen). PLasmids were linearized and probe DNA was 
labeled with [ac-'ZP]dCTP Cuing a commercially available kit 
(dCTP, Ready To Goll, Pharmacia Biotech). Labeled 
DNA was denatured by boiling for 3 min in 1 vol 
formamide before use. 
Northern blotting 
Fifteen pg of total plant leaf RNA were prepared is IN 
Mops buffer, 5% (v/v) formaldehyde, and 50% (v/v) 
formamide. Samples were heated at 60 °C for 10 min, and 
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run on a 1.2% (w/v) agarose gel prepared with 2.2 M 
formaldehyde. The gel was stained in ethidium bromide, 
then soaked for 30 min in 50 mit NaOH/NaH2PO4,5 mM 
EDTA, rinsed in RNAse-free water and soaked for 45 min 
in 20x NaCI/P/EDTA (3.6 M NaCI, 0.2 M Na2IIPO4, 
20 mM EDTA, pH 6.5). The RNA was then transferred to a 
Iiybond N' membrane (Amersham) using a transfer 
pyramid with 20x NaCI/R, /EDTA as the buffer. Following 
16 h transfer, the membrane was air-dried for 45 min and 
the RNA fixed by irradiation with a UV Crosslinker 
(Hoefer Scientific Instruments). Confirmation of uniform 
RNA transfer was by visualization of ethidium bromide 
staining under UV illumination. In addition, a positive 
control nontransgenic flower pooled RNA sample was 
included on the left and right sides of each gel. 
For probing, the membrane was incubated in prehybrid- 
ization buffer [50% (v/v) formamide, 5x NaCI/Pi/EDT 
1% (w/v) SDS, 0.1 % (w/v) sodium tetraborate, 50 mgLý 
heparin] at 42 °C overnight. Denatured probe was added 
for 16 h at 42 °C. The final probe concentration was 
5 ngmV'-kb't of probe complexity equaling 106-107 
dpmml"'. The membrane was washed with 0. lx NaCI/P/ 
EDTA, 0.5% (w/v) SDS at room temperature, and then 
twice at 42 °C, for 30 min with gentle shaking. The brane was washed once with 0. lx NaCI/P; /EDTA at 
room temperature and blotted dry, prior to exposure on 
Biomax MR film (Kodak Scientific Imaging) at -70 °C, for 72 h. 
Protoplasts Isolation and transfection 
Protoplasts were prepared from the leaves of 4 to 6- 
week-old-tobacco as described by Otsuki et al. [39] Proto- 
plasts were subjected to polyethylene glycol-mediated 
transfection exactly as described by Pedrazzini et at. [22] 
and incubated overnight at 25 °C in the dark before pulse labeling. Pulse-chase labeling of Protoplasts using Pro-Mix (a mixture of [35S]Met and [ 5S](4s; Amersham) was 
Performed as described [21]. Cell fractionation and micro- 
some preparation were also performed as described [7]. Homogenization of protoplasts was performed by adding to 
the frozen samples two vols of ice-cold homogenization buffer [150 mit Tris/IICI, 150 nut NaCI, 1.5 mm EDTA 
and 1.5% (v/v) Triton X-100, pit 7.5] supplemented with Complete (Boehringer) protease inhibitor cocktail. 
Immunoprecipitation 
Inununoprecipitation of expressed polypeptides from labe- led protoplasts was performed as described previously [21], 
using rabbit polyclonal antisera raised against mouse IgG 
(Sigma) or BiP [22]. Immunoselected proteins were analyzed by 15% reducing SDS/PAGE and fluorography. For unlabelled plant protoplasts, cell homogenates from 2x 106 cells from each plant line were incubated with a goat 
anti-(mouse IgG) serum. Immunoselected polypeptides 
were analyzed under both reducing and nonreducing 
conditions on SDS/PAGE and blotted onto nitrocellulose 
membranes. The membranes were used either in autoradio- 
graph or immunoblot detection as described above, 
using a rabbit anti-(plant BiP) serum or a goat anti-(mouse IgG) serum and appropriate second-layer alkaline 
phosphatase-conjugated antibodies. 
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RESULTS 
Confirmation of transgenic gene product expression 
in plant lines 
Stable homozygous seed stocks were used to generate the 
plants used in this study. Six plants representing each line 
were selected and the expression of transgenic gene 
product (none, x chain, y chain or both chains) was 
examined by appropriate ELISA and Western blot. All 
transgene products were of the expected relative molecular 
mass (not shown), as previously reported [5]. Withia each 
group of plants, there appeared to be no significant 
difference in expression levels, as measured by the intensity 
of immunoreactive bands on Western blot (data not 
shown). A capture ELISA confirmed four plants in each 
group that had identical titration curves, with the other 
two plants differing by one or two dilution steps (Fig. 1). 
Subsequent experiments were performed using plants that 
expressed equivalent levels of recombinant protein within 
each group, to eliminate the effect of different levels 
of expression of each construct. The relative expression 
levels between groups were calculated from ELISA results, 
as a percentage of total soluble protein by comparison 
with known Ig standards and these were (mean ± SD). 
ic, 0.007% f 0.001; y, 0.207% ± 0.023 and IgG, 
1.27% ± 0.21. 
Detection of BIP mRNA In transgenic plants 
Northern blot analysis of transgenic plants using a BiP 
DNA probe is shown in Fig. 2. Flower and leaf tissue from 
six transgenic plants representing each construct were used 
and results from two plants in each group are shown. The 
positive control nontransgenic flower pooled RNA sample 
indicated uniform transfer of RNA onto the blot in both 
cases (not shown). A transcript of the expected size was 
found in all plant lines in both flowers (Fig. 2A) and leaves 
(Fig. 2B). Overall, the BiP transcript was more prominent in 
flower samples as expected [16J. Between lines, the levels of 
hybridizing transcripts varied, with a consistent pattern 
between flower and leaf samples. BiP transcript was higher 
in those plants expressing the heavy chain alone, and hardly 
detectable (at the levels of film exposure shown here) in the 
wild-type plants or those expressing light chain alone. An 
intermediate level of transcript expression was found in 
plants expressing assembled IgG. Dcnsitometry of the 
bands using the positive control nontransgenic flower 
pooled RNA sample as a standard demonstrated a signi- 
ficant difference between wild-type and Gamma plants, and 
wild-type and IgG plants, but not between gamma and IgG 
plants (not shown). 
The results are in agreement with previous findings that 
BiP is constitutively expressed in flowers, and at lower levels 
in mature leaf tissue [16], but suggest that BiP expression is 
increased when the plant cells are actively synthesiing 
secretory proteins, such as recombinant Ig heavy chain or 
assembled immunoglobulin. However, BiP mRNA levels do 
not correlate with overall recombinant protein expression 
levels, as although IgG plants express approximately sixfold 
more recombinant protein than the respective heavy chain 
plants, the BiP mRNA level is lower. A possible explanation 
is that BiP only operates on unassembled chains and is 
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Fig. I. Titration curses for trattcgenic plant extracts. Six transgenic 
plants expressing either antibxiy light (x) chain, heavy (y) chain or 
both chains were assayed by capture EIASA. For the light and heavy 
chain ELISAs, capture was with the relevant specific goat antiserum 
and detection was with a horseradish peroxidase labeled goat anti- 
kappa or gamma serum. For functional IgG assay, capture was with 
the specific antigen (streptococcal antigen 1 11 at 2 4-ml, -') and 
detection was with a horseradish peroxidase labeled goat anti-gamma 
serum. Controls were Guy's 13 IgG hybridoma cell culture superna- 
tant and an extract from a wild-type nontransformed plant. The 
titration curves for all samples are shown (mean of duplicate wells). 
Positive and negative control samples are shown as large and small 
black squares, respectively. Samples from the two plants that differed 
from the other four an d were not used in further studies (see main text) 
are shown as large a di small open circles. 
gradually displaced upon heavy-light chain assembly (see 
further below). 
Total BiP protein expression in transgenic plants 
Western blotting was used to compare total BiP protein in 
crude extracts prepared from wild-type plants and two 
plants each expressing unassembled light chains, unassem- 
bled heavy chains or assembled iumnunoglobulin. The 
B Loaf W7 IgG 
BiP - ftwrr 
Fig. 2. Northern blot analysis of plant RNA. Fifteen µg total RNA 
from leaf tissue was run in each lane. blotted onto nitrocellulose and 
probed with a labeled anti-BiP DNA probe. The expected position of 
BiP transcript is indicated. Each of the four panels in each set is taken 
from the same nitrocellulose blot and probed in an identica manner. 
WT. wild type nontransformed tobacco; K, kappa chain transgenic 
tobacxo,; y, gamma chain transgenic tobacco, and Ig(i, kappa and 
gamma chain transgenic tobacco. 
protein immunoblot is shown in Fig. 3. As it control, the 
crude extract from the flower of a wild type plant was used 
to demonstrate the expected position of Bill on Western blot 
(Fig. 3, lane 1). The flower extract was used as a marker 
solely because BiP protein levels are normally higher in 
flowers [161. As expected, a band of approximate Afr of 
75 (XX) was detected, and no cross-reactive bands were 
found. Using the same mass of starting leaf material, the 
lowest level of total ßiP was detected in leaf extracts from 
wild-type plants, and similar levels were observed in plants 
that expressed unassembled K chain. The highest levels of 
HiP protein were detected in leaf extracts from plants 
expressing unassembled y heavy chains, and those that 
expressed assembled IgG. 
The iminunoblotting was repeated using all six transgenic 
plants in each group with the same results (not shown). 
Co-immunoprecipitation of BiP with immunoglobulin 
chains in plants 
To investigate the specific association of Bill with recom- 
binant inununoglobulin chains, we prepared protoplasts 
Ir. ý 
«1x 1 1\ "I 1 
Fig. 3. Western blot analytic of total Bill protein in plant extracts. Leaf 
extracts were separated by SDS PM il-and blotted onto nitrocellulose. 
The filter was probed with anti-ßil' serum, tollowcri by an alkaline 
phosphatase conjugated anti-rabbit IgG serum. A flower extract was 
used as a positive control. Results from two plants representing each 
plant line are shown. WT, wild type nuntranst rmed tobacco; ii, kappa 
chain transgenic tobacco; y, gamma chain transgenic tobacco: and 
1gG. kappa and gamma chain transgenic tobacco. 
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from nontransformed and transformed plants and looked 
for coimmunoprecipitaLion of BiP with the recombinant 
proteins (Fig. 4). Initially, protoplasts were prepared from 
transgenic plants. The antibody chains or the whole IgG 
molecule were immunoprecipitated with specific antisera. 
Immunoselected polypeptides were resolved by SDS/ 
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Fig. 4. Western blot analysis of immunoprecipitates from plant proto- 
plasts. The source material was transgenic plants (A. B) or transiently 
transformed protoptasts (C). A and B: the blots were probed with 
rabbit anti-BiP serum followed by alkaline phosphatase conjugated 
anti-rabbit serum. Wf. wild type nontransformed tobacco; K. kappa 
chain transgenic tobacc ; 'y, gamma chain transgenic tobacco; IgG, 
kappa and gamma chain transgenic tobacco; buffer. NET buffer 
containing the goat antiserum used for immunoprecipit Lion; 013 
IgG, Guy's 13 IgG hybridoma cell culture supernatant; IgG cells. 
Protoplast extract from IgG plants; and IgG medium, culture medium 
from IgG protoplasts. (C) protoplasts were transfected with plasmid 
encoding the IgG heavy chain, pulse labelled for Ih and chased for 
5 h. Total cell homogenates (tot) or microsomal (m) and soluble (s) 
fractions were immunoprecipitated with anti-IgG or anti-RiP. Num- 
bers at left indicate molecular mass markers in kDa: protoplasts were 
transfected with plasmids encoding the light chain (k). the heavy chain 
('y) or both chains (IgG). pulse labeled for Ih and homogenized. Cell 
homogenates were immunoprecipitated with the indicated antisera. 
Bands are visualized by autoradiography. The four panels represent 
cells expressing IgG, y. is or control. Immunoprecipitation was with 
anti-x, anti-IgG or anti-Bip antisera as indicated. Immunoprecipitates 
were incubated with (+) or without (--) 4 mm ATP prior to SDS/ 
PAGE. 
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BiP serum. Using the same number of- protoplasts from 
each plant. the highest level of coprecipitating BiP was 
recovered from transgenic plants expressing only heavy 
chains (Fig. 4A, y). Less BiP was coprecipitated from plants 
that produced assembled immunoglobulin (IgG), and it 
faint BiP band was detected fron plants expressing light 
chain only (K). No BiP was precipitated from wild type 
plants that did not express recombinant immunoglohulin 
chains (WT), or from it sample consisting of itmnunoprc- 
cipitation buffer alone (buf er). To demonstrate that Bill 
interaction with iminunoglobulin chains was an intracellular 
phenomenon and not due to nonspecific interactions, the 
immunoprecipitation experiment was also carried out using 
protoplast lysates in comparison with Protoplast culture 
medium (Fig. 413)_ The anti-BiP serum did not cross-react 
with Guy's 13 lgG. BiP was detected in immunoprecipitates 
from lg(i transgenic protoplasts, but not from the proto- 
plast medium, even though lgG, which is normally secreted 
[40], was detected by ELISA in this sample (not shown). 
To assess whether coprecipitation of 1.6 heavy chain 
with BiP was it result of the proteins colocali7ing and not it 
post homogenirttion artefact, we subjected transgcnic pro- 
toplasts to metabolic labelling for I It, homogenized them in 
2% (w/v) sucrose and purified micros>mes [7]. Figure 4C 
shows that both IgG and BiP are retrieved in Ute micro- 
sotnal fraction by inununoprecipitation with either anti-Ig( 
or anti-BiP sera. The interaction between Bil' and the heavy 
chain is prolonged, as both polypeptides are still coselecaable 
after 5 It chase (Fig. 4C). 
To confirm that coprecipitation of Bil' reflected real 
chaperone action, we tested whether the interaction of Bil' 
with immunoglobulin chains was sensitive to ATP. For 
these experiments, protoplasts that transiently expressed the 
recombinant proteins were used. The cells were pulse- 
labeled for I It and cell homogenates were inununoselected 
with either anti-BiP or antisera specific liar single Ig( 
chains. The results confirmed the different levels of coitn- 
munoprecipitating Bill in y- and Ig(]- expressing cells 
(Fig. 41)). 1 lowever, in these assays there was no evidence of 
BiP coimmunoprecipitating with K chain. The results also 
demonstrate that BiP was released from humunoselected 
gamma chain by washing with 4 msi ATP, suggesting it 
ligand chaperone relationship between the two molecules. 
Note that inm unoprecipitation with anti Bill antiseruni in 
all panels of Fig. 41) leads to coselection of an unrelated 
polypeptide of the same site of the y chain. ('oselection of' 
this polypeptide is insensitive to ATP treatment. The 
presence of this contaminant band partly explains why 
ATP release of y chain frone IN' does not seem complete in 
the `y' and 'IgG' panels. 
To further prove that BiP interacts with unassembled 
heavy chains, we reasoned that the coexpression of the 
companion K chain should compete with Bit' für association 
with the IgG heavy chain. We therefore cotransfected 
tobacco protopktsts with it fixed amount of DNA encoding 
heavy chain and with increasing amounts of light-chain 
encoding DNA, then immunoprecipitated the immuno- 
globulin chain (Fig. 5). The results show that when heavy 
chain (y) expression is constant, an increase in light chain (K) 
expression is paralleled by a decrease in the amount of BiP 
that is coselected from the cell homogenates. When the same 
samples were run on nonreducing SUS; PAGE, it was clear 
that cotranslection of the light chain resulted in the 
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Fig. 6. Northern blot analytic of plant RNA. Fifteen pg total RNA 
faint leaf ticwe was run in each lane blotted into nitr t llul se and 
probed with a labeled anticalreticulin DNA probe. The expected 
position of atlreticulin transcript is indicated. Each of the four panels 
in each set is taken from the s mte nitrocellulose blot and probed in an 
identical manner. WT, wild type nontransformed tobacco: sc, kappa 
chain transgenic tobacco. y. gamma chain transgenic tobacco, and 
Ig(i. kappa and g. uttma chain trtnsgenic tobacco. 
. qR chat, DNA 
Fig. 5. Co-exprestiion of k chain competes with Bil' for binding to the 
heavy chain. (A) Protoplasts were cotransfected with a constant 
amount (40 µg) of plasmid encoding heavy chain and with the indi- 
cated amounts of light chain. Cells were pulse labeled for Ih and 
homogenized. Cell homogenates were immunoselected with anti Ig(; 
or anti BiP antisera. resolved by reducing or nonreducing SDS; PAGE 
and poly tides visualized by fluorography. The panel shows the 
result from one of tour independent experiments. Numbers at left 
indicate molecular mass markers in kDa. (B) The intensity of the 
immunoselected BiP hands in A was evaluated by densitometry. The 
results shown are the average of four independent experiments. Bars 
indicate standard deviation. 
assembly of the IgG heterotetramer in a dose-dependent 
manner (Fig. 5A). Therefore, the presence of the light chain 
triggers assembly of the lgG tetramers and causes ßiP to be 
partially released from the heavy chains. 
Detection of calreticulin mRNA and protein in transgenic plants 
RNA extracted from the leaves of'six plants representative 
of each construct was used in Northern hybridizations with 
a calreticulin specific DNA probe, and the results From two 
plants are shown (Fig. 6). The results mirrored those of ßiP 
(Fig. 2). with the levels of hybridizing transcripts being 
highest in plants expressing the heavy chain alone, and 
lowest in the wild type plants or those expressing light chain 
alone, with an intermediate level of transcript expression 
found in plants expressing assembled IgG. 
Western blot analysis of total calreticulin protein expres- 
sion levels in the dit1erent plants also demonstrated a 
pattern similar to that found for BiP. The lowest levels were 
detected in wild-type extracts and plants expressing x chain 
alone. Higher levels of urlreticulin were detected in plants 
expressing assembled I_(; and the highest expression levels 
were in plants expressing unassembled immunaglobulin 
heavy chains (not shown). 
Co-immunoprecipitation of calreticulin 
with plant-expressed immunoglobulin chains 
In contrast to BiP, it was not possible to detect calreticulin in 
association with immunoglobulin chains (Fig. 7). Proto- 
plasts were prepared from nontrtnslormed (WT) and 
transfonned (y and IgG) plants. Lysed cell extracts were 
immunoprecipitated with antiserum to murine IgG (heavy 
and light chains), and after SUS/PAGE and inimunohlot- 
ting, detection was with either anti-calreticulin (A) or anti- 
BiY (B) antisera. No coprecipitating hands of the expected 
size for calreticulin were detected from any plant (Fig. 7A). 
as compared with calreticulin present in it WT flower 
extract. However, as shown previously, coprecipitating Bill 
was detected from the same heavy chain y plant sample but 
not WT (Fig. 713). 
DISCUSSION 
A number of expression systems have been used to produce 
antibody molecules. For full-length antibodies, bacterial 
systems are inappropriate, due to the demands of' protein 
glycosylation and assembly, but IgG can he expressed in 
yeast [41] and in baculovirusiinsect cell systems [42,43]. In 
mammalian cells, the importance of ER resident chaperones 
in the assembly ofimmunoglobulins has been recognized for 
some time [9]. The best characterized of these is BiP (binding 
protein or GRY78 [44]), which was initially shown to hind Ig 




Fig. 7. Western blot anal i. of immunnpmcipitates from plant pmto- 
plas s. The souie material was trensgenic plants. (A) The blot was 
probed with rabbit antir; tlreticulin serum followed by alkaline phos- 
phatase-conjugated anti-rabbit serum. A crude flower extract was 
included as a positive control for w cognition by the antibody. IBI The 
blot was probed with anti-RIP serum followed by alkaline phosphates 
conjugated anti-rabbit serum. M. protein molecular size markers; G 13. 
Guy's 13 IgG hybridoma cell culture supernatant. N N-1. wild type 
nontransformed tobacco; y, gamma chain transgenic tobacco; lgG. 
kappa and gamma chain transgenic tobacco. 
heavy chains, and later light chains (see [33] for review). 
Association with Ig chains occurs immediately alter syn- 
thesis, and usually lasts for a matter of' minutes if there are 
no abnormal folding or assembly events [31,34]. A number 
of Bil' binding sites have been mapped within the antibody 
[45] and dissociation of BiP is ATP-dependent [34]. The 
successful assembly of IgG in yeast and insect cell systems 
may be attributable to the presence of appropriate protein 
chaperones, as yeast possesses a homologue of BiP, termed 
Kart [15,46]. Although a native BiP has not been identified 
in insect cell lines, candidate insect protein chaperones have 
been identified that may perform a similar role [47]. Indeed, 
when insect cells were engineered to express murine BiP. 
increased expression of functional antibodies was found 
alongside a decrease in the formation of abnormal protein 
aggregates [48]. 
One of the potential advantages of the plant expression 
system is the presence of an indigenous BiP which is highly 
conserved as compared with murine BiP. with approxi- 
mately 69% overall homology at the amino acid level. This 
compares with yeast BiP which has 64%%% overall homology 
with murine BiP. In tobacco, BiP mRNA expression is 
highest in tissues containing rapidly dividing cells or those 
that are involved in secretion [16], whereas in maize, BiP is 
expressed most abundantly in endosperm development [17]. 
Also, plant BiP expression is associated with the accumu- 
lation of abnormal proteins [21]. It was previously demon- 
strated that efficient assembly and expression of Igs in plants 
could only be achieved by using a leader sequence to target 
the recombinant immunoglobulin proteins to the ER and 
'u1rý I IBS 
the secretory pathway [4]. This might be due to enhanced 
translation of recombinant proteins or to increased stability 
of the proteins resulting from their subcellular localization. 
In this paper. several lines of evidence have been put 
forward that demonstrate the association of the plant Bill 
homologue with folding and assembly of Ig light and heavy 
chains and we propose that the involvement of PR-resident 
chaperones promotes processing and expression of immu- 
noglohulin molecules in plants. 
Previous analysis of the constitutive expression patterns 
of BiP mRNA has suggested that expression is low in 
tobacco leaves [16]. For this reason, in these investigations 
we have used leaf tissue initially, so that any elevation in 
BiP would be more readily detected over the low back- 
ground of constitutive expression. BiP niRNA was differ- 
entially expressed in four plant lines that expressed no 
transgenic product, Ig light or heavy chain, or assembled 
IgG. The highest BiP expression was found in plants 
expressing heavy chain only, Bill expression was relatively 
lower in plants that express both light and heavy chains, but 
still elevated as compared with nontransgenic plants. The 
results are consistent with the putative role of Bit' in binding 
to and retaining unassembled subunit proteins [9,49] and in 
folding and assembly of immunuglohulin chains in cells that 
are highly active in terms of recombinant protein produc- 
tion and secretion. The relative decrease in Bill niRNA in 
IgCi expressing plants as compared with heavy chain 
expressing plants might he attributable to the successful 
assembly of heavy chains into inununoglohulin. This 
reduces the levels of nonassembled heavy chain, and allows 
the release and recycling of BiP. This is reflected in the total 
extractable BiP from leaf tissue. which was elevated to 
similar levels in both y and IgG transgenic plants. 
BiP protein coprecipitated with immunoglobulin chains 
extracted from protoplast intracellular fluid, but not from 
secreted Ig chains. This indicates that the Bill Ig chain 
interaction in plants is not artelactual and is consistent with 
the model of Bit' binding transiently in the ER tu Ig chains 
during protein folding and processing. The immunoblot 
results matched those found by Northern blot, in that most 
BiP protein was imm nioprecipitated in plants expressing 
the It, heavy chain only. Less was detected from plants 
expressing both light and heavy chains. even though more 
Ig heavy chain protein is consistently recoverable from lgC; - 
expressing plants. Again this is consistent with the model for 
BiP in assisting protein folding and increasing throughput of 
the ER. In mammals, BiP associates with both Ig light and 
heavy chains [9,31]. The evidence for Bill interaction with 
heavy chains in plants is clear, however, inconclusive results 
were obtained for the involvement of Bill with light chain. 
When analysis was performed using samples derived from 
transgenic plants expressing light chain only, it faintly 
discernible BiP hand was immunoproLipitated. I Iowever, no 
such interaction was observed when light chain was 
transiently expressed in protoplasts. The difference in results 
may be due to a difference in expression levels of immu- 
noglobulin light chain between the two systems. Alternat- 
ively, it may reflect a more rapid turnover of transiently 
expressed light chains. which would lead to its interaction 
with the pool of unlabelled BiP within the time frame of our 
observation. In view of the finding that Bill niRNA 
expression was not elevated in single transgenic plants. an 
alternative explanation is that the steady-state levels of light 
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chain polypeptides are generally very low in single trans- 
genic Plants. Previous estimates of the expression levels of 
light chain have generally been significantly lower as 
compared with plants expressing light and heavy chains 
together [4], and this difference has also been found in the 
current study. 
Our preliminary data suggest that in plants expressing 
only Ig light chains, these light chains are normally secreted 
(J. L. Hadlington and L. Frigerio, unpublished results). In 
contrast, when expressed alone, heavy chain accumulates 
intracellularly and colocalizes in the ER with BiP as shown 
in Fig. 4C. When assembled, the immunoglobulin complex 
is secreted [7]. Thus BiP may be involved in the chaperoning 
of light chains in plants, but as the protein is efficiently 
secreted, the detectable signal in the BiP coimmunopreci- 
pitation assay may be too low. The association of heavy 
chain in the ER with BiP is likely to represent chaperone 
activity, as indicated by the fact that upon addition of 
further recombinant protein (i. e. light chain), the BiP levels 
decreased, rather than increased. We cannot formally 
exclude that the BiP levels observed result from an unfolded 
protein response (UPR), but a detailed analysis of UPR 
markers in our transgenic plants is beyond the scope of this 
work. 
In plants, BiP has been shown to interact transiently with 
the monomeric form of the storage protein phaseolin. Upon 
trimerization of phaseolin, BiP is released, indicating that it 
plays a role in trimer assembly [20]. Only when a mutant of 
phaseolin is incapable of forming trimers is it found in 
prolonged association with BiP, until it is eventually 
degraded by quality control [21,22]. Similarly, we show 
here that BiP is tightly associated to single heavy chains, but 
the association is less strong when both heavy and light 
chains are present simultaneously. Moreover, BiP associ- 
ation is reduced when increasing amounts of light chain are 
available for IgG assembly. 
The association of BiP with folding and assembly of 
recombinant immunoglobulin chains in plants is significant 
in demonstrating the suitability and potential versatility of 
transgenic plants for producing a variety of mammalian 
proteins. Protein translocation and folding in the ER can 
be one of the rate limiting steps in protein secretion, and 
the presence of protein chaperones is important for high 
efficiency turnover, leading to high levels of production. It 
has been recently reported that the overexpression of Bi? 
(and PDI) in yeast cells greatly improves the efficiency of 
folding and secretion of single chain antibody fragments 
[50]. Likewise, when BiP is overexpressed in transgenic 
plants, it is able to alleviate ER stress induced by 
tunicamycin [51]. It will be very interesting to test the 
effects of BiP overexpression in plants expressing our 
model Igs. 
The passage of proteins through the secretory pathway 
in plants is a complicated process [52] and it is clear that 
BiP is not the only chaperone involved. In mammals, a 
few other chaperones that are involved with Igs have been 
identified so far [33,34]. Of these, plant homologues to GRP 94, and protein disulphide isomerase [53] have been 
identified, and it will be important to establish their role in 
Ig assembly. In this study, we have investigated whether 
calreticulin might be involved in the folding and assembly 
of immunoglobulins in plants and found no evidence for 
this. Although we cannot exclude the possibility that an 
extremely rapid interaction occurs between calreticulin and 
immunoglobulin chains, our findings appear to be consis- 
tent with the mammalian expression of immunoglobulins 
[33], and demonstrates a specific and appropriate interac- 
tion between Igs and chaperones in plants. With increasing 
evidence for separate chaperone pathways involving either 
BiP or calreticulin/calnexin [54] our demonstration that the 
BiP pathway in plants is functional for mammalian 
proteins provides a functional rationale for the use of 
plants as an expression system. It remains to be deter- 
mined if the plant calreticulin pathway is equally func- 
tional for mammalian proteins. Conversely, the range of 
transgenic plants now available that express all combina- 
tions of Ig chains involved in IgG and SIgA may be useful 
tools to investigate immunoglobulin processing and help to 
identify candidate proteins which may act as chaperones in 
this process. 
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Abstract 
The cDNA encoding a full-length murine immunoglobulin yI heavy chain with its native leader sequence, trans- 
membrane and intracellular domains was introduced into transgenic plants. Transformed plants expressed the 
recombinant polypeptide, but, in contrast to plants expressing the heavy chain without transmembrane sequence, 
the protein appeared to be associated with a plant cell membrane. Extraction of the membrane-associated heavy 
chain required the presence of a non-ionic detergent, and immunofluorescence studies of protoplasts demonstrated 
surface expression of membrane Ig heavy chain on up to 40% of the cells from a transgenic leaf. In plants ex- 
pressing both the membrane Ig heavy chain and its partner light chain, functional antibody was also localised to 
the plant cell membrane and retention of the heavy chain at this site appeared to have no effect on the efficiency 
of antibody assembly. This approach of localising and accumulating recombinant antibody in cell membranes may 
have a number of applications, including passive immunisation against plant pathogens. 
Introduction 
The expression of full-length antibodies and antibody 
fragments in transgenic plants is an important tool 
in plant science which can be used for a number 
of purposes (Ma and Hiatt, 1996). A particular ad- 
vantage of antibodies is the diversity of engineered 
molecular derivatives that can be generated and re- 
tain antigen binding and specificity. Thus expression 
of a single-chain molecule (scFv) has been used to 
modify plant biochemistry (Owen et al., 1992) and to 
induce resistance to disease (Tavladoraki et al, 1993). 
They can be expressed in the cytoplasm, targeted into 
the secretory pathway and retained in the endoplas- 
mic reticulum (ER) or secreted (Firek et al., 1993; 
Artsaenko et at., 1995; Schouten et al, 1996). How- 
ever, there are disadvantages, as scFv molecules bind 
antigen monovalently and therefore cannot cause ag- 
gregation; moreover, they bind less avidly than their 
parent antibodies. The expression levels of scFv are 
often disappointing, up to 0.1% total soluble protein 
when expressed in the cytosol, although this can be 
increased by targeting the scFv to the ER (Firek et al., 
1993) or by retention in the endoplasmic reticulum 
using the KDEL sequence (Schouten et al., 1996). 
In contrast, full-length antibodies which bind antigen 
bivalently are generally expressed at high levels in 
transgenic plants (Hiatt et al., 1989; Ma et al., 1994). 
For the correct assembly of functional full-length im- 
munoglobulins, the individual heavy and light chains 
need to be targeted to the endoplasmic reticulum and 
plant secretory pathway (Hiatt et al., 1989). 
Although the final cellular distribution of recombi- 
nant antibodies has not been fully characterised, a sig- 
nificant amount is accumulated in the apoplastic space, 
which is a relatively stable environment (Hein et al., 
1991). The subsequent fate of these antibodies is also 
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unknown and they may be degraded, be transported 
elsewhere in the plant, or even be reinterualised. 
In mammalian B lymphocytes and plasma cells, 
immunoglobulin molecules exist in two forms: as se- 
creted antibody or as a surface antigen receptor. The 
membrane-associated forms have heavy chains that 
are slightly larger than those of secreted antibody due 
to the presence of an extra 71 amino acid residues at 
the COON terminus. These are arranged in 3 domains, 
a 17 residue acidic extracellular portion, a 26 residue 
hydrophobic intra-membrane portion and a 28 residue 
hydrophilic intracellular portion (Yamakawi-Kataoka 
et al., 1982). These sequences are highly conserved 
within the murine Cy 1, Cy2a and Cy2b as well as Cµ 
genes. The aims of this study were (1) to determine if a 
murine immunoglobulin heavy chain could be targeted 
to the plant cell membrane using the native transmem- 
brane sequence, (2) to examine if correctly assembled 
functional antibody could be retained at this site, and 
(3) to determine the effect of this sequence on the 
expression of Ig heavy chain and assembled IgG in 
transgenic tobacco plants. 
Materials and methods 
DNA cloning and sequencing 
In order to clone the DNA encoding the membrane- 
associated immunoglobulin heavy chain (my 1), mes- 
senger RNA was first purified from the Guy's 13 
hybridoma cell line by acid-guanidinium thiocyanate- 
phenol-chloroform extraction (Chomczynski and Sac- 
chi, 1987). Guy's 13 is a murine IgGI mono- 
clonal antibody that was raised against a strep- 
tococcal surface antigen (111I) (Smith and Lehner, 
1989). cDNA was prepared with MMLV re- 
verse transcriptase (Promega, UK). DNA encod- 
ing the heavy chain, with its native leader and 
transmembrane sequences, was amplified by poly- 
merase chain reaction (PCR) with synthetic oligonu- 
cleotides: GGGCTCGAGATGRRATGSASCTGGRTYKT- 
NYTC (5') and TGTGAATTCCTAGGGCGCTTGCCCAAT 
(3'). The membrane-associated heavy-chain gene was 
ligated into pBluescript (Stratagene, USA) for se- 
quence analysis by the dideoxy chain termination 
procedure (Sequenase, USB, USA). The gene was 
transferred to a constitutive plant expression vector 
(pMON 530) which contains the 35S C. aMV pro- 
moter sequence (Rogers et aL, 1987). The recombi- 
nant vector was used to transform Escherichia coil 
strain DH5-a (Gibco-BRL, UK). Screening for posi- 
tive transformants was done by Southern blotting with 
a radiolabelled DNA probe derived from the original 
PCR product. Plasmid DNA was purified and intro- 
duced into Agrobacterium tumefaciens as described 
(Fraley et a1.1983). 
Transformation and regeneration of transgenic plants 
Leaf discs of Nicotiana tabacum (var. xanthii) were 
transformed as described (Horsch et al., 1985). The 
discs were incubated on medium supplemented with 
kanamycin (200 mg/l) and carbenicillin (500 mg/1) 
for regeneration of shoots, and the shoots were trans- 
ferred to root-inducing medium supplemented with 
kanamycin (200 mg/l). As soon as roots were estab- 
lished, plantlets were transplanted into soil. 
Transgenic plants expressing the secreted form of 
the Guy's 13 heavy chain and its partner light chain 
have already been prepared and described (Ma et al, 
1994). Plants expressing assembled immunoglobulin 
were prepared by cross-fertilisation between heavy- 
chain- (secreted or membrane-associated forms) and 
light-chain-expressing plants as described previously, 
and screened by an antigen-specific ELISA. 
Immunglobulin chain detection 
Young plant leaves were homogenised in 150 mM 
NaCl, 20 mM Tris-UCL pH 8 (TBS) containing 
leupeptin (10 µg/ml, Calbiochem, USA). 1% Non- 
idet P40 (NP40) was included as indicated. After 
centrifugation at 13 000 xg for 2 min, the su- 
pernatant was added in 3-fold dilutions to microtitre 
plates that had previously been coated either with goat 
anti-mouse yl antiserum (1: 1000, Sigma, UK) or 
streptococcal antigen VII (2 ug/ml) and blocked with 
5% non-fat dry milk in TBS containing 0.05% Tween 
20 (TEST). Incubation was done for 2h at 37 °C, 
the plates were then washed three times with TBST 
buffer. Bound immunoglobulin chains were detected 
by incubation with horseradish peroxidase-labelled 
goat anti-mouse y1 antiserum (1: 1000, Nordic Phar- 
maceuticals, Netherlands) for 2 It at 37 °C, followed 
by ABTS (22'-azino-di-(3-ethyl-benzthiazoline sul- 
fonate), Boehringer Mannheim, FRG) as the substrate. 
Antibody concentration was calculated by comparison 
of binding curves with pre-existing standards. Solu- 
ble protein concentration of total plant extracts was 
measured with the BCA protein assay reagent (Pierce, 
USA). 
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Preparation of pmtoplasts 
Sterile tobacco leaf sections were incubated overnight 
in 0.5 M mannitol, 50 mM CaC12,3 mM MES (manni- 
tol buffer) containing 0.4% cellulase and 0.2% pecti- 
nase (Calbiochem, UK) pH 5.4 at room temperature 
in the dark. Gross debris was removed and the pro- 
toplast suspension centrifuged at 65 xg for 10 min. 
The floating layer of cells was removed by pipette, 
washed three times in four volumes of buffer contain- 
ing 150 mM NaC1,5 mM KCI, 125 mM CaC12 and 
5 mM glucose (W5 buffer), then resuspended at ca. 2 
x 106 protoplasts/ml. Protoplasts were not fixed, but 
maintained essentially as live cells. 
Immunoffuorescent labelling of protoplasts 
Either FITC-labelled goat anti-mouse it chain (1: 25, 
Sigma-Aldrich, UK) or FITC-labelled goat anti- 
mouse gI antiserum (1: 25, Sigma-Aldrich, UK) were 
added to protoplasts and incubated for 2h at room 
temperature in the dark. Protoplasts were then washed 
3 times by centrifugation at 65 xg in W5 buffer and 
viewed by fluorescence microscopy. 
For control samples, pmtoplasts from a plant trans- 
formed with an irrelevant protein were incubated for 
2h at room temperature with a polyclonal rabbit an- 
tiserum against Arabidopsis plasma membrane proton 
pump ATPase (1: 100), kindly provided by Dr Mike 
Sussman (University of Wisconsin). Protoplasts were 
washed 3 times in W5 buffer prior to incubation with 
FITC goat anti-rabbit IgG (1: 25, Sigma-Aldrich, UK) 
for a further 2 h, and then washed a further 3 times in 
W5 buffer. 
ELISA analysis ofprotoplasts 
Protoplast supernatants from overnight digestion were 
collected and applied to microtitre plates as described. 
The protoplasts were also harvested on a sucrose cush- 
ion, resuspended in mannitol buffer and disrupted by 
sonication. The samples were centrifuged at 50000 
rpm for 45 min at 4 °C. Cell pellets were resus- 
pended in TBS, leupeptin and 1% NP40 and applied 
to microtitre plates as described previously. 
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Fygure 1. Diagrammatic representation of the 4terminus of my 1 
and predicted amino acid sequence of Guy's 13 my I heavy chain. 
The functional regions are indicated. 
Results 
Cloning, sequencing ofthe Immunglobulin heaºy 
chain and generation of transgenic plants 
DNA encoding the entire heavy chain of a murine 
IgG 1 monoclonal antibody including its native leader 
and transmembrane sequences was amplified by PCR 
using cDNA prepared from the hybridoma cell line. A 
degenerate 5' oligonucleotide primer and a specific 3' 
primer were used that were designed from previously 
published sequences (Yamawaki-Kataoka et a!., 1982; 
Kabat et al., 1999). A PCR product of the expected 
size (ca. 1589 bp) was amplified and cloned. Se- 
quence anaylsis identified the region encoding the na- 
tive signal sequence MEWTWVFLFLLSGTAGVIIS 
and confirmed the DNA sequence of the extracellular 
domains of the Guy's 13 heavy chain. The sequence of 
the 3' end of the DNA fragment is shown in Figure 1 
and is identical to that previously published for the 
2PK-3 membrane IgGI (Tyler et al., 1982). 
The cloned product was introduced into transgenic 
tobacco plants by Agrobacterium-mediated transfor- 
mation. A number of plants were regenerated, from 
which twelve independent transgenic plants were 
identified with an Ig heavy chain-specific ELISA (data 
not shown). Four were used for cross-fertilisation with 
transgenic plants already expressing the Guy's 13 light 
chain (Ma et al., 1994). Of 86 progeny plants screened 
by an antigen-specific ELISA described below, 28 
expressed functional Guy's 13 antibody. 
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Detection of recombinant Ig chains by ELISA 
Representative data from plants expressing Guy's 
13 membrane-associated heavy chain (my l) with or 
without Guy's 13 light chain are shown (Figure 2). 
Addition of NP40 had no effect on the extraction of 
Guy's 13 heavy chain from plants not expressing the 
transmembrane region (IgG) (Figure 2A). However, in 
those plants expressing my 1, the heavy chain could 
only be detected if NP40 was present in the extraction 
buffer. In plants expressing myl with Guy's 13 light 
(K) chain (mIgG) some heavy chain was detected in 
the absence of NP40, but the titre was 2-3 dilution 
steps less than when NP40 was present. 
In these latter plants expressing both my I and K 
chains, the antibody was correctly assembled in the 
plant cell membrane, as demonstrated by an antigen- 
specific ELISA (Figure 213). As before, antibody was 
detected at a level 2-3 dilution steps higher in the 
presence of NP40. The titration curves for IgG activ- 
ity and heavy-chain expression were similar in these 
plants, indicating that thcrc was little free heavy-chain 
present and that most was assembled into functional 
antibody. No antigen binding was observed in extracts 
from plants expressing myl alone. 
As indicated in Figure 2B, the titration curves for 
total heavy-chain detection in mlgG plants are about 
the same as those for my1 plants (Figure 2A). In- 
deed, there was only a 2.5-fold difference in mean 
titres measured from 12 plants each expressing my 1 
or mIgG (results not shown). The mean recovery for 
my 1 and m1gG was 0.5% and 1.1% of total soluble 
plant protein respectively. 
Protoplast analysis 
Detection of my 1 heavy chain from protoplast prepa- 
rations by ELISA is shown in Figure 2C. The recom- 
binant heavy chain was detectable in myl plants in 
the ultracentrifuged membrane pellet resuspended in 
buffer containing NP40, but not the ultracentrifuged 
supernatant from the cell wall digestion buffer sug- 
gesting that recombinant my 1 is not secreted. Similar 
results were found for mIgG plants, although there 
were low levels of functional antibody detected in 
the supernatant. As before, the levels of myl de- 
tection were similar between my I and mIgG plants. 
There was little or no detectable immunoglobulin 
heavy chain in the membrane preparations from trans- 
genic plants expressing the soluble form of IgG only, 
although there were detectable levels of secreted anti- 
body in the culture supernatant. 
Immunofluorescence ofprotoplasts to demonstrate 
membrane-associated heavy chain is shown in Fig- 
ures 3 and 4. The majority of protoplasts appeared 
intact, although some were slightly misshapen, prob- 
ably due to the fact that the protoplasts were prepared 
without fixation. It is also possible that cross-linking 
of membrane proteins by the specific antibodies might 
affect the morphology of the cells. Protoplasts were 
labelled with an FITC anti-mouse y-chain antiserum. 
Protoplasts are autofluorescent (red) under UV illumi- 
nation due to chlorophyll (Figure 3A, panels 1 and 2), 
and this fluorescence is limited to chlomplasts. Cells 
from untransformed (WT) plants were not stained with 
FITC (panel 3). About 1 in 30 protoplasts from un- 
transformed plants exhibited weak fluorescence but 
there were no moderately or brightly stained cells. In 
contrast, cells from the my I plants demonstrate bright 
surface staining (Figure 3B, panel 1) which is distinct 
from the chlonoplasts (Figure 3B, panels 2 and 3). The 
numbers of fluorescing cells in the my 1 leaf prepa- 
rations varied between 10% and 40%. In the most 
highly fluorescing preparations, ca. 20% of the cells 
were brightly fluorescent, a further 20% had moder- 
ate fluorescence and the remainder emitted minimal 
or no fluorescent signals. The fluorescence pattern as- 
sociated with protoplasts expressing my 1 was similar 
to that seen when pmtoplasts were incubated with an 
antiserum to detect plasma membrane II(+)-ATPase, 
i. e. a native plasma membrane marker (Figure 3C, 
panels 3 and 4). In this case, protoplasts were pre- 
pared from a control transformed plant expressing an 
irrelevant secreted antigen. A further control was in- 
cluded to exclude the possibility of non-specific bind- 
ing by the FITC-labelled goat anti-rabbit Ig antiserum 
(Figure 3C, panels 1 and 2). 
Immunofluorescence of protoplasts to demonstrate 
membrane-associated antibody is shown in Figure 4. 
Protoplasts were labelled with either FITC anti-mouse 
K-chain or FITC anti-mouse y-chain antisera. There 
was no specific staining of cells from untransformed 
plants (WT) or those only expressing the myI chain 
(Figure 4A, panels 1-4) with the anti-K reagent. The 
my1 cells, however, were positively stained (as be- 
fore) for anti-y-chain (Figure 413, panels 3 and 4). 
This demonstrates the specificity of the anti-K-chain 
reagent, and absence of cross-reactivity with im- 
munoglobulin heavy chain. Protoplasts from plants 
co-expressing my l and K did demonstrate surface 
staining both with anti-K (Figure 4A, panels 5 and 
6) and anti-y (Figure 413, panels 1 and 2) antisera. 
This confirms the presence of surface immunoglob. 
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Figure 2. ELISA analysis of plant samples from plants expressing Guy's 13 IgG without tratccmrmbrur s quence ll feil. Guy's 13 heavy 
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Figure 3. Immunofluorescent staining of transgenic and untransformed protoplasts. A. tintnnsformed plant (WT) cells incubated with 
FITC-labelled goat anti-mouse yI antiserum showing auto-immunofluorescence under I IV illumination (Panels I and 2) and with a 466 nm 
filter (Panel 3). B. Protoplasts from transgenic plants expressing my I chain, incubated with FIT('-labelled goat anti-mouse yI antiserum under 
UV illumination (Panel 2) and 460 nm fiter (Panels I and 3). C. Protoplasts from a control transformed plant incubated with (Panels 3 and 4) 








WT myl mlgG 
B1 3 
,a 
- _: 11 
1 11 
rIgG m 
Figure 4 Immutnfluorescent staining of trensgenic and untransformed protoplasts with FITC-Iabellai goat anti-mouse antisera. Samples are 
shown with UV illumination. with or without a 460 nm filter. A. Anti-K-chain detection: WT cells (Panels I and 2). my ]cells (Panels 3 and 4) 
and m1gG cells(Panels 5 and 6). B. Anti-y-chain detection: mIgG cells (Panels I and 2) and my I cells (Panels 3 and 4). 
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ulin heavy chain in mIgG plants, as well as the 
co-localisation with a chain at the same site. The 
frequency of brightly stained protoplasts from mlgG 
plants was similar to that found with my 1 plants 
stained with anti-y-chain antiser un. 
Discussion 
In this study we have investigated the targeting of 
full-length antibodies to the plant cell membrane with 
the native murine immunoglobulin transmembrane se- 
quence. The sequence encodes a short extracellular 
region, a hydrophobic transmembrane sequence com- 
prising 26 amino acid residues and a hydrophilic 28 
residue intracellular domain (Tyler et al., 1982). We 
have shown that immunoglobulin heavy chain bearing 
this sequence is retained by the plasma membrane. 
With a simple procedure, soluble recombinant protein 
could not be detected unless extraction was performed 
in the presence of a non-ionic detergent, NP40. It is 
most likely that the recombinant heavy chain is re- 
tained in the cell membrane as the protein was targeted 
to the secretory pathway by a signal sequence, and 
also because the heavy chain was readily detected by 
immunofluorescence of prutoplasts. Furthermore, the 
my 1 assembled correctly with the immunoglobulin 
light chain which does not possess a transmembrane 
sequence but is also targeted for secretion using a re- 
lated signal sequence. Assembly of light and heavy 
chain occurs in the ER in plants (manuscript in prepa- 
ration) and mammals and they emerge at the cell 
membrane as fully assembled immunoglobulin. We 
have demonstrated in the mlgG plants that the u- and 
y-chains are co-localised to the cell membrane using 
immunofluorescence and that they remain correctly 
assembled at this site as antibody, using a functional 
antigen-specific ELISA. The staining pattern of both 
my I and mIgG at the plasma membrane was similar 
to that seen for a native plasma membrane component 
(H(+)-ATPase pump), indicating that these recombi- 
nant proteins are being targeted to the plasma mem- 
brane in a normal manner. Our studies do not however 
exclude the possibility that the recombinant antibodies 
might also be distributed elsewhere in the plant cell. 
Recently it has been demonstrated that engineered im- 
munoglobulins originally targeted for secretion can 
also be retained in the ER and the vacuole (Frigerio 
et al., 2000). It remains tobe determined if the murine 
immunoglobulin transmembrane sequence possesses 
signals that are specifically recognised by plants, but 
the accumulation of a significant proportion of recom- 
binant immunoglobulin heavy chain and antibody at 
the cell membrane suggests a default secretory path- 
way to the cell surface. Further investigation of the 
fine cellular distribution of my 1 and mIgG is required, 
and these molecules may turn out to be useful tools for 
the study of the default pathway for plant membrane 
proteins. 
The mIgG appears to be more readily dissociated 
from plant cell membranes than my I alone as shown 
by the detection of antibodies in plant extracts with- 
out NP-40. This may be due to over-accumulation of 
IgG in the extracellular compartment, or it is possible 
that the additional burden of the membrane anchored 
recombinant antibody destabilises the cell membrane. 
However, protoplasts prepared from these plants ap- 
peared no less robust than others prepared from un- 
transformed plants. Not all the protoplasts expressed 
the my 1 heavy chain and this is consistent with the 
finding that the 35S CaMV promoter does not di- 
rect expression in all cells all of the time (Barnes, 
1990; Benfey and Chua, 1990). Work is going on 
to determine which cell types express the recombi- 
nant immunoglobulin chains and at which stages of 
development. 
There are many potential applications of this form 
of antibody expression in plants, particularly for dis- 
ease resistance, in which the retention and accumu- 
lation of specific antibodies in an extracellular com- 
partment might help to prevent infection by interfer- 
ing with microbial invasion. It is unlikely that non- 
invasive antigens could be taken up across an intact 
cell wall, but there may also be applications related to 
the use of cell suspension cultures or protoplasts, for 
example in large-scale adsorption of antigens. Further. 
more, plant antibodies that accumulate but are largely 
retained in the apoplasm may be useful in the area 
of phytoremediation and environmental clean-up. The 
use of this membrane targeting sequence is not con- 
fined to immunoglobulins, and other bioactive proteins 
could be expressed at the cell surface. As a scientific 
tool this transmembrane sequence could be useful as 
a marker for analysis of protein expression in plants, 
as well as having applications in the sorting of pro- 
toplasts by fluorescence-activated cell sorting (FACS) 
(Galbraith, 1989). In mammalian cells, cross-linking 
of surface proteins often leads to capping and in- 
temalisation and if this occurs in plants, cell surface 
antibodies could be used as a means of internalising 
foreign molecules into protoplasts. 
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Secretory immunoglobulin (Ig) A is a decameric Ig composed of four a-heavy chains, four light chains, a joining Q) chain, 
and a secretory component (SC). The heavy and light chains form two tetrameric Ig molecules that are joined by the J chain 
and associate with the SC. Expression of a secretory monoclonal antibody in tobacco (Nicotiana tabacum) has been described: 
this molecule (secretory IgA/G [SIgA/G]) was modified by having a hybrid heavy chain sequence consisting of 1gG y-chain 
domains linked to constant region domains of an IgA a-chain. In tobacco, about 70% of the protein assembles to its final, decameric structure. We show here that SIgA/G assembly and secretion are slow, with only approximately 10% of the newly 
synthesized molecules being secreted after 24 hand the bulk probably remaining in the endoplasmic reticulum. In addition, 
a proportion of SIgA/G is delivered to the vacuole as at least partially assembled molecules by a process that is blocked by 
the membrane traffic inhibitor brefeldin A. Neither the SC nor the J chain are responsible for vacuolar delivery, because 
IgA/G tetramers have the same fate. The parent IgG tetrameric molecule, containing wild-4W heavy chains, Is instead 
secreted rapidly and efficiently. This strongly suggests that intracellular retention and vacuolar delivery of IgA/G is due to 
the a-domains present in the hybrid a/y-heavy chains and indicates that the plant secretory system may partially deliver 
to the vacuole recombinant proteins expected to be secreted. 
The secretory pathway delivers proteins from the 
endoplasmic reticulum (ER), where secretory pro- 
teins are cotranslationally inserted, to the cell surface 
or the inner hydrolytic compartments (vacuoles in 
plants and yeast, or lysosomes in animals). This traf- 
fic is often mediated by the Golgi complex. A vast 
array of proteins of pharmaceutical importance are 
secreted by different mammalian cells, and trans- 
genic plants are an attractive expression system for 
producing recombinant forms of these proteins. One 
of the major advantages is that many steps of the 
secretory pathway, including protein folding, assem- 
bly, ER-mediated glycosylation, and early steps of 
Golgi-mediated glycan processing, are largely simi- 
lar, when not identical, to those found in mammalian 
cells (Ma and Hein, 1995; Rayon et al., 1998; Sander- 
foot and Raikhel, 1999; Vitale and Denecke, 1999). 
Thus mammalian-secreted proteins can be produced 
with a high degree of fidelity. One such example is 
murine immunoglobulin (Ig) G monoclonal anti- 
body. This molecule comprises four polypeptides- 
two each of a heavy and a light chain, which are 
linked by disulfide bonds. In mammalian plasma 
1 These authors contributed equally to the paper. ' Corresponding author; e-mail vitale@icmmi. cnrit; fax 39-02- 
23699411. 
cells, correct assembly of this molecule is achieved 
within the ER through interactions with a number of 
chaperones and enzymes and the addition of glycans 
prior to secretion from the cell. These events are 
faithfully reproduced in plant cells, to the extent that 
IgG can be expressed that is functionally indistin- 
guishable from the same antibody expressed in mu- 
rine cells and is expressed at levels of 1% of total 
soluble leaf protein (Hiatt et al., 1989; Ma et al., 1995). 
When a related but more complex Ig, a recombi- 
nant secretory Ig A/G (SIgA/G) hybrid, was ex- 
pressed in plants, the levels of accumulation were 
even greater, amounting to 5% to 8% of total soluble 
leaf protein (Ma et al., 1995). Secretory IgA (SIgA) is 
a decameric polypeptide complex. In the ER of 
plasma cells, two standard Ig units (each composed 
of two heavy and two light chains, like IgG) are first 
dimerized by a joining Q) chain to form dimeric IgA 
(dlgA), held by a disulfide bond between each tet- 
ramer and the J chain. In mammals, after secretion 
from plasma cells, dlgA is recognized by a receptor 
present on the basolateral surface of epithelial cells. 
Transcytosis causes transport of the receptor/ligand 
complex to the apical surface, where a proteolytic 
event releases the dIgA associated to a portion of the 
receptor (called secretory component [SCJ), resulting 
in the formation of the full, decameric SIgA molecule 
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(Mestecky and McGhee, 1987). Thus, in its natural 
environment SIgA is the result of the activities of two 
cell types, but in transgenic plants it is successfully 
synthesized in the ER of individual cells. One of the 
roles of the SC is to protect the secretory Ig against 
proteolysis in vivo (Underdown and Dorrington, 
1974). Thus, SIgA is a more stable molecule than IgG, 
however it is unlikely that this alone would account 
for the difference in accumulation levels between 
SIgA/G and IgG in plants. In this study we com- 
pared the fates of the IgG and SIgA/G in plant cells 
to determine if there were any differences in the way 
plants handle these proteins. 
One of the peculiar characteristics of the plant se- 
cretory pathway is the presence of vacuoles. Al- 
though yeast has vacuoles as well and mammals 
have lysosomes (rich in hydrolases, similar to lytic 
plant vacuoles), the ontogeny, variety of functions, 
and protein sorting mechanisms of plant vacuoles are 
unique (Neuhaus and Rogers, 1998; Marty, 1999). We 
report that after entry into the plant secretory path- 
way, a relevant proportion of SIgA/G, but not of IgG, 
is diverted from secretion and eventually delivered as 
at least partially assembled molecules to the central 
vacuole of tobacco (Nicotiana tahacum) leaf mesophyll 
cells. This process is sensitive to the membrane traffic 
inhibitor brefeldin A. Thus, plant cells may deliver to 
the vacuole a proportion of mammalian recombinant 
proteins that are expected to be secreted. 
RESULTS 
Secretion of SIgAIG Is Slow 
In SIgA/G, the heavy chains are hybrids contain- 
ing the variable domains and the constant Cyl and 
Cy2 domains of the IgG y-chain linked to the con- 
stant Caa2 and CO domains of the IgA a-chain. These 
extra domains allow the Ig units (composed of two 
heavy and two light chains) to dimerize by binding 
the j chain and to further associate with the SC (Ma et 
al., 1995). 
We first wanted to establish the efficiency of 
SIgA/G secretion. We isolated protoplasts from 
leaves of SIgA/G-expressing tobacco plants and sub- 
jected them to pulse-chase analysis. We then immu- 
noprecipitated the whole SlgA/G molecule from cell 
lysates and incubation media using polyclonal anti- 
IgG antiserum, and analyzed the polypeptides on 
reducing SDS-PAGE and fluorography. Figure 1 
shows that, at the end of the pulse period, the heavy 
lgA/G chain, and the light chain, together with a 
polypeptide of the expected size for the un- 
glycosylated SC are detected. Glycosylated SC comi- 
grates with the heavy chain, and the J chain, which 
normally forms dimers on reducing SDS-PAGE, 
comigrates with the light chain (F. Wang and M. B. 
Hein, unpublished results). After 12 h, only a small 
proportion (about 10%) of the antibody is retrieved 









Figure 1. SIgA/(, i, sr, r(-t, -(] l IV. I , t, I, 
I. i, i, II,, ni 1, eil I I. 11 
genic toh, tcco expressing SIgM(. Pul, " lur I tl WIii 
I "SIMet and j'SSICys either in the presenco III or in thr" . rhsl v( 
of bre(c"Idin A (RI A) and chased for the indicated periods of time. 
Cells and the corresponding incubation media were homogenised, 
subjected to immunoprecipitation with anti-Ig(, antiserum, and in- 
alyied by 15% (w/v) reducing SI )S-I'A(: I and Iluorography. Num- 
bers at right indicate rnolei"Idar mass rnarker% in kl ). I I, I Leavy c h, tin; 
1, light chain; asterisk, un-t; lyr osylatod S('. 
increases only slightly in the following 12 h, whereas 
the bulk of the antibody remains intracellular. At 5h 
of chase the amount of secreted IgA/G is below our 
detection limit (not shown). Titus, secretion of 
SlgA/G is a very slow and apparently inefficient 
process. This seems to be close to the bottom limit of 
a range observed for heterologous protein-, intro- 
duced into the plant secretory pathway (1)enecke et 
al., 19911), but a variety of wild-type and recombinant 
proteins are secreted in a much shorter time, with 
half-times within 2 to 5h from the time of synthesis 
(Hunt and Chrispeels, 1991; Matsuoka and Naka- 
mura, 1991; Frigerio et al., 1998). When protoplasts 
were incubated in the presence of 10 µ}, ml. 1 brelel- 
din A, secretion was greatly reduced (Fig. 1). This 
concentration of brefeldin A has been shown tºr in- 
hibit membrane traffic from the ER (t3oevink et . il., 
1998). 
After 12 h of chase, several discrete polypeptirles in 
the 15- to 30-kD range were detected in the protoplast 
lysates (Fig. 1, no brefeldin A treatment). fhe prt - 
ence of intracellular If; breakdown products was pre- 
viously reported (Ma et al., 1994,1995). Their absence 
at the end of the pulse and appearance during the 
chase rule out the possibility that these fragments 
were generated during sample honmgenation. The 
appearance of these fragments was efficiently inhib- 
ited by brefeldin A treatment (Fig. 1; 12- and 24-h 
chase in the presence of brefeldin A), indicating that 
fragmentation occurs because of transit to a post-E: R 
compartment through membrane traffic (see further 
below). 
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Vacuolar Targeting of Recombinant ImmunogIohulin. 
The Intracellular Breakdown Products Are 
Located in the Vacuole 
We wanted to investigate where the Ig breakdown 
products are located. The fact that degradation can be 
prevented by brefeldin A treatment, which inhibits 
delivery to plant vacuoles (Gomez and Chrispeels, 
1993), suggested that the vacuole could be the site of 
degradation. To test this hypothesis, we subjected 
SIgA/G-expressing protoplasts to pulse-chase either 
in the presence or in the absence of brefeldin A. We 
then purified vacuoles from protoplasts and immu- 
noselected the Ig (Fig. 2). After 16 h of chase the Ig 
fragmentation products were clearly detectable in the 
vacuolar fraction; consistently, treatment with brefel- 
din A prevented the appearance of the fragments in 
the vacuoles. We then conclude that a proportion of 
the SIgA/G molecules is diverted to the vacuole by 
membrane traffic. Intact light chains also seem to be 
in part located in the vacuoles; whereas the extremely 
low proportion of intact heavy chains in the vacuolar 
fraction is most likely a slight contamination from 
another cellular compartment, because it is also de- 
tectable, at similar levels, at the end of the pulse- 
labeling and is not affected by brefeldin A treatment. 
Immunoelectron microscopy indicated that the 
steady-state level of recombinant protein present in 
vacuoles was not irrelevant. In sections of leaves 
from SIgA/G-expressing plants, gold-conjugated 
anti-y-chain (small particles) decorated large vacuo- 
lar aggregates, which were not detectable in wild- 
type plants (Fig. 3). These aggregates closely resem- 
ble protein body-like structures, which have been 
BFA: + 









Figure 3. SIgNG forms protein holy-lik "ry; 1: r''fSrt n ih v. u . l. 
Ultra-thin sections of transgenic lobar co Irý, rw .c xlný"in( "If; N( 
(lot) panel) were incubated with anti-S(' and anti-IF; . rntiboclir , (hut- 
Irrm panel). Detection was performed using secondary antibodies 
runjugated with 12 nm ((or SO and 0 nm (for I(; ) colloidal gold. 
Arrows indicate the vacuolar protein (x dy-like struriurr-c. (l ,( ihr 
ruflaut; ('W, cell wall; IS, intercellular spar o; V, vn ui lr . Barre I t, rn 
46 
observed when vacuolar proteins (seich as barley Ivc- 
30 tin and 
bean phaseolin) were expressed in leaf cell% 
(Dombrowski et at., 1993; Frigerio et at., 1998). The 
anti-SC antibody (large particles) decorated the same 
protein bodies as the anti-y chain. 
14.3 
Figure 2. A proportion of SIgMG is targeted to the vacuole and 
fragmented. Protoplasts from SIgA/G-expressing plants were pulse- 
labeled for 1h either in the presence (+) or in the absence (--) of 
brefeldin A and chased for the indicated periods of time. total cell 
homogenates (1) or purified vacuoles (V) were then subjected to 
immunoprecipitation with anti-IgG antiserum and analyzed by 1S% 
(w/v) reducing SI)S-PAGE and fluorography. Numbers at right indi- 
cate molecular mass markers in kD. 
Vacuolar Delivery Is Caused by Sequences in the 
IgA/G Tetramer 
The finding that a percentage of antibody in Ow 
SIgA/G plants is not secreted but rerouted to the 
vacuole, raises the question of whether this vacuolar 
targeting is the product of a positive signaling by the 
molecule, or rather represents an escape route for the 
plant endomembrane system when overloaded with 
foreign molecules. 
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Figure 4. Vacuolar targeting and slow c, c reiiort me inrlclu ndc nl of 
the assembly state of SIgA/G. Protoplasts from leaves of transgenic 
tobacco plants expressing lgA/G, dlgA/G, or SIgA/G were pulse- 
labeled for 1h and chased for the indicated periods of time. Cells and 
the corresponding incubation media were hornogenated, subjected 
to immunoprecipitation with anti-IgG antiserum, and analysed by 
6% (w/v) non-reducing SDS-PAGE and fluorography. Numbers at left 
indicate molecular mass markers in kD. 
We first determined whether vacuolar sorting 
could be caused by one or more components of the 
SIgA/G molecule, namely the SC or the J chain. 
Therefore we analyzed transgenic plants expressing 
either the sole IgA/G tetrameric unit (IgA/G) or the 
J-chain linked IgA/G dimer (dlgA/G) and compared 
the fate of these assembly intermediates to that of the 
whole SlgA/G molecule. We subjected protoplasts 
from leaves of the indicated transgenic plants to 
pulse-chase and immunoprecipitation with anti-IgG 
antiserum. We then analyzed the polypeptides by 
non-reducing, 6% (w/v) acrylamide SDS PAGE and 
fluorography (Fig. 4) to establish the level of assem- 
bly of the 19 molecules. In non-reducing conditions 
the vacuolar fragments originating from SIgA/G mi- 
grate in the 45- to 100-kD range (Fig. 4, lanes 14 and 
15). This indicates that the fragments are not fully 
unassembled or disassembled components of the Ig 
molecule. The observation that the majority of the 
polypeptides migrate under non-reducing conditions 
as tetrameric IgA/G units after 1h of pulse (Fig. 4, 
lane 13) indicates fast and efficient assembly of the 
tetramers. 
Clearly, we observed the presence of identical ma- 
jor fragmentation products in all cell types, including 
the ones expressing the tetrameric IgA/G unit only 
(Fig. 4, compare lanes 2 and 3,8 and 9,14 and 15). 
This indicates that delivery to the vacuole does not 
require the J chain or the SC. The ratio of intact to 
fragmented molecules was higher in SIgA/G- 
expressing plants (Fig. 4, lanes 13-18), indicating that 
either the fully assembled SIgA/G is more resistant 
to proteolysis in the vacuole or the SC and the J chain 
1486 
partially inhibit vacuolar delivery of IgA/G. l he 
IgA/G unit seemed to be partially degraded even 
after secretion in the incubation medium (Fig. 4, 
lanes 5 and 6). It has been reported that proteins 
secreted by tobacco protoplasts (Frigerio et al., 1998) 
and cultured cells (Matsuoka et al., 1995) may tin- 
dergo proteolysis. Again, secretion of SIgA/(; was 
slow and inefficient (Fig. 4, lanes 16--1$, and we Fig. 
1, lanes 7-9). A similar rate of secretion was observed 
for the "monomeric" form of the antibody both in 
IgA/G and dIgA/G plants. No secretion of the 
dimeric molecule was detected, because either the 
diners are unavailable for secretion tor unknown rea- 
Sons or the I chain is particularly sou t'ptihh to &'str, i- 
cellular prl)tei ly', Is v, heil not I)i iltt'ý h'd I)V Ili- `A 
Ihr Parent Ig(: Is Rapidly an, I IIIi. ivIII' ret -I 
The results shown so tar inilirate that, even in their 
simplest, tetrameric form, plant-made IgA/(:. are 
inefficiently secreted and in part delivered to the 
vacuole. Is intracellular retention due to domains in 
the IgA/G molecule or is it due to a more general 
problem, as the plant secretory system inust deal 
with the synthesis and assembly of complex, bulky 
molecules such as Igs? If the latter is true, we would 
expect the parent marine I9(; "molecule to undergo 
the same fate as its IgA/G derivative. Ins eed, the 
substitution of the native (y3 domain with (fv2 and 
CO domains from an IgA-set reting hvbritlonºa has 
no negative effect on the assembly and activity of the 
hybrid molecule (Ma et al., 1995,199$) and the sr- 
quence of assembly events is virtually identical 
IgG 
Cook wwdlun 




figure. S. I fw parent g(, it 1- ill, .-, rrI i rIiii IrlIII I'IUWpl. l%tti 
from leaves of transl; r"nil wh, i rý Fills vxpmaing thr" InunrirIun. rl 
Guy's 13 IRG wr"rt" pulse-labeled for I hand i'hasw) for the indir. iur) 
periods of time. Cells and the corresponding inrub, i(tort medi. r wore 
homogenized, suhjl'cle(1 to immunopnv ipitation with anti Ig(: arm 
scrum, and analyird by 6% (w/v) non-reducing S( )S- PA CI and flux 
rography. Nurnhers a1 right indiraU" rnolvt ul. tr rn, t.. In. lrkl'N In kl). 
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To test this, we isolated protoplasts from leaves of 
Guy's 13 IgG producing plants and followed the fate 
of the IgG molecule by pulse-chase (Fig. 5). We found 
that almost all the lgG synthesized during the pulse 
was recovered after 24 h of chase from the protoplast 
incubation medium. The secreted IgG was tetrameric 
and intact, and no intracellular degradation products 
were detectable (Fig. 5). Thus, secretion was nearly 
quantitative. Moreover, the rate of secretion was 
much faster than that of SIgA/G: About 70% of the 
molecules were secreted after 16 h. 
The difference in the fate of lgG compared to that 
of SIgA/G is also evident at steady state (Fig. 6). We 
detected the Ig molecules by immunofluorescence 
confocal laser scanning microscopy on fixed, perme- 
abilized Protoplasts from IgG or SIgA/G transgenic 
plants. The anti-lgG antiserum did not stain any 
structure in cells prepared from tin-transformed to- 
bacco (not shown). In the case of IgG-producing cells 
(Fig. 6, center panel), the steady-state amount of Ig 
detected in the secretory system represents only the 
newly synthesized molecules and the molecules en 
route to secretion, as testified by the relevant propor- 
tion of staining in proximity of the plasma mem- 
brane. This was confirmed by comparison with the 
distribution of the ER resident chaperone BiP (Fig. 6, 
left panel). Whereas the perinuclear and reticular 
structures were similarly stained, staining in proxim- 
ity of the plasma membrane was much less intense. It 
is also evident that the endomembrane system of 
SIgA/G producing plants is literally laden with an- 
tibody molecules (Fig. 6, right panel). The reticular 
structure is similar to the one detectable using anti- 
bodies against the BiP, but in the case of SIgA/G its 
appearance is more swollen and punctate structures, 
possibly representing vacuolar depositions, are often 
detectable as well. 
Vactiolar delivery could in theory result from en- 
docytosis of secreted molecules. However, the results 
shown in Figure 5 indicate that secreted IgGs are 
certainly not subjected to endocytosis to a relevant 
extent, ruling out unspecific uptake of protein from 
Plant Physiol. Vol. 123,2000 
Figure 6. I he bulk of SIgNG is retained in the 
c ndomenihmne system. Protoplasts from either 
I;; <, - or SIgNG-expressirig plants were fixed, 
Iu rmeabilired, and subjected to immunotluo- 
rosrence with primary rabbit anti-Ig(. serum or 
,i iti-BiP serum, followed by secondary 0uores- 
in isothiocyanate-conjugated goat anti-rabbit 
antibody. (ells were observed with a confocaI 
I, ruvr scanning microscope at 494-Firn excitation 
nil 522-nm emission wavelength. I or Ig( cells, 
I, isir intensity was 10%, gain 1,200; for SI1; N(1 
the medium. Moreover, when incubation during the 
chase was performed under agitation in a 10-told 
excess of incubation medium with respect to our 
standard protocol, there was no reduction in the 
efficiency of IgA/G fragmentation (Fig. 7). Therefore, 
most probably vacuolar IgA/G is not a traction of 
secreted molecules that have been endocytosed. 
µl labeling medium: 200 2000 







Figure 7. IgN(, fragmentation is riot din to endocytosis. I'rotOl, l, r, ts 
from plants expressing IgA/(, were pulse-labeled for 1h in tho 
indicated volumes of incubation medium and chased for the indi- 
cated periods of time. Cells were then homogenated and subjected to 
im munoprecipitation with anti-Ig(, antiserum, followed by 6% (w/v) 
non-reducing SI)S-PAG[ and fluorography. Numbers on the left 
indicate molecular mass markers in kI ). ( )nly the intact protein and 
the higher molecular mass fragments are shown. 
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Figure 8. IgA/G does riot associate tightly with membranes. Proto- 
plasts from plants expressing IgA/G were pulse-labeled for 1 It and 
homogenized in 12% (w/w) Suc buffer. Microsomes were prepared 
and resuspended in Suc buffer, in Suc buffer with 1M NaCl, or in 
0.1 M Na2CO31 and incubated on ice for 30 min. Microaomes were 
then reloaded on top of a 17% (w/w) Suc pad and centrifuged for 30 
min at 150,000g. Supernatants (S) and pellets (P) were homogenated, 
immunoprecipitated with anti-IgG antiserum, and analyzed by 6% 
(w/v) non-reducing SDS-PAGE and fluorography. total, Anti-IgG im- 
munoprecipitate from total cell homogenate. soluble, Anti-IgG im- 
munoprecipitate from the supernatant from the first microsome prep- 
aration, containing cytosolic and vacuolar proteins. 
Newly Synthesized IgA/G Is a Soluble Protein 
In mammalian cells, proteins that are anchored to 
the ER membrane follow the secretory pathway until 
they reach the plasma membrane, unless they have 
specific features that allow their ER retention or sort- 
ing to other membranes of the endomembrane sys- 
tem (Pedrazzini et al., 1996). The question of a default 
location for membrane proteins is still open for plant 
cells, and the tonoplast is a possible candidate (Bar- 
rieu and Chrispeels, 1999). In addition the newly 
synthesized precursor of the soluble vacuolar storage 
protein legumin is tightly associated to the lumenal 
side of ER/Golgi membranes and its membrane 
binding is unaffected by agents that usually release 
peripheral membrane proteins (Hinz et al., 1997). It 
has been suggested that high affinity to membranes 
may have a role in the vacuolar sorting of legumin 
and maybe other storage proteins (Saalbach et al., 
1991). We therefore verified whether newly synthe- 
sized IgA/G is tightly associated to the endomem- 
branes. Protoplasts from transgenic leaves were 
pulse-labeled for 1h and homogenated in the ab- 
sence of detergent and the presence of Suc. The ho- 
mogenate was fractionated into a microsomal and a 
soluble fraction. The latter contains cytosolic proteins 
and the content of vacuoles, which break during 
homogenation under these conditions. Consistently, 
newly synthesized IgA/G is mainly recovered in the 
microsomal fraction (Fig. 8, lanes I and 2). Micro- 
somes were then washed with Suc buffer as a control, 
with 1M sodium chloride in Suc buffer, or with 0.1 M 
1488 
sodium carbonate. Sodium carbonate releases soluble 
proteins present in the lumen of microsomes but not 
integral membrane proteins (Fujiki et al., 1982), 
whereas sodium chloride releases proteins peripher- 
ally attached to the cytosolic face of microsomes 
without affecting their lumenal content. As expected 
for a soluble lumenal protein that is not tightly 
bound to the membrane, IgA/G is released by so- 
dium carbonate but not by sodium chloride (Fig. 8, 
lanes 3-8). We conclude that tight association to the 
endomembranes cannot explain the vacuolar deliv- 
ery of IgA/G. 
DISCUSSION 
In this paper we show that secretion of SIgA/G 
proceeds at a very slow rate in tobacco leaf cells. 
Even 24 h after synthesis, the vast majority of mole- 
cules has not been secreted. Moreover, part of the 
protein is transported to the vacuole where it is de- 
tectable as fragmentation products. In contrast the 
parent IgG molecules are quantitatively secreted 
with a half-time of less than 16 h. This raises the 
problem of which are the mechanisms and recogni- 
tion events that lead to vacuolar delivery of a protein 
that is expected to be secreted. Besides the iniplica- 
tions for the production of IgA in plants, this can 
shed light on still unknown features of the plant 
secretory pathway which may have general rele- 
vance for both plant metabolism and the use of plants 
to produce heterologous secretory proteins. 
Slow and Inefficient Secretion 
Our experiments rule out the possibility that the I 
chain and the SC are responsible for the slow secre- 
tion and for vacuolar delivery of SlgA/G. Therefore, 
the modification of the heavy chain by deletion of the 
Cy3 domain and the addition of Ca2 and CO do- 
mains (Ma et al., 1994) is the structural characteristic 
that leads to the altered secretory phenotype. 
The rates of secretion from tobacco protoplasts of 
three bacterial proteins introduced into the secretory 
pathway have been compared previously (Denecke 
et al., 1990). Although the assay used to measure 
secretion was different from ours, the results pointed 
to a high degree of variability in secretion efficiency 
of heterologous proteins in plant cells. An inverse 
correlation was found in that cast- between secretory 
rate and size of the passenger protein, but the reasons 
for such variability remained unknown. 
Secretion rate and efficiency can certainly be deter- 
mined by ER quality control. This mechanism assists 
the folding and assembly of newly synthesized pro- 
teins, in most cases allows their traffic along the 
secretory pathway only upon correct completion of 
these maturation events and eventually targets de- 
fective polypeptides for degradation (Vitale and De- 
necke, 1999). Confocal microscopy suggested that a 
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large fraction of SigA/G is indeed present in the ER. 
Analysis of its oligomerization state by SDS-PAGE in 
non-reducing conditions showed that after 1-h pulse, 
there were no free heavy or light chains, most of the 
molecules assembled into tetrameric IgA/G units, 
and fully assembled SigA/G were already detectable. 
The proportion of assembled SigA/G increased 
markedly after 16 h of chase, to represent more than 
60% of the total immunoprecipitable polypeptides. 
This indicates that the rate and efficiency of het- 
erotetramer formation are high, comparable to those 
of the bean homotrimeric protein phaseolin ex- 
pressed in tobacco leaves (Frigerio et al., 1998), and 
that inefficient assembly is unlikely to be the cause of 
ER retention of IgA/G. 
- In mammalian cells, exposed Cys residues in the C-terminal region of the heavy chains of IgA and 
secretory IgM are recognized by ER quality control; 
as a result, in B lymphocytes tetramers are retained in 
this compartment (Sitia et al., 1990; Guenzi et al., 
1994). The efficiency of this retention is both depen- 
dent on the stage of B cell development and the 
amino acid context surrounding the Cys. In plasma 
cells, IgA but not IgM are secreted, albeit slowly, and 
the different behavior of the two Igs is due to the 
presence of an extra acidic residue upstream of 
the Cys in IgA but not IgM (Guenzi et al., 1994). On 
the other hand, mutation of the critical Cys results in 
very efficient secretion of IgM monomers (Sitia et al., 
1990). Thus, in mammalian cells thiol-mediated re- 
tention is responsible for the decreasing rates of se- 
cretion of IgG, IgA, and secretory IgM tetramers, 
respectively. Our observation that in tobacco the par- 
ent IgG tetramers, which do not have free cysteines, 
are secreted with high efficiency is consistent with 
the possibility that thiol-mediated retention also oc- 
curs in the plant ER. This hypothesis can be tested by 
mutagenesis or in vivo treatment with reducing 
agents. 
We cannot rule out the alternative possibility that, 
in spite of correct assembly and independently of the 
exposed Cys residues, some of the tetramers or 
decamers have conformational defects that lead to 
their prolonged ER retention and eventual slow deg- 
radation. The IgA/G heavy chain is not a naturally 
synthesized molecule-it contains a mixture of 
and a-chain domains, as well as an extra Cat do- 
main. Although this might affect the dimerization of 
heavy chains, it seems unlikely that this modification 
would affect assembly with Ig light chain, or even j 
chain and SC. However, we have no experience of 
how addition of an extra Cat domain in the heavy 
chain might affect interactions with chaperones or 
recognition by quality control mechanisms in the ER. 
Delivery to the Vacuole 
Fragmentation of a proportion of the IgA/G 
(monomer, dimer, or secretory) molecules occurs ei- 
Plant PhysioL Vol. 123,2000 
ther soon before or upon delivery to the vacuole: 
Fragments are detected in vacuoles. This vacuolar 
delivery is inhibited by brefeldin A, indicating active 
vesicular transport out of the ER along the secretory 
pathway. 
Plant cells, like mammalian cells, have a default 
route that delivers out of the cell proteins that are 
inserted into the ER (Denecke et at., 1990). To be 
delivered to the vacuole, soluble proteins need sort- 
ing signals; when these signals are deleted, the mu- 
tated proteins are secreted, albeit with variable effi- 
ciencies (Bednarek et al., 1990; Crofts et al., 1999). 
Although one potential receptor for vacuolar sorting 
has been identified, the mechanisms for vacuolar 
delivery are not yet fully clarified, and certainly more 
than one mechanism exists (Vitale and Raikhel, 1999). 
It has been hypothesized that aggregation and high 
affinity to membranes can be the mechanism that 
sorts some storage proteins to vacuoles (Saalbach et 
al., 1991; Vitale and Raikhel, 1999). However we were 
unable to demonstrate tight binding of IgA/G to 
endomembranes. Endocytosis followed by vacuolar 
delivery also seems an unlikely possibility in the 
light of our results. 
We are not aware of previous reports of vacuolar 
delivery of a protein expected to be secreted in plant 
cells, but other proteins that do not reside in the 
vacuole in their natural cells are in part delivered to 
vacuoles when expressed in transgenic plants. These 
are the maize zeins, which in maize accumulate as 
ER-located protein bodies but are partially found in 
vacuoles in transgenic tobacco (Coleman et al., 1996). 
The recognition events that lead to this mis- 
localization have not been established, but autoph- 
agy has been proposed as a possible explanation 
(Coleman et al., 1996). It is not known whether this 
process can be inhibited by brefeldin A. 
In mammalian cells, prolonged ER retention of un- 
polymerized IgA and IgM tetramers or certain unas- 
sembled mutant light chains can result in quality 
control degradation. Degradation of unassembled 
light chains, IgM and J chains is sensitive to protea- 
some inhibitors, strongly suggesting that it occurs 
upon dislocation of the polypeptides from the ER 
into the cytosol (Chillaron and Haas, 2000; Mancini et 
al., 2000; C. Fagioli and R. Sitia, personal communi- 
cation), a fate similar to the one of several other 
mammalian and yeast proteins subjected to ER asso- 
ciated degradation (Brodsky and McCracken, 1999). 
Therefore, if quality control is responsible for the 
fragmentation of IgA/G in tobacco, the subcellular 
location of the hydrolytic activity is different with 
respect to the one identified in mammalian cells. In 
yeast cells, it has been shown that defective proteins 
can be delivered for degradation to the vacuole 
through the Golgi complex (Hong et al., 1996); again 
the recognition mechanism is not dear but this has 
been suggested to be a quality control disposal route 
alternative to retrotranslocation from the ER in the 
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cytosol, which conversely does not involve vesicular 
traffic. Such a Golgi-mediated route may be active 
also in plant cells and take care of the degradation of 
a proportion of antibody molecules with exposed Cys 
residues or defects that could be not be detected by 
our assays. 
The polypeptides targeted to the vacuole and frag- 
mented are, at least in part, assembled, although we 
have not yet determined their exact assembly status. 
In the light of the analysis of the oligomerization 
state after pulse-labeling, the most reasonable hy- 
pothesis is that the major Ig form delivered to the 
vacuole is the tetrameric unit. A proportion of these 
units would be delivered to the vacuole after pro- 
longed ER retention. The colocalization of the heavy 
chain and the SC in the same vacuolar aggregates, 
detectable by immunoelectron microscopy, does not 
necessarily imply that the two molecules are part of 
the same assembled antibody: when two noninteract- 
ing vacuolar proteins were co-expressed in trans- 
genic plants they colocalized in vacuolar aggregates 
as well (Schroeder et al., 1993). The proportion of SC 
found in the vacuole could in this case be delivered 
to this compartment in different forms: associated to 
intermediates of assembly or as individual, unas- 
sembled molecules, whereas fully assembled SIgA/G 
would be secreted. 
An alternative hypothesis with respect to quality 
control delivery to the vacuole could be that satura- 
tion of secretion, due to high levels of Ig synthesis, 
leads to delivery of the excess of protein to the vac- 
uole, independently of the presence of the J chain and 
SC. We do not favor this hypothesis, because of the 
behavior of IgG and of the much higher proportion of 
fragmented IgA/G molecules generated in the ab- 
sence of the J chain and the SC, but it cannot be 
conclusively ruled out. The opposite is certainly true: 
Overexpression of vacuolar proteins leads to their 
partial Golgi-mediated secretion (Frigerio et al., 
1998). Vacuolar delivery upon high expression 
would imply that secretion from plant cells is a sat- 
urable process. Such a scenario would be against the 
current model that secretion is the default route for 
proteins inserted into the secretory pathway. There is 
very solid evidence that a default route to secretion 
exists, but several observations suggest that active 
selection of cargo proteins destined for secretion may 
also occur (Vitale and Denecke, 1999). The two mech- 
anisms, default and active selection, might co-exist, 
the latter being saturable and its saturation leading to 
vacuolar delivery as an alternative route. This hy- 
pothesis can be tested by co-expressing with SIgA/G 
a protein known to be secreted by plant cells with 
high efficiency. 
Finally, irrespective of the quality control or satu- 
ration hypothesis, our observation that vacuolar frag- 
mentation is higher in the absence of the SC, also 
when the J chain that allows dimerization is synthe- 
sized, indicates an active role for the SC in promoting 
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secretion and/or protecting from degradation in the 
vacuole. We believe this is important. It should be 
remembered that in the natural organism where SlgA 
are produced, addition of the SC is an extracellular 
event. Clearly, this component is also able to alter the 
destiny of Ig molecules within the plant endomem- 
brane system. 
Localization and Stability 
SIgA/G and the parent IgG accumulate in tobacco 
leaves to 5% to 8% and 1% of total soluble proteins, 
respectively (Ma et al., 1994,1995). What is the reason 
of this difference? We originally hypothesized that 
the SC might protect SIgA/G from degradation in the 
apoplast (Ma et al, 1995). The results presented here 
suggest other possible explanations. 
Certainly, a proportion of S1gA/G is present in the 
ER and in the vacuole. The ER has been shown to be 
a very safe compartment for recombinant secretory 
proteins expressed in transgenic plants: when pro- 
teins were retained in the ER via the addition of the 
KDEL signal they showed markedly increased stabil- 
ity (Wandeltet al., 1992; Pueyo et al., 1995; Tabe et al., 
1995; Conrad and Fiedler, 1998). ER retention of 
SIgA/G is certainly not due to the presence of a 
known ER retention signal, and might instead be due 
to quality control, which in this case could favor 
stability. In transgenic tobacco, a mutated phaseolin 
form, that is unable to assemble and is much more 
susceptible to in vitro proteolysis than wild-type 
phaseolin, is subjected to prolonged retention In the 
ER by quality control and accumulates to levels com- 
parable to the wild type counterpart (Pedrazzini et 
al., 1997). 
It is also possible that part of the SIgA/G fragments 
present in the vacuole retain their activity, although 
most probably complete degradation of Ig occurs 
therein to some extent. In this respect, solving the 
problem that leads to partial vacuolar delivery of 
SIgA will not only increase our knowledge on the 
recognition events in the plant secretory pathway but 
also have practical implications for the efficient pro- 
duction of active SIgA. 
MATERIALS AND METHODS 
In Vivo Labeling of Protoplasts and Analysis of Igs 
The generation of transgenic tobacco (Nicotiana tabacum) 
plants expressing the monoclonal Guy's 13 IgG and the 
derivative, hybrid SIgA/G antibody has been described 
(Ma et al., 1994,1995). Protoplasts were purified from 
leaves of transgenic plants expressing Guy's 13 IgG, 
IgA/G, dIgA/G, or SIgA/G as described (Pedrazzini et al., 
1994). Pulse-chase labeling of protoplasts using a mixture 
of [35S]Met and ['SS]Cys (Pro-Mix, Amersham l'harmacia 
Biotech, Little Chalfont, UK), cell homogenization and im- 
munoprecipitation were performed as described previ- 
ously (Pedrazzini et al, 1997). Treatment with brefeldin A 
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was performed by pre-incubating protoplasts for 45 min in 
the presence of 10 µg mL-1 brefeldin A (Boehringer Mann- 
heim, Mannheim, Germany; stock solution 2 mg mL-1 in 
ethanol; a corresponding amount of ethanol was added to 
control protoplasts) and maintaining the same concentra- 
tion of the drug for the entire pulse-chase labeling. Immu- 
noprecipitated polypeptides were resolved onto 15% re- 
ducing or 6% (w/v) non-reducing SDS-PAGE. Gels were 
treated with 2,5-diphenyloxazole dissolved in dimethyl 
sulfoxide and radioactive proteins visualized by fluorog- 
raphy. Vacuolar purification was performed as described 
(Dombrowski et al., 1994). The recovery of vacuoles was 
around 30% based on et-mannosidase activity; this vacuolar 
fraction contained much less than 1% of the total cellular 
amount of the ER resident chaperone BiP, strongly suggest- 
ing very low contamination by other compartments of the 
secretory pathway (not shown). 
For the isolation of microsomes, protoplasts were pulse- 
labeled for 1h and precipitated by adding 3 volumes of W5 
medium (154 mm NaCl, 5 mss KCI, 125 mm CaCl22H20, 
and 5 mm Glc). Cells were resuspended in Suc buffer (100 
mm Trig Its'is(hydroxymethyl)aminomethane]-HCI, pH 7.5, 
10 mm KC1,1 mm EDTA, and 12% [w/w] Suc) and lysed on 
ice by sonication. The homogenate was centrifuged for 5 
min at 1,000g to remove debris and intact cells. The super- 
natant was loaded on top of a 17% (w/w) Suc pad and 
centrifuged for 30 min at 150,000g in a TLA100 rotor (Beck- 
man Instruments, Fullerton, CA), 4°C. The supernatant 
(containing cytosolic and vacuolar proteins) was removed 
and the microsomal pellet was resuspended in Suc buffer, 
in Suc buffer containing 1M NaCl, or in 0.1 M Na2COa 
After 30 min of incubation on ice, the microsome suspen- 
sions were reloaded on top of a 17% (w/w) Suc pad and 
centrifuged for 30 min at 150,000g. Supernatants and pel- 
lets were homogenated in (final) 100 mat Tris-Cl, 100 mm 
NaCI, 1 mm EDTA, and 1% (v/v) Triton X-100, pH 7.5, 
supplemented with protease inhibitor cocktail (Complete, 
Boehringer Mannheim). Igs were immunoprecipitated with 
anti-19G antiserum and analyzed by 6% (w/v) non- 
reducing SDS. PAGE and fluorography. 
Lnmunoelectron Microscopy 
Leaf specimens were taken from transgenic tobacco 
plants expressing SIgA/G grown in standard greenhouse 
conditions for 2 months. For ultrastructural analysis, leaf 
strips were first fixed with 4% (w/v) paraformaldehyde, 
1% (w/v) glutaraldehyde in 100 mat phosphate buffer, pH 
7.4, containing 5% (w/v) Suc. After rinsing in the same 
buffer the leaf strips were fixed again in 1% (w/v) osmium 
tetraoxide in buffer. Leaf strips were washed and dehy- 
drated through an ethanol series, and embedded in Spurr's 
resin- Ultrathin sections of 75 nm were stained with 2% 
(w/v) uranyl acetate and 0.1% (w/v) lead citrate. For ultra- 
structure immunocytochemistry, leaf strips were fixed with 
4% (w/v) paraformaldehyde and 1% (w/v) glutaldehyde. After rinsing and dehydration, the leaf specimens were 
embedded in LR White resin as described (Robinson et al., 
1994) except all the infiltration steps were done at room 
Plant Physiol. VoL 123,2000 
temperature and the resin was polymerized at 52°C. Ultra- 
thin sections (silver and gold in color) were collected onto 
formvar-coated nickel grids, dried in air, and used in 
double-antibody labeling. Grids were wetted in double- 
distilled water and etched with saturated sodium periodate 
for 30 min to unmask excessive fixation. After rinsing in 
double distilled water, the grids were blocked with 1.5% 
(w/v) chicken egg albumin in phosphate buffered saline 
(PBS: 150 mm NaCl and 10 mm potassium phosphate, pH 
7.4) for 30 min. After blocking, grids were incubated with 
sheep anti-rabbit secretory antibody diluted in chicken egg 
albumin containing blocking buffer for 1 h. This first pri- 
mary antibody was rinsed away by floating the grids in 
PBS for 15 min. After blocking in the block buffer for 15 
min, the grids were incubated with a second primary an- 
tibody, affinity-purified rabbit anti-mouse Ig (lgG + IgA + 
IgM, heavy and light chain; Zymed, Carlton Court, CA) 
diluted in the blocking buffer for I h. The grids were 
floated in PBS for 15 min to wash away the second primary 
antibody and blocked with 5% (v/v) normal donkey serum 
diluted in PBS for 30 min. Grids were then incubated with 
gold (12 nm)-conjugated donkey anti-sheep Ig antibody 
Qackson ImmunoResearch Lab, West Grove, PA) and gold 
(6 nm)-conjugated donkey anti-rabbit Jg antibody diluted 
in PBS containing 5% (v/v) normal donkey serum for I h. 
Grids were rinsed in PBS, then in double-distilled water 
and air-dried. Sections were post-stained in 2% (w/v) ura- 
nyl acetate. Electron micrographs were taken with an elec- 
tron microscope (H-600, Hitachi, Tokyo). 
Immunofluorescence Microscopy 
After purification, protoplasts from either IgG or SIgA/ 
G-expressing plants were resuspended in MaCa buffer (0.5 
bt mannitol, 20 mat CaC12, and 0.1% [w/vJ MES, pH 5.7) at 
a concentration of 5X 105 cells mL-i. Three hundred 
microliters of cell suspension was spread onto poly-Lys- 
coated slides (Sigma, St. Louis) and cells were allowed to 
adhere for 30 min at room temperature. Cells were fixed for 
30 min at room temperature in MaCa buffer containing 4% 
(w/v) paraformaldehyde. Cells were then permeabilized 
by washing three times with TSW buffer (10 mimt Tris-HCI, 
pH 7.4,0.9% [w/v] NaCl, 0.25% [w/v] gelatin, 0.02% [w/v J 
SDS, and 0.1% [v/vJ Triton X-100) for 10 min at room 
temperature. Incubation with rabbit anti-lgG antiserum 
(Sigma, dilution 1: 300) or anti-BiP antiserum (I'edrazzini et 
al, 1997; dilution 1: 1,000) was in the same buffer for 1h at 
room temperature. After three washes in TSW, cells were 
incubated for 1h at room temperature with fluorescein 
isothiocyanate-conjugated goat anti-rabbit secondary anti- 
body (Sigma) at a dilution of 1: 200. After three final washes 
in TSW, cells were mounted in Mowiol (Calbiochem, San 
Diego) supplemented with 2.5% (w/v) DABCO (Sigma) as 
an antifade agent. Cells were visualized with a Bio-Rad 
MRC1024 confocal laser scanning microscope equipped 
with a 40X oil immersion objective, at 494 nm excitation 
and 520 nm emission. Thickness of the optical sections was 
2 µm. Laser intensity and gain controls were used as indi- 
cated in the legend to Figure 6. 
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Abstract 
Previous studies have shown that the production of recombinant antibodies in plants is highly efficient and presents 
numerous therapeutic applications. It is, however, known that plant glycoproteins display different glycosylation 
patterns to those exhibited by mammalian glycoproteins. Thus, it is important to know if these plant recombinant 
antibodies could induce undesirable immune responses in mammals; and to date no report has documented the 
potential immunogenicity of parenterally administered plant recombinant antibodies in animals. In order to answer 
this question, mice were immunised subcutaneously with a recombinant mouse monoclonal antibody produced in 
tobacco plants, together with alum as adjuvant. Two control groups were immunised in the same way with either 
the original murine monoclonal antibody or horseradish peroxidase (a plant glycoprotein). Analyses by direct 
immunoassay, competition immunoassay and real-time surface plasmon resonance, showed undetectable levels of 
antibody directed against both the protein and the glycan part of the plant recombinant antibody. These results have 
a direct relevance for the application of plant recombinant proteins as therapeutic agents and vaccines in humans. 
Introduction 
The expression of recombinant antibodies in plants 
was first described a decade ago (Hiatt et al., 1989). 
There are several advantages in the use of plants for 
the production of recombinant proteins such as an- 
tibodies, for example, plant cells can express, fold, 
assemble and glycosylate full-length antibodies ex- 
tremely efficiently (Ma & Hein, 1996; Ma et al., 
1994; Hiatt & Ma, 1993), yielding functional recom- 
binant antibody levels of 1-8% of total soluble leaf 
protein. For applications such as passive immuno- 
therapy (Ma et al., 1998) where large quantities of 
antibody would be required, the potential for scaling 
up production to agricultural levels is also particularly 
attractive. 
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For optimal expression in plants, the recombinant 
immunoglobulin chains are targeted to the plant en- 
doplasmic reticulum and the secretory pathway where 
folding and assembly takes place as well as glycosyla- 
tion. In common with other heterologous expression 
systems, plant glycosylation differs from that found in 
the native cell. Although high mannose type glycans 
are identical in plants and animals, there are differ- 
ences between the complex glycans (Driouich et al., 
1993). For example, plants (like insects and yeast) do 
not incorporate sialic acid, in addition, the complex 
glycans are characterised by aß1 -+ 2 xylose residue 
linked to the ß-mannose and at -3 fucose residue 
linked to the proximal glucosamine (Lerouge et al., 
1998). 
Recently, the N-glycan composition of a mur- 
ine monoclonal IgG l (Guy's 13) was determined 
and compared with the N-glycan structures associ- 
ated with the same monoclonal antibody expressed in 
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plants (Cabanes-Macheteau et al., 1999). The same 
N-glycosylation sites were utilised in both expres- 
sion systems, however, there was a greater diversity 
of glycoforms in the plant-derived antibody than the 
mouse-derived version. Compared with four different 
complex type oligosaccharide structures on the mouse 
Mab, there were eight different oligosaccharides on 
the plant Mab, with structurally related oligosacchar- 
ides ranging from high-mannose type (40%) to mod- 
ified glycans (60%). Some similarities were found 
between the complex type N-glycans from both ex- 
pression systems, such as the common Man GIcNAc2 
cores substituted by terminal G1cNAc residues. How- 
ever, the plant glycans also contained the character- 
istic terminal l1 -> 2 xylose and al -+ 3 fucose 
residues that have been identified previously in plant 
glycoproteins. 
It has been suggested that plant specific complex 
glycan structures may be highly immunogenic, which 
could be a limitation to the use of plants as a recom- 
binant protein expression system for pharmaceutical 
production for humans (Faye et al., 1993; Driouich 
et aL, 1993). Indeed, immunisation of rabbits with 
ß-fructosidase, horseradish peroxidase, peanut per- 
oxidase, or plant lectins (e. g. Wistaria floribunda) 
induced antibody responses that were specific against 
the two glycan motifs - al -s 3 fucose and 01 --º 2 
xylose (Faye et al., 1993; Wilson et al., 1998; Wan 
& van Huystee, 1994; Ramirez-Soto & Poretz, 199 1). 
Furthermore, it has been possible to affinity-purify an- 
tibodies for each specificity (Faye et al., 1993). So 
far, however, these studies have been limited to study- 
ing the immunogenicity of plant glycoproteins, and 
it has not been established that plant glycans remain 
immunogenic when presented in the context of mam- 
malian or self-proteins. For example, carbohydrates in 
themselves are generally poor immunogens due to the 
absence of T-cell epitopes (Seppala & Makela, 1997). 
In a human clinical trial in which a modified ver- 
sion of the mouse Guy's 13 Mab expressed in plants 
was administered on six occasions, no anti-plant an- 
tibody response was detected (Ma et al., 1998). In 
this study, however, the antibody was delivered top- 
ically in the oral cavity and the results would not 
necessarily reflect the response if the antibody was de- 
livered systemically. If recombinant plant antibodies 
are to be used in systemic applications, it would be 
important to determine the potential immunogenicity 
of plant glycans. The purpose of this study was to 
investigate the immunogenicity of a plant recombin- 
ant monoclonal murine IgG antibody in mice when 
administered parenterally. To increase the likelihood 
of generating an immune response, the immunisa- 
tions were carried out with alum as an adjuvant. 
Groups of animals were immunised. either with the 
mouse derived Guy's 13 IgG tic monoclonal antibody, 
the same Guy's 13 antibody produced in transgenic 
plants and bearing plant specific glycans, a standard 
plant glycoprotein (horseradish peroxidase) or phos- 
phate buffered saline; and specific antibody responses 
in each animal were determined by ELISAs and 
biosensor. 
Materials and methods 
Monoclonal antibodies and antlsera 
Mouse monoclonal antibody (Mab) Guy's 13 (igG 1 ic) 
is specific for Streptococcus mutans surface antigen 
1/11 (Lehner et al., 1985). The murine derived anti- 
body was purified from ascitic fluid by protein A 
affinity chromatography (Biogenesis, Poole, UK). 
Gene constructs encoding the light (K) and heavy 
(yt) chains for Mab Guy's 13, their expression and 
co-assembly to form functional antibody in tobacco 
plants (plant rlgGlic) have been previously described 
(Ma et al., 1994). Rabbit anti-plant lectin (Canavalla 
ensiiformis and Riclnus communis) immune-sera were 
obtained from Sigma (Poole, UK). Rabbit immune. 
sera specific for horseradish peroxidase (ZIRP) were 
kindly provided by Dr Lois Faye (Institute for Peptido 
Research, CNRS, University of Rouen, France). 
Purification ofplanl recombinant IgGI is 
For purification of plant rlgülu, tobacco plant 
leaves were homogenised on ice with extraction 
buffer (37.5mM Tris-IICI pI 17.3,50 MM NaCl. 
15 mM EDTA, 75mM sodium citrate, 3% poly- 
vinylpolypyrrolidone, 0.2% sodium t iosulftte and 
10 gg/m1 leupeptin). The suspension was filtered 
through a cheesecloth and its pl I reduced to S. 1 by ad- 
dition of 8M acetate-NaOl l butler pI13.8. The solu- 
tion was centrifugedat 17,000g for20 min at 4°C. The 
p1I of the solution was brought back to 7.0 by addition 
of 1.5 M Tris-IHCI p! I 9.5, and ammonium sulphate 
was added to 16% saturation. After centrifugation at 
17,000g for 20 min at 4°C, the precipitate was dis. 
carded, ammonium sulphate was added to the super. 
natant to 40% saturation. After at least 2h at 4°C, the 
solution was centrifuged again, the pellet was resus- 
pended in PBS to 1/3 of original volume, and the final 
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solution was then centrifuged at 25,000 g for 30 min 
at 4°C. The protein solution was concentrated by 
ultrafiltration through a 30 kDa molecular weight cut- 
off membrane (Amicon, UK) and dialysed overnight 
at 4°C against PBS. The concentrated extract was 
then filtered through a 0.45µm filter and loaded onto 
a HiTrap Protein G column (Pharmacia, Uppsala, 
Sweden). The rIgGIu was eluted with 0.1 M glycine- 
HCI pH 2.7 and neutralised with 1.5 M Tris-HCL pH 
9.5. The preparation was then loaded onto a sheep 
anti-mouse IgGi sepharose column (Sigma), eluted 
with glycine-HC10.1 M pH 2.5, neutralised with 1.5 M 
Tris-HC1 pH 9.5, dialysed overnight against PBS and 
passed through a 0.22 µm filter. Finally, the protein 
concentration was estimated by measuring the absorb- 
ance at 280nm (A2e0 = 1.0 for IgG concentration of 
1.4 mg/ml) and the purity of the preparation assessed 
by SDS-PAGE. 
SDS-PAGE 
For SDS-PAGE analyses, the purified plant rlgG 1K 
samples were boiled for 3 min in 75 mM Tris-HCI (pH 
6.8) containing 2% SDS and 5% 2-mercaptoethanol, 
separated on a 10% acrylamide gel and proteins were 
stained with Coomassie blue. 
Animals and immunisation schedules 
Inbred 6-7 week-old female BALB/c (l1-2d) mice 
were purchased from Charles Rivers, UK. Previous 
studies, had determined that a subcutaneous (s. c. ) in- 
jection of 25-30µg of antigen in alum or IFA (incom- 
plete Freund's adjuvant) followed by two boosts, were 
optimal to obtain >3 Logio of high affinity IgG titre, 
4-5 weeks after the last injection (Chargelegue et al., 
1998; Obeid et al., 1996; Hsu et al., 1999). Thus in 
this investigation, a similar schedule was adopted: four 
groups of six mice were immunised s. c. at the base 
of the tail, with either PBS, 30µg of mouse IgGl ic, 
plant rIgG 1 u, or affinity purified HRP (Sigma, UK) in 
50% alum suspension (Alu-Gel-S, Serva, Boehringer 
Ingelheim, Germany). The mice were boosted twice at 
3 and 9 weeks, with the same dose of immunogen in 
alum and the final bleeds were collected 4-5 weeks 
after the last boost. Pre-immune sera were used as 
negative control samples in all the analyses. 
Biosensor analyses 
Biosensor analyses were done using the BlAcore X 
system (BlAcore AB, Sweden). Approximately 1000 
resonance units (RU) of IgG 1 u, plant rlgG 1 is or II RP 
were immobilised on a CM5 sensorship (BlAcore) us- 
ing a NHSIEDC (N-hydroxysucciniinide/N-ethyl-N'- 
(dimethylaminopropyl) carbodiimide) chemistry (BI- 
Acore). The binding kinetics of mouse and rabbit 
immune-sera were measured at a dilution of 1/5 in 
HBS-tween 0.005% (BIAcore). After each binding 
measurement, the chip was regenerated with 0.1 M 
HCI-glycine p112.0. 
Enzyme Immunoassays 
Maxisorp 96-well microplates (Nunc, Roskilde, Den. 
mark) were coated with 50 µ1 of IgG I K, plant rlgG 1u 
or HRP at 5 µg/ml in PBS pIl 7.4, overnight at 
4°C, washed with water and blocked with 200 tl/well 
of PBS-BSA 2.5% for 2h at 37°C. After wash- 
ing, the plates were incubated with two-fold dilution 
(from 1/20 onwards) of mouse sera or rabbit im- 
mune sera in PBS-Tween 20 (0.1%) BSA (2.5%) 
(diluting buffer) for 2h at 37°C and washed. Plates 
were incubated with appropriate antisera: sheep anti. 
mouse IgG (The Binding Site, Birmingham, UK), 
sheep anti-mouse IgG2a + IgG2b + IgG3 (The Bind. 
ing Site), goat anti-mouse Ig lambda chain (Caltag, 
Burlingame, CA) or sheep anti-rabbit IgG (Boehringer 
Mannheim, Lewes, UK), in diluting buffer, for 1h 
at 37°C. These secondary antibodies were either con- 
jugated with IIRP or alkaline phosphatase (AP). For 
HRP-conjugates, enzyme activity was detected by 
addition of 100µl of substrate solution (0.01% of 
3,3', 5,5'-tctramethylbcnzidine and 0.004% hydrogen 
peroxide in citrate-phosphate buffer, p1I 5.0). After 
10 min at room temperature the enzymatic reaction 
was stopped with 50 µl of 2M 112SO4 and the OD 
was determined at 450mn. For AP-conjugates, en. 
zyme activity was detected by addition of 100µl of 
substrate solution (0.1% p-nitrophenylphosphate in 
Tris-IICI Buffer p119.5 containing 5 mM MgCI2). The 
reaction was stopped with 50 µ1 NaOll 10 M after at 
least 30 min incubation at room temperature and the 
plates were read at 405 nm. 
For the competition ELISAs (Chargeleguo et al., 
1998; Steward and Chargelegue, 1997), 50ItI of serial 
dilution of mouse sera and 50µl of anti-l IRP or anti- 
plant lectins rabbit immune-sera (at a predetermined 
optimal working dilution to give a final OD of 0.8- 
1.0) were incubated overnight at 4°C with IIRP or 
plant rlgGlic coated plates. After washing, bound 
rabbit antibodies were reacted with anti-rabbit AP 









Figure / SDS-PAGE' oft he punfied recombinant plant IgG Ik. Two 
loading amounts of protein are shown. Lane I: 1ouItg: Lane 2: 
20 µ. g, 
37°C. The plates were developed and read as de- 
scribed above. The inhibition titre was expressed 
as the loge) of the reciprocal highest dilution of 
mouse sera giving a 25010 inhibition of the rabbit 
antiserum. 
Results 
Purification o1plant rlgGl k (Gu}'s" 13) 
Recombinant IgOIk was purified from mature tobacco 
plants by ammonium sulphate precipitation and a suc- 
cession of affinity chmmatographies (protein (i and 
anti-1961 columns). The yield of antibody was corn- 
prised between I and 2.5 mg/kg of fresh plant leaves. 
On SDS-PAGF? analysis (Figure 1). the purified anti- 
body consisted of two major hands (heavy and light 
chains). Four other bands of very low intensity were 
observed as well, which were degradation products of 
heavy or/and light chains as confirmed by western-blot 
analyses (data not shown). 
Antibody responses to lgGlic, Plant rlgGl k and IIRI' 
111 'nil e 
To assess the potential immunogenicity of plant 
rlgGIK, groups of six BALI/c mice were immunised 
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Figure 3. Time course of antibody titres (togio) to HRP, IgG 1K and 
plant rIgGIK in inununised mice. The arrows represent first, second 
and third immunisation at weeks 0,3 and 9, respectively. Mean 4 
standard deviation are shown for six mice per group. 
immunised with HRP had IgGs, IgG(2a + 2b + 3) and 
lambda Iogto titres of 3.31 (10.51), 3.11 (10.26) 
and 2.91 (± 0.49) respectively (Figure 2A). All the 
other groups had undetectable antibody titres to IIRP 
(detection limit: logio titre <1.60). 
For the detection of antibody responses to IgG1K 
and to plant rIgGlic, only secondary antibodies spe- 
cific for IgG(2a+2b+3) and lambda light chain 
could be used. There were no detectable antibody re- 
sponses to IgG1u in any of the immunised groups of 
animals (Figure 2B). Similar patterns were observed 
for reactivity to plant rIgGIic (Figure 2C), but two of 
the six animals that were immunised with plant rIgG 1 is 
had very weak antibody titres that were just above 
the limit of detection of the assay (IgG(2a + 2b + 3): 
1-82±0.25; lambda: 1.70 f 0.15). 
The time course of the antibody responses to IIRP, 
IgGIK and plant rIgGlu was also assessed over 15 
weeks (Figure 3). This analysis showed that the anti- 
body titre to HRP rose from weeks 0 to 9, and reached 
a plateau between weeks 9 and 15. Responses in the 
plant rIgG 1K group were seen after the second immun- 
isation in only two out of six animals. Antibody levels 
were very low throughout and were only just above the 
limits of detection for this assay. 
The second part of the analysis was obtained by 
biosensor studies. This method allows measurement 
of real-time interaction between analyte and ligand 
without the use of secondary conjugates. Therefore, 
it should be possible to detect a total Ig (immun- 
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Figure 4. Antibody reactivities of sera fnxn mice immuniaod with 
either MRP, IgGIK, Ptant rlgOlK or saline by surface plawnon ms- 
onai e. Seneorgrama for reactivity to l IRP (A), Igß 1u (B) and Plant 
rlgGlu (C) are shown. 
rlgGlic which could not be done by ELISA. Each 
curie in Figures 4A, 413 and 4C shows binding of 
pooled sera from each group to 1lRP, lgG I ic, and plant 
rlgGlu, respectively. Experiments were also done on 
individual sera, and similar results were obtained (data 
not shown). As shown in Figure 4A, only sera from 
IiRP immunised mice reacted significantly with IIRP; 
295 resonance units (RU) of binding for sera diluted 
at 1/5. No binding to IIRP was observed for sera 
(at 1/5 dilution) from animals immunised with plant 
rlgG l is or saline (Figure 4A). There was no significant 
reactivity to IgG lu in any of the groups immunised 
with saline, IgG 1u or plant rlgG IK (Figure 413). Fig. 
ure 4C represents the binding curves to plant rlgOIK. 
No significant reactivity was observed in all groups 
immunised with IIRP, plant rIgGlic, IgGlic or with 
saline. 
"{4IIU 1i !1 1S IS 
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TaUe 1. HRP and plant lectins rabbit immune-sera reactivity to IgGlic, plant rlgGik and HRP: competition with sera from mice immunised 
with HRP and plant rIgG IK 
Rabbit immune-sera Reactivity to IgG 1u Reactivity to plant Competition with sera Reactivity to HRP Competition with Fers 
IgO LoB10 titre rlgGlic from mice immunised IgG Logto titro from mice immunised 
IgO Loglo titre with plant rlgGlic with ZIRP 
Rabbit anti-ERP < 1.60 3.71 < 0.70b 5.63 2.10: E(0.23)* 
Rabbit anti-lectin 1 <1.60 3.61 <0.7&' 4.91 <0.70b 
Rabbit anti-lectin 2 <1.60 2.89 <0.70b 3.81 <0.70b 
The working dilutions of rabbit anti-sera in the competition ELISA were optimised to give an OD comprised between 0.8 and 1.0. 
5The value represents the Loglp of the reciprocal dilution of mouse sera dilution giving a 25% inhibition of rabbit anti-sera binding (average 
of six animals). bWhen to inhibition of rabbit and-sera was observed the value indicated is the Loglo of the reciprocal of the lowest mouse sera dilution 
tested (limit of detection of the assay). 
Lectin 1: Canavalla ewiformir, Lectin 2: Ricinut communis. 
Cross-reactivity to plant glycans (HRP and plant 
lectins) 
Rabbit anti-HRP and plant lectin immune-sera have 
been shown to react strongly against al -º 3 fucose 
and 01 -. 2 xylose residues (Faye et al., 1993; 
Ramirez-Soto & Poretz, 1991). Thus, rabbit immune- 
sera raised against three different plant glycoproteins; 
HRP and two plant lectins (Canavalia ensiformis and 
Ricinus communis) were used in competition ELISAs 
to study the immune cross-reactivity to plant glycans 
of sera from mice immunised with plant rIgG 1 is and 
IIRP. It is important to note that the working dilutions 
of rabbit immune-sera in the competition-ELISA were 
optimised to obtain a sensitive assay; that is, work- 
ing dilutions gave a final O. D. between 0.8 and 1.0 
(Chargelegue et al., 1998; Steward & Chargelegue 
1997). Rabbit anti-sera to HRP cross-reacted strongly 
with the plant rIgG I is but not the mouse IgG 1u 
(Table 1), confirming the presence of anti-plant Slycan 
antibodies. Furthermore, the two plant lectins anti- 
sera were highly cross-reactive against HRP (Table I). 
This is consistent with the fact that plant lectins are 
N-glycosylated and display a range of plant specific 
N-linked oligosaccharide structures (Wilson et al., 
1998; Marcus et al, 1984; Ashford et al, 1991). 
However, in the competition ELISA, there was no 
detectable inhibition of rabbit anti-HRP antiserum 
binding to plant rIgGlic by the sera from the mice 
immunised with plant rIgG Ii (including the two that 
had weak reactivity in the ELISA) (Table 1). Sera 
from mice immunised with HRP did inhibit this rab- 
bit anti-serum binding to HRP, but the same mouse 
sera did not show any detectable inhibiting activity 
against the rabbit anti-plant lectin sera binding to I IRP 
(Table 1). 
Discussion 
The expression and production of recombinant anti- 
bodies in plant are now well established (Hiatt et al., 
1989; Ma & Vine, 1999). Furthermore, our group has 
recently shown that it was possible to use these re- 
combinant antibodies topically in humans without side 
effects (Ma et al., 1998). However, for other medical 
applications it is evident that antibodies will have to 
be delivered systemically. Although plant recombinant 
antibodies display glycan residues that are charac- 
teristic of plant glycoproteins, little is known about 
the potential immunogenicity of these mammalian 
proteins expressing plant glycans. 
In the present study, we have investigated the im. 
munogenicity of a mouse Mab Guy's 13 produced 
in tobacco (plant rIgGIK) when administered par- 
enterally. The same strain of mice was used in these 
immunisation studies (BALB/c) as was used for gen. 
erating the original monoclonal antibody. Tbus the 
study specifically addresses the immunogenicity of a 
selfprotein displaying foreign plant glycan structures. 
Four groups of six mice were immunised either with 
saline, IgG I K, plant rlgG Iu or I IRP. To optimise the 
likelihood of eliciting an immune response. immunisa- 
tion was performed in the presence of adjuvant (alum). 
although adjuvants are unlikely to be used in nor- 
mal clinical applications of systemically administered 
antibodies. 
As expected, none of the animals immunised with 
mouse IgGIK raised detectable antibody responses, 
by ELISA or biosensor analyses, to IgGlu, plant 
rlgG 1u or I IRR ZIRP possesses both of the prabmin- 
ant immunogenic plant carbohydrate residues, a 1-. 3 
fucose and ß 1-º 2 xylose (Faye et al., 1993), thus 
it was used as a positive control for plant glycopro. 
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tein- The group of mice immunised with HRP did 
raise high IgG titres to HRP, however these antibod- 
ies did not cross-react with plant rIgGlic. Since, the 
plant rIgG 1u also displays al -* 3 fucose and ß 1-* 2 
xylose (Driouich et at, 1993), it is unlikely that the 
mouse antibodies were specific for these plant glycans. 
Indeed, this was confirmed by the fact that the mouse 
antisera did not inhibit the binding of rabbit anti-plant 
lectin antisera to HRP glycan residues. 
In the group immunised with plant rIgG 1 u, two out 
of six mice had low reactivity (just above the detec- 
tion limit) to the plant rlgGlic preparation in ELISA 
(IgG2a, 2b &3 and lambda responses). However, this 
reactivity was not detectable in the biosensor analyses, 
even though total Ig responses (the four IgG subclasses 
and 1gM) could theoretically be monitored. The reason 
for this difference could be that the sensitivity of 
biosensors is not as great as ELISA methods when 
low sera dilutions are used, due to non-specific bind- 
ing of serum components to the sensorchip surface 
(Kubitschko et aL, 1997). 
Furthermore, when the two positive sera were 
tested (at a dilution of 1/5) for their reactivity to plant 
glycans, neither was able to inhibit the binding of the 
anti-HRP rabbit immune-sera to plant rIgGlu. Thus 
it seems unlikely that the two animals mounted a re- 
sponse to glycans present on plant r1gG 1 u. Since these 
two sera did not react to the mouse IgGlic either, it 
is possible that the results represent reactivity to a 
low amount of tobacco plant protein present at the 
end of the double-step affinity purification of plant 
rIgGIic. Analyses by western-blotting using the sera 
from immunised animals were performed, however 
no antibody reactivity to plant contaminants in the 
plant rIgG 1 is preparation nor to whole plant extract 
was detectable (data not shown). It is important to 
note that the level of reactivity in ELISA was only 
just above the detection limit of the assay (sera diluted 
at 1/40, gave an O. D of around 0.3 for only two an- 
imals out of six after overnight incubation), so it is 
unlikely that this level of reactivity will be detectable 
in western blotting. 
An unexpected result of this study was that the 
six mice immunised s. c. with HRP in alum, had un- 
detectable anti-plant glycan reactivities. Indeed, previ- 
ous publications had suggested that both plant glycan 
residues a 1-s 3 fucose and ß 1-s 2 xylose, are highly 
immunogenic when plant glycoproteins were admin- 
istered parentally with adjuvant (Faye et at, 1993; 
Wilson et at, 1998; Wan & van Huystee, 1994; 
Ramirez-Soto & Poretz, 1991). However, all these 
studies have employed rabbit as the animal model and 
used Freund's complete and/or incomplete adjuvant. 
In our study, alum was chosen as the adjuvant, because 
it is licensed for human use in vaccine trials (Gellin 
et al., 1997; Francis et al., 1998). 
In conclusion, our study has demonstrated that 
plant glycans are poorly immunogenic in mice even 
when administered parenterally with adjuvant. This 
appears to be true whether the glycans are associ- 
ated with either foreign (IIRP) or self proteins (plant 
rIgGIK). In the present work, a weak reactivity to the 
plant rIgG 1K preparation was observed in only two 
animals. Since no antibody response to the protein (no 
response to lgG 1 K) and carbohydrate part (no compet- 
ition with anti-IIRP immune-sera) of the plant rIgGtic 
were detected, this is almost certainly due to the pres- 
ence of tobacco plant compounds in small quantity at 
the end of the purification. Therefore, it will be im- 
portant for future clinical work to ensure that these 
contaminants are removed before immunisation (e. g. 
by a final ion-exchange or gel filtration II PLC chroma- 
tograpby). The present study was a pilot investigation 
in experimental mice, and in future it is likely that any 
recombinant plant proteins for human application will 
need to be tested for immunogenicity in humans as 
part of Phase 1/1l trials. 
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Since plants are emerging as an important system for the 
expression of recombinant glycoproteins, especially those 
intended for therapeutic purposes, it is important to scrutinize 
to what extent glycans harbored by mammalian glycoproteins 
produced in transgenic plants differ from their natural 
counterpart. We report here the first detailed analysis of the 
glycosylation of a functional mammalian glycoprotein expressed 
in a transgenic plant. The structures of the N-linked glycans 
attached to the heavy chains of the monoclonal antibody 
Guy's 13 produced in transgenic tobacco plants (plantibody 
Guy's 13) were identified and compared to those found in the 
corresponding IgG1 of murine origin. Both N-glycosylation 
sites located on the heavy chain of the plantibody Guy's 13 are 
N-glycosylated as in mouse. However, the number of Guy's 13 
glycoforms is higher in the plant than in the mammalian 
expression system. Despite the high structural diversity of the 
plantibody N-glycans, glycosylation appears to be sufficient 
for the production of a soluble and biologically active IgG in 
the plant system. In addition to high-mannose-type N-glycans, 
60% of the oligosaccharldes N-linked to the plantibody have 
0(1,2)-xylose and a(1,3)-fucose residues linked to the core 
Man3GkNAc2. 't'hese plant-specific oligosaccharide structures 
are not a limitation to the use of plantibody Guy's 13 for topical 
immunotherapy. However, their immunogenicity may raise 
concerns for systemic applications of plantibodies in human. 
Key words: monoclonal antibody/N-glycosylation/transgenic 
plants 
Introduction 
Transgemc plants are an important system for the expression of 
t erapeWc recombinant proteins (Moffat, 1995). 1iiatt et aL 
(1989) demonstrated that the coexpression in tobacco of light and 
heavy immunoglobulin chains results in the production of 
functional antibodies. Since then, a number of groups have 
expressed antibodies in plants, either to modify plant pcafbrma ce 
or to exploit plants as bioreactors for large-scale production of 
full-length IgG (During et al., 1990; Ma et at., 1994) and 
secretory antibodies (Ma et at., 1995). 
It has been shown that some of the properties of immum- 
globulins depend on their glycosylation. In general, there is one 
conserved N-glycosylation site per heavy chain of IgG in the C112 
domain constitutive of the Fc region (Rademacher et at., 1986). 
Glycosylation of the Fab region has also been described in about 
30% of serum antibodies (Rademacher et at., 1986). The 
N-glycosylation of the Fc contribute to the structural stability of 
the immunoglobulin. The two constitutive oligosaccharides of an 
IgG molecule stabilize the Fc by filling the interstitial region 
between the two CH2 domes (Parekh et at, 1985) and exert a 
subtle influence on protein tertian y and quaternary structures that 
is essential for activity. Aglycosylated IgG usually slows higher 
sensitivity to pretenses and a loss of binding capacity to monocyte 
Fe receptors (for recent reviews, see Jefferis and Lund, 1997; 
Wright and Morrison 1997). As a co"ie ice, the N-gly syLdion 
of recombinant antibodies is one of the key steps foe the p otkictiai 
of frilly functional imnnmogI btdrns by an expression risten 
The N-glycosylation in higher organisms is conserved but 
differs slightly in detail. The processing of the N-linke! glycans 
occurs along the socretory pathway as the glycoprotein moves 
from the endoplasmic reticulum through the Golgi apparatus to 
its final destination. G1ywsid scs mid glycosyltransfixaseg located in 
the Golgi apparatus successively modify the oligosacctLrjlu 
procursor to high-mý"rmose-typo N-glycans and then into con$x- 
type N-glycans. 710 complex-type N-glycans arise from the 
transfix in the Golgi appa tus of momsa ehern la r ucs onto the 
c Man3GlcNAc2 under the ac hn of sc I1 glyoosyltrnnsfirncýs. 
Since some of these modification are specific for the expressk' n 
system, the stricture of m: turo complex type N-glycans asro tided 
with plant, insect, yeast, or mammalian glycoproteins will differ. 
Thus, no heterokoxis system will be able to nprtxtuec nusn Hits 
glycans exactly. Plants, insects, and yeast do not introduce sialic 
acid on their glycopmteins and synthesize N-glycans having 
carbohydrate motifs that we not found in mammals. For instance, 
in plants, complex-type N-gtycans are diaracterirai by the 
presence of ß(1,2}aylose residue linked to the ß-mannose a tVor 
an (41,3)-fucose residue, instead of an ac(1,6)-fucosc residue, 
linked to the proximal glucosaznine (for a recent review, see 
Laouge et at., 1998). Since plants are gaining acceptance for the 
expression of recombinant therapeutic proteins, it is important 10 
COMM in detail to what extent glyain s of mrrmml n glyuo- 
proteins produced in trmgcnic plats dim T from original ate. 
The monoclonal antibody (MAb) Guy's 13 is a mouse IgG I 
class antibody, which recognizes a cell-surface protein of 
&mptocvccus miaans, the bacteria which is the principal cause of 
dental caries in humans (Smith and Ldma, 1989). This MAb 
contains two potential N-glyeosylation sites on its constitutive 
heavy chain. In addition to the highly conserved glycosylation 
site in the Fe region, MAb Guy's 13 has a second Ann-74 Sa 
N-glycosylation consensus sequence located in the Fab part of 
this IgG 1 molecule. A full-Icngth MAb Guy's 13 was expressed 
in tobacco (Ma et al., 19964). This plant MAb or pLmtibody was 
found to be functional in terms of antigen recognition and 
binding. In this article, we report a detailed structural comparison 
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Fig. 1. SDS PAGE and Wcstem blot analysis of the mouse MAb Guy's 13 
and Fab fragment. The purified mouse MAb Guy's 13 (a) and Fab fragment 
(b) were analyzed by SDS-PAGE in reducing conditions and detected by 
silver staining m the gel (lanes 1) or by aff nodetection with RCA of the 
correspotding blots (lanes 2). 1 Guy's 13 heavy chain; K, Guy's 13 fight chain 
of the N-glycans of the MAb Guy's 13 expressed in mouse and 
in tobacco plants using immunochemical and physicochemical 
approaches. 
Results 
N-Glvcosi'/aiion curah'sis oflhe mouse Guy . 'c 13 antihodty 
The MAb Guy's 13 has two potential N-glycosylation sites 
located on the heavy chain: the conserved site in the Fc fragment 
and an additional site on Asn-74 located on the Fab fragment. 7 he 
structure of the N-linked glycans and their distribution on the two 
potential N-glycosylation sites were first investigated by allino- 
detection on blots using Ricinus communis agglutinin (RCA). 
This lectin specifically binds to N-acetyllactosamine sequence 
usually found in mammalian complex-type N-glycans. I kavy 
and light chains constitutive of the mouse Ig(i and the Fab 
fragment were separated by SI S PAGE in reducing conditions, 
and they were affmodetected on blots (Figure I ). In both the Ig(i 
and the Fab, the heavy chain was found to be detected by R('A 
on blots (Figure 1, lanes 2). As a consequence, in addition to the 
oligosaccharide attached to the conserved N-glyc osylation site of 
the Fc, the site (Asn-74) located on the Fab is N-glycosylatcd by 
RCA-positive oligosaccharides. 
The monosaccharide analysis of the mouse MAb was 
performed in two steps. The neutral and ammo sugars were 
released by hydrolysis with 2M TFA. The identification and 
quantification of monosaccharides were done by comparison to 
calibrated standards as previously reported (I lardy, 1989). Fuc, 
Gal, G1cNAc, and Man were detected in the molar ratio 
0.65: 1.5: 3.8: 3.0. Neiuaminic acid released in mild acidic conditions 
(0.2 M TFA) was estimated to represent about I O% of the sugar 
content (Anumula and "[ aylor, 1991)A lie stricture of N-linked 
glycans attached to the mouse MAb were determined by 
chromatographic analysis and nuclear magnetic resonance 
(NMR). The oligosaecharides were released from the MAb with 
PNGase F and analyzed by HYAF-PAD chromatography as 
reported in Rohrer et al. (1995). The mouse MAb N-linked 
glycans were found to be separated into neutral and sialylated 
oligosaccharides in a 9: 1 ratio, confirming that sialylated N-linkal 
glYrms represent about I(& of the total oligosaccharkic-s 
(Figure 2A). Total N-glycans isolated from the mouse MAb were 
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Table 1. Structures of neutral N-linked glycans isolated from the mouse 
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Nig. 3. SDS-PA(; E and Western Not analysis of the plantibody Guy's I i. 
The affinity-purified plantibody Guy's 13 was analwid by SDS PAGE in 
reducing conditions and protein silver staining in the gel (lane I ). or on the 
Cori spording blots by alum tection with concanavalin A (Latte 2) or by 
immunaietection with antibodies sp 5ific fora(!. 3)-fuaxvc (anti-fucose 
antibodies, lane 3) and for N I. 2)-xykste (anti-xykute antibodies, lane 4) 
epitopes of plant N-linked glycanc 
plea tibcxiy was carried out with antibodies specific li r glycan 
epitopes that are found in plant N-glycans. i. e. antibodies specific 
for the a(1,3)-lueosc residue linked to the proximal ghcos: unine 
(anti-fucose wwtibodies) and antibodies specific for the 
I (1,2)-xylose residue linked n) the 13-mminosc of the core 
Man3GlcNAc2 (anti-xylose U11117 dies; Faye ei at. 1993). Hie 
heavy chain was detected oil blots with botch m ti-lucose and 
anti-xylose antibodies (Figure ?. Lutes 3 and 4, respectively). : 1s 
a, consequence, these results indicate that the y chain of the 
plantibody Guy's 13 is N-glycosylital by both high-tnvuxose-type 
N-glyrms, and xylose- and fucuse-cuntauting complex-type 
N-glyc, uts. Platt cutnplex-type N-glycans containing Lewis a 
antigens were recently reported (Fitchette-Laie: el at. 1997; 
Melu et al.. 1997). Ott blot, the plantibcxiy Guy's 13 was not 
imrnunrxietected with Lewis a specific antibodies indicating that 
Lewis a containing complex-type N-glycans are not attached to 
the plantibody (iuy's 13 (data not shown). 
the distribution of plant N-glycans on the two potential 
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Fig. S. HPAE-PAD chromatography of high-mannase type N-glycam 
isolated from the plantibody Guy's 13. High-mannose-type N-glycans were 
isolated by affinity chromatography on a concanavalin A-Sephan ee column 
and then analyzed by HPAEC-PAD. The different oligosaccharides were 
identified by comparing their retention times to standard olgosaccharides 
isolated from mammalian and plant sources. The structures of Man-S to 
Man-8 oligosaccharides are presented in Table H. 
length plantibody Guy's 13 bound to the streptococcal antigen 
coated on plates, was recognized by anti-heavy chain (anti-Fc 
fragment), anti-light chain, and anti-xylose antibodies (Figwe 413, 
columns 1). Fab fragments produced by papain digest of the 
plantibody also bind the streptococcal antigen and were still 
recognized by anti-lig t chain and anti-xylose antibodies but not by 
anti-heavy chain (anti-Fc fragment) antibodies (Figure 413, columns 
2). The detection of plant N-glycans on the Fab fragment was 
confirmed after protein G absorption of the papain digested material 
to remove intact IgG (Figure 4B, columns 3). 
After hydrolysis with 2M TVA of 50 pg of the plantibody, Fuc, 
Xyl, G1cNAc, and Man were detected by HPAEC-PAD in the molar 
ratio 0.5: 05: 3.0: 5.0. The glycans N-linked to the heavy chain were 
released from the whole plant recombinant immunoglobulin by 
sequential digestion with pepsin and PNGase A as previously 
reported (Tomiya et at, 1987; Rayon et at., 1996). PNGase A is a 
plant peptide N-glycosidase which is able to release all Winked 
glycans inhuming oligosaccha<ides having a fucose residue cc-linked 
to the 0-3 of the proximal glucosamine. The N-glycans were then 
purified by ehroon through a AG50 X2 and a CIS columns, desalted 
on a Bio Gel P4 column and analyzed by IIPA&PAD chromato- 
graphy (not shown). The EIPAEC PAD profile has shown a mixture 
ofN-linked glycans which molar ratio were quantified by integrating 
the ampeaometric signals detected by HPAEC-PAD. To filly 
idl'ntify the structure of the different oligossaccharides, the mixture 
of N-glycans released from the plantibody Guy's 13 was faction- 
ated by affinity chromatography on a concanavalin ASepharose 4B 
column in order to separate high-mannose-type N-glycans retained 
by affinity, from unietained complex-type N-glycans. The fraction 
containing the high-mantwse-type N-giycans was analyzed by 










Pig. 6. HPAE chromatography of pyridylamino derivatives of ooni+laaaype 
N-glyeans isolated from the plmWxxiy Guy'. 13. N-linked glycam that were 
not retained on imn died concanavalin A. were coupled with 
eminopyridine and then analyzed by I IPAP. C combinvi io a fluorescence 
detection (A) HPAEC profile of PAoligoeaccheridoe obtained by daiveti<, o 
of N-linked glycatn isolated from the plantiibaly Guy's 13. (B) IIPAEC 
profile of the PAoligoeaccharide obtained aller digestion with Jack ban 
ß-N-acetylglucoeaminidase. Peaks e, b. and c were Identified tr the 
pyridylamino derivatives of o ig. erccherida A. B, and C, rogpoctivdy, 
presented in Table 11. 
and Man-8 oligosacclia ides wait ckyoctat and idauxifiat by 
con4arrng their ret ntion timte w dose of st: sxl. "a+d obgaeiw4mvilcs 
isolated from mammalian mid plant glycopmk'ins (Ra) et a!.. 
1996; Figure 5, Table 11). The structure of the first clutod Mm-7 
isomer (Man-7(l)) was not fully kL ntifiai. The oligosac hunks 
which were not mtainai by affinity on iurunnobiliaxi eonca av ihn A 
were coupled to aminopyridine and dien the resulting PAoligo- 
saccharidcs were analyzed by IIPAE chromate luy arnbinod 
with fluorextnce detection as illustrated an Figure 6.11nue nmjnr 
peaks-a, b, and c-were detected and kfentifixi, msp ctivdy, as 
the pyridyL'nnino derivatives of the plant N-linked glycans A. D. mid 
C presented in Table 11, by cnm i ison of their mention timer with 
standard PAoligosxch kx pmTered fein plait gtycopmcins 
(Figure 6A). The mixture of libeled glycans was d* abrniual to 
an exogtyeosklasse digestion with jack bin P-N-auetylgluans- 
aminidase. As illustrated in Figure 613, during the digestion, 
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Mg. 7. EIectrospray-maa, spectrometry of the PAderivafvea of the xylose. 
and fucose-containing N-glycana isolated fnxn the plantiibody Guy's 13. low 
a. b, and c correspond to the (M+Na)* ions of the pyndylamino derivatives 
of plant N-glycans A, B, and C presented in Table IL b" and c" are the 
double charge (M+2Na)2+ ions of oligosaccharides B and C. 
N-glycans B and C were progressively converted to glycan A as 
represented in Table ! I. This result confirms that oligosaccharides 
B and C eluted in peaks b and c are homologous to oligo- 
saccharide A but have one and two additional terminal G1cNAc 
residues, respectively (Table II). The structures of complex-type 
N-glycans associated with the plantibody Guy's 13 were also 
confirmed by electrospray mass spectrometry (Figure 7). Three 
ions at mh = 1289,1492, and 1695 were detected, which 
correspond to the adduct ions (M+Na)+ of the pyridylamino 
derivatives of respectively the complex oligosaccharides A, B, 
and C, represented Table 11. 
Discussion 
Several mammalian proteins have been successfully produced in 
plants and some of them are indistinguishable from those 
produced in mammalian cells as far as amino acid sequence, 
conformation and eventually biological activity are concerned 
(Owen and Pen, 1996). However, most clinically important 
mammalian proteins are glycosylated and their glycosylation 
affects their physiochemical properties, including resistance to 
protease attack and solubility. Glycans N-linked to therapeutic 
glycoproteins are also responsible for some of their biological 
functions such as antigenicity, immunogenicity, or plasma 
clearance rate. In a field where the utilization of plants as 
expression systems for the production of therapeutic recombinant 
proteins starts to be important, it is urgent to explore the capacity 
of plant cells to produce and glycosylate mammalian glycoproteins. 
Our detailed analysis of the N-glycosylation pattern of the MAb 
Guy's 13, counted with previous results on the biological activity 
of this MAb expressed in transgenic tobacco (Ma et at., 1994), 
constitutes the first complete comparative study of mammalian 
glYcoprotein produced in a transgenic plant system. 
Four different oligosaccharide structures were found N-linked 
to the mouse MAb Guy's 13 and were identified as complex-type 
N-glycans containing a(1,6)-fitcose at their innermost N-acetyl- 
glucosamine residue and galactose and sialic acid to different 
extents. These results are consistent with previous structural 
studies of mouse IgG N-glycans (Rademacher et al., 1986; 
Table IL Structures of the high-mannoee-type (Man-$ to Man-8) and the 
xyloso- and fucoee-containing N-glycans A. B and C isolated from the 
plantibody Guy's 13 
Code Strvctan Mol % 
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Mizuochi et a!., 1987; Rothman et at, 1989. Rolutx et a/., 1995 ). 
The N-glycosylation analysis of the plantibafy Guy's 13 was 
carried out on material purified from mature tob. o plants by 
affinity chromatography on both protein G and inunobiliiAxi 
anti-mouse IgGI antibodies. The diversity of ohgoswclwride 
structures on the plantibody Guy's 13 is far trighcr than on murinc 
MAb. Indeed, we have i entif al eight different oligobacckirkles 
on the plantibody molecule representing an array of structurally 
related oligosaccharicies from high-mann se-type N-glycans 
(40%) to modified glycans (60%). In condusicn, the hctiaugencity 
of the carbohydrate moiety in the antibody Guy's 13 and 
consequently the number of Guy's 13 glycofonns is higher in 
transgenic tobacco than in rouse. The plant N-linked glyca n 
structures A, B, and C containing ß(I, 2)-xykne anti the 
a(1,3)-fucose residues linked to the core Man3GIcNAe2 
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(Table II) were previously found in many plant glycoproteins. 
Furthermore, the complex-type N-glycans B and C, the major 
oligosaccharides N-linked to the plantibody Guy's 13, are 
oligosaccharide structures usually found on plant extracellular 
glycoproteins. These oligosaccharides are known to be rapidly 
trimmed by the action of exoglycosidases when the glycoprotein 
is stored mplant vacuole giving the truncated Man3XylFucGIcNAc2 
glycan A (Lem uge et at, 1998). The presence of such oligosacchar- 
ides with terminal N-acetylglucosamine residues is indicative of the 
secretion of most of the plantibody Guy's 13 expressed in 
transgenic tobacco, which confums a previous study showing that 
plantibodies are secreted by plant cells and accumulates in the 
tobacco apoplasm (Ma and Hein, 1995). However, it cannot be 
excluded that the large structural heterogeneity of the glycans 
found on the plantibody could be the result of the storage of part 
of this recombinant IgG in other compartments of the plant 
secretory pathway. Indeed, storage of the plantibody in the 
endoplasmic reticulum or in the vacuole will result in N-glycans 
having unposed or truncated structures, respectively (Lerouge 
et al., 1998). 
The MAb Guy's 13 contains two potential N-glycosylation 
sites on the heavy chain located on the Fc and the Fab fragments. 
Both sites of the mouse MAb Guy's 13 were found to be 
N-glycosylated by complex-type N-glycans. By ELISA and 
Western blot analysis of the full length or the papain digested 
plantibody, it was demonstrated that plant complex N-glycans are 
also localized on both the Fc and the Fab fragments of the plant 
IgG 1. However, the precise distribution of plant N-linked glycans 
on both sites has not been fully determined, due to the limitations 
related to the small quantities of purified Fab and Fc fragments 
isolated from the plantibody. However, our results clearly 
illustrate that both the highly conserved N-glycosylation site in 
the CH2 domain of the heavy chain of murine IgG and the 
additional site (Asa-74) found on the Fab region of die Guy's 13 are 
occupied in both the murine and in the plant expression system. 
In humans, the mouse MAb Guy's 13 when applied directly to 
the teeth can prevent colonization of oral cavity with S» voaoccus 
mutans and reduce the risk of dental caries (Ma eta!., 1990). The 
production of functional MAb in plants, for a low cost, should 
provide the large amount of immunoglobulin required for 
applications in the area of topical immunotherapy. Plant specific 
glycosylation is sufficient to produce soluble and biologically 
active IgG. However, the oligosaccharide side chains of immuno- 
globulins have many other functions than "spacers" between the 
two Cy2 domains. The IgG N-glycans are necessary for effector 
functions of the antibodies such as recognition by receptors that 
mediate their survival in the circulation, binding to macrophage Fc 
receptors, complement fixation or elimination of antigen-antibody 
complexes (Wright and Morrison, 1997). Further studies will help 
to answer whether or not plantibody N-glycans will also assume 
some of these functions in vivo. 
Differences that exist in the glycosylation patterns in plants 
and mammals could represent an important limitation to the use 
of recombinant mammalian glycoproteins produced in transgenic 
plants for in vivo therapy. In this study, the comparison of murine 
and plantibody Guy's 13 clearly illustrates these differences in the 
glycosylation of the same protein backbone. Some similarities 
exist between complex-type N-glycans from both expression 
systems such as the presence of a common Man3GlcNAc2 core 
substituted by terminal GIcNAc residues. However, additional 
motifs on this core, i. e., the a(1,3)-fucose and the (3(1,2)-xylose 
residues, can be highly immunogenic in mammals. In the context 
of large quantities of antibodies that may be introduced into the 
human organism for some therapies, a sensitization to the plant 
complex-type N-glycans identified on the plantibody Guy's 13, 
might occur. As a consequence, for some In vim applications of 
recombinant antibodies produced in transgenic plants, strategic s 
have to be developed to obtain plantibodies with carbohydrate 
profiles structurally more consistent with ones obtained Gum 
mammalian cells. 
Materials and methods 
Materials 
Ricinus caommunts agglutinin (RCA) coupled with hosuTadish 
peroxidase, pepsin and ß-N-acctylglucosaminidase from Jack 
bean were from Sigma. PNGase A and F were purchased from 
Bockringer Mannheim. Man-5 (RNase 13), Man-6 (RNase B), 
Man-7(H) (bean phasoolin), Man-8 (bean phytol nagglutinin), 
and Man-9 (soybean agglutinin) were isolated from mammalian 
and plant glycoproteins and id entifed by proton NMI. The 
pyridylamino derivative standards of plant N-glycans were 
prepared by labeling with 2-aniinopyridine (i lase et at, 1984) 
complex oligosaccba i des isolated from bean phytohenw lutinin 
(Rayon et at, 1996) and bum AraN hpsLs thal4um Slyao+ruteins. 
Purification of the plantibody Gyv 13 
Mature transgcnic plants expressing Guy's 13 MAb were 
homogenized in 1.5 volume of Tris-bulrercd saline (TBS. 75 mM 
NaCI and 10 mM Tris-IICI, phi 8). After centrifugation of the, 
homogenate at 12,000 xg for 30 min at 4°C, proteins werd 
precipitated from the supernatant in the presax: e of ammonium 
sulfate (50% saturation). Aßen a second centrifugation in the 
same conditions as above, the protein pellet was solubilizAt in 
TBS. The proteins were then submitted to a second precipitation 
with ammonium sulfate (50% saturation). Te sec nxl protein 
precipitate was resuspended in IDS and the solution was passed 
through a 0.45 gm filter. IgG was purified from this protein 
extract by affinity chromatography on a protein G-agarose 
column (MAbtrap (ill, pharmacia 114* ch) folkiwnd by a further 
affinity purification step using Sephcwse 413 bends coupled to 
goat anti-mouse IgG I antibodies (Sigma UK). 
SDS-PAGE and Immunoblotting experiments 
The antibody Guy's 13 was separated in a 15% SL -PAGE in both reducing and na rafucnng conlitiixu aril was dm U-mrmxl 
onto a nitroceflukosc nwmbcanc. Inunw*xf xuctin s with anti-xy4 
or anti-fucosc antibodies were performed according to Faye cr at. 
(1993). Afl nodetection of high-mvnioso-type N-glycans was 
carried out using the concanavalin A/pcroxidaso method (Faye 
and Ch ispecls, 1985). Afrinod. tection by RCA was carried out 
as reported in Fitclxnte-Laine c7 at. (1998). 
Papa in digestion of plantlbody C my r 13 
Ptnifed plantibody Guy's 13 was incubatal with papain (1: 100) 
(Sigma, UK) in 0.1 M Tris-1 ICI p!! 7 containing 2M CDTA anti 
20 mM cysteine, for 16 It at 37°C. The reaction was skpped by 
incubation with 0.1 M iodoacetamida for 1h at 37°C. Con- 
taminating Fc was removed by incubation with protein 0 
Sepharose beads (Pharmacia Biotech, UK) for 5 hat 37°C. and 
the supernatant was recovered by ccutrifugation. 
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ELISA analysis ofplantibody and Fab fragment bound to 
streptococcal antigen 
ELISA plates (Dynatech, hmnulon) were coated with streptococcal 
antigen at a predetermined optimal concentration of 2 pg/mL 
After blocking with 5% nonfat dry milk inTBS containing 0.01% 
Tween 20, plantibody solutions were applied for 2 hat 37°C. The 
plates were washed with TBS containing 0.05% Tween 20, and 
either anti-murine kappa (Bradsime Biologicals, UK), anti-minne 
gamma (anti-Fe fragment) (Sigma, UK) or anti-xylose antibodies 
were applied for 2h at 37°C. After fu ther washings, the next 
incubation was done with an appropriate alkaline phosphatase- 
conjugated antiserum for 2h at 37°C. Finally, detection was 
performed using disodium p-nihiophenylphosphate (Sigma, UK). 
Absorbance was read at 405 nm. 
Monosaccharide analysis 
Ten micrograms of mouse or plantibody Guy's 13 were 
hydrolyzed with 2M TFA at 105°C for 2 h. The samples were 
dried out, and the analysis of monosaccharides was carried out by 
HPAEC-PAD as previously reported (Hardy, 1989). Sialic acids 
were released from the mouse MAb with 0.2 M TFA at 80°C for 
1 h. The analysis and quantification of the sialic acids was done 
by HPAEC-PAD according to Anumula and Taylor (1991). 
Isolation ofN-linked glycans from the mouse MAIb 
The purified mouse Guy's 13 (3 mg) was digested with "in 
0% w/w) in a 50 mM ammonium carbonate buffer, pH 8, for 18 h 
at 37°C. The solution was then heated at 100°C for 5 min and 
treated with PNGase F (10 mU) for 24 h at 37°C. The 
oligosaccharides were purified by successively passing through 
a2 ml AG50 X2 column and a C18 Sep-Pak cartridge. The 
oligosaceharides were finally desalted on a 40 x1 cm Bio Gel P4 
column. 
Isolation of N-linked glycans from the plantibody 
N-linked glycans were released from 2 mg ofpurified plantibody 
Guy's 13 by sequential digestions with pepsin and PNGase A 
(1 mU) as previously reported (Tom ya eta!., 1987; Rayon eta!., 
1996). The resulting free glycans were desalted on a Bio Gel P4 
column. Complex-type N-glycans were then separated from the 
high-mannose-type N-glycans by affinity chromatography on a 
concanavalin A-Sepharose 4B column as reported previously 
(Montreuil et a!., 1986). 
Analysis of N-linked glycans 
HPAE-PAD chromatographies of oligosaccharides released from 
the mouse MAb and high-mannose-type N-glycans isolated from 
the plantibody were achieved on a Dionex DX 500 system 
equipped with a GP 50 gradient pump and a CarboPac PAl 
column. Oligosaccharides were separated using a linear gradient 
from 0 to 100 mM NaOAc in 100 mM NaOH at I ml/min over 
30 min. High-mannose-type N-glycans from the plant MAb were 
identified by comparing their retention times to standard oligo- 
saccharides isolated from RNase B (Man-5 and Man-6), bean 
phaseolin (Man-7(10), bean phytohemagglutinin (Man-8), and 
soybean agglutinin (Man-9) as previously reported (Rayon et al., 
1996). Complex type N-glycans were coupled with aminopyridine 
as described by Hase et al. (1984). Pyridylamino derivatives (PA) 
of the N-linked glycans isolated from the mouse MAb were 
separated by reverse-phase HPLC on a Spherisorb ODS 2 C18 
column (250 x 4.6 mm). Elution and identification of PA-oliigo- 
saccharides were performed as described in Tomiya eta[. (1988). 
The quantification of the molar ratio of the N-linked glycans 
isolated from the mouse MAb was deduced by integrating the 
fluorescence signals of PA-derivatives separated by revetso-phase 
HPLC. HPAE chromatography of the PA-derivatives of complex. 
type N-glycans isolated from the plantibody was achieved as 
described above for the separation of reducing oligosaccharides. 
However, PAoligosaccharides were detected using a Spectra 
System FL 2000 (Spectra-Physics) fluorescence detector with 
excitation and emission wavelength at 320 and 400 nm, 
respectively. The sample was dissolved in 0.1 M NaOI I before 
injection. Exoglycosidase treatment of the PA-obgosacebarides 
was carried out with IU of P-N-acetylglucosaminidase in a 
10 mM NaOAc bu! %r, pH 5, at 25 °C for 18 h. The quantification 
of the molar ratio of the N-linked glycans isolated from the 
plantibody was assessed by integrating the amperometric signals 
detected by IIPAEC-PAD of the mixture of complex and 
high-mannose-type N-glycans. 
E7ectrospray mass Ionization 
Electrospray mass ionization was performed on a quadnipolar 
mass spectrometer NERMAG R 10IOU equipped with an 
Analytica of Branford atmospheric pressure elcctrospray source 
(Quad Servive, Poissy, France). The mass on charge (m/z) range 
was of 2000. The sample was dissolved in a 1: 1 1120C113011 
solution containing 0.05% Cl I3000I i and infused into the 
electrospray ion source at a flow-rate of 1.5 jlmin by aI larvani 
syringe pump (Harvard Apparatus). The ion source temperature 
was 80°C (drying gas). Full scan spectra were acquired in the 
range of 500-1950 at a scan speed of 9s. 
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A functional comparison was made between a monoclonal'. secretory antibody generated in 
transgenic plants and Its parent murine IgG antibody. The affinity constants of both antibodies 
for a Streptococcus mutans adhesion protein were similar. However the secretory antibody had 
a higher functional affinity due to Its dimeric structure. In the human oral cavity, the secretory 
antibody survived forup to three days, compared with one day for the '19G antibody. The plant- 
secretory antibody afforded specific protection In humans against oral streptococcal coloniza. 
tion for at least four months. We demonstrate that transgenic plants can be used to produce 
high affinity, monoclonal secretory antibodies that can prevent specific microbial colonization 
in humans. These findings could be extended to the immunotherapeutic prevention of other 
mucosal infections in humans and animals. 
Plants are increasingly being used for the production of re- 
combinant immunotherapeutic agents'. An important advan- 
tage is the fidelity with which plants . can express, 
fold, 
assemble and process foreign proteins. Moreover, there is a po- 
tentially significant cost benefit in growing bulk quantities of 
recombinant proteins in plants. Comptex multimeric proteins 
such as IgG and secretory antibodies can. . 
be produced with 
high efficiency In transgenic plantsU, presenting an opportu- 
nity for passive immunotherapy, particularly at mucosal sur- 
faces where large quantities of recombinant antibody would 
be required. We have previously demonstrated that topical ap- 
plication of two IgG monoclonal antibodies (mAbs) that 
recognise the 185-Kd cell surface adhesion protein of 
Streptococcus mutans specifically prevents bacterial coloniza- 
tion and the development of dental caries in non-human pri- 
mates4. Prevention of colonization of S. mutans in humans has 
been demonstrated using the same IgG. mAbs". We. have also 
described the engineering and expression of a secretory form 
of. one of these antibodies in transgenic plants'. In this mole- 
cule, a-chain domains from an IgA mAb were engineered into 
the constant region of mAb Guy's 13 (ref. 7), which allowed 
dimerization with j chain and assembly with secretory compo- 
nent. The current study was designed to compare secretory an- 
tibody (SIgA/G) and the original mouse IgG versions of Guy's 
13, with regard to in vitro function and in vivo activity, and 
prevention of bacterial colonization in humans. 
Purification of recombinant secretory antibody 
Constructs encoding the four proteins comprising Guy's 13 
SIgA/G have been described'. Briefly, the heavy chain consisted of 
mouse 71-and a domains, the x light chain and J chain were also 
J 
murlne, and the secretory component was rabbit in origin. 
Recombinant SIgA/G was purified from mature tobacco plants by 
ammonium sulfate precipitation and protein, Gaffinity chromo" 
tography.. The yield of antibody was between 10-80 mg/kg fresh 
weight of plant material. The final preparation was in sterile phos- 
phate buffered saline (PBS), pH 7, at a total protein concentration 
of 10. mg/mL ' Endotoxin contamination. was lesi than 0; 1 endo- 
toxinunits/mL. 
. On SDS"PAGE 
analysis, the purified antibody preparation con- 
sists of four major protein bands (Fig. la). The most abundant 
proteins have the highest molecular weights, which correspond 
to SIgA/G and dimeric IgA/G respectively (Fig. lb). 
Densitometric analyses suggested that these two species repre- 
sent at least 70% of the total protein and that the SIgA/G consti- 
tutes more than half of this, The third major baiid runs alongside 
the M, 200K protein marker and represents monomeric IgA/G 
(Fig. 1a). The fourth major band has an approximate M, of 110K 
and corresponds to the F(ab')a proteolytic fragment. The Identity 
of these bands was determined by comparison with' k western 
blot of crude plant extracts using specific antisera against the dif- 
ferent components of the SIgA/G molecule, which demonstrates 
all of the Immunglobulin related molecules present (Fig. lb). 
There were five additional minor protein bands between M, 
43-68K in the purified SIgA/G preparation (Fig. la) which prob- 
ably represent free. secretory component (SC) and breakdown 
products of the antibody preparation. SIgA can occur to vivo as a 
mixture of covalently and noncovalently linked molecules, 
which may explain the presence of free SC In the protein Im- 
munoblot analysis. In addition, plants produce a number of pro" 
teases;. which - might account for the " fragmentation of immunoglobulinmolecules during processing.:: ': '"` 
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Fig. 1 a, SDS - PAGE of the puri- 
fied plant SIgA/G preparation. 50 - 
Four loading amounts of protein 
are shown. b, Western blot analy- 
sis of recombinant plant proteins. 34 - 
Immunoblots of unpurified plant 
extract separated on a 5-18% 28 - 
tris-tricine gradient gel are 
shown. The antiserum used for detection of each blot is indicated, as are 
the major bands and their deduced structures. 
Affinity and avidity of SIgA/G and IgG 
The binding affinity of the plant SIgA/G to streptococcal antigen 
I/11 was compared with that of the native mouse IgG Guy's 13 by 
surface plasmon resonance. The binding curves for both forms of 
antibody at equimolar concentrations were similar for both the 
association and dissociation phases. A representative sensorgrant 
is shown (Fig. 2u). Hic values for k,,, k,, and Kd were calculated 
from sensorgrams using five concentrations for each antibody. 
There was no difference between the deduced dissociation con- 
stants for plant Sign/(i (Kd = 5.2 x 10 "M) and IgG (Kd = 1.3 x 
10 "M) monoclonal antibodies. This assay is optimized for a 1: 1 
molecular interaction, so it is unlikely that differences in avidity 
would be apparent. However, the Biacore analysis does serve to 
confirm the correct assembly of the antigen binding site of the 
antibody in plants and demonstrates that antigen recognition is 
unaffected by any differences in antibody structure, due to the 








k. (M 's k, (s') Kd (M) 
IgG 1.68x10' 2.18x10' 1.31x10° 
SIgA/G 1.76 x I0° 0.91 x 10' 0.52 x 10' 
Fig. 2 a, Antibody affinity measurement by surface plasmon resonance. 
A representative sensorgram for SIgA/G is shown superimposed on that 
for IgG (both at 87.5 nM concentration), to illustrate association and dis- 
sociation phases. The ka, kd and Kd values were determined from five sen- 
sorgrams using antibody at concentrations between 50-100 nM, 
b, Antibody avidity measurement by competition [LISA. Values shown are 
Sc 









plant and marine glycosylation. 
A comparison of the functional affinities of the two antibody 
preparations was determined using a (onipetitict I: LISA, in 
which, by addition of antigen in the tluicl phase. the antigen is in 
excess to favor multivalent interactions with antibody. 
Approximately 4-fold higher antigen concentration was required 
to inhibit binding of Ig(I to SA I/II by >1NMo I I(:.,, = -4. t nNI), cum- 
pared with the plant SIgA/G IIC,,, = -11 nNti iFig. 21, which 
demonstrates that the SIgA/G preparation had a higher tune- 
tional affinity than IgG. As the dissociation constants ut the twos 
antibodies are the same, this difference can he accounted for by 
the higher avidity of the tetravalent SI} A/(; and IIgA/6 mole- 
cules compared with the bivalent Ig(i molecule'. 
Comparative survival of antibodies in vivo 
It has hecn suggested that secretory antihodicti might survive 



















mean ± standard deviation of triplicate samples. The relative avidities of 
the SIgA/G and IgG MAbs are determined by calculating the concentra- 
tion of free antigen required to inhibit antibody binding by 50% (IC-). 
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Fig. 3 Duration of topically applied mouse Guy's 13 IgG and plant 
SIgA/G in vivo. Representative data from one patient in each group are 
shown. Detection of recoverable antibody was by antigen specific ELISA, 
using either an anti-light chain or anti-SC reagent and the results shown 
are the mean of triplicate samples., Detection of Guy's 13 antibody from 
to the presence of the secretory component which protects the 
molecule against proteolysis" ''. We have investigated this di- 
rectly itt iiru by examining the survival of the two forms of 
Guy's 13 antibodies applied topically into the oral cavity. Six 
human volunteers were used and representative data are shown 
(Fig. 3). The baseline limits of detection were determined using 
control subjects who were given bovine serum albumin in PBS 
by the same method as that used for the mAbs. Following the 
application of mAb solution to the teeth, both antibodies were 
detectable after 31) minutes. In subjects who received Ig(;, the 
recoverable antibodies on teeth and in saliva then decreased 
rapidly and were undetectable after 24 hours. In contrast, 
SIgA/(; was detectable for at least 72 hours on teeth (Fig. 3a) and 
for up to 48 hours in saliva (Fig. 3b). The detection assay re- 
quired functional antigen binding and the SIgA/(; antibody 
could be detected with both an anti-light chain reagent as well 
as an anti-SC reagent which does not crossreact with either 
heavy or light chains`. SC is assembled with the Fc portion of 
the antibody molecule and does not contribute to antigen bind- 
ing, thus the results suggest that the antibody recovered re- 
tnained intact in the oral cavity. 
Local passive immunization in human volunteers 
The clinical protective efficacy of mAb Guy's 13 IgG has previously 
been established by preventing colonization by S. ntutans and den- 
tal caries in animals', as well as by preventing both exogenous col- 
onization' and recolonization by indigenous S. rnutans" in 
humans. In this study, the ability of the plant SIgA/G Guy's 13 
preparation to prevent recolonization by S., nutans was determined 
alongside the marine lgGI mAb. Two control groups were in- 
cluded, one that was sham-immunized with saline and another 
that received a non-specific plant/bovine IgG preparation. The lat- 
ter control was used to exclude the possibility that a non-specific 
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teeth (a) and saliva (b). Samples from the control subject (BSA) are shown 
as dotted lines and demonstrate the baseline detection limits using either 
anti-kappa or anti-SC detection antisera. Samples from the subject given 
SIgA/G are shown as red solid lines and those from the subject given IgG 
as blue solid lines. 
vent bacterial colonization. It was shown previously that three con- 
trol murine mAbs have no effect on S. inutans recolonization in ho- 
mans; ^ 1'. 
The experimental protocol of the in vivo study has been de- 
scribed". Briefiv, volunteers were chosen who already harboured 
oral S. mutans. They were treated with topical chlorhexidine glu- 
conate for nine days to deplete the oral flora and eliminate S. tiru- 
tans. F hereafter, antibody or control solutions were applied directly 
to their teeth for three weeks, two applications per week. Samples 
of dental plaque and saliva were collected at intervals up to four 
months to monitor the recolonization of S. inutans. In every sub- 
ject, topical chlorhexidine reduced the levels of S. inutuns to below 
detectable limits in both plaque and saliva. In saliva (Fig. 4a), recol- 
onizing S. nnutans was initially observed after 21 days in one indi- 
vidual in the group receiving plant/bovine IgG. At 58 days, 
recolonization of S. nitm:. s was found in subjects in both control 
groups, and levels continued to rise until the end of the experiment 
at 120 days. In contrast, neither the four subjects treated with the 
plant SIgA/G preparation nor the tour treated with murine Guy's 
13 IgG recolonized for the duration of the experiment (Fig. 4a). In- 
plaque (Fig. 41, ) recolonization started by day 21 in the 
plant/bovine IgG control group and by day 59 in the saline group 
and S. iirutans was present consistently thereafter. Again no recolo- 
nization was observed in those subjects who received either the 
plant SIgA/G or the murine Gum's 13 lgG. Overall, in the saline 
control group, all subjects had recolonized with S. mutans in at least 
one site by day 88 and in the plant/bovine IgG group by day 58, 
but there was no significant difference between the rate or levels of 
recolonization between the two control groups. In contrast, in the 
groups receiving the SIgA/G or lgo monoclonal antibodies, none 
of the eight subjects had shown signs of recolonization of S. nttttiaü 
by day 118, neither in saliva nor on the teeth. 
The specific nature of this imnu notherapeutic approach was 
tested by monitoring the levels of ciitinoimvices, a Grant positive 
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Fig. 4 Recolonization of S mutons in the oral cavity in saliva (a) and dental 
plaque (b). Results shown are mean levels of S. mutans (+sem) expressed as 
a percentage of the pre-experimental levels set at 100%. Nine days' treat- 
ment with chlorhexidine gluconate is indicated, followed by the six applica- 
commensal bacterial species commonly found in the oral cav- 
ity, in subjects receiving plant/bovine IgU or the plant secretory 
SIgA/G preparation (Fig. S). As with S. inutans, actinomvices tell 
to undetectable levels following treatment with chlorhexidine, 
but in contrast to the finding with S. nnutams, both the non-im- 
munized and immunized groups recolonized within 21 days 
and the actinomvices were restored to pre-experinmental levels 
by 88 days. This finding supports the specific nature of the ac- 
tion of Guv's 13 mAh, as application of the antibody had no ef- 
fect on the recolonization of actinomvices or the rate at which 
this bacterial species was re-established in the oral cavity. 
Absence of adverse side effects 
A number of clinical parameters were examined at regular in- 
tervals to monitor the possibility of any adverse reactions. 
These included dental and oral mucosal examinations, gingival 
inflammation' `, dental plaque index" and self-reporting by the 
patients at each visit. Routine hernatological screening (blood 
indices, hemoglobin, erythrocyte sedimentation rate, differen- 
tial white cell count, serum electrolytes and liver function 
tests) were performed before the experiment and at day 58. No 
significant changes were observed in any of the tests in any of 
the four groups (data not shown). We have also investigated 
the possibility that the plant SIgA/G preparation might be im- 
munogenic by virtue of either the murine or rabbit compo- 
nents or due to the plant specific glycans associated with the 
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Lions of immunizing or control solution. The four study groups are indicated 
and each group comprised tour subjects except for the plant/bovine IgG 
group which had three subjects. Post-chlorhexidine bacteriological samples 
were taken on days 0,21,58,88 and 118. 
groups of patients were assayed by FLISA for antibodies that 
bound to the plant SIgA/G preparation. There were no signifi- 
cant differences between any of the groups in Irre-experimental 
specific IgG, IgA or IgM antibody titres, or binding at 1: 50 diln- 
tion (IgG) or 1: 25 dilution (IgA or Ig\l) and no significant 
changes in those subjects that received either the plant SIgA/(; 
or plant/bovine IgG preparations (Fig. W. Phis suggests that the 
plant preparation containing purified antibodies is not im- 
munogenic when given orally. 
Discussion 
We have extended our previous findings regarding a monoclonal 
secretory antibody expressed in transgenic plants. The plant anti- 
bodies can readily be extracted and purified resulting in a prepara- 
tion containing predominantly dimeric antibody species IdlgA/G 
and SIgA/(; ), of which the majority is SIgA/G. From a therapeutic 
point of view, SIgA may provide an advantage over IgG in the mu- 
cosal environment", although this is not always the case"'. Iltere 
are several possible mechanisms of action for protective secretory 
antibodies at tnucosal sites''" and these include neutralization, 
bacterial aggregation and immune exclusion. In the current model 
of prevention of S. Inntuns colonisation, there are two main poten- 
tial benefits to using a monoclonal secretory antibody. These are 
the increased avidity of secretory antibodies, which enhances bac- 
terial aggregation and immune exclusion, and decreased suscepti- 
bility to proteolytic breakdown in the nuicosal environment. the 
dlgA/G present in the plant preparation may also contribute to 
immune exclusion, but unless it assembles with tree human SC in 
secretions, it is unlikely to survive as long as Slg. A/G in tiro. 
Despite the increased complexity of the plant SIgA/G molecule, 
the assembly of the antigen binding site is well preserved in 
plants, resulting in an affinity that is equivalent to that of the orig- 
inal lgG. The plant SIgA/G antibody was shown to have a higher 
Fig. 5 Re-colonization of Actinomyces noeslundii in the oral cavity in dental 
plaque. Two samples were taken from each patient at each sampling. 
Results shown, are the mean levels of actinomyces (± sem) expressed as a 
percentage of the pre-experimental set at 100%. Nine days' treatment with 
chlorhexidine gluconate is indicated followed by six applications of immu- 
nizing or control solutions. Results are shown for plant/bovine IgG control 
(n = 3) and plant SlgA/G groups (n = 4) of patients. 
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Fig. 6 Serum antibody binding to plant SlgA/G preparation. Mean serum IgG, M and A (t s. d. ) recognition in ELISA of the plant SIgA/G preparation is shown for each patient group pre- and post-immunization. 
avidity than the IgG due to the dimeric structure of this molecule. We have shown previously that Guy's 13 IgG and F(ab')2 fragment 
are protective in humans, but the Fab fragment is not, suggesting 
a requirement for at least bivalent antigen binding. Indeed, in vitro 
growth of S. snutmu with mAb Guy's 13 IgG results in enhanced 
chaining and aggregation of streptococci". The rationale for the 
use of the plant SIgA/G antibody is that there is a progressive In- 
crease in valency and avidity from the ineffective monomeric Fab, 
to the protective dimeric F(ab'), and IgG, to the tetravalent SIgA/G 
which may correlate with protective efficacy. 
A further advantage to using secretory antibodies at mucosal 
surfaces is the resistance to proteolysis observed with SIgA anti- bodies""'. Compared with the rest of the gastro-intestinal tract, 
the mouth does not contain significant amounts of indigenous 
proteases although potentially there are a number of bacterial pro- 
teases. We have shown in a functional in vivo assay, that the plant 
SIgA/G can survive in the oral cavity and be recovered from saliva 
or teeth for up to three days compared with one day for IgG. 
The human trial reported here demonstrates that the plant 
SIgA/G preparation is as protective and specific as the native mAb 
Guy's 13 IgG over a period of four months. At this stage we have 
not optimized the protocol for topical immunotherapy and the ad- 
vantages of using SIgA/G over IgG may only become evident when 
optimum minimum therapeutic dose and frequency of application 
have been determined. There were no clinical, hematological or 
serological adverse effects following administration of the plant an- 
tibody. Given our daily intake of foreign plant and mammalian 
proteins this is not surprising and it is likely that plant derived an- 
tibodies will be safe and acceptable to most people. 
Topical passive immunotherapy requires relatively large 
amounts of antibody. The treatment regime in this trial required 
22.5 mg antibody per course of treatment of six applications. 
This could be purified from approximately 1kg of whole mature 
plants (about 10-15 plants). The purification efficiency was ap- 
proximately 69% of total antibody. At the current levels, it 
should be possible to generate sufficient quantities of antibody 
for most applications, but there is clearly further scope for opti- 
mising antibody expression and purification and subsequent 
scale up to agricultural levels of production. 
This is the first human trial of a monoclonal secretory antibody, 
as well as of a therapeutic agent produced in transgenic plants (see 
Tacket et at. pg. 605). These findings, along with the combination 
of scientific, medical and economic benefits of using recombinant 
plant biotechnology may lead to the development of this approach 
for other microbial infections affecting mucosal sites, including the 
gastrointestinal, respiratory and genito-urinary systems of both hu- 
mans and other animals. 
Methods 
Antibody purification. Murine IgG Guy's 13 was purified from ascitic fluid 
by protein G affinity chromatography. Final preparations were in PBS. The 
fresh plant material was homogenized in 2 volumes of extraction buffer (25 
mM Tris pH 7.5,150 mM NaCl, 10mM EDTA, 1% sodium citrate, 1% PVPP, 
0.2% sodium thiosulfate), frozen overnight and thawed. After centrifugation 
(17,000 g, 60 min) the supernatant was filtered through 0.6 pm and 0.2 Nm 
filters and concentrated by diafiltration using a 300-kD molecular weight 
cutoff MWCO filter (Ultrasette, Pall-Filtron Corporation, Northborough, 
Massachusetts, USA). Immunoglobulins were precipitated with 50% ammo- 
nium sulfate, the precipitate collected by centrifugation (15 min, 17,000 g) 
and re-suspended in PBS. This solution was passed through a protein G aff in- 
ity column (Poros G, Perseptive Biosystems Inc. ) and bound antibody eluted 
with 3M potassium thiocyanate. The antibodies were dialyzed against PBS 
using 1 00-kD MWCO dialysis tubing (Spectrum), precipitated with 50% am- 
monium sulfate and resuspended in PBS saline. The resuspended antibodies 
were dialyzed against phosphate buffered saline using 300-kD MWCO dialy- 
sis tubing (Spectrum) and diluted to a concentration of 10 mg/ml before fil- 
tration though a 0.2 pm filter. This solution was aliquoted and stored at 
-20 C. Endotoxin contamination was measured by the chromogenic limulus 
amoebocyte lysate assay (Pierce, UK Ltd). Plant SIgA/G antibodies were puri- 
fied from mature plants. 
Non-specific bovine IgG was purified from whole milk by protein G 
affinity chromotography. This was added to a crude extract from wild- 
type plants that had been homogenized, filtered and prepared in the 
same way as the initial transgenic plant preparation. The initial solution 
contained bovine IgG at a concentration of 16 mg IgG/kg fresh plant ma- 
terial. The IgG was then recovered similarly to the Guy's 13 SIgA/G. The 
final preparation was at 10 mg/ml in PBS and sterilized by filtration 
through a 0.2 pm filter. No specific binding to either S. mutons cells or pu- 
rified SA I/11 could be detected by ELISA (result not shown). Aliquots were 
stored at -20 °C. 
SDS-PAGE and western blot. For SDS-PAGE, the purified SIgA/G prepara- 
tion samples were boiled for three minutes in 75mM Tris-HCI (pH 6.8), 2% 
SDS, separated on a 7.5% acrylamide gel and proteins were stained with Coomasie Blue. For western blot, unpurified plant extracts were prepared in 1M Tris-HCI (pH 8.45), 8% SDS, 8M urea, 20% glycerol and analyzed on a 5-18% Tris-Tricine gradient gel. The gel was blotted onto nitrocellulose and incubated (2 h, 37 °C) in PBS with 0.05% Tween-20 and 1% non-fat dry 
milk. Detection of individual lanes was with horseradish peroxidase conju- 
gated goat anti-mouse kappa chain, goat anti-mouse alpha chain, goat anti- 
mouse gamma chain antiserum (Southern Biotechnology Associates, Inc., 
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USA), rabbit anti-human I chain antiserum (donated by B. Corthesy) and 
sheep anti-rabbit SC antiserum (donated by B. Underdown) followed by 
horseradish peroxidase conjugated goat anti-rabbit IgG (H+L) or anti-sheep 
IgG (H+L) (Southern Biotechnology Associates, Inc., USA) respectively, as in- 
dicated. Bound antibodies were detected by chemiluminescence (ECL 
Amersham). 
Antibody affinity measurement. Antibody affinities were measured using 
the Biacore X system (Biacore AB, Sweden). Approximately 700 resonance 
units of streptococcal antigen (SA) 1/11 were immobilised on a CMS sensor 
chip (Biacore AB, Sweden) in 10 mM sodium acetate buffer pH 4. The bind- 
ing kinetics of the murine IgG and plant SIgA/G Guy's 13 were measured at 
concentrations of 50,62.5,75,87.5 and 100 nM at a flow rate of 10 
ml/min. After each binding measurement, the surface was regenerated 
with 100 mM HCI. 
Competition ELISA for estimation of antibody avidity. This assay was per- 
formed as described". Briefly, Immulon IV 96-well microplates (Dynatech), 
coated with SA I/II (2 µg/ml), were incubated with twofold serial dilutions of 
SA 1/II (1-100 nM) together with SIgA/G or IgG Guy's 13 (at 4.50 nM anti- 
body combining site). Detection of antibody binding to the solid-phase anti- 
gen was performed by incubation with a biotinylated rabbit anti-mouse IgA, 
G and M conjugate (Boehringer Mannheim, UK Ltd), followed by strepta- 
vidin-peroxidase conjugate (Boehringer Mannheim, UK Ltd., ) and tetram- 
ethylbenzydine dihydrochloride (TMB; Sigma UK Ltd. ). 
Detection of antibody survival In vivo. A single application of murine 
mAb Guy's 13 IgG, plant SlgA/G or BSA in PBS was administered to each of 
two volunteers. Thirty minutes following an oral prophylaxis with pumice 
and saline, 5 µl of each solution (10 mg/ml concentration) was applied to 
every tooth surface. Prefabricated impression trays were inserted and kept 
in place for five minutes and the subjects were requested not to eat, drink 
or rinse for 30 minutes. Otherwise no restrictions were placed on their diet 
or oral hygiene practice. At intervals of 0.5,1.5,6,24,48,72 and 144 
hours, samples of saliva were collected in addition to samples of plaque 
from four teeth-the latter were collected using cotton wool moistened 
with sterile saline and pumice-and immediately stored at -70 °C. Collection fluids were separated by centrifugation and assayed by an anti- 
gen specific ELISA. Microtitre plates were coated with purified SA 1/11 (2 
gg/ml) in TBS (150 mm NaCl, 20 mm Tris-HCI pH 8) and blocked with 5% 
non-fat dry milk in TBS at 37 °C for two hours. Saliva was diluted 1: 32 with 
sterile PBS. Oral samples were added in triplicate, in serial 2-fold dilutions 
to the microtitre plate; incubation was at 4 °C overnight. After washing 
with TBS with 0.05% Tween 20, either a goat anti-mouse ic chain anti- 
serum or a sheep anti-serum to rabbit secretory component was added for 
two hours at 37 °C. After further washing, an appropriate second layer al- 
kaline phosphatase conjugated antibody was applied for two hours at 37 °C. Antibody binding was detected with disodium p-nitrophenyl phos- 
phate (Sigma UK) and absorbance recorded at 405 nm. 
Microbiological sampling of human volunteers. Dental plaque samples were collected from the cervical and fissural surfaces of all central incisors and first molars as described°. Whole saliva was collected directly into sterile tubes cooled to 4 °C. Samples were plated in serial dilutions onto TYC agar (Lab M, UK) supplemented with 20% sucrose and 0.1 U/ml bacitracirt 
TYCSB plates and identified by their characteristic morphology and fermen- 
tation of specific sugars". Total anaerobic counts were determined on the blood agar plates. For determination of actinomyces, samples were plated 
onto CFAT mediump and incubated in 90% air/] 0% CO2 for three days. A. 
naeslundii was identified by its characteristic appearance and positive Gram 
stain. Pre-experimental levels of S. mutans and A. naeslundii were determined 
from three samples taken over an eight day period. 
Local passive immunization. Volunteers used 10 ml 0.2% chlorhexidine 
gluconate mouthwash (Corsodyl, Smithkline Beecham, UK) twice a day 
and had 1% chlorhexidine gel applied daily in stock gel application trays 
(Nupro, Johnson and Johnson, UK) for nine days. On the following day, 
30 minutes before the first application of mAb or control solution, teeth 
were professionally cleaned and an aliquot of 5 pi was then applied to all 
surfaces of each tooth using a Gilson Pipetman. Custom made silicone im- 
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pression trays (Optosil and Xantopren, Bayer Dental, UK) were insert 
for five minutes to prevent washing away or dilution by sali% 
Subsequent treatments were performed without prior cleaning of tl 
teeth. In all, six applications were carried out on days 1,4,8,11,15 ai 
18. 
Serum antibody reactivity to plant SIgA/G preparation. Serum sampl 
were collected before the experiment and one month after the last applic 
tion of topical test solution. For IgG the serum was diluted 1/50 in TBS ar 
for IgA and IgM the dilution was 1/25. These were applied in triplicate 
EUSA plates that had been coated with the SIgA/G preparation in TBS (at 
previously determined optimal concentration of 2 µg/ml) and blocked wi 
5% non-fat dry milk in TBS. Incubation was at 37 °C for two hours. Aft 
washing with TBS with 0.05% Tween 20, bound immunoglobulins were I 
belled using alkaline phosphatase conjugated goat anti-sera to human Igl 
M or A (Sigma UK) for two hours at 37 °C. After further washing, detectic 
was with disodium p-nitrophenyl phosphate (Sigma UK). Absorbance w, 
determined at 405 nm. 
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Four transgenic Nicotiana tabacum plants were generated that expressed a murine mono- 
clonal antibody kappa chain, a hybrid immunoglobulin A-G heavy chain, a murine joining 
chain, and a rabbit secretory component, respectively. Successive sexual crosses between 
these plants and filial recombinants resulted in plants that expressed all four protein chains 
simultaneously. These chains were assembled into a functional, high molecular weight 
secretory immunoglobulin that recognized the native streptococcal antigen I/II cell surface 
adhesion molecule. In plants, single cells are able to assemble secretory antibodies, 
whereas two different cell types are required in mammals. Transgenic plants may be 
suitable for large-scale production of recombinant secretory immunoglobulin A for passive 
mucosal immunotherapy. Plant cells also possess the requisite mechanisms for assembly 
and expression of other complex recombinant protein molecules. 
Secretory immunoglobulin A (SIgA) is the 
most abundant form of immunoglobulin 
(Ig) in mucosal secretions, where it forms 
part of the first line of defense against in- 
fectious agents. The molecule exists mainly 
in the 1IS dimeric form, in which two 
monomeric IgA antibody units are associat- 
ed with the small polypeptide joining (J) 
chain and with a fourth polypeptide, secre- 
tory component (SC). The ability to pro- 
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duce monoclonal SIgA would be of substan- 
tial value, but the synthesis is complicated 
because it requires plasma cells secreting 
dimeric IgA (dIgA) as well as epithelial 
cells expressing the polymeric Ig receptor 
(pIgR). Normally, plgR on the epithelial 
basolateral surface binds dIgA, initiating a 
process of endocytosis, transcytosis, phos- 
phorylation, proteolysis, and ultimate re- 
lease of the SIgA complex at the apical 
surface into the secretion (1). Here, we 
focused on the ability of transgenic plants 
to assemble secretory antibodies. 
Genes encoding the heavy and light 
chains of a murine antibody (Guy's 13), a 
murine J chain, and a rabbit SC were intro- 
duced into separate transgenic tobacco 
plants. Guy's 13 is a murine IgGI monoclo- 
nal antibody (mAb) that recognizes the 
streptococcal antigen (SA) 1/Il cell surface 
adhesion molecule of Streptococcus mutartss 
and S. sobrinus (2). Transgenic full-length 
Guy's 13 has been generated in N. tabacum 
plants and was found to be correctly assem- 
bled (3). Modification of the heavy chain by 
replacement of its Cy3 domain with CO 
and CO domains from an IgA-secreting hy- 
bridoma (MOPC 315) did not affect the 
assembly or function of the antibody (IgA- 
G) produced in transgenic plants (3). Pro- 
tein immunoblot analysis (4) of the IgA-G 
plant extract with antiserum to the K light 
chain under nonreducing conditions showed 
a band of -210 kD, which is consistent with 
the presence of the extra constant region 
domains in the IgA-G antibody construct as 
compared with the original IgGI antibody 
(Fig. IA, lanes 1 and 3). A number of small- 
er proteolytic fragments were also detected, 
which is consistent with previous findings 
(3). A mouse J chain construct that consist- 
ed of coding-length complementary DNA 
(cDNA) was amplified with synthetic oligo- 
nucleotide primers corresponding to the 
NH2-terminal MKTHLL and the COOH- 
terminal SCYPD sequences of the mouse J 
chain (5). The SC construct used in this 
study consisted of coding-length cDNA am- 
plified with synthetic oligonucleotide prim- 
ers corresponding to the NH2-terminal 
MALFLL sequence and the AVQSAE se- 
quence near the COOH-terminus of rabbit 
pIgR (6). Transgenic plants were then regen- 
erated (7). 
The plants that expressed the J chain 
were crossed with those expressing IgA-G. 
The progeny showed a second major Ig band 
at -400 kD, approximately twice the rela- 
tive molecular mass of the IgA-G molecule 
(Fig. IA, lane 4), which suggested that a 
dimeric antibody (dlgA-G) had been assem- 
bled. Mature plants that expressed dIgA-G 
were crossed with a homozygous plant that 
expressed SC. The progeny plants (SIgA-G) 
included those that produced a higher mo- 
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lecular mass hand of -470 kD in protein 
immunohlot analysis under nonreducing 
conditions (Fig. IA, lane 5); such a molec- 
ular size is consistent with that expected for 
a secretory Ig. Detection with antiserum to 
SC confirmed that this high molecular mass 
protein contained SC (Fig. IA, lane 7). The 
plant extracts also contained the 400-ki) 
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Fig. 1. (A) Protein immunoblot of plant extracts 
prepared under nonreducing conditions, detected 
with antisera to the mouse K light chain (lanes 1 to 
6) or to rabbit SC (24) (lanes 7 to 10). Samples 
were prepared (4) and separated on 4% SDS- 
polyacrylamide electrophoresis gel (SDS-PAGE). 
(B) Protein immunoblot of plant extracts prepared 
under reducing conditions. Samples were pre- 
pared as in (4), but with the addition of 5% ß-mer- 
captoethanol. SDS-PAGE in 10% acrylamide was 
performed and the gels were blotted as before. 
Detection was with antisera to the mousey l heavy 
chain (upper panel), the mouse K light chain (mid- 
dle panel), or rabbit SC (lower panel), followed by 
the appropriate second-layer alkaline phospha- 
tase-conjugated antibody. IgG, Guy's 13 mAb (2) 
prepared in hybridoma cell culture supernatant; 
WT, nontransformed wild-type plant; IgA-G, trans- 
genic plant expressing modified heavy and light 
chain genes of Guy's 13; dIgA-G, transgenic plant 
expressing modified heavy and light chain genes of 
Guy's 13 and the J chain; SIgA-G, transgenic plant 
expressing modified heavy and light chain genes of 
Guy's 13, the J chain, and SC; SC, transgenic 
plant expressing SC; and J, transgenic plant ex- 
pressing the J chain. Molecular masses are indi- 
cated in kilodaltons. 
haind 011,, A-ti) and the 210-kI) hand (lgA- 
0), but these were detected only by antiser- 
um to the K light chain and not by antiser- 
um to SC. In the transgenic plant that se- 
creted SC alone, no high molecular mass 
proteins were detected in protein immuno- 
blotting under nonreducing conditions (Fig. 
IA, lane 9), and hence there was no evi- 
dence that SC assembled with endogenous 
plant proteins or formed multimers. 
Further protein immunoblot analysis un- 
der reducing conditions demonstrated that 
extracts from the plants that expressed anti- 
bodies (IgA-G, dlgA-G, and SIgA-G), but 
not those that expressed the J chain or SC, 
contained identical antibody heavy and light 
chains (Fig. lß, upper and middle panels). 
Only the SC and SIgA-G plants expressed 
proteins that were recognized by antiserum 
to SC (lower panel). The dissociation of SC 
from Ig heavy chains only under reducing 
conditions suggests that the SC chain was at 
least partially covalently linked in the assem- 
bled SIgA-G molecule. The molecular mass 
of the major SC hand under reducing con- 
ditions is -50 kD, which is lower than ex- 
pected (66.5 kD). This is probably a result of 
proteolysis, which may occur in the intact 
plant or during sample preparation. SC 
hound to dimeric IgA is often found proteo- 
lyzed to smaller but biologically active forms 
in vivo (8). However, in the protein immu- 
noblot analysis under nonreducing condi- 
tions, the molecular mass difference between 
dIgA-G and SIgA-G was --70 kD, as expect- 
ed (Fig. IA). No cross-reacting proteins were 
detected in extracts from the wild-type con- 
trol plant. 
In mammals, the assembly of SC with 
antibody requires the presence of the J chain 
(9); we next investigated whether this was 
also the case in plants. Plants expressing 
Fig. 2. Coexpression of yo IgA-G with SC. Protein Sf v QP immunoblotting of trans- A 
genic plant extract (4) 
was performed (A) under 482_ 
nonreducing conditions 392- 
on 4% SDS-PAGE and 
detected with goat anti- 
serum to the K light 
292- 
chain, followed by alka- 
line phosphatase-label- 
ed rabbit antiserum to 
goat IgG, and (B; under d 
reducing conditions on 
95- 
10% SDS-PAGE and de- B 
tected with sheep anti- 66- 
serum to SC, followed by 55- 
alkaline phosphatase-la- 
beled donkey antiserum ao 
to sheep IgG. IgA-G-SC, 31- transgenic plant express- 
ing modified heavy and 22- wMr 
light chain genes of Guy's 
13 and SC. 
1234 
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monomeric lggA-G were crossed with St'- 
expressing plants. In the progeny, only the 
210-kD monomeric form of the antibody way 
recognized by antiserum to the K light chain 
(Fig. 2A, lanes 1 and 2); antiserum to SC 
recognized free SC but did not recogni_e 
proteins associated with Ig (Fig. 2B). This 
result was confirmed in all 10 plants exam- 
ined, whereas all 10 plants that coexpressed 
the J chain, the antibody chains, and SC 
assembled the 470-kD SIgA-G molecule. 
This finding confirms the requirement of the 
J chain for SC association with Ig and sug- 
gests that the nature of the association in 
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Fig. 3. Functional antibody expression in trans- 
genic N. tabacum, as measured by absorbance at 
405 nm (A405). (A) Plant extract binding to purified 
SA I/II, detected with HRP-labeled antiserum to 
the K light chain. (B) Plant extract binding to purl 
fied SA I/II, detected with sheep antiserum to SC 
followed by alkaline phosphatase-labeled donkey 
antiserum to sheep Ig. (C) Plant extract binding to 
streptococcal cells, detected with sheep antiser- 
um to SC followed by alkaline phosphatase-la- 
beled donkey antiserum to sheep Ig. Guy's 13 
hybridoma cell culture supernatant (IgG) was used 
as a positive control. The initial concentration of 
each antibody solution was 5µg/ml. Dilution 
numbers represent serial double dilutions. Results 
are mean ± SD of three separate triplicate exper- 
iments. U, SlgA-G; ", dlgA-G; A, IgA-G; O, SC; 
U, J; A, WT; and V, Guy's 13. 
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Functional antibody studies were carried 
out with the five plant constructs by enzyme- 
linked immunosorhent assay (ELISA) (Fig. 
3) (10). All plants expressing antibody light 
and heavy chains assembled functional anti- 
bodies that specifically recognized SA I/II 
(Fig. 3A). The levels of binding and titration 
curves were similar to those of the native 
mouse hybridoma cell supernatant. No SA 
1/II binding was detected with wild-type 
plants or with plants expressing the J chain 
or SC. The binding of antibody to immuhi- 
lized purified SA or native antigen on the 
bacterial cell surface was also detected with 
antiserum to SC (Fig. 3, B and Q. In these 
assays, only the SIgA-G plant antibody bind- 
ing was detected and not the functional an- 
tibodies in the IgA-G or r11gA-G plants. 
These results confirm that SC was assembled 
with antibody in the SIgA-G plant but did 
not interfere with antigen recognition or 
binding. 
The assembly of functional Ig molecules 
in plants is very efficient (I I ). Initial esti- 
mates for the plants expressing SIgA-G sug- 
gest that approximately 50% of the SC is 
associated with dimeric lgA-G in the plant 
extracts (12). Preliminary results indicate 
that the SIKA-G yield from fully expanded 
leaf lamina is 200 to 500 ig per gram of fresh 
weight material. This yield is considerably 
greater than that determined for monomeric 
lgA-G and is consistent with the suggestion 
that SIgA-G might be more resistant to pro- 
teolysis. 
Here, the fidelity of plant assembly has 
Fig. 4. Photomicrographs IF AB 
of transgenic SIgA-G and E 
control N. tabacum leaf 
tissue with immunogold (" i 1T" 
Vb 
1\ 
, detection of munne « 1A chain or rabbit SC (16). (A) t ýý>;. {"..: `S,. %' . 
Phase contrast view of ` '` %: ý, ýT c 
-" 
SIgA-G leaf in cross sec lü. ý" 
tion. (B) Bright field view of 
the same leaf cross sec - ýýL j"j ýt.,, M tion as (A), showing immu- v 
nogold localization of anti- 
body heavy chain. Immu- CJD 
nolocalization of SC on a 
section serial to that pre- 
sented in (A) and (B) 
showed the same cellular 
localization as for antibody i"r,. fir ,;, ."': 
tv "- ,. heavy chain (12). (C) .. r. -. " f_-_,... , 
Phase contrast view of a 
control leaf cross section 
from a transgenic plant 
that did not contain any Ig 
coding sequences. (D) 
E'`Z. ' Bright field view of the 
flf 
,ý, F ,j 
same leaf cross section as 
(C), showing the absence 
of immunogold localization 
of antibody heavy chain. 
(E) Phase contrast illumi- 
B 
x`ý B 
nation of a minor vascular x 
bundle [framed area of (A)]. 
(F) Bright field illumination -ý- "' sxer , 'A of the same field as (E), B 
showing immunogold lo- M 
calization (black) of SC. (G) --- 
Bright field illumination of 
ALP_ 
4a 
serial leaf cross section ý, S 
of the vascular bundle, Ir@ s, r ýa demonstrating the same -- immunogold localization 
(black) of antibody heavy G'c. H 
chain as that shown in 
(F). (H) Bright field illumina- 
tion of a control leaf vascu- } 
lar bundle in cross section, 
showing absence of im- !, ' 
munogold localization of ~ ". 
f) ý" /'f 
antibody heavy chain. A 
control leaf section was .. 
/! 
- 
also incubated with the 
gold-labeled secondary 
antibodies alone, and no .. " --s ,.. " 
ýº 
binding was observed (M 4' 
(12). M, spongy mesophyll - 
cells; E, epidermal cells; S, 
intercellular spaces; P, 
palisade parenchyma cells; Vb, vascular bundles; X, xylem tracheids; and B, bundle sheath cells. Scale bars: 100 µrn (A through D), 10 µm (E through H) 
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been extended to include dimerization of 
monomeric antibody by the J chain. Coex- 
pression of recombinant IgA with the J 
chain through the use of baculovirus in 
insect cells has been reported (13); howev- 
er, only a small proportion of the expressed 
antibody was dimerized, and most remained 
in a monomeric form. By contrast, in plants 
the dimeric antibody population represents 
a major proportion (-57%) of the total 
antibody (Fig. 1A, lane 4). This is also the first report of an assembled secretory anti- body (SIgA-G) that binds as well to the 
corresponding antigen as does the parent 
mAb and constitutes a major proportion of 
the total assembled antibody (-45%; Fig. 
IA, lane 5). Protein immunoblot analysis 
potentially underestimates the total extent 
of assembly of SIgA-G because it only de- 
tects antibody that is covalently linked to 
SC, whereas SIgA can occur in vivo as a 
mixture of covalently and noncovalently 
linked molecules (14). 
The four transgenes for SIgA-G were in- 
troduced into plants with the identical 
pMON530 expression cassette, native leader 
sequences, and a promoter sequence derived 
from the 35S transcript of the cauliflower 
mosaic virus, which directs expression of 
transgenes in a variety of cell types of most 
plant organs (15). The use of the same pro- 
moter for all four transgenes maximized the 
likelihood of coincidental expression in a 
common plant cell. Microscopic observation 
of SIgA-G plants (16) revealed that many 
cell types of the leaves contained SIgA-G 
components (Fig. 4, A and B). The predom- 
inant accumulation of these proteins was in 
the highly vacuolated cells of the mesophyll, 
particularly in bundle sheath cells; the cyto- 
plasmic band surrounding the large central 
vacuole was strongly labeled (Fig. 4, F and G). At the level of light microscopy, it is not 
possible to distinguish between antigens that 
are cytoplasmic and those that are contained 
in the luminal apoplastic space between the 
cell wall and the Plasmalemma, but it is 
evident that the recombinant antibody com- 
ponents do not penetrate the cell wall. 
Restriction of the largest SIgA-G com- 
ponents, SC and heavy chain, within the 
confines of the protoplastic or apoplastic 
compartments of individual cells would 
constrain the assembly of SIg to single cells. 
In contrast, two cell types are required to 
produce SIgA in mammals. In the plant 
system, a mature SC devoid of signals for 
membrane integration, transcytosis, or sub- 
sequent proteolysis can thus be assembled 
with a hybrid Ig containing a domains 
within the secretory pathway of the cell. 
Assembly of monomeric antibody is known 
to require the targeting of both light and heavy chains to the endoplasmic reticulum (ER) (17). Thus SIgA-G assembly might 
occur at two sites: either in the ER, after 
dimerization with the J chain, or in the 
extracellular apoplasm, where the secreted 
antibody is accumulated. 
The inherent functions of IgG-constant 
regions, that is, protein A binding, comple- 
ment fixation, and the ability to bind to 
specific cell surface receptors (Fc receptors), 
may be retained in a dimeric Ig that is 
capable of binding SC. These additional 
properties of SIgA-G may enhance the 
function of the complex in passive immu- 
notherapy, although under some circum- 
stances these biological properties might be 
undesirable. In principle it should not be 
difficult to produce a SIgA-G antibody that 
lacks the Cy2 domain in these cases. 
The development of plants capable of 
generating functional SIgA may have signif- 
icant implications for passive immunothera- 
py. Previously, SIgA has been generated only 
with difficulty, by in vitro conjugation of SC 
with dimeric IgA (18) or by the insertion of 
subcutaneous "backpack" tumors of hybrid- 
oma cells secreting monoclonal IgA (19). 
The plants express SIgA in large amounts, 
and the production can be scaled up to ag- 
ricultural proportions. This method offers an 
economic means of producing large quanti- 
ties of mAbs that could be applied to muco- 
sal surfaces to prevent infection, as has been 
demonstrated in passive immunotherapy 
against streptococci (20). Multivalent anti- 
bodies might be more protective than IgG at 
mucosal surfaces (21), and SC may also have 
postsecretory functions in stabilizing the 
polymeric antibody against proteolysis (22). 
The principle of sexual crossing of transgenic 
plants to accumulate recombinant subunits 
can readily be applied to the assembly of a 
variety of Ig as well as other complex protein 
molecules. 
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